(43918,43918,1,'Leadership: Dawn Terashita & Zachary Rubin, Los Angeles County Department of Public Health on the Future of HAI/AR Response in the Face of COVID-19','leadership-dawn-terashita-zachary-rubin-los-angeles-county-department-of-public-health-on-the-future-of-hai-ar-response-in-the-face-of-covid-19','news/leadership-dawn-terashita-zachary-rubin-los-angeles-county-department-of-public-health-on-the-future-of-hai-ar-response-in-the-face-of-covid-19','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>COVID-19 has impacted healthcare-associated infections and antimicrobial-resistant (HAI/AR) threats across all healthcare settings. Los Angeles County saw an increase in HAIs, such as central line bloodstream infections (CLABSI) as a result of many facilities changing their CLABSI prevention efforts to accommodate the challenges of caring for COVID-19 patients. Additionally, Los Angeles County saw an increase of multidrug-resistant organisms (MDROs), such as <i>Candida auris</i>, due to personal protective equipment (PPE) practices being altered early in the pandemic due to severe shortages. Despite the difficulties brought on by COVID-19, awareness of infection prevention efforts has improved over the last two years, especially in nursing homes.  </p><p>The Covid-19 pandemic has had both negative and positive impacts on infection prevention in healthcare. The negative impacts, such as PPE shortages, staffing shortages, facility crowding, frequent moving of patients throughout the facilities due to COVID-related cohorting, and lack of focus on identifying and containing MDROs, contributed to increased MDRO spread. The positive impacts include new legislative actions, increased funding, and building stronger relationships and partnerships to support infection prevention efforts across the healthcare community. California introduced a new state law requiring all nursing homes to employ a full-time infection preventionist (IP). Funding opportunities from the Centers for Disease Control and Prevention (CDC) at the local and state level have helped to improve infection control and has provided some much-needed resources for nursing homes and other long-term care facilities. Increased funding, stakeholder engagement, and requirements for infection preventionists have helped shaped the backbone for an unprecedented future educational program centered on infection prevention within nursing homes.  </p><p>There are many insights that we have gained while leading the Healthcare Outreach Unit at the Los Angeles County Department of Public Health that can help improve HAI/AR response. We believe that stakeholder engagement is a key to success for health departments. Programs rolled-out by public health departments should be developed in conjunction with stakeholders and should address the concerns that these stakeholders bring to the table. As an example, to support nursing homes, we have hired two geriatricians and nurses with experience working in this setting, who understand many of the concerns and constraints present in these facilities, and already have relationships in the field. We have learned that you should not underestimate the importance of giving each nursing home a specific public health nurse to work with and build rapport. We have also strengthened our ties with the leadership in individual nursing homes and with the nursing homes operators, which helps to improve stakeholder buy-in and input. We plan to use the engagement and trust that we have developed over the last two years to elevate infection prevention across all nursing homes through standardized template policies and training, instead of allowing each facility to develop their IP program unilaterally, which is what many facilities have done in the past with mixed success. </p><p>Overall, we believe the future of HAI/AR response success is dependent on the ability to adapt and remain flexible while refocusing activities beyond COVID-19. The <a href=\\\"https://www.corha.org/\\\">Council for Outbreak Response: Healthcare-Associated Infections and Antimicrobial-Resistant Pathogen (CORHA)</a> plays a vital role in improving practices and policies at the local, state, and national levels regarding HAI/AR outbreaks across the healthcare continuum. We hope that through sharing our experience we can help promote CORHA’s mission to improve practices and policies for the detection, investigation, control, and prevention of HAI/AR outbreaks, with other local health departments and healthcare facilities. </p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Dawn Terashita, MD, MPH, FACPM & Zachary Rubin, MD\"}',1,'2024-07-21 22:11:19','2024-07-21 22:11:19','727f601b-655f-4cff-9cdc-47c6268c6090'),(43919,43919,1,NULL,'__temp_glokdkqjzvpcjpsqtzwphdmpqolnqfzelekg',NULL,NULL,1,'2024-07-21 22:11:19','2024-07-21 22:11:19','8405e905-7f54-40bc-9050-bc4b266082a8'),(43921,43921,1,'Zachary Rubin',NULL,NULL,NULL,1,'2024-07-21 22:14:45','2024-07-21 22:14:45','2e8be9bd-e815-42e5-938b-219cb7568e75'),(43922,43922,1,'Leadership: Dawn Terashita & Zachary Rubin, Los Angeles County Department of Public Health on the Future of HAI/AR Response in the Face of COVID-19','leadership-dawn-terashita-zachary-rubin-los-angeles-county-department-of-public-health-on-the-future-of-hai-ar-response-in-the-face-of-covid-19','news/leadership-dawn-terashita-zachary-rubin-los-angeles-county-department-of-public-health-on-the-future-of-hai-ar-response-in-the-face-of-covid-19','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>COVID-19 has impacted healthcare-associated infections and antimicrobial-resistant (HAI/AR) threats across all healthcare settings. Los Angeles County saw an increase in HAIs, such as central line bloodstream infections (CLABSI) as a result of many facilities changing their CLABSI prevention efforts to accommodate the challenges of caring for COVID-19 patients. Additionally, Los Angeles County saw an increase of multidrug-resistant organisms (MDROs), such as <i>Candida auris</i>, due to personal protective equipment (PPE) practices being altered early in the pandemic due to severe shortages. Despite the difficulties brought on by COVID-19, awareness of infection prevention efforts has improved over the last two years, especially in nursing homes.  </p><p>The Covid-19 pandemic has had both negative and positive impacts on infection prevention in healthcare. The negative impacts, such as PPE shortages, staffing shortages, facility crowding, frequent moving of patients throughout the facilities due to COVID-related cohorting, and lack of focus on identifying and containing MDROs, contributed to increased MDRO spread. The positive impacts include new legislative actions, increased funding, and building stronger relationships and partnerships to support infection prevention efforts across the healthcare community. California introduced a new state law requiring all nursing homes to employ a full-time infection preventionist (IP). Funding opportunities from the Centers for Disease Control and Prevention (CDC) at the local and state level have helped to improve infection control and has provided some much-needed resources for nursing homes and other long-term care facilities. Increased funding, stakeholder engagement, and requirements for infection preventionists have helped shaped the backbone for an unprecedented future educational program centered on infection prevention within nursing homes.  </p><p>There are many insights that we have gained while leading the Healthcare Outreach Unit at the Los Angeles County Department of Public Health that can help improve HAI/AR response. We believe that stakeholder engagement is a key to success for health departments. Programs rolled-out by public health departments should be developed in conjunction with stakeholders and should address the concerns that these stakeholders bring to the table. As an example, to support nursing homes, we have hired two geriatricians and nurses with experience working in this setting, who understand many of the concerns and constraints present in these facilities, and already have relationships in the field. We have learned that you should not underestimate the importance of giving each nursing home a specific public health nurse to work with and build rapport. We have also strengthened our ties with the leadership in individual nursing homes and with the nursing homes operators, which helps to improve stakeholder buy-in and input. We plan to use the engagement and trust that we have developed over the last two years to elevate infection prevention across all nursing homes through standardized template policies and training, instead of allowing each facility to develop their IP program unilaterally, which is what many facilities have done in the past with mixed success. </p><p>Overall, we believe the future of HAI/AR response success is dependent on the ability to adapt and remain flexible while refocusing activities beyond COVID-19. The <a href=\\\"https://www.corha.org/\\\">Council for Outbreak Response: Healthcare-Associated Infections and Antimicrobial-Resistant Pathogen (CORHA)</a> plays a vital role in improving practices and policies at the local, state, and national levels regarding HAI/AR outbreaks across the healthcare continuum. We hope that through sharing our experience we can help promote CORHA’s mission to improve practices and policies for the detection, investigation, control, and prevention of HAI/AR outbreaks, with other local health departments and healthcare facilities. </p><figure class=\\\"image\\\"><img src=\\\"{asset:43897:transform:medium||/assets/images/transf/_medium/43897/Capture.webp}\\\" width=\\\"300\\\" height=\\\"395\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Dawn Terashita</p><figure class=\\\"image\\\"><img src=\\\"{asset:43921:transform:medium||https://corha.org/admin/actions/assets/generate-transform}?transformId=339\\\" width=\\\"300\\\" height=\\\"300\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Zachary Rubin</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Dawn Terashita, MD, MPH, FACPM & Zachary Rubin, MD\"}',1,'2024-07-21 22:15:25','2024-07-21 22:15:25','4cc0d6c3-3016-4f74-8b39-2db271c71344'),(43923,43923,1,'Leadership: New CDC Funding Recognizes Healthcare Outbreak Response Needs','leadership-new-cdc-funding-recognizes-healthcare-outbreak-response-needs','news/leadership-new-cdc-funding-recognizes-healthcare-outbreak-response-needs','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>The Biden-Harris Administration and CDC recently announced a $2.1 billion investment as part of the American Rescue Plan (ARP), to improve infection prevention and control activities across the U.S. public health and healthcare sectors. Health departments received $885 million of this total in late October 2021 to support this work. CORHA interviewed Dr. Joe Perz, our lead representative from CDC and a Governance Committee member, to learn more about the funding.</p><h2><i>What is the new funding we’ve been hearing about?</i></h2><p>The initial funding is divided between two projects that are managed under a <a href=\\\"https://www.cdc.gov/ncezid/dpei/epidemiology-laboratory-capacity.html\\\" target=\\\"_blank\\\" rel=\\\"noreferrer noopener\\\">CDC cooperative agreement with health departments</a>. One of these is the <a href=\\\"https://www.cdc.gov/ncezid/dpei/pdf/guidance-nursing-home-ltc-facility-strike-team-and-infastructure-508.pdf\\\" target=\\\"_blank\\\" rel=\\\"noreferrer noopener\\\">Nursing Home &amp; Long-term Care Facility Strike Team and Infrastructure Project</a> which totals $500 million. The other is the <a href=\\\"https://www.cdc.gov/ncezid/dpei/pdf/guidance-strengthening-haiar-program-capicity-508.pdf\\\" target=\\\"_blank\\\" rel=\\\"noreferrer noopener\\\">Strengthening HAI/AR Program (SHARP) Capacity Project</a> which totals $385 million.</p><h2><i>How is healthcare outbreak response reflected in the new funding?</i></h2><p>Healthcare outbreak response is clearly recognized as a core function and essential need in both new funding opportunities, which cover the response continuum beginning with outbreak detection and extending to on-site investigation as well as longer-term follow-up activities to prevent a recurrence.</p><h2><i>Can you unpack that a bit, in relation to the Nursing Home &amp; Long-term Care Project?</i></h2><p>Sure, the <a href=\\\"https://www.cdc.gov/ncezid/dpei/pdf/guidance-nursing-home-ltc-facility-strike-team-and-infastructure-508.pdf\\\" target=\\\"_blank\\\" rel=\\\"noreferrer noopener\\\">LTC Project Guidance</a> includes a directive to support nursing homes – and other types of long-term care facilities – with COVID-19 outbreak response. That’s the primary motivation, and the funding can be used to support the rapid reactive activities – like testing, cohorting, infection control auditing, and even supplemental staffing – when SARS-CoV-2 has entered a facility and transmission is ramping up.</p><p>The allowable activities also support more proactive measures, like helping equip facilities with technology for infection tracking and reporting or communication with health department partners. In addition, we are supportive of creative approaches for staff recruitment, development, and retention.</p><p>The overall aim here is to build infection prevention infrastructure and achieve a greater quality of care. In other words, greater resilience to SARS-CoV-2 and outbreaks more generally. Susceptibility to the rapid spread of infections is something that nursing homes really must guard against, given the congregate and residential nature of long-term care.</p><h2><i>And what about the SHARP Project?</i></h2><p>Same spirit, spread farther. The SHARP funds are intended to enhance health department HAI/AR (healthcare associated infections/antimicrobial resistance) Program activities across all healthcare settings, not limited to long-term care. The <a href=\\\"https://www.cdc.gov/ncezid/dpei/pdf/guidance-strengthening-haiar-program-capicity-508.pdf\\\" target=\\\"_blank\\\" rel=\\\"noreferrer noopener\\\">SHARP project guidance</a> reflects the central challenge that CORHA was originally founded on, which was the need to build capacity for public health and healthcare to improve outbreak detection, response and prevention. This requires close collaboration and relationship building between public health professionals and healthcare providers, which has been growing steadily but could really blossom now with these ARP-supported investments.</p><p>Outbreak detection should improve thanks to SHARP activities related to both the AR Lab Network and National Healthcare Safety Network (NHSN). These will enhance surveillance for drug-resistant pathogens and HAIs, providing data for action. Likewise, outbreak investigation should benefit from additional staffing and increased engagement with healthcare partners.</p><p>SHARP encourages health departments to build HAI/AR prevention and response capacity throughout their jurisdictions, such as expanded use of local and regional approaches to address HAI/AR threats and controlling the spread of resistant pathogens. The guidance describes requirements for funded HAI/AR programs to establish a lead position to coordinate and oversee HAI response activities and to train staff in outbreak response.</p><h2><i>Advice for CORHA and its member organizations?</i></h2><p>Yes, let’s lean into this opportunity. CORHA is identified as a key source for healthcare outbreak training resources. It would be great to see increased activities in that realm, including collaboration with CORHA’s member organizations to improve and expand our collective offerings.</p><p>Both of the new projects emphasize direct engagement with individual facilities. The SHARP project references activities such as medical product investigations, targeted AR threats, molecular testing methods, patient notification, and many other aspects of healthcare outbreak response. These all represent opportunities for CORHA’s workgroups and member organizations to take our work to the next level.</p><figure class=\\\"image\\\"><img src=\\\"{asset:43928:transform:medium||/assets/images/transf/_medium/43928/Joseph-Perz-300x241-2.webp}\\\" alt=\\\"Joseph Perz Headshot\\\" width=\\\"300\\\" height=\\\"241\\\" /></figure><p><i>                                                                                      Joseph Perz</i></p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Joseph Perz, DrPH, MA\", \"ccabfff6-2908-407e-98d3-a22686d82840\": {\"score\": \"poor\", \"social\": {\"twitter\": {\"title\": \"Leadership: New CDC Funding Recognizes Healthcare Outbreak Response Needs - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"New CDC funding recognizes the pressing needs for effective healthcare outbreak response in the wake of public health challenges.\"}, \"facebook\": {\"title\": \"Leadership: New CDC Funding Recognizes Healthcare Outbreak Response Needs - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"New CDC funding recognizes the pressing needs for effective healthcare outbreak response in the wake of public health challenges.\"}}, \"advanced\": {\"robots\": [], \"canonical\": \"\"}, \"keywords\": [{\"rating\": \"poor\", \"keyword\": \"Health challenges\"}, {\"rating\": \"poor\", \"keyword\": \"compliance regulation\"}, {\"rating\": \"poor\", \"keyword\": \"health care system\"}, {\"rating\": \"poor\", \"keyword\": \"governing entity\"}, {\"rating\": \"good\", \"keyword\": \"CDC\"}, {\"rating\": \"poor\", \"keyword\": \"leadership\"}], \"titleRaw\": {\"1\": \"Leadership: New CDC Funding Recognizes Healthcare Outbreak Response Needs\"}, \"descriptionRaw\": \"New CDC funding recognizes the pressing needs for effective healthcare outbreak response in the wake of public health challenges.\"}, \"dd06f1a1-3c4f-4001-adc3-f3c0a94550ac\": [1558], \"f88904a1-7870-468f-8885-f14ce93db364\": []}',1,'2024-07-21 22:18:12','2024-12-03 20:19:40','4d65d717-fccf-4e4a-adbd-6dc04053da01'),(43924,43924,1,NULL,'__temp_bhoaqpcwliheoxdoefccuqomhlidlzrakdlm',NULL,'{\"b691f1c7-ad7d-4a8b-a9fa-b4feec58e073\": []}',1,'2024-07-21 22:18:15','2024-08-08 16:39:54','5ba1b875-287a-468b-b965-82a3a4d7f327'),(43925,43925,1,'Leadership: New CDC Funding Recognizes Healthcare Outbreak Response Needs','leadership-new-cdc-funding-recognizes-healthcare-outbreak-response-needs','news/leadership-new-cdc-funding-recognizes-healthcare-outbreak-response-needs','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>The Biden-Harris Administration and CDC recently announced a $2.1 billion investment as part of the American Rescue Plan (ARP), to improve infection prevention and control activities across the U.S. public health and healthcare sectors. Health departments received $885 million of this total in late October 2021 to support this work. CORHA interviewed Dr. Joe Perz, our lead representative from CDC and a Governance Committee member, to learn more about the funding.</p><h2><i>What is the new funding we’ve been hearing about?</i></h2><p>The initial funding is divided between two projects that are managed under a <a href=\\\"https://www.cdc.gov/ncezid/dpei/epidemiology-laboratory-capacity.html\\\">CDC cooperative agreement with health departments</a>. One of these is the <a href=\\\"https://www.cdc.gov/ncezid/dpei/pdf/guidance-nursing-home-ltc-facility-strike-team-and-infastructure-508.pdf\\\">Nursing Home &amp; Long-term Care Facility Strike Team and Infrastructure Project</a> which totals $500 million. The other is the <a href=\\\"https://www.cdc.gov/ncezid/dpei/pdf/guidance-strengthening-haiar-program-capicity-508.pdf\\\">Strengthening HAI/AR Program (SHARP) Capacity Project</a> which totals $385 million.</p><h2><i>How is healthcare outbreak response reflected in the new funding?</i></h2><p>Healthcare outbreak response is clearly recognized as a core function and essential need in both new funding opportunities, which cover the response continuum beginning with outbreak detection and extending to on-site investigation as well as longer-term follow-up activities to prevent a recurrence.</p><h2><i>Can you unpack that a bit, in relation to the Nursing Home &amp; Long-term Care Project?</i></h2><p>Sure, the <a href=\\\"https://www.cdc.gov/ncezid/dpei/pdf/guidance-nursing-home-ltc-facility-strike-team-and-infastructure-508.pdf\\\">LTC Project Guidance</a> includes a directive to support nursing homes – and other types of long-term care facilities – with COVID-19 outbreak response. That’s the primary motivation, and the funding can be used to support the rapid reactive activities – like testing, cohorting, infection control auditing, and even supplemental staffing – when SARS-CoV-2 has entered a facility and transmission is ramping up.</p><p>The allowable activities also support more proactive measures, like helping equip facilities with technology for infection tracking and reporting or communication with health department partners. In addition, we are supportive of creative approaches for staff recruitment, development, and retention.</p><p>The overall aim here is to build infection prevention infrastructure and achieve a greater quality of care. In other words, greater resilience to SARS-CoV-2 and outbreaks more generally. Susceptibility to the rapid spread of infections is something that nursing homes really must guard against, given the congregate and residential nature of long-term care.</p><h2><i>And what about the SHARP Project?</i></h2><p>Same spirit, spread farther. The SHARP funds are intended to enhance health department HAI/AR (healthcare associated infections/antimicrobial resistance) Program activities across all healthcare settings, not limited to long-term care. The <a href=\\\"https://www.cdc.gov/ncezid/dpei/pdf/guidance-strengthening-haiar-program-capicity-508.pdf\\\">SHARP project guidance</a> reflects the central challenge that CORHA was originally founded on, which was the need to build capacity for public health and healthcare to improve outbreak detection, response and prevention. This requires close collaboration and relationship building between public health professionals and healthcare providers, which has been growing steadily but could really blossom now with these ARP-supported investments.</p><p>Outbreak detection should improve thanks to SHARP activities related to both the AR Lab Network and National Healthcare Safety Network (NHSN). These will enhance surveillance for drug-resistant pathogens and HAIs, providing data for action. Likewise, outbreak investigation should benefit from additional staffing and increased engagement with healthcare partners.</p><p>SHARP encourages health departments to build HAI/AR prevention and response capacity throughout their jurisdictions, such as expanded use of local and regional approaches to address HAI/AR threats and controlling the spread of resistant pathogens. The guidance describes requirements for funded HAI/AR programs to establish a lead position to coordinate and oversee HAI response activities and to train staff in outbreak response.</p><h2><i>Advice for CORHA and its member organizations?</i></h2><p>Yes, let’s lean into this opportunity. CORHA is identified as a key source for healthcare outbreak training resources. It would be great to see increased activities in that realm, including collaboration with CORHA’s member organizations to improve and expand our collective offerings.</p><p>Both of the new projects emphasize direct engagement with individual facilities. The SHARP project references activities such as medical product investigations, targeted AR threats, molecular testing methods, patient notification, and many other aspects of healthcare outbreak response. These all represent opportunities for CORHA’s workgroups and member organizations to take our work to the next level.</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Joseph Perz, DrPH, MA\"}',1,'2024-07-21 22:25:11','2024-07-21 22:25:11','0891a5cf-9dfb-4b56-9d1e-8430b5fbb5c9'),(43926,43926,1,NULL,'__temp_bhoaqpcwliheoxdoefccuqomhlidlzrakdlm',NULL,NULL,1,'2024-07-21 22:25:11','2024-07-21 22:25:11','e141395b-17da-4458-9d2d-53f948d63d64'),(43928,43928,1,'Joseph Perz 300x241 2',NULL,NULL,NULL,1,'2024-07-21 22:25:52','2024-07-21 22:25:52','461b6799-917c-44c7-97e6-96fb61ee6a6a'),(43929,43929,1,'Leadership: New CDC Funding Recognizes Healthcare Outbreak Response Needs','leadership-new-cdc-funding-recognizes-healthcare-outbreak-response-needs','news/leadership-new-cdc-funding-recognizes-healthcare-outbreak-response-needs','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>The Biden-Harris Administration and CDC recently announced a $2.1 billion investment as part of the American Rescue Plan (ARP), to improve infection prevention and control activities across the U.S. public health and healthcare sectors. Health departments received $885 million of this total in late October 2021 to support this work. CORHA interviewed Dr. Joe Perz, our lead representative from CDC and a Governance Committee member, to learn more about the funding.</p><h2><i>What is the new funding we’ve been hearing about?</i></h2><p>The initial funding is divided between two projects that are managed under a <a href=\\\"https://www.cdc.gov/ncezid/dpei/epidemiology-laboratory-capacity.html\\\">CDC cooperative agreement with health departments</a>. One of these is the <a href=\\\"https://www.cdc.gov/ncezid/dpei/pdf/guidance-nursing-home-ltc-facility-strike-team-and-infastructure-508.pdf\\\">Nursing Home &amp; Long-term Care Facility Strike Team and Infrastructure Project</a> which totals $500 million. The other is the <a href=\\\"https://www.cdc.gov/ncezid/dpei/pdf/guidance-strengthening-haiar-program-capicity-508.pdf\\\">Strengthening HAI/AR Program (SHARP) Capacity Project</a> which totals $385 million.</p><h2><i>How is healthcare outbreak response reflected in the new funding?</i></h2><p>Healthcare outbreak response is clearly recognized as a core function and essential need in both new funding opportunities, which cover the response continuum beginning with outbreak detection and extending to on-site investigation as well as longer-term follow-up activities to prevent a recurrence.</p><h2><i>Can you unpack that a bit, in relation to the Nursing Home &amp; Long-term Care Project?</i></h2><p>Sure, the <a href=\\\"https://www.cdc.gov/ncezid/dpei/pdf/guidance-nursing-home-ltc-facility-strike-team-and-infastructure-508.pdf\\\">LTC Project Guidance</a> includes a directive to support nursing homes – and other types of long-term care facilities – with COVID-19 outbreak response. That’s the primary motivation, and the funding can be used to support the rapid reactive activities – like testing, cohorting, infection control auditing, and even supplemental staffing – when SARS-CoV-2 has entered a facility and transmission is ramping up.</p><p>The allowable activities also support more proactive measures, like helping equip facilities with technology for infection tracking and reporting or communication with health department partners. In addition, we are supportive of creative approaches for staff recruitment, development, and retention.</p><p>The overall aim here is to build infection prevention infrastructure and achieve a greater quality of care. In other words, greater resilience to SARS-CoV-2 and outbreaks more generally. Susceptibility to the rapid spread of infections is something that nursing homes really must guard against, given the congregate and residential nature of long-term care.</p><h2><i>And what about the SHARP Project?</i></h2><p>Same spirit, spread farther. The SHARP funds are intended to enhance health department HAI/AR (healthcare associated infections/antimicrobial resistance) Program activities across all healthcare settings, not limited to long-term care. The <a href=\\\"https://www.cdc.gov/ncezid/dpei/pdf/guidance-strengthening-haiar-program-capicity-508.pdf\\\">SHARP project guidance</a> reflects the central challenge that CORHA was originally founded on, which was the need to build capacity for public health and healthcare to improve outbreak detection, response and prevention. This requires close collaboration and relationship building between public health professionals and healthcare providers, which has been growing steadily but could really blossom now with these ARP-supported investments.</p><p>Outbreak detection should improve thanks to SHARP activities related to both the AR Lab Network and National Healthcare Safety Network (NHSN). These will enhance surveillance for drug-resistant pathogens and HAIs, providing data for action. Likewise, outbreak investigation should benefit from additional staffing and increased engagement with healthcare partners.</p><p>SHARP encourages health departments to build HAI/AR prevention and response capacity throughout their jurisdictions, such as expanded use of local and regional approaches to address HAI/AR threats and controlling the spread of resistant pathogens. The guidance describes requirements for funded HAI/AR programs to establish a lead position to coordinate and oversee HAI response activities and to train staff in outbreak response.</p><h2><i>Advice for CORHA and its member organizations?</i></h2><p>Yes, let’s lean into this opportunity. CORHA is identified as a key source for healthcare outbreak training resources. It would be great to see increased activities in that realm, including collaboration with CORHA’s member organizations to improve and expand our collective offerings.</p><p>Both of the new projects emphasize direct engagement with individual facilities. The SHARP project references activities such as medical product investigations, targeted AR threats, molecular testing methods, patient notification, and many other aspects of healthcare outbreak response. These all represent opportunities for CORHA’s workgroups and member organizations to take our work to the next level.</p><figure class=\\\"image\\\"><img src=\\\"{asset:43928:transform:medium||https://corha.org/admin/actions/assets/generate-transform}?transformId=342\\\" width=\\\"300\\\" height=\\\"241\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Joseph Perz</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Joseph Perz, DrPH, MA\"}',1,'2024-07-21 22:26:16','2024-07-21 22:26:16','abac0c69-3687-4ad7-92d8-6cb05c61d559'),(43930,43930,1,'Leadership: Linda Greene, Director of Hospital Infection Prevention at the University of Rochester Highland Hospital','leadership-linda-greene-director-of-hospital-infection-prevention-at-the-university-of-rochester-highland-hospital','news/leadership-linda-greene-director-of-hospital-infection-prevention-at-the-university-of-rochester-highland-hospital','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>As a front-line infection preventionist and Director of Infection Prevention in a healthcare organization, preventing healthcare-associated infections and addressing antimicrobial resistance are both high priorities of mine. Prior to the COVID-19 pandemic, my work with outbreaks included surgical site infections and an outbreak of healthcare-associated influenza. The influenza outbreak investigation and response were remarkably successful and stemmed from our ability to identify an initial source of the outbreak and implement several recommended infection prevention measures. Response actions included closing the unit to new admissions, carefully screening staff, and administering pre- and post-exposure prophylaxis. However, in my experience, the greatest outbreak and infection prevention and control challenges I have witnessed were related to COVID-19.  </p><blockquote><p>\\\"…The greatest outbreak and infection prevention and control challenges I have witnessed were related to COVID-19.\\\"</p></blockquote><p>Our hospital’s COVID-19 clusters were associated with myriad issues including staff-to-staff transmission, patient-to-staff transmission, and staff-to-patient transmission. In addition, patient and visitor non-compliance with masking, risk from aerosol generating procedures, patients who initially test negative and incubate on admission, as well as contamination during donning and doffing personal protective equipment were the main difficulties we navigated. Another challenge was the shortage of private rooms and medical supply delays, especially at the height of the pandemic, which exacerbated our containment efforts. These matters have highlighted areas and opportunities for improvement in practices, testing, and hardwiring processes. Looking to the future of outbreak investigation, we need access at the local level to important tools such as whole genome sequencing. Once these and other tools become more readily available, we will be able to identify, attribute, and mitigate outbreaks in a more comprehensive and timely manner.  </p><p>I have gained many insights from my involvement in CORHA. Most notably, I have a greater appreciation for and recognition of the link between hospital infection prevention and public health. This is an important and essential relationship, as I have acquired invaluable knowledge from both my public health colleagues in my state and in COHRA. Recently, I worked with CORHA to develop the <a href=\\\"https://corha.org/assets/documents/COVID-19-HC-Outbreak-Definition-Guidance_January-2024.pdf\\\" target=\\\"_blank\\\" rel=\\\"noreferrer noopener\\\"><i>CORHA/CSTE Proposed Investigation/Reporting Thresholds and Outbreak Definitions for COVID-19</i> <i>in Healthcare</i> <i>Settings</i></a>, and more broadly to review <a href=\\\"{entry:8535@1:url||https://corha.org/principles-practices-for-outbreak-response}\\\" target=\\\"_blank\\\" rel=\\\"noreferrer noopener\\\"><i>CORHA’s Principles and Practices for Outbreak Response</i></a>. </p><p>As a former APIC president, my perceptions and experiences have granted me the ability to contribute to CORHA in a distinctive way. APIC’s competencies for Infection Preventionists are critical during the COVID-19 pandemic, in particular the leadership competencies: communication, collaboration, critical thinking, behavioral science, program management, and mentorship. My hope for the future of CORHA is to expand its strategy and awareness to other emerging pathogens and continue development of principles and practices for addressing product and device associated infections, as well as important healthcare-associated infection outbreaks. The diverse organizations who contribute to COHRA represent an abundance of knowledge and expertise and embody the essential link between patient safety, infection prevention, and public health.  </p><figure class=\\\"image\\\"><img src=\\\"{asset:43932:transform:medium||/assets/images/transf/_medium/43932/Linda-Greene-200x300.webp}\\\" alt=\\\"Linda Greene Headshot\\\" width=\\\"300\\\" height=\\\"450\\\" /></figure><p><i>                                                                                    Linda Greene</i></p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Linda Greene, RN, MPS, CIC, FAPIC\", \"ccabfff6-2908-407e-98d3-a22686d82840\": {\"score\": \"poor\", \"social\": {\"twitter\": {\"title\": \"Leadership: Linda Greene, Director of Hospital Infection Prevention at the University of Rochester Highland Hospital - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"Linda Greene, director of infection prevention at the University of Rochester Highland Hospital (NY), discusses leadership in public health.\"}, \"facebook\": {\"title\": \"Leadership: Linda Greene, Director of Hospital Infection Prevention at the University of Rochester Highland Hospital - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"Linda Greene, director of infection prevention at the University of Rochester Highland Hospital (NY), discusses leadership in public health.\"}}, \"advanced\": {\"robots\": [], \"canonical\": \"\"}, \"keywords\": [{\"rating\": \"good\", \"keyword\": \"leadership\"}, {\"rating\": \"poor\", \"keyword\": \"health challenges\"}, {\"rating\": \"poor\", \"keyword\": \"health communication\"}, {\"rating\": \"poor\", \"keyword\": \"NY\"}], \"titleRaw\": {\"1\": \"Leadership: Linda Greene, Director of Hospital Infection Prevention at the University of Rochester Highland Hospital\"}, \"descriptionRaw\": \"Linda Greene, director of infection prevention at the University of Rochester Highland Hospital (NY), discusses leadership in public health.\"}, \"dd06f1a1-3c4f-4001-adc3-f3c0a94550ac\": [1558], \"f88904a1-7870-468f-8885-f14ce93db364\": []}',1,'2024-07-21 22:26:48','2024-12-03 20:20:43','d506e619-bc08-42fc-9d9b-a2a58621492e'),(43931,43931,1,NULL,'__temp_uuqnhftgycxwxzpcxbcypxcsnmbvnigpkzxa',NULL,'{\"b691f1c7-ad7d-4a8b-a9fa-b4feec58e073\": []}',1,'2024-07-21 22:26:51','2024-08-08 16:39:54','ace2d624-d9ea-43b3-80ca-2e706d4263f9'),(43932,43932,1,'Linda Greene 200x300',NULL,NULL,NULL,1,'2024-07-21 22:29:48','2024-07-21 22:29:48','a203acc3-2f39-47e8-bd3c-0f6069121d10'),(43933,43933,1,'Leadership: Linda Greene, Director of Hospital Infection Prevention at the University of Rochester Highland Hospital','leadership-linda-greene-director-of-hospital-infection-prevention-at-the-university-of-rochester-highland-hospital','news/leadership-linda-greene-director-of-hospital-infection-prevention-at-the-university-of-rochester-highland-hospital','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<blockquote><p><strong>“…The greatest outbreak and infection prevention and control challenges I have witnessed were related to COVID-19.”</strong></p></blockquote><p>As a front-line infection preventionist and Director of Infection Prevention in a healthcare organization, preventing healthcare-associated infections and addressing antimicrobial resistance are both high priorities of mine. Prior to the COVID-19 pandemic, my work with outbreaks included surgical site infections and an outbreak of healthcare-associated influenza. The influenza outbreak investigation and response were remarkably successful and stemmed from our ability to identify an initial source of the outbreak and implement several recommended infection prevention measures. Response actions included closing the unit to new admissions, carefully screening staff, and administering pre- and post-exposure prophylaxis. However, in my experience, the greatest outbreak and infection prevention and control challenges I have witnessed were related to COVID-19.  </p><p>Our hospital’s COVID-19 clusters were associated with myriad issues including staff-to-staff transmission, patient-to-staff transmission, and staff-to-patient transmission. In addition, patient and visitor non-compliance with masking, risk from aerosol generating procedures, patients who initially test negative and incubate on admission, as well as contamination during donning and doffing personal protective equipment were the main difficulties we navigated. Another challenge was the shortage of private rooms and medical supply delays, especially at the height of the pandemic, which exacerbated our containment efforts. These matters have highlighted areas and opportunities for improvement in practices, testing, and hardwiring processes. Looking to the future of outbreak investigation, we need access at the local level to important tools such as whole genome sequencing. Once these and other tools become more readily available, we will be able to identify, attribute, and mitigate outbreaks in a more comprehensive and timely manner.  </p><p>I have gained many insights from my involvement in CORHA. Most notably, I have a greater appreciation for and recognition of the link between hospital infection prevention and public health. This is an important and essential relationship, as I have acquired invaluable knowledge from both my public health colleagues in my state and in COHRA. Recently, I worked with CORHA to develop the <a href=\\\"https://www.corha.org/resources/corha-cste-proposed-investigation-reporting-thresholds-and-outbreak-definitions-for-covid-19-in-healthcare-settings/\\\"><i>CORHA/CSTE Proposed Investigation/Reporting Thresholds and Outbreak Definitions for COVID-19</i> <i>in Healthcare</i> <i>Settings</i></a>, and more broadly to review <a href=\\\"https://www.corha.org/resources/corha-principles-and-practices-for-outbreak-response/\\\"><i>CORHA’s Principles and Practices for Outbreak Response</i></a>. </p><p>As a former APIC president, my perceptions and experiences have granted me the ability to contribute to CORHA in a distinctive way. APIC’s competencies for Infection Preventionists are critical during the COVID-19 pandemic, in particular the leadership competencies: communication, collaboration, critical thinking, behavioral science, program management, and mentorship. My hope for the future of CORHA is to expand its strategy and awareness to other emerging pathogens and continue development of principles and practices for addressing product and device associated infections, as well as important healthcare-associated infection outbreaks. The diverse organizations who contribute to COHRA represent an abundance of knowledge and expertise and embody the essential link between patient safety, infection prevention, and public health.  </p><figure class=\\\"image\\\"><img src=\\\"{asset:43932:transform:medium||https://corha.org/admin/actions/assets/generate-transform}?transformId=345\\\" width=\\\"300\\\" height=\\\"450\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Linda Greene</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Linda Greene, RN, MPS, CIC, FAPIC\"}',1,'2024-07-21 22:30:20','2024-07-21 22:30:20','c2a2029e-7ba4-4f7e-9fbd-8ca45fbd0b8d'),(43934,43934,1,NULL,'__temp_uuqnhftgycxwxzpcxbcypxcsnmbvnigpkzxa',NULL,NULL,1,'2024-07-21 22:30:20','2024-07-21 22:30:20','1edc00ba-450e-489e-9556-2e1a2ddeb5ca'),(43936,43936,1,'Leadership: Linda Greene, Director of Hospital Infection Prevention at the University of Rochester Highland Hospital','leadership-linda-greene-director-of-hospital-infection-prevention-at-the-university-of-rochester-highland-hospital','news/leadership-linda-greene-director-of-hospital-infection-prevention-at-the-university-of-rochester-highland-hospital','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>As a front-line infection preventionist and Director of Infection Prevention in a healthcare organization, preventing healthcare-associated infections and addressing antimicrobial resistance are both high priorities of mine. Prior to the COVID-19 pandemic, my work with outbreaks included surgical site infections and an outbreak of healthcare-associated influenza. The influenza outbreak investigation and response were remarkably successful and stemmed from our ability to identify an initial source of the outbreak and implement several recommended infection prevention measures. Response actions included closing the unit to new admissions, carefully screening staff, and administering pre- and post-exposure prophylaxis. However, in my experience, the greatest outbreak and infection prevention and control challenges I have witnessed were related to COVID-19.  </p><blockquote><p>…The greatest outbreak and infection prevention and control challenges I have witnessed were related to COVID-19.</p></blockquote><p>Our hospital’s COVID-19 clusters were associated with myriad issues including staff-to-staff transmission, patient-to-staff transmission, and staff-to-patient transmission. In addition, patient and visitor non-compliance with masking, risk from aerosol generating procedures, patients who initially test negative and incubate on admission, as well as contamination during donning and doffing personal protective equipment were the main difficulties we navigated. Another challenge was the shortage of private rooms and medical supply delays, especially at the height of the pandemic, which exacerbated our containment efforts. These matters have highlighted areas and opportunities for improvement in practices, testing, and hardwiring processes. Looking to the future of outbreak investigation, we need access at the local level to important tools such as whole genome sequencing. Once these and other tools become more readily available, we will be able to identify, attribute, and mitigate outbreaks in a more comprehensive and timely manner.  </p><p>I have gained many insights from my involvement in CORHA. Most notably, I have a greater appreciation for and recognition of the link between hospital infection prevention and public health. This is an important and essential relationship, as I have acquired invaluable knowledge from both my public health colleagues in my state and in COHRA. Recently, I worked with CORHA to develop the <a href=\\\"https://www.corha.org/resources/corha-cste-proposed-investigation-reporting-thresholds-and-outbreak-definitions-for-covid-19-in-healthcare-settings/\\\"><i>CORHA/CSTE Proposed Investigation/Reporting Thresholds and Outbreak Definitions for COVID-19</i> <i>in Healthcare</i> <i>Settings</i></a>, and more broadly to review <a href=\\\"https://www.corha.org/resources/corha-principles-and-practices-for-outbreak-response/\\\"><i>CORHA’s Principles and Practices for Outbreak Response</i></a>. </p><p>As a former APIC president, my perceptions and experiences have granted me the ability to contribute to CORHA in a distinctive way. APIC’s competencies for Infection Preventionists are critical during the COVID-19 pandemic, in particular the leadership competencies: communication, collaboration, critical thinking, behavioral science, program management, and mentorship. My hope for the future of CORHA is to expand its strategy and awareness to other emerging pathogens and continue development of principles and practices for addressing product and device associated infections, as well as important healthcare-associated infection outbreaks. The diverse organizations who contribute to COHRA represent an abundance of knowledge and expertise and embody the essential link between patient safety, infection prevention, and public health.  </p><figure class=\\\"image\\\"><img src=\\\"{asset:43932:transform:medium||/assets/images/transf/_medium/43932/Linda-Greene-200x300.webp}\\\" alt=\\\"\\\" width=\\\"300\\\" height=\\\"450\\\" /></figure><p>Linda Greene</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Linda Greene, RN, MPS, CIC, FAPIC\"}',1,'2024-07-21 22:31:13','2024-07-21 22:31:13','23bd48ef-5332-44d3-b3b6-4ab32ce9c36d'),(43938,43938,1,'Leadership: Linda Greene, Director of Hospital Infection Prevention at the University of Rochester Highland Hospital','leadership-linda-greene-director-of-hospital-infection-prevention-at-the-university-of-rochester-highland-hospital','news/leadership-linda-greene-director-of-hospital-infection-prevention-at-the-university-of-rochester-highland-hospital','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>As a front-line infection preventionist and Director of Infection Prevention in a healthcare organization, preventing healthcare-associated infections and addressing antimicrobial resistance are both high priorities of mine. Prior to the COVID-19 pandemic, my work with outbreaks included surgical site infections and an outbreak of healthcare-associated influenza. The influenza outbreak investigation and response were remarkably successful and stemmed from our ability to identify an initial source of the outbreak and implement several recommended infection prevention measures. Response actions included closing the unit to new admissions, carefully screening staff, and administering pre- and post-exposure prophylaxis. However, in my experience, the greatest outbreak and infection prevention and control challenges I have witnessed were related to COVID-19.  </p><blockquote><p>\\\"…The greatest outbreak and infection prevention and control challenges I have witnessed were related to COVID-19.\\\"</p></blockquote><p>Our hospital’s COVID-19 clusters were associated with myriad issues including staff-to-staff transmission, patient-to-staff transmission, and staff-to-patient transmission. In addition, patient and visitor non-compliance with masking, risk from aerosol generating procedures, patients who initially test negative and incubate on admission, as well as contamination during donning and doffing personal protective equipment were the main difficulties we navigated. Another challenge was the shortage of private rooms and medical supply delays, especially at the height of the pandemic, which exacerbated our containment efforts. These matters have highlighted areas and opportunities for improvement in practices, testing, and hardwiring processes. Looking to the future of outbreak investigation, we need access at the local level to important tools such as whole genome sequencing. Once these and other tools become more readily available, we will be able to identify, attribute, and mitigate outbreaks in a more comprehensive and timely manner.  </p><p>I have gained many insights from my involvement in CORHA. Most notably, I have a greater appreciation for and recognition of the link between hospital infection prevention and public health. This is an important and essential relationship, as I have acquired invaluable knowledge from both my public health colleagues in my state and in COHRA. Recently, I worked with CORHA to develop the <a href=\\\"https://www.corha.org/resources/corha-cste-proposed-investigation-reporting-thresholds-and-outbreak-definitions-for-covid-19-in-healthcare-settings/\\\"><i>CORHA/CSTE Proposed Investigation/Reporting Thresholds and Outbreak Definitions for COVID-19</i> <i>in Healthcare</i> <i>Settings</i></a>, and more broadly to review <a href=\\\"https://www.corha.org/resources/corha-principles-and-practices-for-outbreak-response/\\\"><i>CORHA’s Principles and Practices for Outbreak Response</i></a>. </p><p>As a former APIC president, my perceptions and experiences have granted me the ability to contribute to CORHA in a distinctive way. APIC’s competencies for Infection Preventionists are critical during the COVID-19 pandemic, in particular the leadership competencies: communication, collaboration, critical thinking, behavioral science, program management, and mentorship. My hope for the future of CORHA is to expand its strategy and awareness to other emerging pathogens and continue development of principles and practices for addressing product and device associated infections, as well as important healthcare-associated infection outbreaks. The diverse organizations who contribute to COHRA represent an abundance of knowledge and expertise and embody the essential link between patient safety, infection prevention, and public health.  </p><figure class=\\\"image\\\"><img src=\\\"{asset:43932:transform:medium||/assets/images/transf/_medium/43932/Linda-Greene-200x300.webp}\\\" alt=\\\"\\\" width=\\\"300\\\" height=\\\"450\\\" /></figure><p>Linda Greene</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Linda Greene, RN, MPS, CIC, FAPIC\"}',1,'2024-07-21 22:31:44','2024-07-21 22:31:44','cab21890-efff-4a20-917c-f8cb3d6a225b'),(43940,43940,1,'Leadership: Linda Greene, Director of Hospital Infection Prevention at the University of Rochester Highland Hospital','leadership-linda-greene-director-of-hospital-infection-prevention-at-the-university-of-rochester-highland-hospital','news/leadership-linda-greene-director-of-hospital-infection-prevention-at-the-university-of-rochester-highland-hospital','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>As a front-line infection preventionist and Director of Infection Prevention in a healthcare organization, preventing healthcare-associated infections and addressing antimicrobial resistance are both high priorities of mine. Prior to the COVID-19 pandemic, my work with outbreaks included surgical site infections and an outbreak of healthcare-associated influenza. The influenza outbreak investigation and response were remarkably successful and stemmed from our ability to identify an initial source of the outbreak and implement several recommended infection prevention measures. Response actions included closing the unit to new admissions, carefully screening staff, and administering pre- and post-exposure prophylaxis. However, in my experience, the greatest outbreak and infection prevention and control challenges I have witnessed were related to COVID-19.  </p><blockquote><p>\\\"…The greatest outbreak and infection prevention and control challenges I have witnessed were related to COVID-19.\\\"</p></blockquote><p>Our hospital’s COVID-19 clusters were associated with myriad issues including staff-to-staff transmission, patient-to-staff transmission, and staff-to-patient transmission. In addition, patient and visitor non-compliance with masking, risk from aerosol generating procedures, patients who initially test negative and incubate on admission, as well as contamination during donning and doffing personal protective equipment were the main difficulties we navigated. Another challenge was the shortage of private rooms and medical supply delays, especially at the height of the pandemic, which exacerbated our containment efforts. These matters have highlighted areas and opportunities for improvement in practices, testing, and hardwiring processes. Looking to the future of outbreak investigation, we need access at the local level to important tools such as whole genome sequencing. Once these and other tools become more readily available, we will be able to identify, attribute, and mitigate outbreaks in a more comprehensive and timely manner.  </p><p>I have gained many insights from my involvement in CORHA. Most notably, I have a greater appreciation for and recognition of the link between hospital infection prevention and public health. This is an important and essential relationship, as I have acquired invaluable knowledge from both my public health colleagues in my state and in COHRA. Recently, I worked with CORHA to develop the <a href=\\\"https://www.corha.org/resources/corha-cste-proposed-investigation-reporting-thresholds-and-outbreak-definitions-for-covid-19-in-healthcare-settings/\\\"><i>CORHA/CSTE Proposed Investigation/Reporting Thresholds and Outbreak Definitions for COVID-19</i> <i>in Healthcare</i> <i>Settings</i></a>, and more broadly to review <a href=\\\"https://www.corha.org/resources/corha-principles-and-practices-for-outbreak-response/\\\"><i>CORHA’s Principles and Practices for Outbreak Response</i></a>. </p><p>As a former APIC president, my perceptions and experiences have granted me the ability to contribute to CORHA in a distinctive way. APIC’s competencies for Infection Preventionists are critical during the COVID-19 pandemic, in particular the leadership competencies: communication, collaboration, critical thinking, behavioral science, program management, and mentorship. My hope for the future of CORHA is to expand its strategy and awareness to other emerging pathogens and continue development of principles and practices for addressing product and device associated infections, as well as important healthcare-associated infection outbreaks. The diverse organizations who contribute to COHRA represent an abundance of knowledge and expertise and embody the essential link between patient safety, infection prevention, and public health.  </p><figure class=\\\"image\\\"><img src=\\\"{asset:43932:transform:medium||/assets/images/transf/_medium/43932/Linda-Greene-200x300.webp}\\\" alt=\\\"\\\" width=\\\"300\\\" height=\\\"450\\\" /></figure><p class=\\\"main content photo-caption\\\">Linda Greene</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Linda Greene, RN, MPS, CIC, FAPIC\"}',1,'2024-07-21 22:32:36','2024-07-21 22:32:36','6d3247d8-598f-4182-a37a-9bc42bbdfd60'),(43941,43941,1,'Leadership: Kelley Garner, Arkansas Department of Health, on the Value of Mentorship in the HAI/AR Outbreak Response','leadership-kelley-garner-arkansas-department-of-health-on-the-value-of-mentorship-in-the-hai-ar-outbreak-response','news/leadership-kelley-garner-arkansas-department-of-health-on-the-value-of-mentorship-in-the-hai-ar-outbreak-response','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>Mentorship is an important part of the public health profession and the HAI/AR outbreak response field. Not only does it guide, direct, and shape your present situation and future opportunities for the better, but it also improves the ways in which we respond to HAI/AR outbreaks. I have had numerous experiences with being both a mentor and mentee in my career. I started as an intern at the Arkansas Department of Health where I faced many challenges as the sole coordinator in the HAI Program. I was fortunate to have mentors in various roles, from diverse professional backgrounds and with a broad scope of expertise. Surrounding myself with mentors early in my career helped me improve and master both my technical and leadership skills and helped me to overcome those challenges I experienced as an intern and continues to shape a lot of my current work.</p><blockquote><p>\\\"Don’t be afraid of mentorship at every level of your career – constantly surround yourself with experts in the field.\\\"</p></blockquote><p>A key mentor in my career was Dr. Nate Smith, the former state health official from Arkansas, whose interest and involvement in our HAI/AR Program activities was instrumental in establishing and guiding the direction of our HAI Program. From day one, Dr. Smith invested his time in boosting my confidence, such as when he ensured I felt comfortable presenting data in front of Arkansas’s HAI/AR Advisory Committee early on in my career. He encouraged me to be creative to meet the public health needs for HAI/AR, as well as taught me to think big. Finally, Dr. Smith appreciated my input and asked questions, which allowed me to develop control measures and descriptive work to tackle an outbreak of a new species of mycobacterium within the state.</p><p>I was later hired and promoted to a supervisor, and now, the Chief of Epidemiology on HAI/AR at the Arkansas Department of Health. Throughout my career, my mentors have been “safe spaces” and part of my support system to help me excel in my roles. HAI/AR outbreak response can be complex and sometimes we encounter unique situations that may benefit from additional guidance or perspectives from others in the field. During these times, mentors are pivotal for either providing you with the information and guidance necessary or working with you through the challenge to reach a solution. For example, I recall an outbreak linked to contaminated saline bottles in a rural part of Arkansas, which required a process of documentation and analyses with limited available “written” guidance. My mentors helped me manage that outbreak and supported me through that experience.</p><p>While I’ve continued to surround myself with experts in the field who continue to serve as my mentors, I’ve also taken on roles as a mentor to others. I currently mentor college students and scholars in public health and I have formed mentor relationships with HAI Coordinators in neighboring states like Missouri and Oklahoma, where I support them in their IPC and HAI outbreak response work. Such a role has been particularly valuable because of the cross-collaboration and relationship-building this has contributed to our HAI/AR outbreak response activities. For example, we’ve invited states to participate in Infection Control Assessment and Responses, which has allowed us to get an outside perspective on Arkansas’s outbreak response and for other states to learn from our processes. Additionally, we’ve assisted states with analyzing complex data, which further expanded our state’s resources across the spectrum of HAI/AR. Finally, working with other states has created a sense of community within the infectious disease field, and has mutually instilled confidence in us as state health leaders of HAI/AR. I’m proud of the many success stories that have emerged from my mentorships.</p><p>Throughout my past and current mentorship experiences, I’ve gained insight into what makes a mentorship successful. Good mentors:</p><ul><li>Have similar shared experiences and starting points as their mentees, exercise transparency in sharing both successes and failures, set realistic expectations, and create a safe space for mentees to try new things within boundaries</li><li>Help their mentees learn through experience</li><li>Can boost confidence, foster, and instill critical leadership skills such as communication, decision-making, responding to the press, conducting patient notifications and other outbreak response skills</li><li>Emphasize the broader impact of HAI/AR response</li><li>Serve as inspiration for their mentee to succeed</li></ul><p>Mentorship is a two-way street, and it’s important for both the mentor and mentee to reach a consensus on the goals for the relationship as the roles change over time. While traditional and formal mentorship opportunities through fellowships and peer-to-peer convenings such as CSTE or ASTHO can create a strong foundation to learn and build relationships, there are equally impactful mentorship experiences that can occur informally and organically, with people in various roles, and with diverse experiences, skills, and expertise.</p><p>Groups like the CORHA can also support mentorship in the HAI/AR outbreak community as they develop tools and resources that bridge public health and healthcare outbreak response. Mentorship in the HAI/AR outbreak field is critical and to those that are early in their career, a mentor can help you identify your priorities and manage your expectations.  Find a mentor with the right personality and someone who understands where you are coming from. Also, look for mentors who are transparent and honest and give you the space to think creatively. I believe mentorships are critical at all levels and just as important. For those who have progressed in their career, don’t be afraid to embrace mentorship experiences at all levels and to continuously surround yourself with experts.</p><figure class=\\\"image\\\"><img src=\\\"{asset:43943:transform:medium||/assets/images/transf/_medium/43943/Kelley-Garner-300v2.webp}\\\" alt=\\\"Kelly Garner Headshot\\\" width=\\\"300\\\" height=\\\"270\\\" /></figure><p><i>                                                                                    Kelly Garner</i></p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Kelley Garner, MPH\", \"ccabfff6-2908-407e-98d3-a22686d82840\": {\"score\": \"poor\", \"social\": {\"twitter\": {\"title\": \"Leadership: Kelley Garner, Arkansas Department of Health, on the Value of Mentorship in the HAI/AR Outbreak Response - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"Kelley Garner (AR State Department of Health) emphasizes the value of mentorship in enhancing HAI AR outbreak response within public health frameworks.\"}, \"facebook\": {\"title\": \"Leadership: Kelley Garner, Arkansas Department of Health, on the Value of Mentorship in the HAI/AR Outbreak Response - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"Kelley Garner (AR State Department of Health) emphasizes the value of mentorship in enhancing HAI AR outbreak response within public health frameworks.\"}}, \"advanced\": {\"robots\": [], \"canonical\": \"\"}, \"keywords\": [{\"rating\": \"poor\", \"keyword\": \"intervention\"}, {\"rating\": \"poor\", \"keyword\": \"technical assistance\"}, {\"rating\": \"poor\", \"keyword\": \"training\"}, {\"rating\": \"good\", \"keyword\": \"AR\"}, {\"rating\": \"poor\", \"keyword\": \"state health department\"}], \"titleRaw\": {\"1\": \"Leadership: Kelley Garner, Arkansas Department of Health, on the Value of Mentorship in the HAI/AR Outbreak Response\"}, \"descriptionRaw\": \"Kelley Garner (AR State Department of Health) emphasizes the value of mentorship in enhancing HAI AR outbreak response within public health frameworks.\"}, \"dd06f1a1-3c4f-4001-adc3-f3c0a94550ac\": [1558], \"f88904a1-7870-468f-8885-f14ce93db364\": []}',1,'2024-07-21 22:32:49','2024-12-03 20:21:42','535b68ee-9832-4478-b8b6-8f3386b811c6'),(43942,43942,1,NULL,'__temp_doabsgiflqswvauiugyrmothoobptzgehmqb',NULL,'{\"b691f1c7-ad7d-4a8b-a9fa-b4feec58e073\": []}',1,'2024-07-21 22:33:07','2024-08-08 16:39:54','f6e9101f-b1be-4515-8577-7f756894b5eb'),(43943,43943,1,'Kelley Garner 300v2',NULL,NULL,NULL,1,'2024-07-21 22:34:42','2024-07-21 22:34:42','10488761-73a6-48cb-a88a-73fdeccda95e'),(43944,43944,1,'Leadership: Kelley Garner, Arkansas Department of Health, on the Value of Mentorship in the HAI/AR Outbreak Response','leadership-kelley-garner-arkansas-department-of-health-on-the-value-of-mentorship-in-the-hai-ar-outbreak-response','news/leadership-kelley-garner-arkansas-department-of-health-on-the-value-of-mentorship-in-the-hai-ar-outbreak-response','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>Mentorship is an important part of the public health profession and the HAI/AR outbreak response field. Not only does it guide, direct, and shape your present situation and future opportunities for the better, but it also improves the ways in which we respond to HAI/AR outbreaks. I have had numerous experiences with being both a mentor and mentee in my career. I started as an intern at the Arkansas Department of Health where I faced many challenges as the sole coordinator in the HAI Program. I was fortunate to have mentors in various roles, from diverse professional backgrounds and with a broad scope of expertise. Surrounding myself with mentors early in my career helped me improve and master both my technical and leadership skills and helped me to overcome those challenges I experienced as an intern and continues to shape a lot of my current work.</p><blockquote><p>\\\"Don’t be afraid of mentorship at every level of your career – constantly surround yourself with experts in the field.\\\"</p></blockquote><p>A key mentor in my career was Dr. Nate Smith, the former state health official from Arkansas, whose interest and involvement in our HAI/AR Program activities was instrumental in establishing and guiding the direction of our HAI Program. From day one, Dr. Smith invested his time in boosting my confidence, such as when he ensured I felt comfortable presenting data in front of Arkansas’s HAI/AR Advisory Committee early on in my career. He encouraged me to be creative to meet the public health needs for HAI/AR, as well as taught me to think big. Finally, Dr. Smith appreciated my input and asked questions, which allowed me to develop control measures and descriptive work to tackle an outbreak of a new species of mycobacterium within the state.</p><p>I was later hired and promoted to a supervisor, and now, the Chief of Epidemiology on HAI/AR at the Arkansas Department of Health. Throughout my career, my mentors have been “safe spaces” and part of my support system to help me excel in my roles. HAI/AR outbreak response can be complex and sometimes we encounter unique situations that may benefit from additional guidance or perspectives from others in the field. During these times, mentors are pivotal for either providing you with the information and guidance necessary or working with you through the challenge to reach a solution. For example, I recall an outbreak linked to contaminated saline bottles in a rural part of Arkansas, which required a process of documentation and analyses with limited available “written” guidance. My mentors helped me manage that outbreak and supported me through that experience.</p><p>While I’ve continued to surround myself with experts in the field who continue to serve as my mentors, I’ve also taken on roles as a mentor to others. I currently mentor college students and scholars in public health and I have formed mentor relationships with HAI Coordinators in neighboring states like Missouri and Oklahoma, where I support them in their IPC and HAI outbreak response work. Such a role has been particularly valuable because of the cross-collaboration and relationship-building this has contributed to our HAI/AR outbreak response activities. For example, we’ve invited states to participate in Infection Control Assessment and Responses, which has allowed us to get an outside perspective on Arkansas’s outbreak response and for other states to learn from our processes. Additionally, we’ve assisted states with analyzing complex data, which further expanded our state’s resources across the spectrum of HAI/AR. Finally, working with other states has created a sense of community within the infectious disease field, and has mutually instilled confidence in us as state health leaders of HAI/AR. I’m proud of the many success stories that have emerged from my mentorships.</p><p>Throughout my past and current mentorship experiences, I’ve gained insight into what makes a mentorship successful. Good mentors:</p><ul><li>Have similar shared experiences and starting points as their mentees, exercise transparency in sharing both successes and failures, set realistic expectations, and create a safe space for mentees to try new things within boundaries</li><li>Help their mentees learn through experience</li><li>Can boost confidence, foster, and instill critical leadership skills such as communication, decision-making, responding to the press, conducting patient notifications and other outbreak response skills</li><li>Emphasize the broader impact of HAI/AR response</li><li>Serve as inspiration for their mentee to succeed</li></ul><p>Mentorship is a two-way street, and it’s important for both the mentor and mentee to reach a consensus on the goals for the relationship as the roles change over time. While traditional and formal mentorship opportunities through fellowships and peer-to-peer convenings such as CSTE or ASTHO can create a strong foundation to learn and build relationships, there are equally impactful mentorship experiences that can occur informally and organically, with people in various roles, and with diverse experiences, skills, and expertise.</p><p>Groups like the Council for Outbreak Response can also support mentorship in the HAI/AR outbreak community as they develop tools and resources that bridge public health and healthcare outbreak response. Mentorship in the HAI/AR outbreak field is critical and to those that are early in their career, a mentor can help you identify your priorities and manage your expectations.  Find a mentor with the right personality and someone who understands where you are coming from. Also, look for mentors who are transparent and honest and give you the space to think creatively. I believe mentorships are critical at all levels and just as important. For those who have progressed in their career, don’t be afraid to embrace mentorship experiences at all levels and to continuously surround yourself with experts.</p><figure class=\\\"image\\\"><img src=\\\"{asset:43943:transform:medium||https://corha.org/admin/actions/assets/generate-transform}?transformId=348\\\" width=\\\"300\\\" height=\\\"270\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Kelly Garner</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Kelley Garner, MPH\"}',1,'2024-07-21 22:35:05','2024-07-21 22:35:05','4813b8ef-e083-41e0-92c0-e603b5390e8d'),(43945,43945,1,NULL,'__temp_doabsgiflqswvauiugyrmothoobptzgehmqb',NULL,NULL,1,'2024-07-21 22:35:05','2024-07-21 22:35:05','b37c12a7-3940-40f3-8270-aace548b0abb'),(43947,43947,1,'Leadership: Kelley Garner, Arkansas Department of Health, on the Value of Mentorship in the HAI/AR Outbreak Response','leadership-kelley-garner-arkansas-department-of-health-on-the-value-of-mentorship-in-the-hai-ar-outbreak-response','news/leadership-kelley-garner-arkansas-department-of-health-on-the-value-of-mentorship-in-the-hai-ar-outbreak-response','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>Mentorship is an important part of the public health profession and the HAI/AR outbreak response field. Not only does it guide, direct, and shape your present situation and future opportunities for the better, but it also improves the ways in which we respond to HAI/AR outbreaks. I have had numerous experiences with being both a mentor and mentee in my career. I started as an intern at the Arkansas Department of Health where I faced many challenges as the sole coordinator in the HAI Program. I was fortunate to have mentors in various roles, from diverse professional backgrounds and with a broad scope of expertise. Surrounding myself with mentors early in my career helped me improve and master both my technical and leadership skills and helped me to overcome those challenges I experienced as an intern and continues to shape a lot of my current work.</p><blockquote><p>\\\"Don’t be afraid of mentorship at every level of your career – constantly surround yourself with experts in the field.\\\"</p></blockquote><p>A key mentor in my career was Dr. Nate Smith, the former state health official from Arkansas, whose interest and involvement in our HAI/AR Program activities was instrumental in establishing and guiding the direction of our HAI Program. From day one, Dr. Smith invested his time in boosting my confidence, such as when he ensured I felt comfortable presenting data in front of Arkansas’s HAI/AR Advisory Committee early on in my career. He encouraged me to be creative to meet the public health needs for HAI/AR, as well as taught me to think big. Finally, Dr. Smith appreciated my input and asked questions, which allowed me to develop control measures and descriptive work to tackle an outbreak of a new species of mycobacterium within the state.</p><p>I was later hired and promoted to a supervisor, and now, the Chief of Epidemiology on HAI/AR at the Arkansas Department of Health. Throughout my career, my mentors have been “safe spaces” and part of my support system to help me excel in my roles. HAI/AR outbreak response can be complex and sometimes we encounter unique situations that may benefit from additional guidance or perspectives from others in the field. During these times, mentors are pivotal for either providing you with the information and guidance necessary or working with you through the challenge to reach a solution. For example, I recall an outbreak linked to contaminated saline bottles in a rural part of Arkansas, which required a process of documentation and analyses with limited available “written” guidance. My mentors helped me manage that outbreak and supported me through that experience.</p><p>While I’ve continued to surround myself with experts in the field who continue to serve as my mentors, I’ve also taken on roles as a mentor to others. I currently mentor college students and scholars in public health and I have formed mentor relationships with HAI Coordinators in neighboring states like Missouri and Oklahoma, where I support them in their IPC and HAI outbreak response work. Such a role has been particularly valuable because of the cross-collaboration and relationship-building this has contributed to our HAI/AR outbreak response activities. For example, we’ve invited states to participate in Infection Control Assessment and Responses, which has allowed us to get an outside perspective on Arkansas’s outbreak response and for other states to learn from our processes. Additionally, we’ve assisted states with analyzing complex data, which further expanded our state’s resources across the spectrum of HAI/AR. Finally, working with other states has created a sense of community within the infectious disease field, and has mutually instilled confidence in us as state health leaders of HAI/AR. I’m proud of the many success stories that have emerged from my mentorships.</p><p>Throughout my past and current mentorship experiences, I’ve gained insight into what makes a mentorship successful. Good mentors:</p><ul><li>Have similar shared experiences and starting points as their mentees, exercise transparency in sharing both successes and failures, set realistic expectations, and create a safe space for mentees to try new things within boundaries</li><li>Help their mentees learn through experience</li><li>Can boost confidence, foster, and instill critical leadership skills such as communication, decision-making, responding to the press, conducting patient notifications and other outbreak response skills</li><li>Emphasize the broader impact of HAI/AR response</li><li>Serve as inspiration for their mentee to succeed</li></ul><p>Mentorship is a two-way street, and it’s important for both the mentor and mentee to reach a consensus on the goals for the relationship as the roles change over time. While traditional and formal mentorship opportunities through fellowships and peer-to-peer convenings such as CSTE or ASTHO can create a strong foundation to learn and build relationships, there are equally impactful mentorship experiences that can occur informally and organically, with people in various roles, and with diverse experiences, skills, and expertise.</p><p>Groups like the Council for Outbreak Response can also support mentorship in the HAI/AR outbreak community as they develop tools and resources that bridge public health and healthcare outbreak response. Mentorship in the HAI/AR outbreak field is critical and to those that are early in their career, a mentor can help you identify your priorities and manage your expectations.  Find a mentor with the right personality and someone who understands where you are coming from. Also, look for mentors who are transparent and honest and give you the space to think creatively. I believe mentorships are critical at all levels and just as important. For those who have progressed in their career, don’t be afraid to embrace mentorship experiences at all levels and to continuously surround yourself with experts.</p><figure class=\\\"image\\\"><img src=\\\"{asset:43943:transform:medium||/assets/images/transf/_medium/43943/Kelley-Garner-300v2.webp}\\\" width=\\\"300\\\" height=\\\"270\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Kelly Garner</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Kelley Garner, MPH\"}',1,'2024-07-21 22:35:18','2024-07-21 22:35:18','cb64fd4a-0eac-42f2-a0e8-39f67f730cf0'),(43948,43948,1,'Leadership: Perspectives from Dr. David Gifford','leadership-leadership-perspectives-from-dr-david-gifford','news/leadership-leadership-perspectives-from-dr-david-gifford','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>My work over the past 20 years has focused on how to improve the healthcare system to ultimately improve healthcare outcomes. In pursuit of this life goal, I have worked with numerous agencies in furthering healthcare quality improvement efforts. I helped create the Quality Department at the American Health Care Association, which assists providers in their quality improvement. I also directed the Centers for Medicare and Medicaid (CMS) Quality Improvement Organization nursing home-based quality improvement efforts when I served as Chief Medical Officer for Quality Partners of Rhode Island. Now, I work on initiatives with the National Trade Association representing long-term care providers.</p><p>During my 6 years as Director of the Rhode Island State Department of Health, I led the state’s response on several disease outbreaks, such as the H1N1 influenza outbreaks. Throughout the past couple of decades, I have gained insight into improving HAI/AR outbreak response from both the public health and healthcare perspectives. Adequate investigation, surveillance, and clear guidance are necessary in developing and implementing evidence-based actions to prevent the spread of infections in healthcare settings. This was exemplified during the COVID-19 pandemic where inconsistent guidance led to challenges in responding to these outbreaks. The COVID-19 pandemic underscores the need for standardized approaches, frameworks, and guidance that are clear and implementable, as well as the importance of CORHA and the work that its members and partners are doing to develop these tools. One outcome of the pandemic response is how it has bolstered both the provider and public health communities’ collaborative efforts against the common threat of HAI/AR outbreaks.</p><p>In my new role on CORHA, I aim to help support the Council in developing and promoting guidance and resources that can be widely adopted to help improve HAI/AR outbreak investigation in a more consistent, timely, and efficient manner. I look forward to integrating the provider community into public health’s HAI/AR outbreak response and protocols and strengthening sustainable relationships between the provider and public health communities. Finally, I hope that CORHA will help advance and highlight the important role of rapid whole genome sequencing more widely as part of HAI/AR outbreak investigations.<br /><br />I believe that civic service is one of the most rewarding, challenging, and underappreciated jobs. Our colleagues in public health and healthcare are some of the most passionate and mission-driven individuals I have had the pleasure of working with. Thank you all for the work you have done so far in improving HAI/AR outbreak response standards. I look forward to all of you continuing to achieve the Council’s mission of protecting patients and preventing harm from HAI/AR outbreaks.</p><figure class=\\\"image\\\"><img src=\\\"{asset:43950:transform:medium||/assets/images/transf/_medium/43950/David-Gifford-300x241-1.webp}\\\" alt=\\\"David Gifford Headshot\\\" width=\\\"300\\\" height=\\\"241\\\" /></figure><p><i>                                                                                    David Gifford</i></p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"David Gifford, MD, MPH\", \"ccabfff6-2908-407e-98d3-a22686d82840\": {\"score\": \"poor\", \"social\": {\"twitter\": {\"title\": \"Leadership: Perspectives from Dr. David Gifford - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"Dr. David Gifford shares his leadership perspectives on effective public health strategies and outbreak management.\"}, \"facebook\": {\"title\": \"Leadership: Perspectives from Dr. David Gifford - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"Dr. David Gifford shares his leadership perspectives on effective public health strategies and outbreak management.\"}}, \"advanced\": {\"robots\": [], \"canonical\": \"\"}, \"keywords\": [{\"rating\": \"good\", \"keyword\": \"leadership\"}, {\"rating\": \"poor\", \"keyword\": \"health challenges\"}, {\"rating\": \"poor\", \"keyword\": \"health communication\"}, {\"rating\": \"poor\", \"keyword\": \"AHCA\"}, {\"rating\": \"poor\", \"keyword\": \"CMS\"}], \"titleRaw\": {\"1\": \"Leadership: Perspectives from Dr. David Gifford\"}, \"descriptionRaw\": \"Dr. David Gifford shares his leadership perspectives on effective public health strategies and outbreak management.\"}, \"dd06f1a1-3c4f-4001-adc3-f3c0a94550ac\": [1558], \"f88904a1-7870-468f-8885-f14ce93db364\": []}',1,'2024-07-21 22:35:46','2024-12-03 20:22:45','75ea2bc3-228d-401d-8e07-d95c98a1f415'),(43949,43949,1,NULL,'__temp_adrluhulfmnryhkjevtzbtbcmbvuwquwltcq',NULL,'{\"b691f1c7-ad7d-4a8b-a9fa-b4feec58e073\": []}',1,'2024-07-21 22:36:13','2024-08-08 16:39:54','873e9850-c7af-4088-94eb-a9e6ef145faf'),(43950,43950,1,'David Gifford 300x241 1',NULL,NULL,NULL,1,'2024-07-21 22:37:13','2024-07-21 22:37:13','274cd1e9-391f-4c4e-b158-3ce5a41b7a55'),(43951,43951,1,'Leadership: Leadership Perspectives from Dr. David Gifford','leadership-leadership-perspectives-from-dr-david-gifford','news/leadership-leadership-perspectives-from-dr-david-gifford','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>My work over the past 20 years has focused on how to improve the healthcare system to ultimately improve healthcare outcomes. In pursuit of this life goal, I have worked with numerous agencies in furthering healthcare quality improvement efforts. I helped create the Quality Department at the American Health Care Association, which assists providers in their quality improvement. I also directed the Centers for Medicare and Medicaid (CMS) Quality Improvement Organization nursing home-based quality improvement efforts when I served as Chief Medical Officer for Quality Partners of Rhode Island. Now, I work on initiatives with the National Trade Association representing long-term care providers.</p><p>During my 6 years as Director of the Rhode Island State Department of Health, I led the state’s response on several disease outbreaks, such as the H1N1 influenza outbreaks. Throughout the past couple of decades, I have gained insight into improving HAI/AR outbreak response from both the public health and healthcare perspectives. Adequate investigation, surveillance, and clear guidance are necessary in developing and implementing evidence-based actions to prevent the spread of infections in healthcare settings. This was exemplified during the COVID-19 pandemic where inconsistent guidance led to challenges in responding to these outbreaks. The COVID-19 pandemic underscores the need for standardized approaches, frameworks, and guidance that are clear and implementable, as well as the importance of CORHA and the work that its members and partners are doing to develop these tools. One outcome of the pandemic response is how it has bolstered both the provider and public health communities’ collaborative efforts against the common threat of HAI/AR outbreaks.</p><p>In my new role on CORHA, I aim to help support the Council in developing and promoting guidance and resources that can be widely adopted to help improve HAI/AR outbreak investigation in a more consistent, timely, and efficient manner. I look forward to integrating the provider community into public health’s HAI/AR outbreak response and protocols and strengthening sustainable relationships between the provider and public health communities. Finally, I hope that CORHA will help advance and highlight the important role of rapid whole genome sequencing more widely as part of HAI/AR outbreak investigations.<br /><br />I believe that civic service is one of the most rewarding, challenging, and underappreciated jobs. Our colleagues in public health and healthcare are some of the most passionate and mission-driven individuals I have had the pleasure of working with. Thank you all for the work you have done so far in improving HAI/AR outbreak response standards. I look forward to all of you continuing to achieve the Council’s mission of protecting patients and preventing harm from HAI/AR outbreaks.</p><figure class=\\\"image\\\"><img src=\\\"{asset:43950:transform:medium||https://corha.org/admin/actions/assets/generate-transform}?transformId=351\\\" width=\\\"300\\\" height=\\\"241\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">David Gifford</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"David Gifford, MD, MPH\"}',1,'2024-07-21 22:37:47','2024-07-21 22:37:47','a9dcb041-a45d-4632-a0c3-8ad1340cdb12'),(43952,43952,1,NULL,'__temp_adrluhulfmnryhkjevtzbtbcmbvuwquwltcq',NULL,NULL,1,'2024-07-21 22:37:47','2024-07-21 22:37:47','045a9c74-b992-4dc2-badc-95cd0ac43584'),(43953,43953,1,'Local: LTCF Vaccine Education Program Vital to Chicago’s COVID-19 Outbreak Response Effort','local-ltcf-vaccine-education-program-vital-to-chicagos-covid-19-outbreak-response-effort','news/local-ltcf-vaccine-education-program-vital-to-chicagos-covid-19-outbreak-response-effort','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>The COVID-19 vaccine roll out in Chicago’s long-term care facilities (LTCFs) was a component of a larger initiative to increase vaccine uptake in the City of Chicago. As the Federal Pharmacy Partnership Program (PPP) was introduced, the Chicago Department of Public Health (CDPH) offered to liaise with LTCFs and facilitate the vaccination process. We were uniquely positioned to assist in LTCFs because of existing relationships with LTCFs after the past year of routine individual facility engagement for COVID-19-related infection control guidance. We worked with the community and leveraged the healthcare facility communication platforms we created to support LTCFs during the pandemic to address vaccine hesitancy and provide vaccine education.</p><p>We acted quickly to facilitate vaccination coordination in LTCFs because they were included in the first phase of vaccine distribution due to their residents’ high risk of COVID-19 morbidity and mortality. In partnership with Project Hope, we held two listening sessions with Directors of Nursing, Assistant Directors of Nursing, and Infection Preventionists at LTCFs in Chicago where we assessed their levels of vaccine hesitancy, discussed vaccine hesitancy among residents, and collected ideas on how to increase vaccine uptake. For example, during the listening sessions we heard concerns from communities of color who felt targeted and pressured to get vaccinated and were hesitant about getting it.</p><p>We used the information shared and questions asked during the listening sessions to better tailor our vaccine education efforts in LTCFs. These efforts included:</p><ul><li>Converting our weekly COVID-19 LTCF roundtables into a vaccine education and implementation series. During these roundtables, we discussed vaccine hesitancy and encouraged LTCF leaders to empower their staff to become vaccine influencers. We also shared with LTCF leadership concerns we heard from staff and residents and suggested LTCF leaders use the information to adjust their vaccine responses to the needs of residents and staff. For example, we heard that some LTCF staff were hesitant because of how quickly it was being rolled out and concerns about being used as test subjects, so many administrators got the vaccine in front of their staff to show confidence in it. In the early stages of the PPP, representatives from different pharmacies spoke about logistics and provided answers about the vaccination process.</li><li>The CDPH Commissioner hosting a Q&amp;A session for all facilities, which was advertised to all residents and their families.</li><li>Transforming our existing testing strike teams into vaccine mobilization and education teams. The vaccine education teams used the information from the listening sessions to address the concerns of LTCF staff and residents. People viewed the vaccine education teams as trusted sources of information that could speak about the vaccine without outside influences. At one facility, we saw a 40 percent increase in vaccine uptake after one education event. Leadership at the LTCF and the vaccine education team worked together to organize the event.</li></ul><p>We kept learning new information as our efforts continued, like the importance of expanding vaccine education initiatives beyond staff and residents at LTCFs. We found that, in many cases, the healthcare power of attorney for residents of LTCFs declined the vaccine on behalf of the residents. Typically, the healthcare powers of attorney do not attend the vaccine education events and miss these opportunities. This gap underscored the importance of empowering family and community members to be vaccine champions.</p><p>During the roll out of COVID-19 vaccinations in LTCFs, we continued to appreciate the importance of coordination and planning. Much planning was required to make the vaccine readily available in facilities, particularly second doses. A lot of coordination was also needed to ensure a seamless transition to LTC pharmacies when the PPP ended. Before the PPP ended, we quickly surveyed facilities to identify their LTC pharmacies and encouraged those pharmacies to enroll as COVID-19 vaccine providers. We found that some of Chicago’s LTC pharmacies were located outside of Chicago borders. We could not deliver vaccine to those facilities because the union contracts of our drivers meant they could only drive within the boundaries of Chicago. In order to overcome this roadblock, we partnered with the Illinois Department of Public Health (IDPH) and provided them with doses of Moderna through Tiberius. IDPH then distributed the vaccine to LTC pharmacies that served Chicago facilities, but were based outside of city limits.</p><p>The challenges, successes, and experiences supporting COVID-19 vaccine uptake at LTCFs helped us identify strategies to address vaccine hesitancy going forward. Given high staff and resident turnover in LTCFs, it is important to keep high vaccination coverage in LTCFs. It is also important to continue education efforts about vaccines and vaccine hesitancy. We saw that individuals who were hesitant to receive the COVID-19 vaccine may have also been hesitant to get the influenza vaccine. Overall, the educational and coordination strategies we used to address vaccine hesitancy, resources we shared for informed decision making, and methods to increase access of the COVID-19 vaccine in LTCFs will be critical for future vaccine initiatives.</p><figure class=\\\"image\\\"><img src=\\\"{asset:43960:transform:medium||/assets/images/transf/_medium/43960/Shannon-Xydis.webp}\\\" alt=\\\"Shannon Xydis Headshot\\\" width=\\\"300\\\" height=\\\"273\\\" /></figure><p><i>Shannon Xydis, Projects Administrator, HAI Coordinator, Chicago Department of Public Health</i></p><figure class=\\\"image\\\"><img src=\\\"{asset:43959:transform:medium||/assets/images/transf/_medium/43959/Liz-Shane.webp}\\\" alt=\\\"Liz Shane Headshot\\\" width=\\\"300\\\" height=\\\"273\\\" /></figure><p><i>Liz Shane, MPH, CIC. Infection Prevention Specialist, Chicago Department of Public Health</i></p><figure class=\\\"image\\\"><img src=\\\"{asset:43958:transform:medium||/assets/images/transf/_medium/43958/Christy-Zelinski.webp}\\\" alt=\\\"Christy Zelinski Headshot\\\" width=\\\"300\\\" height=\\\"273\\\" /></figure><p><i>Christy Zelinski, MPH, Project Manager and Contractor, COVID-19 Response Bureau, Chicago Department of Public Health</i></p><p> </p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Shannon Xydis, Liz Shane, MPH, & Christy Zelinski, MPH\", \"ccabfff6-2908-407e-98d3-a22686d82840\": {\"score\": \"poor\", \"social\": {\"twitter\": {\"title\": \"Local: LTCF Vaccine Education Program Vital to Chicago’s COVID-19 Outbreak Response Effort - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"Local LTCF vaccine education program from proves vital to Chicago (IL)\'s COVID-19 outbreak response efforts and community health outcomes.\"}, \"facebook\": {\"title\": \"Local: LTCF Vaccine Education Program Vital to Chicago’s COVID-19 Outbreak Response Effort - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"Local LTCF vaccine education program from proves vital to Chicago (IL)\'s COVID-19 outbreak response efforts and community health outcomes.\"}}, \"advanced\": {\"robots\": [], \"canonical\": \"\"}, \"keywords\": [{\"rating\": \"poor\", \"keyword\": \"training\"}, {\"rating\": \"poor\", \"keyword\": \"best practices\"}, {\"rating\": \"poor\", \"keyword\": \"health communication\"}, {\"rating\": \"poor\", \"keyword\": \"infectious disease\"}, {\"rating\": \"poor\", \"keyword\": \"disease outbreak\"}, {\"rating\": \"good\", \"keyword\": \"LTCF\"}, {\"rating\": \"good\", \"keyword\": \"Chicago\"}, {\"rating\": \"poor\", \"keyword\": \"local health department\"}], \"titleRaw\": {\"1\": \"Local: LTCF Vaccine Education Program Vital to Chicago’s COVID-19 Outbreak Response Effort\"}, \"descriptionRaw\": \"Local LTCF vaccine education program from proves vital to Chicago (IL)\'s COVID-19 outbreak response efforts and community health outcomes.\"}, \"dd06f1a1-3c4f-4001-adc3-f3c0a94550ac\": [1558], \"f88904a1-7870-468f-8885-f14ce93db364\": []}',1,'2024-07-21 22:38:12','2024-12-03 20:26:30','cb58b4ad-9ed0-43f1-9e7c-777f47a49cbb'),(43954,43954,1,NULL,'__temp_sozuhstdiupdlrwxixaaustdalqrzkeiqgux',NULL,'{\"b691f1c7-ad7d-4a8b-a9fa-b4feec58e073\": []}',1,'2024-07-21 22:38:23','2024-08-08 16:39:54','2557dcc1-0ef9-4efa-89c2-05a515368398'),(43955,43955,1,'Local: LTCF Vaccine Education Program Vital to Chicago’s COVID-19 Outbreak Response Effort','local-ltcf-vaccine-education-program-vital-to-chicagos-covid-19-outbreak-response-effort','news/local-ltcf-vaccine-education-program-vital-to-chicagos-covid-19-outbreak-response-effort','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>The COVID-19 vaccine roll out in Chicago’s long-term care facilities (LTCFs) was a component of a larger initiative to increase vaccine uptake in the City of Chicago. As the Federal Pharmacy Partnership Program (PPP) was introduced, the Chicago Department of Public Health (CDPH) offered to liaise with LTCFs and facilitate the vaccination process. We were uniquely positioned to assist in LTCFs because of existing relationships with LTCFs after the past year of routine individual facility engagement for COVID-19-related infection control guidance. We worked with the community and leveraged the healthcare facility communication platforms we created to support LTCFs during the pandemic to address vaccine hesitancy and provide vaccine education.</p><p>We acted quickly to facilitate vaccination coordination in LTCFs because they were included in the first phase of vaccine distribution due to their residents’ high risk of COVID-19 morbidity and mortality. In partnership with Project Hope, we held two listening sessions with Directors of Nursing, Assistant Directors of Nursing, and Infection Preventionists at LTCFs in Chicago where we assessed their levels of vaccine hesitancy, discussed vaccine hesitancy among residents, and collected ideas on how to increase vaccine uptake. For example, during the listening sessions we heard concerns from communities of color who felt targeted and pressured to get vaccinated and were hesitant about getting it.</p><p>We used the information shared and questions asked during the listening sessions to better tailor our vaccine education efforts in LTCFs. These efforts included:</p><ul><li>Converting our weekly COVID-19 LTCF roundtables into a vaccine education and implementation series. During these roundtables, we discussed vaccine hesitancy and encouraged LTCF leaders to empower their staff to become vaccine influencers. We also shared with LTCF leadership concerns we heard from staff and residents and suggested LTCF leaders use the information to adjust their vaccine responses to the needs of residents and staff. For example, we heard that some LTCF staff were hesitant because of how quickly it was being rolled out and concerns about being used as test subjects, so many administrators got the vaccine in front of their staff to show confidence in it. In the early stages of the PPP, representatives from different pharmacies spoke about logistics and provided answers about the vaccination process.</li><li>The CDPH Commissioner hosting a Q&amp;A session for all facilities, which was advertised to all residents and their families.</li><li>Transforming our existing testing strike teams into vaccine mobilization and education teams. The vaccine education teams used the information from the listening sessions to address the concerns of LTCF staff and residents. People viewed the vaccine education teams as trusted sources of information that could speak about the vaccine without outside influences. At one facility, we saw a 40 percent increase in vaccine uptake after one education event. Leadership at the LTCF and the vaccine education team worked together to organize the event.</li></ul><p>We kept learning new information as our efforts continued, like the importance of expanding vaccine education initiatives beyond staff and residents at LTCFs. We found that, in many cases, the healthcare power of attorney for residents of LTCFs declined the vaccine on behalf of the residents. Typically, the healthcare powers of attorney do not attend the vaccine education events and miss these opportunities. This gap underscored the importance of empowering family and community members to be vaccine champions.</p><p>During the roll out of COVID-19 vaccinations in LTCFs, we continued to appreciate the importance of coordination and planning. Much planning was required to make the vaccine readily available in facilities, particularly second doses. A lot of coordination was also needed to ensure a seamless transition to LTC pharmacies when the PPP ended. Before the PPP ended, we quickly surveyed facilities to identify their LTC pharmacies and encouraged those pharmacies to enroll as COVID-19 vaccine providers. We found that some of Chicago’s LTC pharmacies were located outside of Chicago borders. We could not deliver vaccine to those facilities because the union contracts of our drivers meant they could only drive within the boundaries of Chicago. In order to overcome this roadblock, we partnered with the Illinois Department of Public Health (IDPH) and provided them with doses of Moderna through Tiberius. IDPH then distributed the vaccine to LTC pharmacies that served Chicago facilities, but were based outside of city limits.</p><p>The challenges, successes, and experiences supporting COVID-19 vaccine uptake at LTCFs helped us identify strategies to address vaccine hesitancy going forward. Given high staff and resident turnover in LTCFs, it is important to keep high vaccination coverage in LTCFs. It is also important to continue education efforts about vaccines and vaccine hesitancy. We saw that individuals who were hesitant to receive the COVID-19 vaccine may have also been hesitant to get the influenza vaccine. Overall, the educational and coordination strategies we used to address vaccine hesitancy, resources we shared for informed decision making, and methods to increase access of the COVID-19 vaccine in LTCFs will be critical for future vaccine initiatives.</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Shannon Xydis, Projects Administrator, HAI Coordinator, Chicago Department of Public Health; Liz Shane, MPH, CIC. Infection Prevention Specialist, Chicago Department of Public Health, and Christy Zelinski, MPH, Project Manager and Contractor, COVID-19 Response Bureau, Chicago Department of Public Health\"}',1,'2024-07-21 22:39:06','2024-07-21 22:39:06','443f8fbf-3ffd-48e1-a25e-5fbd914f508f'),(43956,43956,1,NULL,'__temp_sozuhstdiupdlrwxixaaustdalqrzkeiqgux',NULL,NULL,1,'2024-07-21 22:39:06','2024-07-21 22:39:06','52e524ce-088f-4c1d-8ca7-106581837f82'),(43958,43958,1,'Christy Zelinski',NULL,NULL,NULL,1,'2024-07-21 22:40:29','2024-07-21 22:40:29','1c255c8a-c88b-4ad3-9493-b66348d4074a'),(43959,43959,1,'Liz Shane',NULL,NULL,NULL,1,'2024-07-21 22:40:30','2024-07-21 22:40:30','db31729d-643f-4463-9171-adc8e1e2d598'),(43960,43960,1,'Shannon Xydis',NULL,NULL,NULL,1,'2024-07-21 22:40:30','2024-07-21 22:40:30','4352d2f3-e3d8-49e6-8ee7-02690b82c621'),(43961,43961,1,'Local: LTCF Vaccine Education Program Vital to Chicago’s COVID-19 Outbreak Response Effort','local-ltcf-vaccine-education-program-vital-to-chicagos-covid-19-outbreak-response-effort','news/local-ltcf-vaccine-education-program-vital-to-chicagos-covid-19-outbreak-response-effort','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>The COVID-19 vaccine roll out in Chicago’s long-term care facilities (LTCFs) was a component of a larger initiative to increase vaccine uptake in the City of Chicago. As the Federal Pharmacy Partnership Program (PPP) was introduced, the Chicago Department of Public Health (CDPH) offered to liaise with LTCFs and facilitate the vaccination process. We were uniquely positioned to assist in LTCFs because of existing relationships with LTCFs after the past year of routine individual facility engagement for COVID-19-related infection control guidance. We worked with the community and leveraged the healthcare facility communication platforms we created to support LTCFs during the pandemic to address vaccine hesitancy and provide vaccine education.</p><p>We acted quickly to facilitate vaccination coordination in LTCFs because they were included in the first phase of vaccine distribution due to their residents’ high risk of COVID-19 morbidity and mortality. In partnership with Project Hope, we held two listening sessions with Directors of Nursing, Assistant Directors of Nursing, and Infection Preventionists at LTCFs in Chicago where we assessed their levels of vaccine hesitancy, discussed vaccine hesitancy among residents, and collected ideas on how to increase vaccine uptake. For example, during the listening sessions we heard concerns from communities of color who felt targeted and pressured to get vaccinated and were hesitant about getting it.</p><p>We used the information shared and questions asked during the listening sessions to better tailor our vaccine education efforts in LTCFs. These efforts included:</p><ul><li>Converting our weekly COVID-19 LTCF roundtables into a vaccine education and implementation series. During these roundtables, we discussed vaccine hesitancy and encouraged LTCF leaders to empower their staff to become vaccine influencers. We also shared with LTCF leadership concerns we heard from staff and residents and suggested LTCF leaders use the information to adjust their vaccine responses to the needs of residents and staff. For example, we heard that some LTCF staff were hesitant because of how quickly it was being rolled out and concerns about being used as test subjects, so many administrators got the vaccine in front of their staff to show confidence in it. In the early stages of the PPP, representatives from different pharmacies spoke about logistics and provided answers about the vaccination process.</li><li>The CDPH Commissioner hosting a Q&amp;A session for all facilities, which was advertised to all residents and their families.</li><li>Transforming our existing testing strike teams into vaccine mobilization and education teams. The vaccine education teams used the information from the listening sessions to address the concerns of LTCF staff and residents. People viewed the vaccine education teams as trusted sources of information that could speak about the vaccine without outside influences. At one facility, we saw a 40 percent increase in vaccine uptake after one education event. Leadership at the LTCF and the vaccine education team worked together to organize the event.</li></ul><p>We kept learning new information as our efforts continued, like the importance of expanding vaccine education initiatives beyond staff and residents at LTCFs. We found that, in many cases, the healthcare power of attorney for residents of LTCFs declined the vaccine on behalf of the residents. Typically, the healthcare powers of attorney do not attend the vaccine education events and miss these opportunities. This gap underscored the importance of empowering family and community members to be vaccine champions.</p><p>During the roll out of COVID-19 vaccinations in LTCFs, we continued to appreciate the importance of coordination and planning. Much planning was required to make the vaccine readily available in facilities, particularly second doses. A lot of coordination was also needed to ensure a seamless transition to LTC pharmacies when the PPP ended. Before the PPP ended, we quickly surveyed facilities to identify their LTC pharmacies and encouraged those pharmacies to enroll as COVID-19 vaccine providers. We found that some of Chicago’s LTC pharmacies were located outside of Chicago borders. We could not deliver vaccine to those facilities because the union contracts of our drivers meant they could only drive within the boundaries of Chicago. In order to overcome this roadblock, we partnered with the Illinois Department of Public Health (IDPH) and provided them with doses of Moderna through Tiberius. IDPH then distributed the vaccine to LTC pharmacies that served Chicago facilities, but were based outside of city limits.</p><p>The challenges, successes, and experiences supporting COVID-19 vaccine uptake at LTCFs helped us identify strategies to address vaccine hesitancy going forward. Given high staff and resident turnover in LTCFs, it is important to keep high vaccination coverage in LTCFs. It is also important to continue education efforts about vaccines and vaccine hesitancy. We saw that individuals who were hesitant to receive the COVID-19 vaccine may have also been hesitant to get the influenza vaccine. Overall, the educational and coordination strategies we used to address vaccine hesitancy, resources we shared for informed decision making, and methods to increase access of the COVID-19 vaccine in LTCFs will be critical for future vaccine initiatives.</p><figure class=\\\"image\\\"><img src=\\\"{asset:43960:transform:medium||https://corha.org/admin/actions/assets/generate-transform}?transformId=360\\\" width=\\\"300\\\" height=\\\"273\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Shannon Xydis</p><figure class=\\\"image\\\"><img src=\\\"{asset:43959:transform:medium||https://corha.org/admin/actions/assets/generate-transform}?transformId=359\\\" width=\\\"300\\\" height=\\\"273\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Liz Shane</p><figure class=\\\"image\\\"><img src=\\\"{asset:43958:transform:medium||https://corha.org/admin/actions/assets/generate-transform}?transformId=358\\\" width=\\\"300\\\" height=\\\"273\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Christy Zelinski</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Shannon Xydis, Projects Administrator, HAI Coordinator, Chicago Department of Public Health; Liz Shane, MPH, CIC. Infection Prevention Specialist, Chicago Department of Public Health, and Christy Zelinski, MPH, Project Manager and Contractor, COVID-19 Response Bureau, Chicago Department of Public Health\"}',1,'2024-07-21 22:41:41','2024-07-21 22:41:41','333f81b3-b433-4d85-9e57-5c4f9e4638ea'),(43962,43962,1,'State: How the Texas State Healthcare-Associated Infections (HAI) Program Increased Capacity in Public Health Regions to Support Healthcare Facilities During the COVID-19 Response','state-how-the-texas-state-healthcare-associated-infections-hai-program-increased-capacity-in-public-health-regions-to-support-healthcare-facilities-during-the-covid-19-response','news/state-how-the-texas-state-healthcare-associated-infections-hai-program-increased-capacity-in-public-health-regions-to-support-healthcare-facilities-during-the-covid-19-response','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>The COVID-19 pandemic presented challenges in how our Healthcare-Associated Infections and Antimicrobial-Resistant Pathogens (HAI/AR) Program provides support to long-term care facilities (LTCF) experiencing outbreaks. As the pandemic unfolded, we quickly realized the need to increase our infection prevention capacity. We sought out support from leadership and partners to modify our staffing structures in order to provide continued quality and focused support to our healthcare facilities.</p><p>The Texas Department of State Health Services (DSHS) is divided into 8 public health regions, with 64 local health departments that operate at the county or city level. Texas has approximately 4,000 licensed nursing facilities, assisted living facilities, and group homes including 1,200 Centers for Medicare &amp; Medicaid Services (CMS)-certified nursing homes, across 254 counties. Traditionally, one HAI Epidemiologist is assigned to each public health region to lead and support HAI outbreak response activities, including providing direct assistance and on-site infection control assessments to healthcare facilities. The Texas Department of State Health Services (DSHS) is divided into 8 public health regions, with 64 local health departments that operate at the county or city level. Texas has approximately 4,000 licensed nursing facilities, assisted living facilities, and group homes including 1,200 Centers for Medicare &amp; Medicaid Services (CMS)-certified nursing homes, across 254 counties. Traditionally, one HAI Epidemiologist is assigned to each public health region to lead and support HAI outbreak response activities, including providing direct assistance and on-site infection control assessments to healthcare facilities.</p><p>This structure worked for our team until the onset of the COVID-19 pandemic when it became evident that one HAI Epidemiologist per public health region was insufficient to support the surge in COVID-19 cases. So, we explored the options of increasing infection prevention staff at our public health regions to build capacity for our COVID-19 response.</p><p>We received approval and support to build staffing capacity from DSHS leadership, and they provided us with the resources to contract with 3 Infection Preventionists per public health region, for a total of 24 additional Infection Preventionists throughout the state. The real challenge, however, was finding certified Infection Preventionists to recruit. At that time, healthcare facilities and local health departments were also in the process of recruiting Infection Preventionists, so we were competing for contractors in a limited pool. We decided to partner with the Association for Professionals in Infection Control and Epidemiology (APIC) who aided with the recruitment process. Out of the 24 Infection Preventionists we sought to recruit, we were able to contract with 17. These additional Infection Preventionists were instrumental in building our capacity during the response. They performed on-site infection control assessments and provided dedicated support to meet the needs of facilities.</p><p>From the first quarter of 2021, we started seeing a decrease in the number of requests for assistance from our regulatory partners and healthcare facilities, and as a result, we reduced the number of APIC contractors. It was important for us to still maintain a reasonable number of staff to assist with the continued pandemic, so we currently have at least one contracted Infection Preventionist in each public health region to assist the assigned HAI Epidemiologist with outbreak response activities.</p><p>Coordinating with the Texas Health and Human Services Commission (HHSC)—our regulatory branch—and utilizing established communication pathways facilitated the coordination of our response activities. We held daily meetings with HHSC, DSHS, and the Division of Emergency Management’s State Operations Center (SOC), where all communication plans and guidance were developed for dissemination to facilities by HHSC.</p><p>Thanks to the support of DSHS leadership and partners, as well as the dedication of our team, we worked together in a coordinated fashion to build capacity and respond to COVID-19 outbreaks in healthcare facilities.</p><figure class=\\\"image\\\"><img src=\\\"{asset:43965:transform:medium||/assets/images/transf/_medium/43965/enyinnaya-merengwa.webp}\\\" alt=\\\"Enyinnaya Merengwa Headshot\\\" width=\\\"300\\\" height=\\\"275\\\" /></figure><p><i>Enyinnaya Merengwa, Healthcare Safety Investigations Group Manager and State HAI Coordinator at the Texas Department of State Health Services</i></p><figure class=\\\"image\\\"><img src=\\\"{asset:43964:transform:medium||/assets/images/transf/_medium/43964/thi-dang.webp}\\\" alt=\\\"Thi Dang Headshot\\\" width=\\\"300\\\" height=\\\"301\\\" /></figure><p><i>Thi Dang, HAI Epidemiologist at the Texas Department of State Health Services</i></p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Enyinnaya Merengwa, MD, DrPH, MHA, MPH & Thi Dang\", \"ccabfff6-2908-407e-98d3-a22686d82840\": {\"score\": \"poor\", \"social\": {\"twitter\": {\"title\": \"State: How the Texas State Healthcare-Associated Infections (HAI) Program Increased Capacity in Public Health Regions to Support Healthcare Facilities During the COVID-19 Response - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"Texas\'s HAI program enhances capacity in public health regions to support healthcare facilities during the COVID-19 response efforts.\"}, \"facebook\": {\"title\": \"State: How the Texas State Healthcare-Associated Infections (HAI) Program Increased Capacity in Public Health Regions to Support Healthcare Facilities During the COVID-19 Response - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"Texas\'s HAI program enhances capacity in public health regions to support healthcare facilities during the COVID-19 response efforts.\"}}, \"advanced\": {\"robots\": [], \"canonical\": \"\"}, \"keywords\": [{\"rating\": \"poor\", \"keyword\": \"best practices\"}, {\"rating\": \"poor\", \"keyword\": \"health communication\"}, {\"rating\": \"poor\", \"keyword\": \"infectious disease\"}, {\"rating\": \"poor\", \"keyword\": \"health challenges\"}, {\"rating\": \"good\", \"keyword\": \"HAI\"}, {\"rating\": \"good\", \"keyword\": \"Texas\"}, {\"rating\": \"poor\", \"keyword\": \"state health department\"}], \"titleRaw\": {\"1\": \"State: How the Texas State Healthcare-Associated Infections (HAI) Program Increased Capacity in Public Health Regions to Support Healthcare Facilities During the COVID-19 Response\"}, \"descriptionRaw\": \"Texas\'s HAI program enhances capacity in public health regions to support healthcare facilities during the COVID-19 response efforts.\"}, \"dd06f1a1-3c4f-4001-adc3-f3c0a94550ac\": [1558], \"f88904a1-7870-468f-8885-f14ce93db364\": []}',1,'2024-07-21 22:42:20','2024-12-03 20:26:13','1d5c4fa4-d7d8-4edb-99ae-e4db63a95649'),(43963,43963,1,NULL,'__temp_xvexlirlbrwikocwjvbesmzqtuudcktanfdg',NULL,'{\"b691f1c7-ad7d-4a8b-a9fa-b4feec58e073\": [49827]}',1,'2024-07-21 22:42:23','2025-03-24 19:07:53','b39d55ce-57ad-438a-b3b3-51f7815390e6'),(43964,43964,1,'Thi dang',NULL,NULL,NULL,1,'2024-07-21 22:43:41','2024-07-21 22:43:41','88725b63-95cd-4fb3-9779-6b6a2bd860f6'),(43965,43965,1,'Enyinnaya merengwa',NULL,NULL,NULL,1,'2024-07-21 22:43:41','2024-07-21 22:43:41','5e5885a8-b6d1-4391-9705-14d32d79d51d'),(43966,43966,1,'State: How the Texas State Healthcare-Associated Infections (HAI) Program Increased Capacity in Public Health Regions to Support Healthcare Facilities During the COVID-19 Response','state-how-the-texas-state-healthcare-associated-infections-hai-program-increased-capacity-in-public-health-regions-to-support-healthcare-facilities-during-the-covid-19-response','news/state-how-the-texas-state-healthcare-associated-infections-hai-program-increased-capacity-in-public-health-regions-to-support-healthcare-facilities-during-the-covid-19-response','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>The COVID-19 pandemic presented challenges in how our Healthcare-Associated Infections and Antimicrobial-Resistant Pathogens (HAI/AR) Program provides support to long-term care facilities (LTCF) experiencing outbreaks. As the pandemic unfolded, we quickly realized the need to increase our infection prevention capacity. We sought out support from leadership and partners to modify our staffing structures in order to provide continued quality and focused support to our healthcare facilities.</p><p>The Texas Department of State Health Services (DSHS) is divided into 8 public health regions, with 64 local health departments that operate at the county or city level. Texas has approximately 4,000 licensed nursing facilities, assisted living facilities, and group homes including 1,200 Centers for Medicare &amp; Medicaid Services (CMS)-certified nursing homes, across 254 counties. Traditionally, one HAI Epidemiologist is assigned to each public health region to lead and support HAI outbreak response activities, including providing direct assistance and on-site infection control assessments to healthcare facilities. The Texas Department of State Health Services (DSHS) is divided into 8 public health regions, with 64 local health departments that operate at the county or city level. Texas has approximately 4,000 licensed nursing facilities, assisted living facilities, and group homes including 1,200 Centers for Medicare &amp; Medicaid Services (CMS)-certified nursing homes, across 254 counties. Traditionally, one HAI Epidemiologist is assigned to each public health region to lead and support HAI outbreak response activities, including providing direct assistance and on-site infection control assessments to healthcare facilities.</p><p>This structure worked for our team until the onset of the COVID-19 pandemic when it became evident that one HAI Epidemiologist per public health region was insufficient to support the surge in COVID-19 cases. So, we explored the options of increasing infection prevention staff at our public health regions to build capacity for our COVID-19 response.</p><p>We received approval and support to build staffing capacity from DSHS leadership, and they provided us with the resources to contract with 3 Infection Preventionists per public health region, for a total of 24 additional Infection Preventionists throughout the state. The real challenge, however, was finding certified Infection Preventionists to recruit. At that time, healthcare facilities and local health departments were also in the process of recruiting Infection Preventionists, so we were competing for contractors in a limited pool. We decided to partner with the Association for Professionals in Infection Control and Epidemiology (APIC) who aided with the recruitment process. Out of the 24 Infection Preventionists we sought to recruit, we were able to contract with 17. These additional Infection Preventionists were instrumental in building our capacity during the response. They performed on-site infection control assessments and provided dedicated support to meet the needs of facilities.</p><p>From the first quarter of 2021, we started seeing a decrease in the number of requests for assistance from our regulatory partners and healthcare facilities, and as a result, we reduced the number of APIC contractors. It was important for us to still maintain a reasonable number of staff to assist with the continued pandemic, so we currently have at least one contracted Infection Preventionist in each public health region to assist the assigned HAI Epidemiologist with outbreak response activities.</p><p>Coordinating with the Texas Health and Human Services Commission (HHSC)—our regulatory branch—and utilizing established communication pathways facilitated the coordination of our response activities. We held daily meetings with HHSC, DSHS, and the Division of Emergency Management’s State Operations Center (SOC), where all communication plans and guidance were developed for dissemination to facilities by HHSC.</p><p>Thanks to the support of DSHS leadership and partners, as well as the dedication of our team, we worked together in a coordinated fashion to build capacity and respond to COVID-19 outbreaks in healthcare facilities.</p><figure class=\\\"image\\\"><img src=\\\"{asset:43965:transform:medium||https://corha.org/admin/actions/assets/generate-transform}?transformId=365\\\" width=\\\"300\\\" height=\\\"275\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Enyinnaya Merengwa</p><figure class=\\\"image\\\"><img src=\\\"{asset:43964:transform:medium||https://corha.org/admin/actions/assets/generate-transform}?transformId=366\\\" width=\\\"300\\\" height=\\\"301\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Thi Dang</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Dr. Enyinnaya Merengwa, Healthcare Safety Investigations Group Manager and State HAI Coordinator at the Texas Department of State Health Services and Thi Dang, HAI Epidemiologist at the Texas Department of State Health Services\"}',1,'2024-07-21 22:44:30','2024-07-21 22:44:30','a536960b-9c0b-443c-8011-6df1b930fa2c'),(43967,43967,1,NULL,'__temp_xvexlirlbrwikocwjvbesmzqtuudcktanfdg',NULL,NULL,1,'2024-07-21 22:44:30','2024-07-21 22:44:30','b7f2e078-797d-40bc-bbe3-c748f683d755'),(43968,43968,1,'State: Montana Leverages Partnerships to Manage COVID-19 Outbreaks in Long-Term Care Facilities','state-montana-leverages-partnerships-to-manage-covid-19-outbreaks-in-long-term-care-facilities','news/state-montana-leverages-partnerships-to-manage-covid-19-outbreaks-in-long-term-care-facilities','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>Montana, the fourth largest state geographically in the U.S., spans more than 147,000 square miles (slightly larger than Japan) and is home to about 1 million people. Montana has a decentralized public health system so a lot of the authority and responsibility for implementing rules and regulations and every aspect of pandemic response actually land with the counties, many of which have limited staff. In order to provide public health support to city and rural areas, we partnered with our state’s local health departments, survey agency, Quality Innovation Network-Quality Improvement Organization (QIN/QIO), hospital and public health preparedness teams, and laboratory partners to identify and provide support to LTCF experiencing COVID-19 outbreaks. We worked closely with these partners prior to the pandemic, so these existing relationships led to a coordinated approach during the COVID-19 response.</p><p>Our team coordinates outbreak response efforts with local public health departments, healthcare facilities, and the state survey agency. At the beginning of the pandemic, I communicated with facilities at least daily to get updates on their COVID-19 outbreaks and to provide guidance and technical assistance, including offering COVID-19 focused infection control assessments (ICAR) to all healthcare facilities in Montana. I now check in with LTCFs/ALFs and local public health at least weekly to monitor active outbreaks. Our local health departments really stepped up during the pandemic. Given Montana’s decentralized governance structure, our local health department staff take on multiple roles and usually do not have a dedicated communicable disease staff person, so their collaboration with us and their engagement with the facilities was a huge benefit to the response.</p><p>The Montana HAI Program hosted weekly webinars for all Montana APIC chapter members, as well as Infection Preventionists from other states. This webinar series—which was established prior to the pandemic—provided a platform to communicate updates, share resources and provide trainings to Infection Preventionists. It also helped strengthen our relationship with Infection Preventionists, which led to timely and frequent communication about outbreaks in facilities. Additionally, in November of 2020, our HAI Program partnered with a local acute care hospital and the Agency for Healthcare Research and Quality to provide a 16-week LTCF training course primarily focused on COVID-19. We also leveraged our good relationship with QIN/QIOs and our hospital association to use their communications channels to send important messages and updates to facilities state-wide.</p><p>As a rural state, we faced unique challenges when it came to reaching every facility. Testing for example was a huge logistical challenge, since some facilities are not located near a hospital and our laboratory courier system could not reach every facility. We were fortunate to have our Governor’s support and some time to plan and respond, so we worked with our state public health laboratory and other laboratory partners to figure out ways to offer baseline testing and implement surveillance testing prior to national LTCF testing recommendations took effect.</p><p>We also worked closely with the hospital preparedness and public health preparedness programs (HPP), using data from the National Healthcare Safety Network (NHSN) to address PPE and other supply shortages in LTCFs. Each week, the HPP Coordinator submitted the State LTCF Integrated Red Report, which we used to reach out to facilities reporting PPE and staffing shortages. During this outreach, we reminded facilities of the staffing and PPE resources available through the state and communicated information on how to obtain these resources.</p><p>One of the biggest contributing factors to the success of our response was the additional funding from CDC which led to the growth of our HAI Program. We were able to expand our HAI Program team to four Infection Preventionists who now consult with facilities, perform infection control assessments, and provide direct support and assistance to facilities. The additional funding has also allowed us to expand the services we offer to facilities. As a rural state, we have more Critical Access Hospitals, so our infection prevention activities have focused on providing one-on-one support to these facilities, which typically have limited staff who are stretched across multiple roles. During the pandemic, we were able to expand these services to LTCFs and Assisted Living Facilities and have hopes to expand to other types of congregate living settings including outpatient health clinics, dialysis centers, schools, and jails.</p><p>Our experience during this pandemic has highlighted the importance of infection control. We have learned that infection control is a responsibility and duty of everyone in the facility, and this facility-wide approach to infection prevention can contribute to a successful outcome. We also recognize the importance of inter and intra-facility communication, as well as communicating information to residents and family members to prevent the spread of infections and outbreaks. We were met with challenges every day, but because of our hard working and dedicated Infection Preventionists, we were able to overcome a lot of them. It has also been inspiring to work with our amazing healthcare workers and public health staff during the response. We have a lot of work in front us, but I remain excited because this experience has been the catalyst for us to enhance our infection prevention activities, expand our reach and support, and provide guidance and education on infection prevention standards.</p><figure class=\\\"image\\\"><img src=\\\"{asset:43970:transform:medium||/assets/images/transf/_medium/43970/erika-baldry.webp}\\\" alt=\\\"Erika Baldry Headshot\\\" width=\\\"300\\\" height=\\\"401\\\" /></figure><p><i>Erika Baldry, Healthcare-Associated Infections and Antimicrobial Resistance (HAI/AR) Epidemiologist and Program Coordinator at the Montana Department of Public Health and Human Services (DPHHS)</i></p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Erika Baldry, MPH, CIC\", \"ccabfff6-2908-407e-98d3-a22686d82840\": {\"score\": \"poor\", \"social\": {\"twitter\": {\"title\": \"State: Montana Leverages Partnerships to Manage COVID-19 Outbreaks in Long-Term Care Facilities - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"Montana leverages partnerships to effectively manage COVID-19 outbreaks in long-term care facilities, ensuring better health outcomes.\"}, \"facebook\": {\"title\": \"State: Montana Leverages Partnerships to Manage COVID-19 Outbreaks in Long-Term Care Facilities - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"Montana leverages partnerships to effectively manage COVID-19 outbreaks in long-term care facilities, ensuring better health outcomes.\"}}, \"advanced\": {\"robots\": [], \"canonical\": \"\"}, \"keywords\": [{\"rating\": \"poor\", \"keyword\": \"best practices\"}, {\"rating\": \"good\", \"keyword\": \"partnerships\"}, {\"rating\": \"poor\", \"keyword\": \"infectious disease\"}, {\"rating\": \"poor\", \"keyword\": \"health challenges\"}, {\"rating\": \"poor\", \"keyword\": \"MT\"}, {\"rating\": \"poor\", \"keyword\": \"state health department\"}], \"titleRaw\": {\"1\": \"State: Montana Leverages Partnerships to Manage COVID-19 Outbreaks in Long-Term Care Facilities\"}, \"descriptionRaw\": \"Montana leverages partnerships to effectively manage COVID-19 outbreaks in long-term care facilities, ensuring better health outcomes.\"}, \"dd06f1a1-3c4f-4001-adc3-f3c0a94550ac\": [1558], \"f88904a1-7870-468f-8885-f14ce93db364\": []}',1,'2024-07-21 22:44:51','2024-12-03 20:27:55','292cca7c-9492-4f61-8880-30822f85e230'),(43969,43969,1,NULL,'__temp_dvsobebzouyzkcsnsecuqdvoricmwkavmsyk',NULL,'{\"b691f1c7-ad7d-4a8b-a9fa-b4feec58e073\": []}',1,'2024-07-21 22:45:10','2024-08-08 16:39:54','ff3c4579-6355-44ab-87e8-d22c11292aff'),(43970,43970,1,'Erika baldry',NULL,NULL,NULL,1,'2024-07-21 22:46:49','2024-07-21 22:46:49','26fd289c-baa0-4552-ab07-4da8579b2f97'),(43971,43971,1,'State: Montana Leverages Partnerships to Manage COVID-19 Outbreaks in Long-Term Care Facilities','state-montana-leverages-partnerships-to-manage-covid-19-outbreaks-in-long-term-care-facilities','news/state-montana-leverages-partnerships-to-manage-covid-19-outbreaks-in-long-term-care-facilities','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>Montana, the fourth largest state geographically in the U.S., spans more than 147,000 square miles (slightly larger than Japan) and is home to about 1 million people. Montana has a decentralized public health system so a lot of the authority and responsibility for implementing rules and regulations and every aspect of pandemic response actually land with the counties, many of which have limited staff. In order to provide public health support to city and rural areas, we partnered with our state’s local health departments, survey agency, Quality Innovation Network-Quality Improvement Organization (QIN/QIO), hospital and public health preparedness teams, and laboratory partners to identify and provide support to LTCF experiencing COVID-19 outbreaks. We worked closely with these partners prior to the pandemic, so these existing relationships led to a coordinated approach during the COVID-19 response.</p><p>Our team coordinates outbreak response efforts with local public health departments, healthcare facilities, and the state survey agency. At the beginning of the pandemic, I communicated with facilities at least daily to get updates on their COVID-19 outbreaks and to provide guidance and technical assistance, including offering COVID-19 focused infection control assessments (ICAR) to all healthcare facilities in Montana. I now check in with LTCFs/ALFs and local public health at least weekly to monitor active outbreaks. Our local health departments really stepped up during the pandemic. Given Montana’s decentralized governance structure, our local health department staff take on multiple roles and usually do not have a dedicated communicable disease staff person, so their collaboration with us and their engagement with the facilities was a huge benefit to the response.</p><p>The Montana HAI Program hosted weekly webinars for all Montana APIC chapter members, as well as Infection Preventionists from other states. This webinar series—which was established prior to the pandemic—provided a platform to communicate updates, share resources and provide trainings to Infection Preventionists. It also helped strengthen our relationship with Infection Preventionists, which led to timely and frequent communication about outbreaks in facilities. Additionally, in November of 2020, our HAI Program partnered with a local acute care hospital and the Agency for Healthcare Research and Quality to provide a 16-week LTCF training course primarily focused on COVID-19. We also leveraged our good relationship with QIN/QIOs and our hospital association to use their communications channels to send important messages and updates to facilities state-wide.</p><p>As a rural state, we faced unique challenges when it came to reaching every facility. Testing for example was a huge logistical challenge, since some facilities are not located near a hospital and our laboratory courier system could not reach every facility. We were fortunate to have our Governor’s support and some time to plan and respond, so we worked with our state public health laboratory and other laboratory partners to figure out ways to offer baseline testing and implement surveillance testing prior to national LTCF testing recommendations took effect.</p><p>We also worked closely with the hospital preparedness and public health preparedness programs (HPP), using data from the National Healthcare Safety Network (NHSN) to address PPE and other supply shortages in LTCFs. Each week, the HPP Coordinator submitted the State LTCF Integrated Red Report, which we used to reach out to facilities reporting PPE and staffing shortages. During this outreach, we reminded facilities of the staffing and PPE resources available through the state and communicated information on how to obtain these resources.</p><p>One of the biggest contributing factors to the success of our response was the additional funding from CDC which led to the growth of our HAI Program. We were able to expand our HAI Program team to four Infection Preventionists who now consult with facilities, perform infection control assessments, and provide direct support and assistance to facilities. The additional funding has also allowed us to expand the services we offer to facilities. As a rural state, we have more Critical Access Hospitals, so our infection prevention activities have focused on providing one-on-one support to these facilities, which typically have limited staff who are stretched across multiple roles. During the pandemic, we were able to expand these services to LTCFs and Assisted Living Facilities and have hopes to expand to other types of congregate living settings including outpatient health clinics, dialysis centers, schools, and jails.</p><p>Our experience during this pandemic has highlighted the importance of infection control. We have learned that infection control is a responsibility and duty of everyone in the facility, and this facility-wide approach to infection prevention can contribute to a successful outcome. We also recognize the importance of inter and intra-facility communication, as well as communicating information to residents and family members to prevent the spread of infections and outbreaks. We were met with challenges every day, but because of our hard working and dedicated Infection Preventionists, we were able to overcome a lot of them. It has also been inspiring to work with our amazing healthcare workers and public health staff during the response. We have a lot of work in front us, but I remain excited because this experience has been the catalyst for us to enhance our infection prevention activities, expand our reach and support, and provide guidance and education on infection prevention standards.</p><figure class=\\\"image\\\"><img src=\\\"{asset:43970:transform:medium||https://corha.org/admin/actions/assets/generate-transform}?transformId=369\\\" width=\\\"300\\\" height=\\\"401\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Erika Baldry</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Erika Baldry, Healthcare-Associated Infections and Antimicrobial Resistance (HAI/AR) Epidemiologist and Program Coordinator at the Montana Department of Public Health and Human Services (DPHHS)\"}',1,'2024-07-21 22:47:20','2024-07-21 22:47:20','c106c174-9367-452c-99b7-9565a8d8e8f8'),(43972,43972,1,NULL,'__temp_dvsobebzouyzkcsnsecuqdvoricmwkavmsyk',NULL,NULL,1,'2024-07-21 22:47:20','2024-07-21 22:47:20','05edf709-b9d2-4933-8758-be4f74ed0e9c'),(43975,43975,1,'November 2023 Fall Meeting Recap','november-2023-fall-meeting-recap','news/november-2023-fall-meeting-recap','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>CORHA members and partners convened in Atlanta, GA for the annual hybrid CORHA Fall Meeting. Council members engaged in two days of meeting discussions that ranged from data modernization and sharing of HAI/AR data, detection and response for respiratory viruses, and robust breakout sessions from CORHA’s three <a href=\\\"https://www.corha.org/corha-governance-committee-members/corha-workgroups/\\\">workgroups</a>. In addition, Council members were briefed on updates to the <a href=\\\"https://www.corha.org/resources/corha-principles-and-practices-for-outbreak-response/\\\">CORHA Principles and Practices for Healthcare Outbreak Response</a> chapters and other products, such as a <a href=\\\"https://old.corha.org/wp-content/uploads/2023/11/HAI-Patient-Notification-Framework-one-pager_Oct-2023.pdf\\\">one-pager</a> to accompany the <a href=\\\"https://old.corha.org/wp-content/uploads/2020/04/Framework-for-HAI-Outbreak-Notification.pdf\\\">Framework for Healthcare-Associated Infection Outbreak Notification</a> document.</p><p>The Council also analyzed the <a href=\\\"https://www.corha.org/corha-governance-committee-members/strategies/\\\">strategic map</a> and considered key strategies for CORHA to achieve its <a href=\\\"https://www.corha.org/corha-governance-committee-members/mission-vision-and-membership/\\\">mission, vision, and goals</a>. The primary strategies discussed were (1) review pertinent policies and guidance documents issued by CORHA’s member organizations to ensure they meet the needs of the Council’s stakeholders, and (2) raise awareness amongst policymakers and the public to support HAI/AR outbreak response. In response to these areas of focus, members discussed how CORHA will continue to engage with and identify member organization needs, set priorities, and explore ways to review and disseminate new guidance documents. Members also agreed that endorsement by CORHA is highly valued, and opportunities for CORHA to provide such endorsements and aggregate multidisciplinary feedback will be explored. Addressing the second strategy, members identified that CORHA can collaborate with state health departments for surveillance and data reports, using storytelling and other methods to make data more widely accessible. Finally, leveraging member organizations’ social media for increased CORHA visibility, proactively preparing materials in advance of outbreaks, and rethinking data sharing are other key strategies to further the goals of the Council.</p><figure class=\\\"image\\\"><img src=\\\"{asset:43855:url||/assets/images/Picture1-1-1.jpg}\\\" width=\\\"800\\\" height=\\\"450\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">2023 CORHA Fall Meeting Attendees</p><p>Priority areas for CORHA members are efforts to enhance awareness of CORHA’s goals and objectives among policymakers, the public, and both public health and healthcare professionals. Council members also strive to increase the utilization of genomic data in outbreak scenarios, enhance public sharing of outbreak information, and address gaps in respiratory illnesses, multidrug-resistant organisms, and outbreaks of non-reportable conditions. Future activities also involve updating existing guidance, such as transforming influenza and COVID-19 guidance into universal respiratory infection guidance.</p><p>As CORHA heads into 2024, the Council will begin working on drafting a new strategic map for 2025 onwards. Fall Meeting discussions will continue to be deepened and expanded upon through workgroup and governance committee activities. Workgroup and Council-wide discussions will frame the direction of CORHA and inform ongoing and future activities to provide the most up-to-date resources to build, standardize, and improve HAI/AR outbreak detection, reporting, investigation, and control. To stay informed on CORHA activities, please continue reading the monthly <a href=\\\"https://naccho.realmagnet.land/corha-correspondence-newsletter\\\">CORHA Correspondence</a> newsletter.</p>\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CORHA members and partners convened in Atlanta, GA for the annual hybrid CORHA Fall Meeting.\"}',1,'2024-07-21 22:50:46','2024-07-21 22:50:46','2b2ff843-c6e6-4fd9-ac12-5e0266719655'),(43976,43976,1,NULL,'__temp_psvfiyzokncevcbyvgspvvhbbwykkibaezoq',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>CORHA members and partners convened in Atlanta, GA for the annual hybrid CORHA Fall Meeting. </p>\"}',1,'2024-07-21 22:50:46','2024-07-21 22:50:46','e440a31b-2785-4c85-93bb-0b647aea003d'),(43977,201,2,'Community home page 1',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','317eecb3-45db-475f-8b8b-6bda4acfe64e'),(43978,202,2,'Community home page 2',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','2b5b9eb1-ab3a-47ec-a967-8f20c7ae3bdf'),(43979,203,2,'Home page education2',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','c6d2431a-a15c-47a6-8a04-4592d31edeb7'),(43980,204,2,'14749172 ml women',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','0ca40579-8d09-4478-933f-27ffbe756cff'),(43981,205,2,'Technology unexpected consequences web',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','6cd4345f-f468-4f88-be05-09816885e7b7'),(43982,374,2,'Sequence 01_Vimeo on Vimeo',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','5a64743c-c5fa-4259-b94b-d6a91841f136'),(43983,413,2,'Sequence 01_Vimeo',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','63434150-cc1e-4b9d-8b02-a9ade131f97a'),(43984,790,2,'Pathogen scabies',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','089e25d7-ed58-47a1-8f8d-034e1ec83fc9'),(43985,1030,2,'Header pathogen detail',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','e3cb1627-3c85-4917-80d6-509168d0134a'),(43986,1031,2,'Header pathogen detail mobile',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','1d1374ec-c141-424f-ab43-c2fdc3221ff7'),(43987,1032,2,'Header pathogen detail tablet',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','d95f984f-02a3-49b7-a098-fc4b53425144'),(43988,1033,2,'Header scabies',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','d3b8baca-713a-496b-9615-5a654e3b0bc2'),(43989,1034,2,'Header simpler2 1',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','1f2e145d-5243-42eb-8e56-3c2f2829b4c4'),(43990,1035,2,'Header simpler2 1',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','7a79d716-f372-46be-86bb-374bdefac449'),(43991,1543,2,'Headshot',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','0a3428f6-becd-4db5-8500-e166df59903d'),(43992,1544,2,'1f361f3412cf20ed2fcba55cc7443284 1',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','d2bc4776-79b3-4573-9917-63f4df018a35'),(43993,1547,2,'83c67d8b9d776cae0c9b1510d52af95e',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','9dfa0dab-2b45-4c60-8b33-f9e237a75e7c'),(43994,1550,2,'B45e4a3e367dd113c944bc0bfa837645',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','47ff4873-b96f-4791-9730-55acfcfb635a'),(43995,1553,2,'14eed339057a3b0d93878e2f2477eb90',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','463534a0-b175-4696-bda9-c685f6f29993'),(43996,1557,2,'305fe57496acb9a1db30e7e0795e2bce',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','345a364b-444b-4dfa-9f85-7e7aa1a0df43'),(43997,1638,2,'Video',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','ea22e877-5f8a-4017-a3df-aa39dd58f86f'),(43998,1922,2,'6491eaf37493128edf39c48fb553bf3f min',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','c094d829-04d5-464b-9d4a-3e444a230577'),(43999,1924,2,'6491eaf37493128edf39c48fb553bf3f min',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','1b2492a1-2924-4f87-ac95-f3dc4c5180d7'),(44000,1933,2,'Bylaws min',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','f0691575-3cb5-4b49-a518-61fef41a76f3'),(44001,2072,2,'651becd78c76827acca3755b2c80ed6e min',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','d7f2a5d0-09d3-473f-a22d-d94cff632f0e'),(44002,2222,2,'Header Simpler2 1 3',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','a932d0bb-f543-4a97-915f-372b840b4027'),(44003,2431,2,'Archer Point Top 10 Reasons Moving from GP BC Infographic',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','d0139a4c-72a8-49f7-9df0-4c7f5c115cf5'),(44004,2437,2,'Loan Fund Investment Program LPP RFQ',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','6ca734dc-0026-4d2c-a8c8-24c5f79545dc'),(44005,2443,2,'Desktop Landing Page OPTION 1',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','07fe684c-9d9d-4674-8e41-e93fcab64964'),(44006,2449,2,'Rankings 187',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','947625fa-4057-4ce2-bbaa-2e766166e536'),(44007,3384,2,'About vision',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','96e3d1f9-103d-46c8-ba89-a4320ccb06a8'),(44008,3385,2,'About mission',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','5daf9590-433c-4bd7-a390-7c44640abc98'),(44009,3403,2,'Headers general workgroups min',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','059db1bb-eb83-4bbf-85b3-0a2f1c9ab8e4'),(44010,3431,2,'Policy Workgroup Charge Revised November 2022',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','33b9d9aa-da82-450d-adee-2d92564e732a'),(44011,3459,2,'Detection and Response Charge',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','e51fead8-2ae1-45ff-a9a4-4422b8555741'),(44012,3521,2,'Laboratory Workgroup Charge 2019',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','63650244-1da7-4fad-b52a-010e0d130f0e'),(44013,3639,2,'State Hover Brand CDC',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','3e143c4a-937a-418f-9211-efebab93c167'),(44014,3645,2,'State Hover Brand APIC',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','f340f9f4-5939-4c4c-883e-9e998a39fec1'),(44015,3653,2,'State Hover Brand Other',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','4f01e4c8-76e3-4f57-9c40-9c4ae627fc0a'),(44016,3663,2,'NACCHO',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','660c01ab-d876-4e65-8f0e-943954123c7f'),(44017,3674,2,'CSTE',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','39a1f430-88c4-4dbb-95f2-d96618faad27'),(44018,3685,2,'APIC',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','0345778f-32ed-470d-bb02-0bfe073bc1ff'),(44019,3696,2,'CDC',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','7db0bfca-4feb-4e25-a136-fe8fbdf9bdd7'),(44020,3708,2,'APHL',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','954d59ee-ac2b-4ba6-a10d-93fe962b8a06'),(44021,3722,2,'ASTHO',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','c91c8644-6463-4a5b-9edf-af40f5e9a0bb'),(44022,3738,2,'SHEA',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','ff6cc762-d736-4d8b-92c4-014fe763bcd5'),(44023,3792,2,'CDC 1',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','78af34c1-71ad-4587-b844-dbfe79b05124'),(44024,3811,2,'APIC Logo',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','f6ce3ff7-cd78-4c4e-a4b7-3c9688642339'),(44025,3830,2,'Cste large logo scaled e1632844105244 1',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','b4e421d3-2907-401d-be81-ca860e56631a'),(44026,3849,2,'Cste large logo scaled e1632844105244 1 1',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','c54b5d4b-6def-4073-a369-1271d5959a91'),(44027,3895,2,'Cste large logo scaled e1632844105244 1 2',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','69f02b6c-e4ed-4510-aae8-2c75db00dd29'),(44028,3905,2,'Cste large logo scaled e1632844105244 1 3',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','e6ec5ca5-7592-4a56-bd8f-cfb6a6d3292f'),(44029,3924,2,'Cste large logo scaled e1632844105244 1 4',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','34ed0c25-e515-4f98-841b-aa3f1d9717cd'),(44030,5630,2,'Icon role',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','835f97c7-5e12-471e-a9fb-c58f803e3027'),(44031,5633,2,'Icon facility',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','26fb97ec-560b-4954-aeda-6be39f549d2a'),(44032,7944,2,'Leadership erin epson',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','54e49329-639e-42fc-9449-eb6bccbcd72b'),(44033,7947,2,'Leadership joseph perz',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','9abfaa74-ce08-4dec-baa3-dd950387d50f'),(44034,7950,2,'Leadership dawn terashita',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','f7718000-19a3-46ba-aa78-d87cd530134d'),(44035,7951,2,'Leadership dawn terashita',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','e481101e-6d0e-4afe-98ec-ea336bf7c075'),(44036,7954,2,'Leadership natsha bagdasarian',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','ecc4e00e-b87a-4c45-a52f-d795f2334735'),(44037,7957,2,'Headers general leadership min',NULL,NULL,NULL,1,'2024-07-22 02:39:20','2024-07-22 02:39:20','3c1f39d4-3984-4152-a986-0a786da80e8e'),(44038,7958,2,'Headers general leadership min',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','881fa8d3-8d50-404d-8234-777eff51b99f'),(44039,7963,2,'Headers general leadership min',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','acd67457-9ca9-437f-8659-79047b22c474'),(44040,8167,2,'Headers general leadership min',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','096d18e5-83ea-4bf3-9cf1-b28a1df1b674'),(44041,8173,2,'Header general about min',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','e5006b42-7383-4645-baf6-2263754de798'),(44042,8180,2,'Header general bylaws min',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','c50de775-66ab-4399-ac04-65f72ec7f786'),(44043,8183,2,'Header general organizations min',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','84b73862-c9ed-4639-aee6-f5b2ea3d4fc2'),(44044,8190,2,'Header general organizations',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','c349c46f-c3ad-470a-92ce-4e2e05874e3d'),(44045,8195,2,'Header general map',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','a8607c6a-a8db-4060-a2e0-720299a252ff'),(44046,8216,2,'EKC Header',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','ad7ab3ae-54fe-4fcf-b5be-f4ca47f74a16'),(44047,8388,2,'Header general contact min',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','599064e3-e03f-490f-ade1-434f9306abd2'),(44048,8538,2,'Header chapters index',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','d31285da-8d37-40ae-bf64-e323a2193eff'),(44049,8616,2,'Header pathogens index',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','5b36473e-71c1-44e5-90a1-eab7fa8e4133'),(44050,8639,2,'EKC',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','889b12a6-410c-4a9b-a3c2-dc0f1e1f6ab1'),(44051,8663,2,'D9d78a52a7dacc64378803a4876eba89',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','62f7e2d7-30cd-4805-b88a-50343564723c'),(44052,8690,2,'3ae19f702c52f516349eac1aafa78a16',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','d2c77ed2-16a0-458d-bb23-95b548ecf150'),(44053,8720,2,'16a86c9419c50c1f31db2eb808c3b6bf',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','b65a1326-27d3-43d4-a526-2ed053a53641'),(44054,8766,2,'Icon copy link',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','3bae7f1b-b4be-4111-8d1f-5c020a4d074f'),(44055,8771,2,'Fce67bf8bf43dc07bc75e3057de2de26',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','6ade015b-8efa-4eb0-ba55-a9b038bef699'),(44056,8776,2,'Header chapters index min',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','5e3a3c23-0c00-402b-9384-18e443224e10'),(44057,8862,2,'http://staging.corha.org/assets/embed',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','735c1a07-022f-41c8-8984-ffade8c85695'),(44058,8863,2,'http://staging.corha.org/assets/embed',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','14b2eed6-0797-4433-8ade-647efeb79332'),(44059,8874,2,'4121618 uhd 3840 2160 25fps',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','ba28b8b0-2059-43e2-b919-bce2f3481d56'),(44060,9765,2,'1',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','9c2b2e09-5829-4a64-ae7b-30396062c83d'),(44061,9766,2,'2',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','ca1ca2c4-cb9b-450f-bd06-14eee10aaa7a'),(44062,9767,2,'3',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','6bac86a9-7e84-4b77-9f45-162e9a98351c'),(44063,9773,2,'4',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','b0281abf-de12-49e1-9712-01f269e00f40'),(44064,9774,2,'5',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','28d227fd-5773-49aa-93f9-83a28222ce55'),(44065,9775,2,'6',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','0ade7d19-0e4b-4204-b16b-4635b5752e07'),(44066,9776,2,'7',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','35d7c5d0-1b55-431b-a70f-bbba70c70ef1'),(44067,9777,2,'8',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','3439603b-6aed-483b-a533-4bd98d8d2282'),(44068,9778,2,'Medical product investigations',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','a8dfe0dc-53ab-4cdc-aa74-d3069497b556'),(44069,9779,2,'Supplement b',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','0dcb8573-2d43-4b2e-8a29-2f25c46c8ed9'),(44070,10640,2,'Burkholderia Cepacia',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','94c5480e-c565-4ba2-adad-48397f06873b'),(44071,10678,2,'Ebola',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','a85fcac3-c1ae-42f9-81d2-cd7f279d3470'),(44072,10749,2,'Fungal mold',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','39fcbc4c-cd60-4e89-8d75-b6c572e512ed'),(44073,10800,2,'Fungal mold',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','59733f08-8d89-4ac0-8078-edf09d8a012e'),(44074,12810,2,'23311 lores',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','0c2e3645-9349-48e7-ab54-241413e69b22'),(44075,14400,2,'COVID-19 Header',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','0e53ce4a-2c55-4fce-aa40-078c276648a5'),(44076,16018,2,'Legionella pneumophila',NULL,NULL,NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','5fb6d18b-31da-4195-a690-c51e51b38981'),(44077,1558,2,'Spotlight Series','spotlight-series','news-categories/spotlight-series','{\"102df2a3-623b-4df3-8e68-bd9829d72d3e\": \"Join us for a look at the successes and challenges experienced on the local, state, and national levels when responding to and managing HAI/AR outbreaks. Articles in the series span the healthcare continuum and include leadership perspectives and ideas for improving policies and practices related to healthcare outbreak detection, investigation, and control.\", \"e53a5ae1-81eb-4a5c-8da8-dd4c536e3a91\": \"CORHA profiles, stories, and updates\"}',1,'2024-07-22 02:39:21','2024-08-08 16:05:55','02707320-94e6-4ba0-ba20-52f2bd57117d'),(44078,2715,2,'Los Angeles County Dept. of Public Health','los-angeles-county-dept','resource-sources/los-angeles-county-dept',NULL,1,'2024-07-22 02:39:21','2024-07-22 02:39:21','257ab974-3502-4c6c-8053-b0904664d6e3'),(44079,2716,2,'CORHA','corha','resource-sources/corha',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','1052ad16-266e-4480-8b82-de18f59ea58b'),(44080,2808,2,'CDC','cdc','resource-sources/cdc',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','86775e2d-bbfd-4b3c-b460-db08684c14e5'),(44081,2908,2,'Federal Bureau of Prisons','federal-bureau-of-prisons','resource-sources/federal-bureau-of-prisons',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','5033d099-e365-4bed-8a9c-68dd69ceabc0'),(44082,4054,2,'Michigan Dept. of Health & Human Services','michigan-dept-of-health-human-services','resource-sources/michigan-dept-of-health-human-services',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','8b5ee840-0462-44bd-907e-1087ec29ef21'),(44083,8585,2,'Overview','overview','topic-tags/overview',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','2f34b2ec-99ea-48bd-bd5b-2ddac77d9002'),(44084,8586,2,'Detection','detection','topic-tags/detection',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','f82a4c0c-6854-46d6-a0a1-700ba05b8311'),(44085,8587,2,'Investigation','investigation','topic-tags/investigation',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','d9ad55cb-4bd6-4882-9112-45446164c756'),(44086,8588,2,'Management','management','topic-tags/management',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','e53c8d09-f520-4246-a885-3773b69acb6e'),(44087,8589,2,'Preparation','preparation','topic-tags/preparation',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','ae2218f2-be94-453f-b2e9-2c72f727c68a'),(44088,8590,2,'Treatment','treatment','topic-tags/treatment',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','980b63a0-cbae-41c6-854a-0f1c8d3e4c01'),(44089,10844,2,'World Health Organization','world-health-organization','resource-sources/world-health-organization',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','67147c4e-7498-4c38-9445-198c7b4384f1'),(44090,12047,2,'Chicago Department of Public Health','chicago-department-of-public-health','resource-sources/chicago-department-of-public-health',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','63fbd237-3797-4a3a-aaec-ed04fe7a5baa'),(44091,12124,2,'CDC; Chicago Department of Public Health','cdc-chicago-department-of-public-health','resource-sources/cdc-chicago-department-of-public-health',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','cc4ab448-acfe-4b96-811d-c715fa62408b'),(44092,12681,2,'CDC; Arkansas Department of Health','cdc-arkansas-department-of-health','resource-sources/cdc-arkansas-department-of-health',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','6710cdc6-51e5-4547-9c27-d3b74b22c891'),(44093,12964,2,'CTSE','ctse','resource-sources/ctse',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','13a9dd4e-9380-4726-8ea4-13e76fd5b8c0'),(44094,14447,2,'CDC; CSTE','cdc-cste','resource-sources/cdc-cste',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','f8c067fa-6651-4de5-ba71-517ebc797ea5'),(44095,14465,2,'CORHA; CSTE','corha-cste','resource-sources/corha-cste',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','4393ba0a-30bf-4164-a79b-24193b2bd367'),(44096,14468,2,'Multiple Sources','multiple-sources','resource-sources/multiple-sources',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','11f1c737-3cba-428a-b101-2beec149bee2'),(44097,14529,2,'FDA','fda','resource-sources/fda',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','a1de5218-765c-413f-b185-30fc85502760'),(44098,14914,2,'Journal','journal','resource-sources/journal',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','46c6a9b7-8c94-44c4-a822-7d28b8c216b4'),(44099,15117,2,'California Department of Public Health','california-department-of-public-health','resource-sources/california-department-of-public-health',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','ef16196d-01eb-43c0-bdd6-ff03d359de45'),(44100,15296,2,'Morbidity and Mortality Weekly Report (MMWR)','morbidity-and-mortality-weekly-report-mmwr','resource-sources/morbidity-and-mortality-weekly-report-mmwr',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','97e01d42-b72a-4b3d-bc04-5483a2c596bc'),(44101,15405,2,'SHEA','shea','resource-sources/shea',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','9b9c1e3c-cda1-418e-8be8-5789cf1aef53'),(44102,15522,2,'IDSA','idsa','resource-sources/idsa',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','2aaf740d-0be4-4067-8495-bec2dd54465f'),(44103,15699,2,'IDSA; SHEA','idsa-shea','resource-sources/idsa-shea',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','a6ddc934-8954-47e5-99ec-46fbcaee449c'),(44104,16293,2,'APIC','apic','resource-sources/apic',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','b5669600-b24e-49b0-9e29-b4bf807df237'),(44105,17303,2,NULL,'__temp_bhpfayiglzkczcdbchihczvdlwaojgzdtkmq','news-categories/__temp_bhpfayiglzkczcdbchihczvdlwaojgzdtkmq',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','add8761f-b8b7-495f-bc69-08ff31245cf0'),(44106,17351,2,'Minnesota Department of Health','minnesota-department-of-health','resource-sources/minnesota-department-of-health',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','2214b3de-1605-428b-9491-594c24ac5923'),(44107,18536,2,'Oregon Health Authority','oregon-health-authority','resource-sources/oregon-health-authority',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','889c0389-238a-4b5e-95c0-36807ecfff8d'),(44108,28707,2,'Illinois Dept of Health','illinois-dept-of-health','resource-sources/illinois-dept-of-health',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','63571bba-619e-4305-8a16-5b3ac3a7fff3'),(44109,28771,2,'Roswell Park Comprehensive Cancer Center','roswell-park-comprehensive-cancer-center','resource-sources/roswell-park-comprehensive-cancer-center',NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','a24b0e61-e964-4b97-96ec-5fe79dc5582e'),(44110,1559,2,'Tag','tag',NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','8cd1bb11-c56c-475e-ba8a-d05c76188fb6'),(44111,1560,2,'Tag2','tag2',NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','ab4c5efe-6f75-412e-9684-1cb5e559d335'),(44112,1561,2,'Tag3','tag3',NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','4b799701-fa93-46a2-825d-cfa9fc9019a9'),(44113,16030,2,'Mpox Header',NULL,NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','756ac9af-c054-4687-a8c0-e1d0bfc6c8ab'),(44114,16032,2,'Mpox Header',NULL,NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','9d7aec07-f699-4e80-860d-549340c68b75'),(44115,17153,2,'Medical Products Header',NULL,NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','246fd870-3232-47ea-8b71-374836b49017'),(44116,17204,2,'Medical Products Header',NULL,NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','f81f3e25-301d-4e84-9849-94e7146ca29e'),(44117,17278,2,'Main nav arrow vibrant blue down',NULL,NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','92512e49-9b45-482b-9d7f-f7e38bb7c2fd'),(44118,17279,2,'Main nav arrow vibrant blue',NULL,NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','08b2b854-d4e1-49ca-8432-e260262e67a2'),(44119,17352,2,'Measles',NULL,NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','bf5a06ff-ce0d-41b1-bcb0-6b76f11011ae'),(44120,17438,2,'Hepatitis',NULL,NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','a5b45191-d04d-43cc-92aa-349fc60aac0e'),(44121,17468,2,'Cdiff',NULL,NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','beb66a47-ba93-4c5b-9b05-cce5f6421260'),(44122,17672,2,'Ziehl Nellsen stained mycobacterium',NULL,NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','ce667b50-22aa-493b-8ecf-17d24b5fd8d3'),(44123,18788,2,'Legionella pneumophila',NULL,NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','5a7103cc-e288-437a-afa0-b6326993dad0'),(44124,18789,2,'Measles',NULL,NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','5bffb3a8-b0ae-411b-8476-947af1f91dae'),(44125,18810,2,'Cdiff',NULL,NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','5822196d-5f5a-4b3b-a8b7-36926bb88395'),(44126,18811,2,'Hepatitis',NULL,NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','64ffa665-707c-49c8-99f1-2c7b21191b37'),(44127,18846,2,'CDI Recommendations for Healthcare Outbreak Response',NULL,NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','6fe6378d-9495-4b1b-9b81-7b73893aa43f'),(44128,18881,2,'CDI Recommendations for Healthcare Outbreak Response',NULL,NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','627fd22e-df8d-4e41-a4ac-c1854268913f'),(44129,19290,2,'Influenza',NULL,NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','7568cbca-3b4b-4bca-933f-efd3754e73c2'),(44130,19621,2,'Icon search vibrant blue',NULL,NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','63a07f01-64a1-4927-bc35-bbba6d843245'),(44131,19622,2,'Welcome to Public Health Research at Lancaster',NULL,NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','11913e77-dd20-4aa4-9b82-bb3d9a24fc59'),(44132,19629,2,'White arrow up',NULL,NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','63353c22-8f2a-46dc-bcdf-3c7856ea0d23'),(44133,22072,2,'Icon search arrow',NULL,NULL,NULL,1,'2024-07-22 02:39:22','2024-07-22 02:39:22','00802f7c-b497-4663-8bc0-0ec6524a9d39'),(44134,22168,2,'Icon arrow dropdown gray',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','0eb550cc-3154-4043-9504-1f1c5b9618aa'),(44135,22242,2,'News',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','fdf6be21-dde2-4e15-b31a-a8e0f2883ffd'),(44136,27141,2,'CORHA PP Chapter 1',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','13d6097c-495a-44d9-aefc-ce46a9c85687'),(44137,27186,2,'CORHA Principles and Practices Chapter 1 Overview',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','3c77a924-16d5-4564-8024-7fa0259fc51c'),(44138,27205,2,'CORHA Principles and Practices Chapter 2 Fundamental Concepts',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','cd77e68a-ee91-4914-9835-af38f1109479'),(44139,27256,2,'CORHA Principles and Practices Chapter 3 Planning Preparation',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','59a17bed-c2e8-44a0-8a27-0d918a4b7d74'),(44140,27280,2,'CORHA Principles and Practices Chapter 3 Planning Preparation',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','c61d04c5-6ec2-4c88-bcbe-8bb758f17622'),(44141,27293,2,'CORHA Principles and Practices Chapter 3 Planning and Preparation',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','c6d5c35d-ec8b-49cb-a3a8-93d4a1b72f16'),(44142,27309,2,'CORHA Principles and Practices Chapter 4 Outbreak Detection and Reporting',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','d70167c8-cfbb-45d8-bdf8-ce1e856fc3d7'),(44143,27373,2,'CORHA Principles and Practices Chapter 5 Investigation and Control',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','8591e98e-4792-46d1-86ff-1609fd4df073'),(44144,27409,2,'CORHA Principles and Practices Chapter 6 Laboratory Best Practices',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','1a9b735f-61a7-4b5e-81d9-5b1858d06fb7'),(44145,27457,2,'CORHA PP Chapter 8',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','af8d8edb-294d-45b8-b146-024837c09cda'),(44146,27458,2,'CORHA Principles and Practices Chapter 1 Overview',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','241c3724-498b-45a6-a069-9736068d0644'),(44147,27497,2,'CORHA Principles and Practices Chapter 8 Notification and Communication',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','b2cada02-69c0-45e1-be44-8427ae091fe6'),(44148,27529,2,'CORHA Principles and Practices Supplement B Infection Control Breach Investigations',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','3c5761e6-6fbf-4770-8dc7-cf54abfc8d84'),(44149,27564,2,'CORHA Principles and Practices Supplement A Medical Product Investigations',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','513367ea-de35-4ed4-99e2-bda9ae321c56'),(44150,27727,2,'APHL',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','800a60ea-f26b-4a5e-978d-9f1890e5d198'),(44151,27728,2,'APIC',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','10ca3bba-b777-422b-872f-a8a1c7c1f860'),(44152,27729,2,'ASTHO',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','0b239970-9ce0-47e2-a86c-191a3dc3ae86'),(44153,27730,2,'CDC',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','fd77af09-664a-4f79-a3e0-1ebf148e27cc'),(44154,27731,2,'CSTE',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','20b7aa05-134f-48f7-b766-a02a5c95ff7e'),(44155,27732,2,'NACCHO',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','34db7ccf-91d7-447d-a3b0-b531fb8f13c6'),(44156,27733,2,'SHEA',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','68e6eb2c-3774-4dcc-87a5-42c7ce2df88d'),(44157,27750,2,'https://www.train.org/cdctrain/course/1114178/comp',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','813710fa-5fde-4739-9c9f-672db6d1b17c'),(44158,27752,2,'https://www.train.org/cdctrain/course/1114178/comp',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','9a757372-b987-4710-8bb8-1769b3f689f8'),(44159,27772,2,'CORHA Principles and Practices Chapter 8 Notification and Communication',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','12deff5a-49f2-456a-b9e2-5266976e4d11'),(44160,28471,2,'RED Cap Database: CDC HAI Data Collection Data Dictionary',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','f62e8f99-52ca-447f-ba8d-77613a0e79b1'),(44161,28473,2,'Healthcare-associated Infection HAI Outbreak Standardized Variables List',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','321220fb-82c0-46c9-abbe-cf64cb07d2ff'),(44162,28495,2,'HAI-AR Tracking System',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','8942e607-64ba-402f-a593-27883382074e'),(44163,28496,2,'HAI-AR Tracking System Data Dictionary',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','762749d8-139e-482b-b937-367fbbb5efe7'),(44164,28708,2,'Influenza',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','b15fd510-dc82-4b58-9f25-1434a0f72f5b'),(44165,28710,2,'Influenza',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','b6b507e9-a500-494e-8094-cd71011150da'),(44166,28766,2,'Drug diversion',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','7d65392f-0006-40ad-a9ff-dce54a0b4e12'),(44167,28768,2,'Drug diversion',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','f5e60bcc-1b4c-42fb-89c6-26f15e55572d'),(44168,28833,2,'Dialysis',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','68fedace-8bec-4113-8d70-e6fce3bc882e'),(44169,28835,2,'Dialysis',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','b4640811-9132-48a1-8dfe-4cae54d67833'),(44170,28895,2,'Injections',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','31714270-c283-4a9c-8ff0-f4a0d628ecbd'),(44171,28897,2,'Injections',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','bbd464ef-98ab-47b1-9e57-b8a9d3e12768'),(44172,29216,2,'Header tools index',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','207e3869-a4f4-4a9c-8f8f-e967e9782c4a'),(44173,29253,2,'Overview',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','aa10bc1d-6b22-4f70-90f1-9255c2824107'),(44174,29278,2,'Environmental Fungi Molds',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','305964a1-ff00-44d6-a1d3-45cafceeab1b'),(44175,29280,2,'Environmental Fungi Molds',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','4b5f435d-d4c7-44d8-b552-3ce616b7e9ce'),(44176,29306,2,'Environmental Fungi Molds 1',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','fe1483b0-daf7-4f0b-8257-81b1e83be6fa'),(44177,29328,2,'Fundamental Concepts',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','c99c75f7-948f-4ffa-9a19-ccbd363408d2'),(44178,29353,2,'Burkholderia Cepacia',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','475d249b-7bf7-4068-a713-174956ee20c2'),(44179,29380,2,'Candida Auris',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','60e3fe38-a65c-411b-ba81-a670adef704b'),(44180,29402,2,'COVID 19',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','da92731c-0565-42ba-b3fe-7ad6a3f00438'),(44181,29427,2,'Ebola',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','9a90d241-fb11-4bdd-a048-1b27a3c51e14'),(44182,29453,2,'Epidemic Keratoconjunctivitis EKC',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','78d537e4-659f-464a-943a-edd76f5ccb5e'),(44183,29455,2,'13695 lores',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','6a097326-5f34-44bc-bac8-2abcf6dcb0f4'),(44184,29477,2,'Influenza',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','347f518e-4c44-4334-85e0-eab1bc27f13d'),(44185,29498,2,'Legionella',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','d1b4016b-ae34-49c4-bba2-fae380a82d88'),(44186,29523,2,'Measles',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','b5259196-3858-46d0-933a-a075903b1ceb'),(44187,29543,2,'Mpox',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','54113315-5617-454f-aef1-d3737743b93a'),(44188,29550,2,'Nontuberculous Mycobacteria NTM',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','ebf382e0-962e-4123-8bd6-e15080611bdc'),(44189,29580,2,'Drug Diversion EDIT',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','8a2b6faf-89bd-4d8b-a2cf-ae2c2584f992'),(44190,29599,2,'Injections EDIT',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','6414fd2c-cfce-4c93-8d12-9829e7f6f8eb'),(44191,29608,2,'Investigation Tracking System',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','9689bf3d-d801-47ee-a99f-d1cc2dc90a23'),(44192,29651,2,'Overview',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','503bad4f-309e-47a0-b243-cd4774856e69'),(44193,29675,2,'Overview',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','720c48a5-74c7-4706-847a-494d40b43c5d'),(44194,29797,2,'All Pathogens Diseases',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','8b466029-6dd0-4fad-958f-b2cfd2fe68c7'),(44195,29802,2,'Investigation Resources',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','7715c3fc-5077-4d37-bbf3-40d9818a0930'),(44196,29813,2,'Hemodialysis Setting',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','835d75be-d000-45bd-a914-667d6a2a537c'),(44197,29877,2,'Viral Hepatitis',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','1578b262-0147-4e82-8a6b-fed1f75cbf99'),(44198,29904,2,'Drug Diversion EDIT 2',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','0e38789f-6bdd-4241-9535-b51dfa440bd1'),(44199,29905,2,'7452210 many pills',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','e5e2b0e5-5504-4c78-90d6-61a0c4cf0394'),(44200,29927,2,'C Diff',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','16f492e0-9024-4c3e-b544-5e82c6b14797'),(44201,29945,2,'Tool 1 variables',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','79bad614-87c4-4dc7-b777-727f64bf4809'),(44202,29946,2,'Tool 2 data',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','085cae59-3dde-4c7d-9da8-11ef4197b983'),(44203,29947,2,'Tool 3 course',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','4e3141a7-aa36-430a-aa6d-b65fcfa736ce'),(44204,29948,2,'Tools 4 medical',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','f7391f5d-c89a-4b07-afea-c88b3b9ec368'),(44205,40928,2,'Result',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','bb68690b-9fd9-4f2f-92e5-ea86ed6374c2'),(44206,43657,2,'Spotlight',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','67a802b7-ffe3-45ce-84bd-034fbb53d51e'),(44207,43696,2,'Picture1 1',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','8e98c7cc-0e01-4fda-8e72-200c469a365c'),(44208,43747,2,'JTP 0741 1',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','92da09ed-e2d5-4ad3-995e-96e19f1ed96f'),(44209,43764,2,'JTP 8332',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','00f3b618-4d29-4ee7-852b-018d4776b04b'),(44210,43767,2,'JTP 5941 1',NULL,NULL,NULL,1,'2024-07-22 02:39:23','2024-07-22 02:39:23','e7905873-05b0-4944-ad23-a732636fc16b'),(44211,43834,2,'Lisa Hannah 276x300',NULL,NULL,NULL,1,'2024-07-22 02:39:24','2024-07-22 02:39:24','d4a927bd-dd77-4dcc-90e9-2fd208d9420a'),(44212,43838,2,'Lisa Hannah 276x300',NULL,NULL,NULL,1,'2024-07-22 02:39:24','2024-07-22 02:39:24','08d704da-7b23-4626-a1a0-f85ee0e40ac2'),(44213,43844,2,'Lisa Hannah 276x300',NULL,NULL,NULL,1,'2024-07-22 02:39:24','2024-07-22 02:39:24','2f6dac0c-d55e-4f9b-bc2f-30bc3449db00'),(44214,43855,2,'Picture1 1 1',NULL,NULL,NULL,1,'2024-07-22 02:39:24','2024-07-22 02:39:24','478c23fc-acae-4f7e-8c4c-382e3252a9fc'),(44215,43873,2,'Fall 2022 Meeting scaled',NULL,NULL,NULL,1,'2024-07-22 02:39:24','2024-07-22 02:39:24','1d1b6524-b483-46fd-894c-1be8421e2eb4'),(44216,43895,2,'Maureen Tierney',NULL,NULL,NULL,1,'2024-07-22 02:39:24','2024-07-22 02:39:24','641f15c1-3348-4053-a3d2-9e43e901c8a4'),(44217,43896,2,'Moon Kim 232x300',NULL,NULL,NULL,1,'2024-07-22 02:39:24','2024-07-22 02:39:24','2658b31c-1aa7-43e3-9600-f60dff50faa4'),(44218,43897,2,'Capture',NULL,NULL,NULL,1,'2024-07-22 02:39:24','2024-07-22 02:39:24','57977348-2e8d-42e8-9732-3d1efa5eb7a4'),(44219,43913,2,'Kelly Wroblewski',NULL,NULL,NULL,1,'2024-07-22 02:39:24','2024-07-22 02:39:24','560253c7-653c-44f6-b0b1-516c5037b8cf'),(44220,43921,2,'Zachary Rubin',NULL,NULL,NULL,1,'2024-07-22 02:39:24','2024-07-22 02:39:24','a733af21-a473-49e3-8336-40582130efd5'),(44221,43928,2,'Joseph Perz 300x241 2',NULL,NULL,NULL,1,'2024-07-22 02:39:24','2024-07-22 02:39:24','966e0fec-f878-4aec-9ae7-de59aa477226'),(44222,43932,2,'Linda Greene 200x300',NULL,NULL,NULL,1,'2024-07-22 02:39:24','2024-07-22 02:39:24','3333e1ef-e14e-4e17-a2d6-1691d61f3781'),(44223,43943,2,'Kelley Garner 300v2',NULL,NULL,NULL,1,'2024-07-22 02:39:24','2024-07-22 02:39:24','589e4517-e4c5-4586-8633-b7c3d7e3a180'),(44224,43950,2,'David Gifford 300x241 1',NULL,NULL,NULL,1,'2024-07-22 02:39:24','2024-07-22 02:39:24','e83d7955-ac71-4155-96d1-b9be3ccfb640'),(44225,43958,2,'Christy Zelinski',NULL,NULL,NULL,1,'2024-07-22 02:39:24','2024-07-22 02:39:24','984854bc-91d6-446b-bd54-aacb4e608308'),(44226,43959,2,'Liz Shane',NULL,NULL,NULL,1,'2024-07-22 02:39:24','2024-07-22 02:39:24','d4440558-3255-4ae7-a31e-d4a5716ed270'),(44227,43960,2,'Shannon Xydis',NULL,NULL,NULL,1,'2024-07-22 02:39:24','2024-07-22 02:39:24','0cac7e63-6380-4e1d-9a59-a7e4d69b84a0'),(44228,43964,2,'Thi dang',NULL,NULL,NULL,1,'2024-07-22 02:39:24','2024-07-22 02:39:24','d9cfd2ad-4afe-4315-bf12-0b462009deff'),(44229,43965,2,'Enyinnaya merengwa',NULL,NULL,NULL,1,'2024-07-22 02:39:24','2024-07-22 02:39:24','eaba9240-9463-4f6a-83a5-aadb36627b82'),(44230,43970,2,'Erika baldry',NULL,NULL,NULL,1,'2024-07-22 02:39:24','2024-07-22 02:39:24','fbf5e24f-f8b3-473b-a441-5f66602bba5f'),(44231,43977,1,'Policy Workgroup','policy-workgroup',NULL,NULL,1,'2024-07-25 16:04:23','2024-07-25 16:04:23','d34ae756-9cd9-4794-868a-7b7345024763'),(44232,43977,2,'Policy Workgroup','policy-workgroup',NULL,NULL,1,'2024-07-25 16:04:23','2024-07-25 16:04:23','661b11dd-1319-4b2c-ba3b-860a681e5858'),(44234,43979,1,'Policy','policy',NULL,NULL,1,'2024-07-25 16:04:32','2024-07-25 16:04:32','7cf86bc3-92ec-4dc9-b0f1-3c42c4cf2f5e'),(44235,43979,2,'Policy','policy',NULL,NULL,1,'2024-07-25 16:04:32','2024-07-25 16:04:32','284da499-77a8-416b-904c-98247a70dadf'),(44236,43980,1,'Outbreak Notification','outbreak-notification',NULL,NULL,1,'2024-07-25 16:04:40','2024-07-25 16:04:40','3639b4f6-aa37-4230-ac0b-eb30a09b976d'),(44237,43980,2,'Outbreak Notification','outbreak-notification',NULL,NULL,1,'2024-07-25 16:04:40','2024-07-25 16:04:40','6be6a4a9-078c-46ae-8973-81affaa76162'),(44238,43981,1,'The Importance of Patient Notification and CORHA’s HAI Outbreak Notification Framework (Part 1)','the-importance-of-patient-notification-and-corhas-hai-outbreak-notification-framework-part-1','news/the-importance-of-patient-notification-and-corhas-hai-outbreak-notification-framework-part-1','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p><i>Part One: Truth and Transparency</i></p><p>Patient notification is at the forefront now more than ever due to the COVID-19 pandemic. The CORHA Policy Workgroup has been working to develop an HAI Outbreak Notification Framework to help assist health departments and facilities with the process of notifying patients and providers during outbreaks. In this post, we will be discussing the importance of notification and the benefits to everyone involved. Check back soon for part two, where we will discuss the HAI Outbreak Notification Framework in more detail.   </p><p>Notifying patients about outbreaks enables them to make informed decisions about their health and take actions to protect themselves. Transparency promotes confidence and increased trust between patients and providers, making clear and transparent communication key. Patients want and need to be informed of potential impacts on their health and wellbeing and we have personally heard from facilities that patients and their families generally appreciate transparency about outbreaks. Patients appreciate providers discussing risks, the impact on their care, information on how to protect themselves, and what the facility is doing to prevent new infections.  </p><p>Although the circumstances surrounding outbreaks vary, communication needs to be truthful, clear, and timely. Ideally notification should be done as soon as an outbreak has been identified so changes or enhancements in infection control practices can be adhered to by patients, visitors, and healthcare providers. Outbreak control measures can impact patients, visitors, and healthcare personnel and often include actions like case finding, immediate implementation of strict hand hygiene, enhanced environmental cleaning, personal protective equipment use, or patient isolation. It’s also important that as additional information becomes available, it is communicated to the affected groups. Outbreaks are complex, so acknowledging what is known and what is still unknown, can also help educate individuals regarding risks and actions to prevent further transmission.  </p><p>Communicating timely, accurate information can address inaccuracies and help stop further transmission. On the other hand, with poor communication, people could take inappropriate or unnecessary actions – like not seeking care or delaying necessary care – or feel they had been misled if information regarding their care is withheld. Another common dilemma occurs when a large number of people may need to be notified about a longstanding error in sterilizing instruments, but the likelihood of individual patient exposure is uncertain, and the risk of infection could be very low. These are just a few of the tough communication challenges faced regarding patient notification. </p><figure class=\\\"image\\\"><img src=\\\"{asset:43895:transform:medium||/assets/images/transf/_medium/43895/Maureen-Tierney.webp}\\\" alt=\\\"\\\" width=\\\"300\\\" height=\\\"340\\\" /></figure><p>Maureen Tierney</p><figure class=\\\"image\\\"><img src=\\\"{asset:43896:transform:medium||/assets/images/transf/_medium/43896/Moon-Kim-232x300.webp}\\\" alt=\\\"\\\" width=\\\"300\\\" height=\\\"388\\\" /></figure><p>Moon Kim</p><figure class=\\\"image\\\"><img src=\\\"{asset:43897:transform:medium||/assets/images/transf/_medium/43897/Capture.webp}\\\" alt=\\\"\\\" width=\\\"300\\\" height=\\\"395\\\" /></figure><p>Dawn Terashita</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Maureen Tierney, MD, MSc., FIDSA, Moon Kim, MD, MPH, & Dawn Terashita, MD, MPH\"}',1,'2024-07-25 16:05:25','2024-07-25 16:05:25','6662b5b0-4046-4f2f-b636-ddc924072820'),(44239,43982,1,'Leadership','leadership',NULL,NULL,1,'2024-07-25 16:18:51','2024-07-25 16:18:51','5050565e-ce23-436e-9dec-a81493705552'),(44240,43982,2,'Leadership','leadership',NULL,NULL,1,'2024-07-25 16:18:51','2024-07-25 16:18:51','a84a818a-1523-41fd-a87e-3716d67b1035'),(44242,43984,1,'APHL','aphl',NULL,NULL,1,'2024-07-25 16:18:57','2024-07-25 16:18:57','ffca9c1e-ba33-45bb-91c4-5b8385e2238d'),(44243,43984,2,'APHL','aphl',NULL,NULL,1,'2024-07-25 16:18:57','2024-07-25 16:18:57','b8f15b75-cbd2-46d3-8935-dd2fee38bc61'),(44244,43985,1,'Response','response',NULL,NULL,1,'2024-07-25 16:19:07','2024-07-25 16:19:07','ea93d43c-fa42-4395-8717-fd4e2fc29169'),(44245,43985,2,'Response','response',NULL,NULL,1,'2024-07-25 16:19:07','2024-07-25 16:19:07','9b485b96-e93a-420e-9429-8fa89bd567e1'),(44246,43986,1,'COVID-19','covid-19',NULL,NULL,1,'2024-07-25 16:19:16','2024-07-25 16:19:16','d90cf798-3dfd-4d6b-84af-0378434a662c'),(44247,43986,2,'COVID-19','covid-19',NULL,NULL,1,'2024-07-25 16:19:16','2024-07-25 16:19:16','c6dd7c42-3e44-421c-964a-0387f535653d'),(44248,43987,1,'Leadership: Pandemic Response – Public Health Laboratories Rise to the Challenges, with Kelly Wroblewski, Association of Public Health Laboratories','leadership-pandemic-response-public-health-laboratories-rise-to-the-challenges-with-kelly-wroblewski-association-of-public-health-laboratories','news/leadership-pandemic-response-public-health-laboratories-rise-to-the-challenges-with-kelly-wroblewski-association-of-public-health-laboratories','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>Public health laboratories are foundational to our nation’s public health infrastructure. While the COVID-19 pandemic response presented many significant challenges for public health laboratories, it has also provided opportunities to strengthen partnerships and implement new technologies that will enhance the ability to detect and respond to healthcare associated infections (HAIs) moving forward.</p><figure class=\\\"image\\\"><a href=\\\"{asset:43913:transform:medium||/assets/images/transf/_medium/43913/Kelly-Wroblewski.webp}\\\"><img src=\\\"{asset:43913:transform:medium||/assets/images/transf/_medium/43913/Kelly-Wroblewski.webp}\\\" width=\\\"300\\\" height=\\\"300\\\" alt=\\\"\\\" /></a></figure><p class=\\\"main content photo-caption\\\">Kelly Wroblewski</p><p>From the earliest days of the COVID-19 response, public health laboratories faced scarcity of laboratory reagents and supplies, staff shortages, inability to meet high testing demands, and outdated test ordering and reporting systems. Although several of those challenges remain, public health laboratories have adapted to the pandemic response by installing high throughput testing platforms, implementing electronic test order and result systems, enhancing their capability and capacity to perform genomic surveillance, and establishing training programs for point of care testing.</p><p>Public health laboratories’ genomic sequencing capacity is one of the most striking examples of technologic advancements made during the pandemic. While the recent COVID-19 Omicron variant wave exacerbated ongoing issues with testing, it also highlighted the significant developments made in genomic sequencing capacity and the ability of health departments to effectively utilize point of care tests performed in a wide variety of healthcare settings, both of which were not common practices early in the pandemic. Since March 2020, the number of public health laboratories that are performing genomic sequencing for SARS-CoV-2 to monitor the emergence and spread of variants and identify transmission networks has increased from five to 71.</p><p>Partnerships with HAI/AR programs, healthcare facilities and other entities have also been vital in preventing the spread of COVID-19 in healthcare settings. During the early stages of the pandemic, it quickly became apparent that residents of congregate settings would be at the highest risk of contracting COVID-19 and would be especially vulnerable to severe illness and death. Given this, public health laboratories worked with partners to rapidly develop interventions to respond to these populations’ unique needs.</p><p>Some of the most significant partnerships between public health laboratories and HAI/AR programs during the pandemic occurred through interventions aimed at limiting transmission and preventing outbreaks in long-term care facilities (LTCFs). To support implementation of a CMS testing directive encouraging serial screening of residents and health care personnel (HCP) to facilitate rapid case identification, public health laboratories worked with HAI/AR programs and LTCFs to develop testing training programs, extend CLIA licenses, support acquisition of CLIA certificates of waiver, and establish mechanisms for reporting. Notably, a collaboration between Minnesota’s HAI/AR program and public health laboratories demonstrated the <a href=\\\"https://www.cdc.gov/mmwr/volumes/69/wr/mm6937a3.htm\\\">importance of serial screening in LTCFs to limit the spread of COVID-19</a>, and the utility of genomic sequencing to determine the source of transmission. In addition, the Michigan Department of Health developed a <a href=\\\"https://www.michigan.gov/coronavirus/0,9753,7-406-98178_100722---,00.html\\\">COVID-19 webpage</a> specific to LTCFs with training materials and videos that public health laboratories helped develop to ensure that testing is conducted properly.</p><p>Gains made during the COVID-19 pandemic response can be leveraged to improve detection, reporting, response, and investigation of future HAI/AR outbreaks. For example, public health laboratories’ advancements in performing genomic sequencing are already being applied to support SARS-CoV-2 testing, as well as other HAIs and AR pathogens including carbapenem-resistant Enterobacterales and <i>Candida auris</i>. HAI/AR programs and public health laboratories partnerships that were strengthened during the pandemic will continue to be valuable for sustainable and innovative approaches to prevent and control HAI/AR outbreaks. Similarly, public health laboratories’ experiences are helping inform development of resources such as CORHA’s product offerings and will continue to equip health departments and healthcare facilities with the tools to improve HAI/AR outbreak responses.</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Kelly Wroblewski\"}',1,'2024-07-25 16:19:21','2024-07-25 16:19:21','a948de79-b899-4cd4-9f36-4e83a322a327'),(44250,43989,1,'Local','local',NULL,NULL,1,'2024-07-25 16:20:00','2024-07-25 16:20:00','be048b75-0c31-4c9b-8e32-a67dffa0bee3'),(44251,43989,2,'Local','local',NULL,NULL,1,'2024-07-25 16:20:00','2024-07-25 16:20:00','fc54d9df-4721-4bb0-a395-c5af522ac911'),(44252,43990,1,'LHD','lhd',NULL,NULL,1,'2024-07-25 16:20:05','2024-07-25 16:20:05','d6d24adb-6962-4c2f-a618-ba22866bd8eb'),(44253,43990,2,'LHD','lhd',NULL,NULL,1,'2024-07-25 16:20:05','2024-07-25 16:20:05','8de528b1-0b5a-418d-a0ed-9fb0fc9227a3'),(44254,43991,1,'Leadership: Dawn Terashita & Zachary Rubin, Los Angeles County Department of Public Health on the Future of HAI/AR Response in the Face of COVID-19','leadership-dawn-terashita-zachary-rubin-los-angeles-county-department-of-public-health-on-the-future-of-hai-ar-response-in-the-face-of-covid-19','news/leadership-dawn-terashita-zachary-rubin-los-angeles-county-department-of-public-health-on-the-future-of-hai-ar-response-in-the-face-of-covid-19','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>COVID-19 has impacted healthcare-associated infections and antimicrobial-resistant (HAI/AR) threats across all healthcare settings. Los Angeles County saw an increase in HAIs, such as central line bloodstream infections (CLABSI) as a result of many facilities changing their CLABSI prevention efforts to accommodate the challenges of caring for COVID-19 patients. Additionally, Los Angeles County saw an increase of multidrug-resistant organisms (MDROs), such as <i>Candida auris</i>, due to personal protective equipment (PPE) practices being altered early in the pandemic due to severe shortages. Despite the difficulties brought on by COVID-19, awareness of infection prevention efforts has improved over the last two years, especially in nursing homes.  </p><p>The Covid-19 pandemic has had both negative and positive impacts on infection prevention in healthcare. The negative impacts, such as PPE shortages, staffing shortages, facility crowding, frequent moving of patients throughout the facilities due to COVID-related cohorting, and lack of focus on identifying and containing MDROs, contributed to increased MDRO spread. The positive impacts include new legislative actions, increased funding, and building stronger relationships and partnerships to support infection prevention efforts across the healthcare community. California introduced a new state law requiring all nursing homes to employ a full-time infection preventionist (IP). Funding opportunities from the Centers for Disease Control and Prevention (CDC) at the local and state level have helped to improve infection control and has provided some much-needed resources for nursing homes and other long-term care facilities. Increased funding, stakeholder engagement, and requirements for infection preventionists have helped shaped the backbone for an unprecedented future educational program centered on infection prevention within nursing homes.  </p><p>There are many insights that we have gained while leading the Healthcare Outreach Unit at the Los Angeles County Department of Public Health that can help improve HAI/AR response. We believe that stakeholder engagement is a key to success for health departments. Programs rolled-out by public health departments should be developed in conjunction with stakeholders and should address the concerns that these stakeholders bring to the table. As an example, to support nursing homes, we have hired two geriatricians and nurses with experience working in this setting, who understand many of the concerns and constraints present in these facilities, and already have relationships in the field. We have learned that you should not underestimate the importance of giving each nursing home a specific public health nurse to work with and build rapport. We have also strengthened our ties with the leadership in individual nursing homes and with the nursing homes operators, which helps to improve stakeholder buy-in and input. We plan to use the engagement and trust that we have developed over the last two years to elevate infection prevention across all nursing homes through standardized template policies and training, instead of allowing each facility to develop their IP program unilaterally, which is what many facilities have done in the past with mixed success. </p><p>Overall, we believe the future of HAI/AR response success is dependent on the ability to adapt and remain flexible while refocusing activities beyond COVID-19. The <a href=\\\"https://www.corha.org/\\\">Council for Outbreak Response: Healthcare-Associated Infections and Antimicrobial-Resistant Pathogen (CORHA)</a> plays a vital role in improving practices and policies at the local, state, and national levels regarding HAI/AR outbreaks across the healthcare continuum. We hope that through sharing our experience we can help promote CORHA’s mission to improve practices and policies for the detection, investigation, control, and prevention of HAI/AR outbreaks, with other local health departments and healthcare facilities. </p><figure class=\\\"image\\\"><img src=\\\"{asset:43897:transform:medium||/assets/images/transf/_medium/43897/Capture.webp}\\\" width=\\\"300\\\" height=\\\"395\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Dawn Terashita</p><figure class=\\\"image\\\"><img src=\\\"{asset:43921:transform:medium||/assets/images/transf/_medium/43921/Zachary-Rubin.webp}\\\" width=\\\"300\\\" height=\\\"300\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Zachary Rubin</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Dawn Terashita, MD, MPH, FACPM & Zachary Rubin, MD\"}',1,'2024-07-25 16:20:18','2024-07-25 16:20:18','ea859790-fb2c-4232-bf0d-232545addc0e'),(44256,43993,1,'CDC','cdc',NULL,NULL,1,'2024-07-25 16:20:53','2024-07-25 16:20:53','3a6a2c79-b590-4721-8baa-2d8e9c289b35'),(44257,43993,2,'CDC','cdc',NULL,NULL,1,'2024-07-25 16:20:53','2024-07-25 16:20:53','9fd5cb46-0872-4bae-967d-ba5fcea16743'),(44258,43994,1,'Funding','funding',NULL,NULL,1,'2024-07-25 16:20:59','2024-07-25 16:20:59','a62d67e1-4feb-4cd9-9e65-5a7bbc74299c'),(44259,43994,2,'Funding','funding',NULL,NULL,1,'2024-07-25 16:20:59','2024-07-25 16:20:59','3cc41a44-1ef9-48e7-923b-8707c2e584f6'),(44260,43995,1,'Outbreak Response','outbreak-response',NULL,NULL,1,'2024-07-25 16:21:11','2024-07-25 16:21:11','4fc53276-5fd3-4e84-8d29-c1a609694852'),(44261,43995,2,'Outbreak Response','outbreak-response',NULL,NULL,1,'2024-07-25 16:21:11','2024-07-25 16:21:11','225be985-ddab-41de-9256-3fd5c981235b'),(44262,43996,1,'Leadership: New CDC Funding Recognizes Healthcare Outbreak Response Needs','leadership-new-cdc-funding-recognizes-healthcare-outbreak-response-needs','news/leadership-new-cdc-funding-recognizes-healthcare-outbreak-response-needs','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>The Biden-Harris Administration and CDC recently announced a $2.1 billion investment as part of the American Rescue Plan (ARP), to improve infection prevention and control activities across the U.S. public health and healthcare sectors. Health departments received $885 million of this total in late October 2021 to support this work. CORHA interviewed Dr. Joe Perz, our lead representative from CDC and a Governance Committee member, to learn more about the funding.</p><h2><i>What is the new funding we’ve been hearing about?</i></h2><p>The initial funding is divided between two projects that are managed under a <a href=\\\"https://www.cdc.gov/ncezid/dpei/epidemiology-laboratory-capacity.html\\\">CDC cooperative agreement with health departments</a>. One of these is the <a href=\\\"https://www.cdc.gov/ncezid/dpei/pdf/guidance-nursing-home-ltc-facility-strike-team-and-infastructure-508.pdf\\\">Nursing Home &amp; Long-term Care Facility Strike Team and Infrastructure Project</a> which totals $500 million. The other is the <a href=\\\"https://www.cdc.gov/ncezid/dpei/pdf/guidance-strengthening-haiar-program-capicity-508.pdf\\\">Strengthening HAI/AR Program (SHARP) Capacity Project</a> which totals $385 million.</p><h2><i>How is healthcare outbreak response reflected in the new funding?</i></h2><p>Healthcare outbreak response is clearly recognized as a core function and essential need in both new funding opportunities, which cover the response continuum beginning with outbreak detection and extending to on-site investigation as well as longer-term follow-up activities to prevent a recurrence.</p><h2><i>Can you unpack that a bit, in relation to the Nursing Home &amp; Long-term Care Project?</i></h2><p>Sure, the <a href=\\\"https://www.cdc.gov/ncezid/dpei/pdf/guidance-nursing-home-ltc-facility-strike-team-and-infastructure-508.pdf\\\">LTC Project Guidance</a> includes a directive to support nursing homes – and other types of long-term care facilities – with COVID-19 outbreak response. That’s the primary motivation, and the funding can be used to support the rapid reactive activities – like testing, cohorting, infection control auditing, and even supplemental staffing – when SARS-CoV-2 has entered a facility and transmission is ramping up.</p><p>The allowable activities also support more proactive measures, like helping equip facilities with technology for infection tracking and reporting or communication with health department partners. In addition, we are supportive of creative approaches for staff recruitment, development, and retention.</p><p>The overall aim here is to build infection prevention infrastructure and achieve a greater quality of care. In other words, greater resilience to SARS-CoV-2 and outbreaks more generally. Susceptibility to the rapid spread of infections is something that nursing homes really must guard against, given the congregate and residential nature of long-term care.</p><h2><i>And what about the SHARP Project?</i></h2><p>Same spirit, spread farther. The SHARP funds are intended to enhance health department HAI/AR (healthcare associated infections/antimicrobial resistance) Program activities across all healthcare settings, not limited to long-term care. The <a href=\\\"https://www.cdc.gov/ncezid/dpei/pdf/guidance-strengthening-haiar-program-capicity-508.pdf\\\">SHARP project guidance</a> reflects the central challenge that CORHA was originally founded on, which was the need to build capacity for public health and healthcare to improve outbreak detection, response and prevention. This requires close collaboration and relationship building between public health professionals and healthcare providers, which has been growing steadily but could really blossom now with these ARP-supported investments.</p><p>Outbreak detection should improve thanks to SHARP activities related to both the AR Lab Network and National Healthcare Safety Network (NHSN). These will enhance surveillance for drug-resistant pathogens and HAIs, providing data for action. Likewise, outbreak investigation should benefit from additional staffing and increased engagement with healthcare partners.</p><p>SHARP encourages health departments to build HAI/AR prevention and response capacity throughout their jurisdictions, such as expanded use of local and regional approaches to address HAI/AR threats and controlling the spread of resistant pathogens. The guidance describes requirements for funded HAI/AR programs to establish a lead position to coordinate and oversee HAI response activities and to train staff in outbreak response.</p><h2><i>Advice for CORHA and its member organizations?</i></h2><p>Yes, let’s lean into this opportunity. CORHA is identified as a key source for healthcare outbreak training resources. It would be great to see increased activities in that realm, including collaboration with CORHA’s member organizations to improve and expand our collective offerings.</p><p>Both of the new projects emphasize direct engagement with individual facilities. The SHARP project references activities such as medical product investigations, targeted AR threats, molecular testing methods, patient notification, and many other aspects of healthcare outbreak response. These all represent opportunities for CORHA’s workgroups and member organizations to take our work to the next level.</p><figure class=\\\"image\\\"><img src=\\\"{asset:43928:transform:medium||/assets/images/transf/_medium/43928/Joseph-Perz-300x241-2.webp}\\\" width=\\\"300\\\" height=\\\"241\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Joseph Perz</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Joseph Perz, DrPH, MA\"}',1,'2024-07-25 16:21:15','2024-07-25 16:21:15','5d5ce627-83cd-43b7-8783-65a651d56611'),(44264,43998,1,'Infection Preventionist','infection-preventionist',NULL,NULL,1,'2024-07-25 16:21:47','2024-07-25 16:21:47','4ac2a755-b6d3-4172-88af-7df397f8b20e'),(44265,43998,2,'Infection Preventionist','infection-preventionist',NULL,NULL,1,'2024-07-25 16:21:47','2024-07-25 16:21:47','040768e4-2c6b-4e7c-b114-fda85ae71536'),(44266,43999,1,'Hospital','hospital',NULL,NULL,1,'2024-07-25 16:21:53','2024-07-25 16:21:53','fab2c225-6a1a-4552-b6b1-9749d338ec3a'),(44267,43999,2,'Hospital','hospital',NULL,NULL,1,'2024-07-25 16:21:53','2024-07-25 16:21:53','a6b7e785-63f3-4cf0-9132-094221430a87'),(44268,44000,1,'Leadership: Linda Greene, Director of Hospital Infection Prevention at the University of Rochester Highland Hospital','leadership-linda-greene-director-of-hospital-infection-prevention-at-the-university-of-rochester-highland-hospital','news/leadership-linda-greene-director-of-hospital-infection-prevention-at-the-university-of-rochester-highland-hospital','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>As a front-line infection preventionist and Director of Infection Prevention in a healthcare organization, preventing healthcare-associated infections and addressing antimicrobial resistance are both high priorities of mine. Prior to the COVID-19 pandemic, my work with outbreaks included surgical site infections and an outbreak of healthcare-associated influenza. The influenza outbreak investigation and response were remarkably successful and stemmed from our ability to identify an initial source of the outbreak and implement several recommended infection prevention measures. Response actions included closing the unit to new admissions, carefully screening staff, and administering pre- and post-exposure prophylaxis. However, in my experience, the greatest outbreak and infection prevention and control challenges I have witnessed were related to COVID-19.  </p><blockquote><p>\\\"…The greatest outbreak and infection prevention and control challenges I have witnessed were related to COVID-19.\\\"</p></blockquote><p>Our hospital’s COVID-19 clusters were associated with myriad issues including staff-to-staff transmission, patient-to-staff transmission, and staff-to-patient transmission. In addition, patient and visitor non-compliance with masking, risk from aerosol generating procedures, patients who initially test negative and incubate on admission, as well as contamination during donning and doffing personal protective equipment were the main difficulties we navigated. Another challenge was the shortage of private rooms and medical supply delays, especially at the height of the pandemic, which exacerbated our containment efforts. These matters have highlighted areas and opportunities for improvement in practices, testing, and hardwiring processes. Looking to the future of outbreak investigation, we need access at the local level to important tools such as whole genome sequencing. Once these and other tools become more readily available, we will be able to identify, attribute, and mitigate outbreaks in a more comprehensive and timely manner.  </p><p>I have gained many insights from my involvement in CORHA. Most notably, I have a greater appreciation for and recognition of the link between hospital infection prevention and public health. This is an important and essential relationship, as I have acquired invaluable knowledge from both my public health colleagues in my state and in COHRA. Recently, I worked with CORHA to develop the <a href=\\\"https://www.corha.org/resources/corha-cste-proposed-investigation-reporting-thresholds-and-outbreak-definitions-for-covid-19-in-healthcare-settings/\\\"><i>CORHA/CSTE Proposed Investigation/Reporting Thresholds and Outbreak Definitions for COVID-19</i> <i>in Healthcare</i> <i>Settings</i></a>, and more broadly to review <a href=\\\"https://www.corha.org/resources/corha-principles-and-practices-for-outbreak-response/\\\"><i>CORHA’s Principles and Practices for Outbreak Response</i></a>. </p><p>As a former APIC president, my perceptions and experiences have granted me the ability to contribute to CORHA in a distinctive way. APIC’s competencies for Infection Preventionists are critical during the COVID-19 pandemic, in particular the leadership competencies: communication, collaboration, critical thinking, behavioral science, program management, and mentorship. My hope for the future of CORHA is to expand its strategy and awareness to other emerging pathogens and continue development of principles and practices for addressing product and device associated infections, as well as important healthcare-associated infection outbreaks. The diverse organizations who contribute to COHRA represent an abundance of knowledge and expertise and embody the essential link between patient safety, infection prevention, and public health.  </p><figure class=\\\"image\\\"><img src=\\\"{asset:43932:transform:medium||/assets/images/transf/_medium/43932/Linda-Greene-200x300.webp}\\\" alt=\\\"\\\" width=\\\"300\\\" height=\\\"450\\\" /></figure><p class=\\\"main content photo-caption\\\">Linda Greene</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Linda Greene, RN, MPS, CIC, FAPIC\"}',1,'2024-07-25 16:22:00','2024-07-25 16:22:00','1e1bb9a2-f531-4fe3-9596-35897914eb8b'),(44270,44002,1,'ASTHO','astho',NULL,NULL,1,'2024-07-25 16:22:37','2024-07-25 16:22:37','9ce52fff-f681-46d7-ab63-40665c5b6952'),(44271,44002,2,'ASTHO','astho',NULL,NULL,1,'2024-07-25 16:22:37','2024-07-25 16:22:37','49a93c95-a035-4519-8527-b2cdc6e92957'),(44272,44003,1,'State','state',NULL,NULL,1,'2024-07-25 16:22:43','2024-07-25 16:22:43','3549bfa4-84f5-42e9-9589-42e51c1d0d1b'),(44273,44003,2,'State','state',NULL,NULL,1,'2024-07-25 16:22:43','2024-07-25 16:22:43','cb58f3bd-749a-4b43-a437-c76079c49045'),(44274,44004,1,'SHD','shd',NULL,NULL,1,'2024-07-25 16:22:48','2024-07-25 16:22:48','6c8a4b78-f4b2-40ba-aac8-4fdd2d8a90c9'),(44275,44004,2,'SHD','shd',NULL,NULL,1,'2024-07-25 16:22:48','2024-07-25 16:22:48','9c98bbc1-7964-4be3-91e1-dad698a2a7e6'),(44276,44005,1,'Leadership: Kelley Garner, Arkansas Department of Health, on the Value of Mentorship in the HAI/AR Outbreak Response','leadership-kelley-garner-arkansas-department-of-health-on-the-value-of-mentorship-in-the-hai-ar-outbreak-response','news/leadership-kelley-garner-arkansas-department-of-health-on-the-value-of-mentorship-in-the-hai-ar-outbreak-response','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>Mentorship is an important part of the public health profession and the HAI/AR outbreak response field. Not only does it guide, direct, and shape your present situation and future opportunities for the better, but it also improves the ways in which we respond to HAI/AR outbreaks. I have had numerous experiences with being both a mentor and mentee in my career. I started as an intern at the Arkansas Department of Health where I faced many challenges as the sole coordinator in the HAI Program. I was fortunate to have mentors in various roles, from diverse professional backgrounds and with a broad scope of expertise. Surrounding myself with mentors early in my career helped me improve and master both my technical and leadership skills and helped me to overcome those challenges I experienced as an intern and continues to shape a lot of my current work.</p><blockquote><p>\\\"Don’t be afraid of mentorship at every level of your career – constantly surround yourself with experts in the field.\\\"</p></blockquote><p>A key mentor in my career was Dr. Nate Smith, the former state health official from Arkansas, whose interest and involvement in our HAI/AR Program activities was instrumental in establishing and guiding the direction of our HAI Program. From day one, Dr. Smith invested his time in boosting my confidence, such as when he ensured I felt comfortable presenting data in front of Arkansas’s HAI/AR Advisory Committee early on in my career. He encouraged me to be creative to meet the public health needs for HAI/AR, as well as taught me to think big. Finally, Dr. Smith appreciated my input and asked questions, which allowed me to develop control measures and descriptive work to tackle an outbreak of a new species of mycobacterium within the state.</p><p>I was later hired and promoted to a supervisor, and now, the Chief of Epidemiology on HAI/AR at the Arkansas Department of Health. Throughout my career, my mentors have been “safe spaces” and part of my support system to help me excel in my roles. HAI/AR outbreak response can be complex and sometimes we encounter unique situations that may benefit from additional guidance or perspectives from others in the field. During these times, mentors are pivotal for either providing you with the information and guidance necessary or working with you through the challenge to reach a solution. For example, I recall an outbreak linked to contaminated saline bottles in a rural part of Arkansas, which required a process of documentation and analyses with limited available “written” guidance. My mentors helped me manage that outbreak and supported me through that experience.</p><p>While I’ve continued to surround myself with experts in the field who continue to serve as my mentors, I’ve also taken on roles as a mentor to others. I currently mentor college students and scholars in public health and I have formed mentor relationships with HAI Coordinators in neighboring states like Missouri and Oklahoma, where I support them in their IPC and HAI outbreak response work. Such a role has been particularly valuable because of the cross-collaboration and relationship-building this has contributed to our HAI/AR outbreak response activities. For example, we’ve invited states to participate in Infection Control Assessment and Responses, which has allowed us to get an outside perspective on Arkansas’s outbreak response and for other states to learn from our processes. Additionally, we’ve assisted states with analyzing complex data, which further expanded our state’s resources across the spectrum of HAI/AR. Finally, working with other states has created a sense of community within the infectious disease field, and has mutually instilled confidence in us as state health leaders of HAI/AR. I’m proud of the many success stories that have emerged from my mentorships.</p><p>Throughout my past and current mentorship experiences, I’ve gained insight into what makes a mentorship successful. Good mentors:</p><ul><li>Have similar shared experiences and starting points as their mentees, exercise transparency in sharing both successes and failures, set realistic expectations, and create a safe space for mentees to try new things within boundaries</li><li>Help their mentees learn through experience</li><li>Can boost confidence, foster, and instill critical leadership skills such as communication, decision-making, responding to the press, conducting patient notifications and other outbreak response skills</li><li>Emphasize the broader impact of HAI/AR response</li><li>Serve as inspiration for their mentee to succeed</li></ul><p>Mentorship is a two-way street, and it’s important for both the mentor and mentee to reach a consensus on the goals for the relationship as the roles change over time. While traditional and formal mentorship opportunities through fellowships and peer-to-peer convenings such as CSTE or ASTHO can create a strong foundation to learn and build relationships, there are equally impactful mentorship experiences that can occur informally and organically, with people in various roles, and with diverse experiences, skills, and expertise.</p><p>Groups like the Council for Outbreak Response can also support mentorship in the HAI/AR outbreak community as they develop tools and resources that bridge public health and healthcare outbreak response. Mentorship in the HAI/AR outbreak field is critical and to those that are early in their career, a mentor can help you identify your priorities and manage your expectations.  Find a mentor with the right personality and someone who understands where you are coming from. Also, look for mentors who are transparent and honest and give you the space to think creatively. I believe mentorships are critical at all levels and just as important. For those who have progressed in their career, don’t be afraid to embrace mentorship experiences at all levels and to continuously surround yourself with experts.</p><figure class=\\\"image\\\"><img src=\\\"{asset:43943:transform:medium||/assets/images/transf/_medium/43943/Kelley-Garner-300v2.webp}\\\" width=\\\"300\\\" height=\\\"270\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Kelly Garner</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Kelley Garner, MPH\"}',1,'2024-07-25 16:22:56','2024-07-25 16:22:56','c2321e6a-8f13-439b-9076-866c3930081d'),(44278,44007,1,'AHCA','ahca',NULL,NULL,1,'2024-07-25 16:23:29','2024-07-25 16:23:29','6f2b8027-11b0-45de-b7c5-886a0f69bc27'),(44279,44007,2,'AHCA','ahca',NULL,NULL,1,'2024-07-25 16:23:29','2024-07-25 16:23:29','8df0f9f6-1394-4320-8868-c6459aa40802'),(44280,44008,1,'Leadership: Leadership Perspectives from Dr. David Gifford','leadership-leadership-perspectives-from-dr-david-gifford','news/leadership-leadership-perspectives-from-dr-david-gifford','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>My work over the past 20 years has focused on how to improve the healthcare system to ultimately improve healthcare outcomes. In pursuit of this life goal, I have worked with numerous agencies in furthering healthcare quality improvement efforts. I helped create the Quality Department at the American Health Care Association, which assists providers in their quality improvement. I also directed the Centers for Medicare and Medicaid (CMS) Quality Improvement Organization nursing home-based quality improvement efforts when I served as Chief Medical Officer for Quality Partners of Rhode Island. Now, I work on initiatives with the National Trade Association representing long-term care providers.</p><p>During my 6 years as Director of the Rhode Island State Department of Health, I led the state’s response on several disease outbreaks, such as the H1N1 influenza outbreaks. Throughout the past couple of decades, I have gained insight into improving HAI/AR outbreak response from both the public health and healthcare perspectives. Adequate investigation, surveillance, and clear guidance are necessary in developing and implementing evidence-based actions to prevent the spread of infections in healthcare settings. This was exemplified during the COVID-19 pandemic where inconsistent guidance led to challenges in responding to these outbreaks. The COVID-19 pandemic underscores the need for standardized approaches, frameworks, and guidance that are clear and implementable, as well as the importance of CORHA and the work that its members and partners are doing to develop these tools. One outcome of the pandemic response is how it has bolstered both the provider and public health communities’ collaborative efforts against the common threat of HAI/AR outbreaks.</p><p>In my new role on CORHA, I aim to help support the Council in developing and promoting guidance and resources that can be widely adopted to help improve HAI/AR outbreak investigation in a more consistent, timely, and efficient manner. I look forward to integrating the provider community into public health’s HAI/AR outbreak response and protocols and strengthening sustainable relationships between the provider and public health communities. Finally, I hope that CORHA will help advance and highlight the important role of rapid whole genome sequencing more widely as part of HAI/AR outbreak investigations.<br /><br />I believe that civic service is one of the most rewarding, challenging, and underappreciated jobs. Our colleagues in public health and healthcare are some of the most passionate and mission-driven individuals I have had the pleasure of working with. Thank you all for the work you have done so far in improving HAI/AR outbreak response standards. I look forward to all of you continuing to achieve the Council’s mission of protecting patients and preventing harm from HAI/AR outbreaks.</p><figure class=\\\"image\\\"><img src=\\\"{asset:43950:transform:medium||/assets/images/transf/_medium/43950/David-Gifford-300x241-1.webp}\\\" width=\\\"300\\\" height=\\\"241\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">David Gifford</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"David Gifford, MD, MPH\"}',1,'2024-07-25 16:23:32','2024-07-25 16:23:32','249e5e78-e7a5-4310-b028-03f958d8c920'),(44282,44010,1,'LTCF','ltcf',NULL,NULL,1,'2024-07-25 16:24:23','2024-07-25 16:24:23','b0429ac0-6815-4137-99a1-d0ab10d44aa8'),(44283,44010,2,'LTCF','ltcf',NULL,NULL,1,'2024-07-25 16:24:23','2024-07-25 16:24:23','755b046f-f88b-4b8a-b20c-b519ce9454b6'),(44284,44011,1,'Local: LTCF Vaccine Education Program Vital to Chicago’s COVID-19 Outbreak Response Effort','local-ltcf-vaccine-education-program-vital-to-chicagos-covid-19-outbreak-response-effort','news/local-ltcf-vaccine-education-program-vital-to-chicagos-covid-19-outbreak-response-effort','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>The COVID-19 vaccine roll out in Chicago’s long-term care facilities (LTCFs) was a component of a larger initiative to increase vaccine uptake in the City of Chicago. As the Federal Pharmacy Partnership Program (PPP) was introduced, the Chicago Department of Public Health (CDPH) offered to liaise with LTCFs and facilitate the vaccination process. We were uniquely positioned to assist in LTCFs because of existing relationships with LTCFs after the past year of routine individual facility engagement for COVID-19-related infection control guidance. We worked with the community and leveraged the healthcare facility communication platforms we created to support LTCFs during the pandemic to address vaccine hesitancy and provide vaccine education.</p><p>We acted quickly to facilitate vaccination coordination in LTCFs because they were included in the first phase of vaccine distribution due to their residents’ high risk of COVID-19 morbidity and mortality. In partnership with Project Hope, we held two listening sessions with Directors of Nursing, Assistant Directors of Nursing, and Infection Preventionists at LTCFs in Chicago where we assessed their levels of vaccine hesitancy, discussed vaccine hesitancy among residents, and collected ideas on how to increase vaccine uptake. For example, during the listening sessions we heard concerns from communities of color who felt targeted and pressured to get vaccinated and were hesitant about getting it.</p><p>We used the information shared and questions asked during the listening sessions to better tailor our vaccine education efforts in LTCFs. These efforts included:</p><ul><li>Converting our weekly COVID-19 LTCF roundtables into a vaccine education and implementation series. During these roundtables, we discussed vaccine hesitancy and encouraged LTCF leaders to empower their staff to become vaccine influencers. We also shared with LTCF leadership concerns we heard from staff and residents and suggested LTCF leaders use the information to adjust their vaccine responses to the needs of residents and staff. For example, we heard that some LTCF staff were hesitant because of how quickly it was being rolled out and concerns about being used as test subjects, so many administrators got the vaccine in front of their staff to show confidence in it. In the early stages of the PPP, representatives from different pharmacies spoke about logistics and provided answers about the vaccination process.</li><li>The CDPH Commissioner hosting a Q&amp;A session for all facilities, which was advertised to all residents and their families.</li><li>Transforming our existing testing strike teams into vaccine mobilization and education teams. The vaccine education teams used the information from the listening sessions to address the concerns of LTCF staff and residents. People viewed the vaccine education teams as trusted sources of information that could speak about the vaccine without outside influences. At one facility, we saw a 40 percent increase in vaccine uptake after one education event. Leadership at the LTCF and the vaccine education team worked together to organize the event.</li></ul><p>We kept learning new information as our efforts continued, like the importance of expanding vaccine education initiatives beyond staff and residents at LTCFs. We found that, in many cases, the healthcare power of attorney for residents of LTCFs declined the vaccine on behalf of the residents. Typically, the healthcare powers of attorney do not attend the vaccine education events and miss these opportunities. This gap underscored the importance of empowering family and community members to be vaccine champions.</p><p>During the roll out of COVID-19 vaccinations in LTCFs, we continued to appreciate the importance of coordination and planning. Much planning was required to make the vaccine readily available in facilities, particularly second doses. A lot of coordination was also needed to ensure a seamless transition to LTC pharmacies when the PPP ended. Before the PPP ended, we quickly surveyed facilities to identify their LTC pharmacies and encouraged those pharmacies to enroll as COVID-19 vaccine providers. We found that some of Chicago’s LTC pharmacies were located outside of Chicago borders. We could not deliver vaccine to those facilities because the union contracts of our drivers meant they could only drive within the boundaries of Chicago. In order to overcome this roadblock, we partnered with the Illinois Department of Public Health (IDPH) and provided them with doses of Moderna through Tiberius. IDPH then distributed the vaccine to LTC pharmacies that served Chicago facilities, but were based outside of city limits.</p><p>The challenges, successes, and experiences supporting COVID-19 vaccine uptake at LTCFs helped us identify strategies to address vaccine hesitancy going forward. Given high staff and resident turnover in LTCFs, it is important to keep high vaccination coverage in LTCFs. It is also important to continue education efforts about vaccines and vaccine hesitancy. We saw that individuals who were hesitant to receive the COVID-19 vaccine may have also been hesitant to get the influenza vaccine. Overall, the educational and coordination strategies we used to address vaccine hesitancy, resources we shared for informed decision making, and methods to increase access of the COVID-19 vaccine in LTCFs will be critical for future vaccine initiatives.</p><figure class=\\\"image\\\"><img src=\\\"{asset:43960:transform:medium||/assets/images/transf/_medium/43960/Shannon-Xydis.webp}\\\" width=\\\"300\\\" height=\\\"273\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Shannon Xydis</p><figure class=\\\"image\\\"><img src=\\\"{asset:43959:transform:medium||/assets/images/transf/_medium/43959/Liz-Shane.webp}\\\" width=\\\"300\\\" height=\\\"273\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Liz Shane</p><figure class=\\\"image\\\"><img src=\\\"{asset:43958:transform:medium||/assets/images/transf/_medium/43958/Christy-Zelinski.webp}\\\" width=\\\"300\\\" height=\\\"273\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Christy Zelinski</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Shannon Xydis, Projects Administrator, HAI Coordinator, Chicago Department of Public Health; Liz Shane, MPH, CIC. Infection Prevention Specialist, Chicago Department of Public Health, and Christy Zelinski, MPH, Project Manager and Contractor, COVID-19 Response Bureau, Chicago Department of Public Health\"}',1,'2024-07-25 16:24:29','2024-07-25 16:24:29','33e96561-2772-422f-9f02-28f03d6d031e'),(44286,44013,1,'State: How the Texas State Healthcare-Associated Infections (HAI) Program Increased Capacity in Public Health Regions to Support Healthcare Facilities During the COVID-19 Response','state-how-the-texas-state-healthcare-associated-infections-hai-program-increased-capacity-in-public-health-regions-to-support-healthcare-facilities-during-the-covid-19-response','news/state-how-the-texas-state-healthcare-associated-infections-hai-program-increased-capacity-in-public-health-regions-to-support-healthcare-facilities-during-the-covid-19-response','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>The COVID-19 pandemic presented challenges in how our Healthcare-Associated Infections and Antimicrobial-Resistant Pathogens (HAI/AR) Program provides support to long-term care facilities (LTCF) experiencing outbreaks. As the pandemic unfolded, we quickly realized the need to increase our infection prevention capacity. We sought out support from leadership and partners to modify our staffing structures in order to provide continued quality and focused support to our healthcare facilities.</p><p>The Texas Department of State Health Services (DSHS) is divided into 8 public health regions, with 64 local health departments that operate at the county or city level. Texas has approximately 4,000 licensed nursing facilities, assisted living facilities, and group homes including 1,200 Centers for Medicare &amp; Medicaid Services (CMS)-certified nursing homes, across 254 counties. Traditionally, one HAI Epidemiologist is assigned to each public health region to lead and support HAI outbreak response activities, including providing direct assistance and on-site infection control assessments to healthcare facilities. The Texas Department of State Health Services (DSHS) is divided into 8 public health regions, with 64 local health departments that operate at the county or city level. Texas has approximately 4,000 licensed nursing facilities, assisted living facilities, and group homes including 1,200 Centers for Medicare &amp; Medicaid Services (CMS)-certified nursing homes, across 254 counties. Traditionally, one HAI Epidemiologist is assigned to each public health region to lead and support HAI outbreak response activities, including providing direct assistance and on-site infection control assessments to healthcare facilities.</p><p>This structure worked for our team until the onset of the COVID-19 pandemic when it became evident that one HAI Epidemiologist per public health region was insufficient to support the surge in COVID-19 cases. So, we explored the options of increasing infection prevention staff at our public health regions to build capacity for our COVID-19 response.</p><p>We received approval and support to build staffing capacity from DSHS leadership, and they provided us with the resources to contract with 3 Infection Preventionists per public health region, for a total of 24 additional Infection Preventionists throughout the state. The real challenge, however, was finding certified Infection Preventionists to recruit. At that time, healthcare facilities and local health departments were also in the process of recruiting Infection Preventionists, so we were competing for contractors in a limited pool. We decided to partner with the Association for Professionals in Infection Control and Epidemiology (APIC) who aided with the recruitment process. Out of the 24 Infection Preventionists we sought to recruit, we were able to contract with 17. These additional Infection Preventionists were instrumental in building our capacity during the response. They performed on-site infection control assessments and provided dedicated support to meet the needs of facilities.</p><p>From the first quarter of 2021, we started seeing a decrease in the number of requests for assistance from our regulatory partners and healthcare facilities, and as a result, we reduced the number of APIC contractors. It was important for us to still maintain a reasonable number of staff to assist with the continued pandemic, so we currently have at least one contracted Infection Preventionist in each public health region to assist the assigned HAI Epidemiologist with outbreak response activities.</p><p>Coordinating with the Texas Health and Human Services Commission (HHSC)—our regulatory branch—and utilizing established communication pathways facilitated the coordination of our response activities. We held daily meetings with HHSC, DSHS, and the Division of Emergency Management’s State Operations Center (SOC), where all communication plans and guidance were developed for dissemination to facilities by HHSC.</p><p>Thanks to the support of DSHS leadership and partners, as well as the dedication of our team, we worked together in a coordinated fashion to build capacity and respond to COVID-19 outbreaks in healthcare facilities.</p><figure class=\\\"image\\\"><img src=\\\"{asset:43965:transform:medium||/assets/images/transf/_medium/43965/enyinnaya-merengwa.webp}\\\" width=\\\"300\\\" height=\\\"275\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Enyinnaya Merengwa</p><figure class=\\\"image\\\"><img src=\\\"{asset:43964:transform:medium||/assets/images/transf/_medium/43964/thi-dang.webp}\\\" width=\\\"300\\\" height=\\\"301\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Thi Dang</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Dr. Enyinnaya Merengwa, Healthcare Safety Investigations Group Manager and State HAI Coordinator at the Texas Department of State Health Services and Thi Dang, HAI Epidemiologist at the Texas Department of State Health Services\"}',1,'2024-07-25 16:25:10','2024-07-25 16:25:10','0e83e5f9-cb16-4994-ae86-e1a2c16b2648'),(44288,44015,1,'State: Montana Leverages Partnerships to Manage COVID-19 Outbreaks in Long-Term Care Facilities','state-montana-leverages-partnerships-to-manage-covid-19-outbreaks-in-long-term-care-facilities','news/state-montana-leverages-partnerships-to-manage-covid-19-outbreaks-in-long-term-care-facilities','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>Montana, the fourth largest state geographically in the U.S., spans more than 147,000 square miles (slightly larger than Japan) and is home to about 1 million people. Montana has a decentralized public health system so a lot of the authority and responsibility for implementing rules and regulations and every aspect of pandemic response actually land with the counties, many of which have limited staff. In order to provide public health support to city and rural areas, we partnered with our state’s local health departments, survey agency, Quality Innovation Network-Quality Improvement Organization (QIN/QIO), hospital and public health preparedness teams, and laboratory partners to identify and provide support to LTCF experiencing COVID-19 outbreaks. We worked closely with these partners prior to the pandemic, so these existing relationships led to a coordinated approach during the COVID-19 response.</p><p>Our team coordinates outbreak response efforts with local public health departments, healthcare facilities, and the state survey agency. At the beginning of the pandemic, I communicated with facilities at least daily to get updates on their COVID-19 outbreaks and to provide guidance and technical assistance, including offering COVID-19 focused infection control assessments (ICAR) to all healthcare facilities in Montana. I now check in with LTCFs/ALFs and local public health at least weekly to monitor active outbreaks. Our local health departments really stepped up during the pandemic. Given Montana’s decentralized governance structure, our local health department staff take on multiple roles and usually do not have a dedicated communicable disease staff person, so their collaboration with us and their engagement with the facilities was a huge benefit to the response.</p><p>The Montana HAI Program hosted weekly webinars for all Montana APIC chapter members, as well as Infection Preventionists from other states. This webinar series—which was established prior to the pandemic—provided a platform to communicate updates, share resources and provide trainings to Infection Preventionists. It also helped strengthen our relationship with Infection Preventionists, which led to timely and frequent communication about outbreaks in facilities. Additionally, in November of 2020, our HAI Program partnered with a local acute care hospital and the Agency for Healthcare Research and Quality to provide a 16-week LTCF training course primarily focused on COVID-19. We also leveraged our good relationship with QIN/QIOs and our hospital association to use their communications channels to send important messages and updates to facilities state-wide.</p><p>As a rural state, we faced unique challenges when it came to reaching every facility. Testing for example was a huge logistical challenge, since some facilities are not located near a hospital and our laboratory courier system could not reach every facility. We were fortunate to have our Governor’s support and some time to plan and respond, so we worked with our state public health laboratory and other laboratory partners to figure out ways to offer baseline testing and implement surveillance testing prior to national LTCF testing recommendations took effect.</p><p>We also worked closely with the hospital preparedness and public health preparedness programs (HPP), using data from the National Healthcare Safety Network (NHSN) to address PPE and other supply shortages in LTCFs. Each week, the HPP Coordinator submitted the State LTCF Integrated Red Report, which we used to reach out to facilities reporting PPE and staffing shortages. During this outreach, we reminded facilities of the staffing and PPE resources available through the state and communicated information on how to obtain these resources.</p><p>One of the biggest contributing factors to the success of our response was the additional funding from CDC which led to the growth of our HAI Program. We were able to expand our HAI Program team to four Infection Preventionists who now consult with facilities, perform infection control assessments, and provide direct support and assistance to facilities. The additional funding has also allowed us to expand the services we offer to facilities. As a rural state, we have more Critical Access Hospitals, so our infection prevention activities have focused on providing one-on-one support to these facilities, which typically have limited staff who are stretched across multiple roles. During the pandemic, we were able to expand these services to LTCFs and Assisted Living Facilities and have hopes to expand to other types of congregate living settings including outpatient health clinics, dialysis centers, schools, and jails.</p><p>Our experience during this pandemic has highlighted the importance of infection control. We have learned that infection control is a responsibility and duty of everyone in the facility, and this facility-wide approach to infection prevention can contribute to a successful outcome. We also recognize the importance of inter and intra-facility communication, as well as communicating information to residents and family members to prevent the spread of infections and outbreaks. We were met with challenges every day, but because of our hard working and dedicated Infection Preventionists, we were able to overcome a lot of them. It has also been inspiring to work with our amazing healthcare workers and public health staff during the response. We have a lot of work in front us, but I remain excited because this experience has been the catalyst for us to enhance our infection prevention activities, expand our reach and support, and provide guidance and education on infection prevention standards.</p><figure class=\\\"image\\\"><img src=\\\"{asset:43970:transform:medium||/assets/images/transf/_medium/43970/erika-baldry.webp}\\\" width=\\\"300\\\" height=\\\"401\\\" alt=\\\"\\\" /></figure><p class=\\\"main content photo-caption\\\">Erika Baldry</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Erika Baldry, Healthcare-Associated Infections and Antimicrobial Resistance (HAI/AR) Epidemiologist and Program Coordinator at the Montana Department of Public Health and Human Services (DPHHS)\"}',1,'2024-07-25 16:25:47','2024-07-25 16:25:47','3371f492-63aa-46e9-b6ec-a9f138eeb77a'),(44298,44025,1,'Carbapenem-Resistant Enterobacterales','carbapenem-resistant-enterobacterales','diseases-pathogens/carbapenem-resistant-enterobacterales','{\"8a0179a9-5d67-4563-85ee-348d0dc6b55d\": false, \"b0e373e6-78db-4059-8c91-7bf51b328e7b\": true, \"f9bb51ff-9dbb-464f-9bc4-ed50685e6e0b\": {\"score\": \"poor\", \"social\": {\"twitter\": {\"title\": \"Carbapenem-Resistant Enterobacterales - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"Understand the threat of carbapenem-resistant Enterobacterales (CRE), its impact on healthcare, and strategies for prevention and control of antibiotic resistance. Download resources.\"}, \"facebook\": {\"title\": \"Carbapenem-Resistant Enterobacterales - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"Understand the threat of carbapenem-resistant Enterobacterales (CRE), its impact on healthcare, and strategies for prevention and control of antibiotic resistance. Download resources.\"}}, \"advanced\": {\"robots\": [], \"canonical\": \"\"}, \"keywords\": [{\"rating\": \"good\", \"keyword\": \"carbapenem-resistant Enterobacterales\"}, {\"rating\": \"good\", \"keyword\": \"CRE\"}, {\"rating\": \"poor\", \"keyword\": \"antibiotic-resistant bacteria\"}, {\"rating\": \"poor\", \"keyword\": \"infectious disease\"}, {\"rating\": \"poor\", \"keyword\": \"disease outbreak\"}], \"titleRaw\": {\"1\": \"Carbapenem-Resistant Enterobacterales\"}, \"descriptionRaw\": \"Understand the threat of carbapenem-resistant Enterobacterales (CRE), its impact on healthcare, and strategies for prevention and control of antibiotic resistance. Download resources.\"}}',1,'2024-07-25 17:51:31','2024-12-03 17:44:03','53da4df3-91da-4b70-b85d-7e937af2ce4c'),(44299,44026,1,NULL,'__temp_dvnahxzlcwzuscyiruyvhneoygytjpnidjry',NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Bacteria\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-07-25 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-07-25 07:00:00\"}}',1,'2024-07-25 17:51:35','2024-08-01 20:39:47','8b22a133-740f-4bf9-af76-30adba8cc4a0'),(44300,44027,1,NULL,'__temp_pylubquqdbunksggnmkxlmjnphsltkrjzhlz',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also referred to as CRE</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Carbapenem-Resistant Enterobacterales\"}',1,'2024-07-25 17:51:36','2024-07-25 21:08:01','d415bac1-b6d8-41e8-9549-e7ba6fb79501'),(44301,44028,1,NULL,NULL,NULL,NULL,1,'2024-07-25 17:53:58','2024-07-25 17:53:58','14805104-d24a-4288-af44-ffe894df892e'),(44302,44029,1,NULL,'__temp_wnpjebmzrbbrfbercwllfaqzhjqgeebnsdma',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Enterobacterales are a large family of bacteria that include Escherichia coli (E. coli) and Klebsiella pneumoniae. Carbapenem-resistant Enterobacterales (CRE) are a type of Enterobacterales that are resistant to a group of antibiotics called carbapenems. CRE can cause outbreaks in healthcare settings, such as hospitals and nursing homes. CRE in one facility can lead to CRE in other facilities. Providers should follow public health guidance for detection, tracking and reporting of CRE.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About CRE\"}',1,'2024-07-25 17:54:06','2024-07-25 17:54:30','f49b1b12-ac97-4860-a622-dab58ca7fe9a'),(44303,44030,1,NULL,NULL,NULL,NULL,1,'2024-07-25 17:55:29','2024-07-25 17:55:29','38ea6155-cbca-477a-af99-b3a3e06a4d0a'),(44304,44031,1,NULL,'__temp_mczeqwfhorlakupyjhxpgtcxndsxmsrleyaj',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE: Recommendations for Healthcare Outbreak Response\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"8d07cb41-da70-4198-9c8d-e5de926d4a0d\": {\"date\": \"2023-02-01 08:00:00\"}, \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [2716], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://corha.org/assets/documents/CORHA-CRE_February-2023-1.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CORHA-developed product addresses outbreak detection, reporting, investigation and control.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 17:55:32','2024-09-23 17:28:18','d4deff5c-343d-4d39-b0fa-1bbc59e8129e'),(44305,44032,1,NULL,NULL,NULL,NULL,1,'2024-07-25 17:55:33','2024-07-25 17:55:33','5e0421c3-8cd7-42ad-87b0-89795824d2cb'),(44306,44033,1,NULL,'__temp_iewdglllnctgpubfqoaqlwjfmwbqhxpcdtku',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE Infection Control\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [2808], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/cre/hcp/infection-control/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Recommendations that healthcare providers and health departments can use to reduce the spread of CRE infections\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 17:55:36','2024-08-10 20:45:41','d7506629-f4c0-419d-a721-65b10e2d80e6'),(44307,44034,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:04:49','2024-07-25 18:04:49','4dfe7fd4-eb35-4e20-8e62-7632cbec20a7'),(44308,44035,1,NULL,'__temp_zhhcdigssqnrjxfnuctgqalhtealjvccwrmg',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Preventing MDROs (multidrug-resistant organisms)\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [2808], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/php/preventing-mdros/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This website introduces valuable concepts and strategies for preventing and containing MDROs including CRE.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:04:52','2024-08-10 20:45:41','d84f2366-e756-4107-86d6-277c15e81931'),(44309,44036,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:05:20','2024-07-25 18:05:20','7f21ce3c-1bf3-48d2-ae29-e4a148eb1606'),(44310,44037,1,NULL,'__temp_ajhzqvrzylszpvkccoqrqhcbodohwriuppsv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE Handout: Information for Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [2808], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/CRE-handout-V7-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Two-page flyer with CRE information covering nomenclature, transmission, colonization, and prevention\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:05:23','2024-08-10 20:45:41','d9a4d323-e16e-4f00-9c09-a18544f84480'),(44311,44038,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:06:13','2024-07-25 18:06:13','c3604ae1-b53b-47fc-b2c9-6d355e445fcd'),(44312,44039,1,NULL,'__temp_iystdoheimlpsucfsfktiktitmjpiwzmfhfv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Inter-facility Infection Control Transfer Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [2808], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/CRE-handout-V7-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An essential aide to facilitate communication during patient transfers, to prevent spread of CRE or other MDROs\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:06:16','2024-08-10 20:45:41','6124c676-88c2-4f20-914d-9822a99809c5'),(44313,44040,1,'Pathogen Thumbnail_Carbapenem-Resistant Enterobacterales',NULL,NULL,NULL,1,'2024-07-25 18:08:16','2024-12-03 17:43:12','6f0f7d24-ca70-4089-a0c2-74f5a0ce1400'),(44314,44040,2,'CRE',NULL,NULL,NULL,1,'2024-07-25 18:08:16','2024-07-25 18:08:16','a4c8c8ee-3a43-49c9-ac34-0ff403bf8fef'),(44315,44041,1,'CRE',NULL,NULL,NULL,1,'2024-07-25 18:08:25','2024-07-25 18:08:25','b68dbd27-6666-4f6f-acd3-e2488d57848d'),(44316,44041,2,'CRE',NULL,NULL,NULL,1,'2024-07-25 18:08:25','2024-07-25 18:08:25','feac6bee-81ff-4e99-968b-385476c06374'),(44317,44042,1,'Carbapenem-Resistant Enterobacterales','carbapenem-resistant-enterobacterales','diseases-pathogens/carbapenem-resistant-enterobacterales',NULL,1,'2024-07-25 18:08:28','2024-07-25 18:08:28','4f9a5999-4e2f-4914-8a24-e4c4dbbe7de0'),(44318,44043,1,NULL,'__temp_pylubquqdbunksggnmkxlmjnphsltkrjzhlz',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also referred to as CRE</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Carbapenem-Resistant Enterobacterales\"}',1,'2024-07-25 18:08:28','2024-07-25 18:08:28','1fe6b9b8-f51e-42d4-8e0c-8ac6e908b38e'),(44319,44044,1,NULL,'__temp_dvnahxzlcwzuscyiruyvhneoygytjpnidjry',NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Bacteria\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-07-25 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-07-25 07:00:00\"}}',1,'2024-07-25 18:08:28','2024-07-25 18:08:28','07e9c536-b29c-4d66-87fa-3bb80f2ddf76'),(44320,44045,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:08:28','2024-07-25 18:08:28','f1c1f79d-b265-4943-8d7f-6362d7962045'),(44321,44046,1,NULL,'__temp_wnpjebmzrbbrfbercwllfaqzhjqgeebnsdma',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Enterobacterales are a large family of bacteria that include Escherichia coli (E. coli) and Klebsiella pneumoniae. Carbapenem-resistant Enterobacterales (CRE) are a type of Enterobacterales that are resistant to a group of antibiotics called carbapenems. CRE can cause outbreaks in healthcare settings, such as hospitals and nursing homes. CRE in one facility can lead to CRE in other facilities. Providers should follow public health guidance for detection, tracking and reporting of CRE.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About CRE\"}',1,'2024-07-25 18:08:28','2024-07-25 18:08:28','6e3ec141-3d84-4882-b02f-c3e7c017b7af'),(44322,44047,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:08:28','2024-07-25 18:08:28','113703f8-7e5e-4a44-88a4-c7544c7ea7f3'),(44323,44048,1,NULL,'__temp_mczeqwfhorlakupyjhxpgtcxndsxmsrleyaj',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE: Recommendations for Healthcare Outbreak Response\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"8d07cb41-da70-4198-9c8d-e5de926d4a0d\": {\"date\": \"2023-02-01 08:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://old.corha.org/wp-content/uploads/2019/06/CORHA-CRE_February-2023-1.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CORHA-developed product addresses outbreak detection, reporting, investigation and control.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:08:29','2024-07-25 18:08:29','21beaa79-4e96-49a1-9092-6aceea23979a'),(44324,44049,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:08:29','2024-07-25 18:08:29','a269c83d-8df5-42d2-bd6c-bbfcc37bbeef'),(44325,44050,1,NULL,'__temp_iewdglllnctgpubfqoaqlwjfmwbqhxpcdtku',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE Infection Control\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/cre/hcp/infection-control/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Recommendations that healthcare providers and health departments can use to reduce the spread of CRE infections\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:08:29','2024-07-25 18:08:29','bfb12688-94d4-4f17-b3e3-60077e66a24b'),(44326,44051,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:08:29','2024-07-25 18:08:29','cf0f9662-f163-4b45-9c70-9692bb7378bc'),(44327,44052,1,NULL,'__temp_zhhcdigssqnrjxfnuctgqalhtealjvccwrmg',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Preventing MDROs (multidrug-resistant organisms)\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/php/preventing-mdros/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This website introduces valuable concepts and strategies for preventing and containing MDROs including CRE.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:08:29','2024-07-25 18:08:29','82c4dd4a-6718-445c-bcf0-9a8643e57f52'),(44328,44053,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:08:29','2024-07-25 18:08:29','e57e969d-8b10-4292-a0e5-45fd14fe17e3'),(44329,44054,1,NULL,'__temp_ajhzqvrzylszpvkccoqrqhcbodohwriuppsv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE Handout: Information for Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/CRE-handout-V7-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Two-page flyer with CRE information covering nomenclature, transmission, colonization, and prevention\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:08:29','2024-07-25 18:08:29','f47b67a3-8fdf-4c5a-b6e2-52c1a1fdc6c6'),(44330,44055,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:08:29','2024-07-25 18:08:29','606c30ce-b194-4578-830b-feede4eca2c5'),(44331,44056,1,NULL,'__temp_iystdoheimlpsucfsfktiktitmjpiwzmfhfv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Inter-facility Infection Control Transfer Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/CRE-handout-V7-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An essential aide to facilitate communication during patient transfers, to prevent spread of CRE or other MDROs\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:08:29','2024-07-25 18:08:29','0bde6fa3-66cc-4198-9859-0a0a8c73164d'),(44342,44067,1,'Carbapenem-Resistant Enterobacterales (CRE)','carbapenem-resistant-enterobacterales','diseases-pathogens/carbapenem-resistant-enterobacterales',NULL,1,'2024-07-25 18:09:57','2024-07-25 18:09:57','eb1777dc-24f7-433a-8cde-5eaa31d8ac31'),(44343,44068,1,NULL,'__temp_pylubquqdbunksggnmkxlmjnphsltkrjzhlz',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Carbapenem-Resistant Enterobacterales (CRE)\"}',1,'2024-07-25 18:09:57','2024-07-25 18:09:57','c8b45049-3b1f-447e-b341-288e3b5f1a1f'),(44344,44069,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:09:57','2024-07-25 18:09:57','09de6835-23d2-40cf-8328-b56276297b31'),(44345,44070,1,NULL,'__temp_iewdglllnctgpubfqoaqlwjfmwbqhxpcdtku',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE Infection Control\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/cre/hcp/infection-control/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Recommendations that healthcare providers and health departments can use to reduce the spread of CRE infections\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:09:57','2024-07-25 18:09:57','4234808c-1740-4476-a760-fb60a44dfe31'),(44346,44071,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:09:58','2024-07-25 18:09:58','fe7a8d7d-c620-458b-a943-e28ea1006f05'),(44347,44072,1,NULL,'__temp_zhhcdigssqnrjxfnuctgqalhtealjvccwrmg',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Preventing MDROs (multidrug-resistant organisms)\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/php/preventing-mdros/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This website introduces valuable concepts and strategies for preventing and containing MDROs including CRE.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:09:58','2024-07-25 18:09:58','eb807ff3-2a16-447a-95fc-30a386458616'),(44348,44073,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:09:58','2024-07-25 18:09:58','ca6eb37f-36bd-4a38-99ad-bc1e5a3fca58'),(44349,44074,1,NULL,'__temp_ajhzqvrzylszpvkccoqrqhcbodohwriuppsv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE Handout: Information for Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/CRE-handout-V7-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Two-page flyer with CRE information covering nomenclature, transmission, colonization, and prevention\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:09:58','2024-07-25 18:09:58','d7dfca38-388a-4ec9-af90-75426962169a'),(44350,44075,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:09:58','2024-07-25 18:09:58','556996d5-47b9-4c6d-91f2-a9c3b8b15122'),(44351,44076,1,NULL,'__temp_iystdoheimlpsucfsfktiktitmjpiwzmfhfv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Inter-facility Infection Control Transfer Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/CRE-handout-V7-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An essential aide to facilitate communication during patient transfers, to prevent spread of CRE or other MDROs\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:09:58','2024-07-25 18:09:58','0ddb78f8-596f-4586-8688-afb01e814061'),(44368,44093,1,'Environmental Protection Agency (EPA)','environmental-protection-agency-epa','resource-sources/environmental-protection-agency-epa',NULL,1,'2024-07-25 18:21:22','2024-07-25 18:24:27','340da2db-763d-4678-87a9-6d99bb453abc'),(44369,44093,2,'Environmental Protection Agency (EPA)','__temp_fumiqgpsordxmqdajofqokynvocgzwfskbhn','resource-sources/__temp_fumiqgpsordxmqdajofqokynvocgzwfskbhn',NULL,1,'2024-07-25 18:21:22','2024-07-25 18:24:27','94d4ce7b-8596-4fda-82b7-db8447b2c35e'),(44377,44101,1,NULL,'__temp_yfzpyzhujyelrbnggvpxtogdpunrytbinrmb',NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Risk of infection or colonization with <i>C. auris </i>is greatest among persons: a) with extensive healthcare exposures, especially in long-term care facilities providing ventilator care; b) infected or colonized with another multidrug-resistant organism, especially carbapenemase-producing organisms (CPOs); c) with invasive medical devices such as central venous catheters and with tracheostomy, or gastrostomy tubes.</p>\"}',1,'2024-07-25 18:24:23','2024-07-25 18:24:23','2144c480-f3a9-434a-89cc-2086ef10ffe9'),(44378,44102,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:24:24','2024-07-25 18:24:24','7678e96d-b878-4f60-b66e-a7f9ff1366f0'),(44379,44103,1,NULL,'__temp_zantjlhdqpstwwdfwekawhdwvzqvkrczjlns',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Antimicrobial Products Effective Against Candida auris\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [44093], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.epa.gov/pesticide-registration/epas-registered-antimicrobial-products-effective-against-candida-auris-list\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"The EPA\'s List P provides information on registered antimicrobial products listed as effective against C. auris.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:24:24','2024-08-10 19:40:59','ea5d5197-57b5-4af5-b808-894418bbdcf5'),(44380,44104,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:24:24','2024-07-25 18:24:24','d0832f9f-3670-47a8-9b74-104aedac7e76'),(44381,44105,1,NULL,'__temp_hcunbavkrfugxblnduessxokbsjwzmjodlqc',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Tracking Candida auris\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [2808], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/candida-auris/tracking-c-auris/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"C. auris cases are nationally notifiable; this page offers reporting information, case counts and maps.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:24:24','2024-08-10 19:40:59','4dbf757d-d490-4b7b-9e17-fc2acf99375f'),(44382,44106,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:24:24','2024-07-25 18:24:24','f3694668-e3c7-483d-81e6-8a19d3441ddd'),(44383,44107,1,NULL,'__temp_kdhsyvlsnpojsuxumulsjhrzhnbtxodswqtt',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Inter-Facility Infection Control Transfer Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [2808], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/interfacility-ic-transfer-form-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This tool fosters communication about C. auris colonization and infection at transitions of care, essential to preventing further spread.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:24:24','2024-08-10 19:40:59','d24f89d1-4e72-4887-bcb7-5fcbd62b5b87'),(44384,44108,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:24:24','2024-07-25 18:24:24','2b525212-7e64-4746-91c6-b9b3ccfd0f1c'),(44385,44109,1,NULL,'__temp_vvlxghjhqexglvavvjczjbeltdcvwppxlwam',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Implementation of Personal Protective Equipment Use in Nursing Homes to Prevent the Spread of Multidrug-Resistant Organisms\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [2808], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/long-term-care-facilities/hcp/prevent-mdro/ppe.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This long term care facility specific guidance provides an alternative to Contact Precautions. It clarifies the precautions needed based on the population at risk and the regional prevalence of C. auris.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:24:24','2024-08-10 19:40:59','319c53b1-c28e-4978-b4e7-e0e6afdc68db'),(44386,44110,1,'Candida auris (C. auris)','c-auris','diseases-pathogens/c-auris',NULL,1,'2024-07-25 18:24:24','2024-07-25 18:24:24','947ea722-251f-4a6f-a593-cd8e6c63d747'),(44387,44111,1,NULL,'__temp_mgxgiouzofnmkbhidqgmctqezrknagtyorzu',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Candida auris (C. auris)\"}',1,'2024-07-25 18:24:24','2024-07-25 18:24:24','054a4af2-999f-484b-bfac-70f2429692ad'),(44388,44112,1,NULL,'__temp_gawqpckiwiqstbmvxrkjeapbpbyyzonfvvdm',NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Yeast\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-07-25 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-01 07:00:00\"}}',1,'2024-07-25 18:24:24','2024-07-25 18:24:24','51356b28-0c87-4823-aafa-a6792c7c691b'),(44389,44113,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:24:24','2024-07-25 18:24:24','1193616b-aea9-498f-8403-bc019d248cb0'),(44390,44114,1,NULL,'__temp_vkuypqsxbkpwvmavpkjtviioxfsqttyvevaj',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p><i>Candida auris (C. auris) </i>is an emerging multidrug-resistant yeast that can cause invasive infections associated with high mortality. It can be difficult to identify with standard laboratory methods. <i>C. auris</i> can persist on surfaces and medical equipment, spread between patients, and lead to outbreaks in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About C. auris\"}',1,'2024-07-25 18:24:24','2024-07-25 18:24:24','6637fb85-bce9-4cd7-8d53-d8ddc44607cd'),(44391,44115,1,NULL,'__temp_yfzpyzhujyelrbnggvpxtogdpunrytbinrmb',NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Risk of infection or colonization with <i>C. auris </i>is greatest among persons: a) with extensive healthcare exposures, especially in long-term care facilities providing ventilator care; b) infected or colonized with another multidrug-resistant organism, especially carbapenemase-producing organisms (CPOs); c) with invasive medical devices such as central venous catheters and with tracheostomy, or gastrostomy tubes.</p>\"}',1,'2024-07-25 18:24:24','2024-07-25 18:24:24','937da710-2058-49a6-b932-7693c93ee047'),(44392,44116,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:24:24','2024-07-25 18:24:24','bf79a0bb-8f83-410a-a6aa-2d0f90857c57'),(44393,44117,1,NULL,'__temp_xnefwmcxgxryloedzmdvdgpzhhjqthftraze',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Candida auris: Recommended Practices for Healthcare Outbreak Response\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"8d07cb41-da70-4198-9c8d-e5de926d4a0d\": {\"date\": \"2022-08-01 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://old.corha.org/wp-content/uploads/2021/08/Candida-auris-Recommendations-for-Healthcare-Outbreak-Response.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CORHA developed product includes proposed investigation/reporting thresholds and an outbreak definition for C. auris.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:24:24','2024-07-25 18:24:24','7a86fff9-5b54-4735-b096-75ea961ac1d6'),(44394,44118,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:24:24','2024-07-25 18:24:24','117822af-eff9-4f00-8875-ec5f96ca3290'),(44395,44119,1,NULL,'__temp_qmhcxyvtsbbfepftnwkiivogawelgczjtxsi',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Control Guidance: Candida auris\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/candida-auris/hcp/infection-control/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CDC product outlines measures to control C. auris including setting-specific guidance.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:24:24','2024-07-25 18:24:24','41766f07-1ca3-479d-9c9c-c08f967a619b'),(44396,44120,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:24:24','2024-07-25 18:24:24','88fc64ec-fa04-4141-bc31-7893e4a0c2a0'),(44397,44121,1,NULL,'__temp_odwrxknpunbllrstogttzfwrmsxyltsxnctc',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Screening for Candida auris Colonization\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/candida-auris/hcp/screening-hcp/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CDC resource provides detailed recommendations on screening for C. auris colonization.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:24:24','2024-07-25 18:24:24','6f34d600-89d8-44c8-a050-ea8acc0db4c9'),(44398,44122,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:24:24','2024-07-25 18:24:24','95a3f3d7-ceb8-420c-aa04-dd35511da3bd'),(44399,44123,1,NULL,'__temp_zantjlhdqpstwwdfwekawhdwvzqvkrczjlns',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Antimicrobial Products Effective Against Candida auris\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.epa.gov/pesticide-registration/epas-registered-antimicrobial-products-effective-against-candida-auris-list\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"The EPA\'s List P provides information on registered antimicrobial products listed as effective against C. auris.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:24:24','2024-07-25 18:24:24','d360137f-facf-43a9-a3b5-7367e6297fd0'),(44400,44124,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:24:24','2024-07-25 18:24:24','290df03c-7fff-4b98-9767-fecb0e7540cc'),(44401,44125,1,NULL,'__temp_hcunbavkrfugxblnduessxokbsjwzmjodlqc',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Tracking Candida auris\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/candida-auris/tracking-c-auris/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"C. auris cases are nationally notifiable; this page offers reporting information, case counts and maps.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:24:24','2024-07-25 18:24:24','f1dda47d-1820-4fb9-b8a7-a0f9404cb29e'),(44402,44126,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:24:25','2024-07-25 18:24:25','19bca45a-7a66-4b44-b6fe-4412dade7cab'),(44403,44127,1,NULL,'__temp_kdhsyvlsnpojsuxumulsjhrzhnbtxodswqtt',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Inter-Facility Infection Control Transfer Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/interfacility-ic-transfer-form-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This toolfosters communication about C. auris colonization and infection at transitions of care, essential to preventing further spread.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:24:25','2024-07-25 18:24:25','f8b3e672-a64b-4dd5-bfe5-29fe05a6628a'),(44404,44128,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:24:25','2024-07-25 18:24:25','8f53b97d-d7a7-4edc-aea5-3083323464bc'),(44405,44129,1,NULL,'__temp_vvlxghjhqexglvavvjczjbeltdcvwppxlwam',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Implementation of Personal Protective Equipment Use in Nursing Homes to Prevent the Spread of Multidrug-Resistant Organisms\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/long-term-care-facilities/hcp/prevent-mdro/ppe.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This long term care facility specific guidance provides an alternative to Contact Precautions. It clarifies the precautions needed based on the population at risk and the regional prevalence of C. auris.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:24:25','2024-07-25 18:24:25','81d432f1-0f38-4fab-9763-af0c843dd01d'),(44406,44130,1,'Group A Streptococcus','group-a-streptococcus','diseases-pathogens/group-a-streptococcus','{\"8a0179a9-5d67-4563-85ee-348d0dc6b55d\": false, \"b0e373e6-78db-4059-8c91-7bf51b328e7b\": true, \"f9bb51ff-9dbb-464f-9bc4-ed50685e6e0b\": {\"score\": \"poor\", \"social\": {\"twitter\": {\"title\": \"Group A Streptococcus - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"Explore Group A Streptococcus, including its infections, symptoms, treatment options, and prevention measures to reduce infection risk. Download resources.\"}, \"facebook\": {\"title\": \"Group A Streptococcus - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"Explore Group A Streptococcus, including its infections, symptoms, treatment options, and prevention measures to reduce infection risk. Download resources.\"}}, \"advanced\": {\"robots\": [], \"canonical\": \"\"}, \"keywords\": [{\"rating\": \"good\", \"keyword\": \"Group A streptococcus\"}, {\"rating\": \"poor\", \"keyword\": \"GAS\"}, {\"rating\": \"poor\", \"keyword\": \"streptococcal infections\"}, {\"rating\": \"poor\", \"keyword\": \"bacterial pathogens\"}, {\"rating\": \"poor\", \"keyword\": \"infectious disease\"}, {\"rating\": \"poor\", \"keyword\": \"disease outbreak\"}], \"titleRaw\": {\"1\": \"Group A Streptococcus\"}, \"descriptionRaw\": \"Explore Group A Streptococcus, including its infections, symptoms, treatment options, and prevention measures to reduce infection risk. Download resources.\"}}',1,'2024-07-25 18:24:59','2024-12-03 17:42:02','05d815c5-fe58-4f6e-94ab-021d374f2109'),(44407,44131,1,NULL,'__temp_thgogifghptncchxkatfxestxojplmxapbyz',NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Bacteria\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-07-25 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-07-25 07:00:00\"}}',1,'2024-07-25 18:25:05','2024-08-01 20:39:48','2ccaec75-7703-4d7a-a72f-7e83322bfca0'),(44408,44132,1,NULL,'__temp_eusblbislnunmsfkjvxyoqinzapzcnjligyy',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also referred to as group A strep or GAS</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Group A Streptococcus\"}',1,'2024-07-25 18:25:05','2024-07-25 18:25:51','a6974e9e-34e3-4432-9ae3-32046cada4c0'),(44409,44133,1,'Pathogen Thumbnail_Group A Streptococcus',NULL,NULL,NULL,1,'2024-07-25 18:28:17','2024-12-03 17:40:39','24b62193-6cc1-4a23-80ff-5434395105f0'),(44410,44133,2,'GAS',NULL,NULL,NULL,1,'2024-07-25 18:28:17','2024-07-25 18:28:17','f6d433f1-2176-4bb0-844d-87bf9c225404'),(44411,44134,1,'Header Image_Group A Streptococcus',NULL,NULL,NULL,1,'2024-07-25 18:29:52','2024-12-03 17:40:17','ae5038aa-4bfa-484d-b559-0df09ae53e41'),(44412,44134,2,'Group A Streptococcus GAS 1',NULL,NULL,NULL,1,'2024-07-25 18:30:56','2024-07-25 18:30:56','ecfac9ad-600b-4818-811c-ee20528f6c92'),(44413,44135,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:31:15','2024-07-25 18:31:15','9674219f-18b6-48d4-9619-6ad9c13fedef'),(44414,44136,1,NULL,'__temp_zsfusiqwvyoprragaudjynmygwxvbqrigieu',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Bacteria called group A <i>Streptococcus</i> can cause many different infections. Invasive group A strep (iGAS) infections include necrotizing fasciitis and streptococcal toxic shock syndrome. The most common iGAS outbreaks investigated in the United States are those occurring in long-term care (LTC) facilities. Healthcare-associated iGAS clusters can also involve postpartum and post-surgical infections. <br /><br />GAS is spread by respiratory droplets, direct contact with mucus or secretions of an infected person, or by contact with infected or colonized wounds. <br /><br />Outbreaks and clusters of healthcare-associated iGAS often require urgent public health action. Even a single case of iGAS usually warrants investigation and follow-up, to rule out a larger problem.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About GAS\"}',1,'2024-07-25 18:31:27','2024-07-25 18:31:38','123de554-8814-451e-8bb8-85d225f92f1c'),(44416,44138,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:32:21','2024-07-25 18:32:21','4b9c7f1d-6729-4870-9781-84914f0b4e53'),(44417,44139,1,NULL,'__temp_nxhkcsmvdnpcriebxnpdzcbjmcbdqsqcprrx',NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>CDC is available to assist state, tribal, local, and territorial health departments for GAS outbreaks, particularly for persistent, large, or severe outbreaks. For assistance, contact gasoutbreaks@cdc.gov.</p>\"}',1,'2024-07-25 18:32:28','2024-07-25 18:32:49','1f195c61-9883-403c-84f2-1f1817aa7e0f'),(44418,44140,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:33:26','2024-07-25 18:33:26','de38bf9d-c227-4c5b-aff5-b65221f26362'),(44419,44141,1,NULL,'__temp_rvkopaqsbubmmvejrxhiekmarmexwnzdniwm',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Decision Tool for Investigating GAS Infections in Long-Term Care Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [2808], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/group-a-strep/php/ltcf-toolkit/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This toolkit outlines detailed actions that investigators should consider, depending on the number of cases of GAS identified.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:33:29','2024-08-10 20:47:42','ba9cfc3a-17bb-4841-afeb-c6c26070bb65'),(44420,44142,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:34:01','2024-07-25 18:34:01','c7439e37-a0b5-4008-ab3a-27662009e317'),(44421,44143,1,NULL,'__temp_tguaffzxjjypaculktbdqpkfvaohqtbghjqh',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Additional GAS Investigation Resources\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [2808], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/group-a-strep/php/ltcf-toolkit/resources.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Compilation of links to helpful resources from state health departments including sample line lists and facility letters; CDC\'s interfacility infection control transfer form is also included.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:34:04','2024-08-10 20:47:42','4f9ab753-9b0b-4003-af6f-786aeedf9dba'),(44422,44144,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:34:28','2024-07-25 18:34:28','ae50462f-f735-43b4-8794-fddae74e3478'),(44423,44145,1,NULL,'__temp_vuzqxxcouacsacxfjiewyuxxkmpoeqywvlhc',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevention of iGAS among household contacts of case patients and among postpartum and postsurgical patients; recommendations from the Centers for Disease Control and Prevention\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [44146], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/12355382/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Recommendations for controlling iGAS among exposed household contacts and for responding to postpartum and postsurgical iGAS.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:34:31','2024-08-10 20:47:42','3cd0ca3e-4b38-40ff-bc66-15c4d88caf20'),(44424,44146,1,'Prevention of iGAS Infections Workshop Participants','prevention-of-igas-infections-workshop-participants','resource-sources/prevention-of-igas-infections-workshop-participants',NULL,1,'2024-07-25 18:35:19','2024-07-25 18:42:46','f146f1be-6e9d-442c-9f33-fb4602f8de1a'),(44425,44146,2,'Prevention of iGAS Infections Workshop Participants','__temp_fnuijrwwqgsfmotpccgbsfyrbipypxanufzr','resource-sources/__temp_fnuijrwwqgsfmotpccgbsfyrbipypxanufzr',NULL,1,'2024-07-25 18:35:19','2024-07-25 18:42:46','90957c45-f7a5-4e82-9295-a7a8ef2b8f7e'),(44426,44147,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:36:29','2024-07-25 18:36:29','ab4d56f8-1638-4277-bc41-b0da20fa2778'),(44427,44148,1,NULL,'__temp_dwsoomkpzmmvotnvjgklzuaiiajdnypxnxnp',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Cluster of Group A Streptococcal Infections in a Skilled Nursing Facility—the Potential Role of Healthcare Worker Presenteeism\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [14914], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742861/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Outbreak report that examined the role of working while ill, or “presenteeism,” in the introduction and transmission of GAS within a skilled nursing facility.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:36:32','2024-08-10 20:47:42','5edcb193-eacd-4101-8aeb-beb8b9743892'),(44428,44149,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:37:59','2024-07-25 18:37:59','c53ce6b9-9553-4f39-b59c-8d9bffcf0a4d'),(44429,44150,1,NULL,'__temp_otftwxpcqnfrnoryhdbkusswaalvrjzxtjjh',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"ICAR Observation Form - Wound Care\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [2808], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/infection-control/media/pdfs/icar-ipc-obs-form-wound-care-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Audit tool to help identify infection control issues during wound care, a common source of GAS transmission in LTC outbreaks.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:38:03','2024-08-10 20:47:42','9d4eb5e9-6bfc-42d2-b4c8-ab323ee954e5'),(44430,44151,1,'Group A Streptococcus','group-a-streptococcus','diseases-pathogens/group-a-streptococcus',NULL,1,'2024-07-25 18:42:44','2024-07-25 18:42:44','a718477b-5bc3-419b-b86c-60ab6e4fd7e5'),(44431,44152,1,NULL,'__temp_eusblbislnunmsfkjvxyoqinzapzcnjligyy',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also referred to as group A strep or GAS</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Group A Streptococcus\"}',1,'2024-07-25 18:42:44','2024-07-25 18:42:44','f8062605-8e43-4f48-82cb-621fc93d4af1'),(44432,44153,1,NULL,'__temp_thgogifghptncchxkatfxestxojplmxapbyz',NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Bacteria\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-07-25 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-07-25 07:00:00\"}}',1,'2024-07-25 18:42:44','2024-07-25 18:42:44','64fffe70-04ee-401d-b15d-335a61eb4b1a'),(44433,44154,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:42:44','2024-07-25 18:42:44','425a5457-5a21-4bb9-8540-3faf9239fcc1'),(44434,44155,1,NULL,'__temp_zsfusiqwvyoprragaudjynmygwxvbqrigieu',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Bacteria called group A <i>Streptococcus</i> can cause many different infections. Invasive group A strep (iGAS) infections include necrotizing fasciitis and streptococcal toxic shock syndrome. The most common iGAS outbreaks investigated in the United States are those occurring in long-term care (LTC) facilities. Healthcare-associated iGAS clusters can also involve postpartum and post-surgical infections. <br /><br />GAS is spread by respiratory droplets, direct contact with mucus or secretions of an infected person, or by contact with infected or colonized wounds. <br /><br />Outbreaks and clusters of healthcare-associated iGAS often require urgent public health action. Even a single case of iGAS usually warrants investigation and follow-up, to rule out a larger problem.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About GAS\"}',1,'2024-07-25 18:42:44','2024-07-25 18:42:44','b21a8db8-90ec-431b-bfb4-e0a35d1959f4'),(44435,44156,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:42:44','2024-07-25 18:42:44','858e7138-5a69-41d0-a63a-0e1a7d62e54b'),(44436,44157,1,NULL,'__temp_nxhkcsmvdnpcriebxnpdzcbjmcbdqsqcprrx',NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>CDC is available to assist state, tribal, local, and territorial health departments for GAS outbreaks, particularly for persistent, large, or severe outbreaks. For assistance, contact gasoutbreaks@cdc.gov.</p>\"}',1,'2024-07-25 18:42:44','2024-07-25 18:42:44','74d03787-c166-4942-993b-505211106f78'),(44437,44158,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:42:44','2024-07-25 18:42:44','d11b28ef-ffb8-4a1c-a347-12a2d2fc6531'),(44438,44159,1,NULL,'__temp_rvkopaqsbubmmvejrxhiekmarmexwnzdniwm',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Decision Tool for Investigating GAS Infections in Long-Term Care Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/group-a-strep/php/ltcf-toolkit/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This toolkit outlines detailed actions that investigators should consider, depending on the number of cases of GAS identified.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:42:44','2024-07-25 18:42:44','c6df58b9-73a3-4fa4-a49d-392856de9d60'),(44439,44160,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:42:44','2024-07-25 18:42:44','327d3ae0-404c-4443-8938-4328a1e19f1f'),(44440,44161,1,NULL,'__temp_tguaffzxjjypaculktbdqpkfvaohqtbghjqh',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Additional GAS Investigation Resources\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/group-a-strep/php/ltcf-toolkit/resources.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Compilation of links to helpful resources from state health departments including sample line lists and facility letters; CDC\'s interfacility infection control transfer form is also included.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:42:44','2024-07-25 18:42:44','cba97d0b-bcb0-4526-b2dc-5a45acb44931'),(44441,44162,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:42:44','2024-07-25 18:42:44','bcc85110-4ce8-4259-8ff9-7d903dd4e6ec'),(44442,44163,1,NULL,'__temp_vuzqxxcouacsacxfjiewyuxxkmpoeqywvlhc',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevention of iGAS among household contacts of case patients and among postpartum and postsurgical patients; recommendations from the Centers for Disease Control and Prevention\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"8d07cb41-da70-4198-9c8d-e5de926d4a0d\": {\"date\": \"2002-09-26 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/12355382/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Recommendations for controlling iGAS among exposed household contacts and for responding to postpartum and postsurgical iGAS.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:42:44','2024-07-25 18:42:44','07f3b463-dee9-47d7-a3f0-3bbf6769d81c'),(44443,44164,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:42:44','2024-07-25 18:42:44','5726ae25-37ed-4ae2-b29b-d24c6b67beed'),(44444,44165,1,NULL,'__temp_dwsoomkpzmmvotnvjgklzuaiiajdnypxnxnp',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Cluster of Group A Streptococcal Infections in a Skilled Nursing Facility—the Potential Role of Healthcare Worker Presenteeism\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"8d07cb41-da70-4198-9c8d-e5de926d4a0d\": {\"date\": \"2017-12-26 08:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742861/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Outbreak report that examined the role of working while ill, or “presenteeism,” in the introduction and transmission of GAS within a skilled nursing facility.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:42:44','2024-07-25 18:42:44','2dd7d85c-961b-4945-a3e1-1bc2a0624f2a'),(44445,44166,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:42:44','2024-07-25 18:42:44','5e69eb0c-b6b0-45e0-93d0-77cd92481047'),(44446,44167,1,NULL,'__temp_otftwxpcqnfrnoryhdbkusswaalvrjzxtjjh',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"ICAR Observation Form - Wound Care\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"8d07cb41-da70-4198-9c8d-e5de926d4a0d\": {\"date\": \"2023-01-27 08:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/infection-control/media/pdfs/icar-ipc-obs-form-wound-care-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Audit tool to help identify infection control issues during wound care, a common source of GAS transmission in LTC outbreaks.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:42:44','2024-07-25 18:42:44','96a05827-fcb7-48a3-9f39-c6b4cf5773ed'),(44457,44178,1,'Carbapenem-Resistant Enterobacterales (CRE)','carbapenem-resistant-enterobacterales','diseases-pathogens/carbapenem-resistant-enterobacterales',NULL,1,'2024-07-25 18:44:47','2024-07-25 18:44:47','2b814cb2-bfde-4db6-9e73-42da50cb12aa'),(44458,44179,1,NULL,'__temp_pylubquqdbunksggnmkxlmjnphsltkrjzhlz',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CRE\"}',1,'2024-07-25 18:44:47','2024-07-25 18:44:47','50f878f0-5164-47a5-9a5d-8a5ee43926d5'),(44459,44180,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:44:47','2024-07-25 18:44:47','947d1704-44b0-4062-a9df-32ad081eb568'),(44460,44181,1,NULL,'__temp_iewdglllnctgpubfqoaqlwjfmwbqhxpcdtku',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE Infection Control\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/cre/hcp/infection-control/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Recommendations that healthcare providers and health departments can use to reduce the spread of CRE infections\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:44:47','2024-07-25 18:44:47','176ec002-9286-4e53-8870-3bc1e4951c53'),(44461,44182,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:44:47','2024-07-25 18:44:47','1fb0135a-9a28-4bc5-ad53-d4be89496022'),(44462,44183,1,NULL,'__temp_zhhcdigssqnrjxfnuctgqalhtealjvccwrmg',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Preventing MDROs (multidrug-resistant organisms)\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/php/preventing-mdros/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This website introduces valuable concepts and strategies for preventing and containing MDROs including CRE.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:44:47','2024-07-25 18:44:47','ffcf51ea-d879-4578-86fa-e21a474d0d3c'),(44463,44184,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:44:47','2024-07-25 18:44:47','b108bbc8-636e-48d8-b252-9af489a58a02'),(44464,44185,1,NULL,'__temp_ajhzqvrzylszpvkccoqrqhcbodohwriuppsv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE Handout: Information for Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/CRE-handout-V7-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Two-page flyer with CRE information covering nomenclature, transmission, colonization, and prevention\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:44:47','2024-07-25 18:44:47','b83f0f6c-209a-4da6-9707-43b1312b98a4'),(44465,44186,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:44:47','2024-07-25 18:44:47','ff629940-6956-43ca-9e10-294b79b4d5b8'),(44466,44187,1,NULL,'__temp_iystdoheimlpsucfsfktiktitmjpiwzmfhfv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Inter-facility Infection Control Transfer Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/CRE-handout-V7-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An essential aide to facilitate communication during patient transfers, to prevent spread of CRE or other MDROs\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:44:47','2024-07-25 18:44:47','252a2974-bbf4-4f36-bd74-2fa5e2d15c1d'),(44481,44202,1,'C. auris','c-auris','diseases-pathogens/c-auris',NULL,1,'2024-07-25 18:45:38','2024-07-25 18:45:38','c05bb2f8-4d52-4ef0-8616-6266b4491a74'),(44482,44203,1,NULL,'__temp_mgxgiouzofnmkbhidqgmctqezrknagtyorzu',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Candida auris\"}',1,'2024-07-25 18:45:38','2024-07-25 18:45:38','e9a33a33-7c98-4bb6-8bff-5633b107fa14'),(44483,44204,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:45:38','2024-07-25 18:45:38','8e41584c-52a4-4053-a2df-8763d7e7999a'),(44484,44205,1,NULL,'__temp_qmhcxyvtsbbfepftnwkiivogawelgczjtxsi',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Control Guidance: Candida auris\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/candida-auris/hcp/infection-control/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CDC product outlines measures to control C. auris including setting-specific guidance.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:45:38','2024-07-25 18:45:38','15c13e7a-9144-452c-aeac-98fba5afc8d7'),(44485,44206,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:45:38','2024-07-25 18:45:38','68bba2c5-daba-47cc-8aac-186b6ad86056'),(44486,44207,1,NULL,'__temp_odwrxknpunbllrstogttzfwrmsxyltsxnctc',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Screening for Candida auris Colonization\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/candida-auris/hcp/screening-hcp/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CDC resource provides detailed recommendations on screening for C. auris colonization.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:45:38','2024-07-25 18:45:38','a1dea419-9372-40ce-a02c-55126d3b4478'),(44487,44208,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:45:38','2024-07-25 18:45:38','9a1f70be-bf89-41a8-a8b6-a2fb014ccade'),(44488,44209,1,NULL,'__temp_zantjlhdqpstwwdfwekawhdwvzqvkrczjlns',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Antimicrobial Products Effective Against Candida auris\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.epa.gov/pesticide-registration/epas-registered-antimicrobial-products-effective-against-candida-auris-list\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"The EPA\'s List P provides information on registered antimicrobial products listed as effective against C. auris.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:45:38','2024-07-25 18:45:38','2686a13c-5f09-4abb-942c-d0709f573f4f'),(44489,44210,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:45:38','2024-07-25 18:45:38','917f1414-a7b1-415a-a9db-ac5bf1560e54'),(44490,44211,1,NULL,'__temp_hcunbavkrfugxblnduessxokbsjwzmjodlqc',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Tracking Candida auris\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/candida-auris/tracking-c-auris/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"C. auris cases are nationally notifiable; this page offers reporting information, case counts and maps.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:45:38','2024-07-25 18:45:38','c10f2c48-678f-449b-b874-51a41095ab9f'),(44491,44212,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:45:38','2024-07-25 18:45:38','f66d1d27-498a-4aae-8500-2fbf7ef4e450'),(44492,44213,1,NULL,'__temp_kdhsyvlsnpojsuxumulsjhrzhnbtxodswqtt',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Inter-Facility Infection Control Transfer Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/interfacility-ic-transfer-form-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This toolfosters communication about C. auris colonization and infection at transitions of care, essential to preventing further spread.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:45:38','2024-07-25 18:45:38','eaa028b8-fdaf-4e46-ac8d-86439fa659e3'),(44493,44214,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:45:39','2024-07-25 18:45:39','a694e778-1c23-4892-8bfe-125c2c1ea2ed'),(44494,44215,1,NULL,'__temp_vvlxghjhqexglvavvjczjbeltdcvwppxlwam',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Implementation of Personal Protective Equipment Use in Nursing Homes to Prevent the Spread of Multidrug-Resistant Organisms\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/long-term-care-facilities/hcp/prevent-mdro/ppe.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This long term care facility specific guidance provides an alternative to Contact Precautions. It clarifies the precautions needed based on the population at risk and the regional prevalence of C. auris.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:45:39','2024-07-25 18:45:39','8d412fec-5e63-46c4-b17e-f55a5e4df941'),(44495,44216,1,'Carbapenem-Resistant Enterobacterales (CRE)','carbapenem-resistant-enterobacterales','diseases-pathogens/carbapenem-resistant-enterobacterales',NULL,1,'2024-07-25 18:48:47','2024-07-25 18:48:47','c50ee85f-5433-4a3f-955f-248af3228879'),(44496,44217,1,NULL,'__temp_pylubquqdbunksggnmkxlmjnphsltkrjzhlz',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also referred to as CRE</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CRE\"}',1,'2024-07-25 18:48:47','2024-07-25 18:48:47','e927f1a1-4c9c-4b2d-a000-221e908e04aa'),(44497,44218,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:48:47','2024-07-25 18:48:47','a295acf6-dfd0-4fc2-bb5c-bb125979881a'),(44498,44219,1,NULL,'__temp_iewdglllnctgpubfqoaqlwjfmwbqhxpcdtku',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE Infection Control\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/cre/hcp/infection-control/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Recommendations that healthcare providers and health departments can use to reduce the spread of CRE infections\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:48:47','2024-07-25 18:48:47','5414c6b1-6481-4934-96d6-9a31a99e9d2e'),(44499,44220,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:48:47','2024-07-25 18:48:47','aef4433e-449b-4594-9463-5fa2c79b7ee3'),(44500,44221,1,NULL,'__temp_zhhcdigssqnrjxfnuctgqalhtealjvccwrmg',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Preventing MDROs (multidrug-resistant organisms)\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/php/preventing-mdros/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This website introduces valuable concepts and strategies for preventing and containing MDROs including CRE.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:48:47','2024-07-25 18:48:47','4db06287-94bc-4a4e-a628-4e6ea7277fea'),(44501,44222,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:48:47','2024-07-25 18:48:47','6f39cc2e-2382-4e68-825d-4637b18883f6'),(44502,44223,1,NULL,'__temp_ajhzqvrzylszpvkccoqrqhcbodohwriuppsv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE Handout: Information for Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/CRE-handout-V7-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Two-page flyer with CRE information covering nomenclature, transmission, colonization, and prevention\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:48:47','2024-07-25 18:48:47','01a79115-85a2-45fd-84e4-2991bf9e64c5'),(44503,44224,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:48:47','2024-07-25 18:48:47','8d64ab05-92ec-4baf-b458-5add7f0e7fb2'),(44504,44225,1,NULL,'__temp_iystdoheimlpsucfsfktiktitmjpiwzmfhfv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Inter-facility Infection Control Transfer Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/CRE-handout-V7-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An essential aide to facilitate communication during patient transfers, to prevent spread of CRE or other MDROs\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:48:47','2024-07-25 18:48:47','8db15909-e946-41f4-a8ea-3d3a08bd9a3a'),(44519,44240,1,'C. auris','c-auris','diseases-pathogens/c-auris',NULL,1,'2024-07-25 18:49:10','2024-07-25 18:49:10','7ffeabec-31b6-477e-807b-56b0c28e6de3'),(44520,44241,1,NULL,'__temp_mgxgiouzofnmkbhidqgmctqezrknagtyorzu',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also referred to as C. auris</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Candida auris\"}',1,'2024-07-25 18:49:10','2024-07-25 18:49:10','d4f46ebc-c4a3-4c86-9008-fcfaee945eb5'),(44521,44242,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:49:10','2024-07-25 18:49:10','8d3d1270-bdc4-4a3e-bb19-0f1ce7262e40'),(44522,44243,1,NULL,'__temp_qmhcxyvtsbbfepftnwkiivogawelgczjtxsi',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Control Guidance: Candida auris\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/candida-auris/hcp/infection-control/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CDC product outlines measures to control C. auris including setting-specific guidance.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:49:10','2024-07-25 18:49:10','9204b54e-483e-4ce1-bfaa-93a3d6a82087'),(44523,44244,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:49:10','2024-07-25 18:49:10','a606ab3d-4b57-4857-84b1-6617580af845'),(44524,44245,1,NULL,'__temp_odwrxknpunbllrstogttzfwrmsxyltsxnctc',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Screening for Candida auris Colonization\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/candida-auris/hcp/screening-hcp/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CDC resource provides detailed recommendations on screening for C. auris colonization.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:49:10','2024-07-25 18:49:10','1ae9d967-4340-40a3-bdd8-e4d3e9535592'),(44525,44246,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:49:10','2024-07-25 18:49:10','488f9ef5-b957-448b-82ab-be438325aaf7'),(44526,44247,1,NULL,'__temp_zantjlhdqpstwwdfwekawhdwvzqvkrczjlns',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Antimicrobial Products Effective Against Candida auris\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.epa.gov/pesticide-registration/epas-registered-antimicrobial-products-effective-against-candida-auris-list\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"The EPA\'s List P provides information on registered antimicrobial products listed as effective against C. auris.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:49:10','2024-07-25 18:49:10','456b9ae4-9280-4646-9f84-4df4247079be'),(44527,44248,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:49:10','2024-07-25 18:49:10','7a0d70d1-f31a-4247-a766-704ff99badc6'),(44528,44249,1,NULL,'__temp_hcunbavkrfugxblnduessxokbsjwzmjodlqc',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Tracking Candida auris\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/candida-auris/tracking-c-auris/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"C. auris cases are nationally notifiable; this page offers reporting information, case counts and maps.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:49:10','2024-07-25 18:49:10','7480c0ee-7470-41b0-9030-131a5df40777'),(44529,44250,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:49:10','2024-07-25 18:49:10','0eb43f02-1488-419b-aebc-93ffc14235c9'),(44530,44251,1,NULL,'__temp_kdhsyvlsnpojsuxumulsjhrzhnbtxodswqtt',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Inter-Facility Infection Control Transfer Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/interfacility-ic-transfer-form-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This toolfosters communication about C. auris colonization and infection at transitions of care, essential to preventing further spread.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:49:10','2024-07-25 18:49:10','39e45b06-e958-4e18-9432-1eb735e029d1'),(44531,44252,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:49:10','2024-07-25 18:49:10','923592ea-9c10-4888-a516-35c0fd0d2fdb'),(44532,44253,1,NULL,'__temp_vvlxghjhqexglvavvjczjbeltdcvwppxlwam',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Implementation of Personal Protective Equipment Use in Nursing Homes to Prevent the Spread of Multidrug-Resistant Organisms\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/long-term-care-facilities/hcp/prevent-mdro/ppe.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This long term care facility specific guidance provides an alternative to Contact Precautions. It clarifies the precautions needed based on the population at risk and the regional prevalence of C. auris.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:49:10','2024-07-25 18:49:10','28de261e-5669-4d21-bcaf-4c9e93241068'),(44533,44254,1,'Norovirus','norovirus','diseases-pathogens/norovirus','{\"8a0179a9-5d67-4563-85ee-348d0dc6b55d\": false, \"b0e373e6-78db-4059-8c91-7bf51b328e7b\": true, \"f9bb51ff-9dbb-464f-9bc4-ed50685e6e0b\": {\"score\": \"poor\", \"social\": {\"twitter\": {\"title\": \"Norovirus - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"Discover key information about norovirus, a leading cause of gastroenteritis, including symptoms, transmission, and prevention tips for healthcare. Download resources.\"}, \"facebook\": {\"title\": \"Norovirus - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"Discover key information about norovirus, a leading cause of gastroenteritis, including symptoms, transmission, and prevention tips for healthcare. Download resources.\"}}, \"advanced\": {\"robots\": [], \"canonical\": \"\"}, \"keywords\": [{\"rating\": \"poor\", \"keyword\": \"infectious disease\"}, {\"rating\": \"poor\", \"keyword\": \"foodborne illness\"}, {\"rating\": \"poor\", \"keyword\": \"viral outbreaks\"}, {\"rating\": \"poor\", \"keyword\": \"disease outbreak\"}, {\"rating\": \"good\", \"keyword\": \"norovirus\"}, {\"rating\": \"poor\", \"keyword\": \"gastroenteritis\"}], \"titleRaw\": {\"1\": \"Norovirus\"}, \"descriptionRaw\": \"Discover key information about norovirus, a leading cause of gastroenteritis, including symptoms, transmission, and prevention tips for healthcare. Download resources.\"}}',1,'2024-07-25 18:49:20','2024-12-03 17:39:37','2ce0e760-9d76-4bbd-b905-77441e4a71bd'),(44534,44255,1,NULL,'__temp_bzmoxhjbkupkqxfothbbvstgurpzujnbfqkh',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Norovirus\", \"b691f1c7-ad7d-4a8b-a9fa-b4feec58e073\": [44260]}',1,'2024-07-25 18:49:25','2024-08-07 15:16:57','da9daa6e-d5c4-446e-aa0e-8cf9527dc188'),(44535,44256,1,NULL,'__temp_oemcttyigjpunxlhhjidhajbmvcukdyjlcig',NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Virus\", \"130805c6-9ae8-47a6-8c71-21bb141e317d\": [44259], \"1e9a303d-3b96-4a6d-9600-7da4c0d5648a\": {\"date\": \"2025-01-01 05:00:00\"}, \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-07-25 04:00:00\"}}',1,'2024-07-25 18:49:26','2025-01-30 19:35:45','ac2eedbd-d115-4997-a2b0-77739e3eab00'),(44536,44257,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:49:49','2024-07-25 18:49:49','e92308dd-2452-4d0e-9d3b-10fec2589ce8'),(44537,44258,1,NULL,'__temp_cmoscdjckdcgdwbjkydycyxnqoelscnjmblu',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Norovirus is a highly contagious virus that causes acute gastroenteritis, marked by vomiting and diarrhea. The virus spreads easily and quickly, both from infected people to others and through contaminated foods and surfaces. An outbreak of is defined as the occurrence of two or more norovirus illnesses resulting from a common exposure. Healthcare, including long-term care facilities and hospitals, represents a common setting for norovirus outbreaks. </p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Norovirus\"}',1,'2024-07-25 18:49:53','2024-07-25 18:50:00','5be87010-a630-4b27-97c4-b3af73375088'),(44538,44259,1,'Pathogen Thumbnail_Norovirus',NULL,NULL,NULL,1,'2024-07-25 18:51:32','2024-12-03 17:34:04','7b28cbb8-d981-45b5-a975-0283e44b7552'),(44539,44259,2,'Norovirus',NULL,NULL,NULL,1,'2024-07-25 18:51:32','2024-07-25 18:51:32','26bc2289-bc47-4341-9c08-777f58b9bed2'),(44540,44260,1,'Header Image_Norovirus',NULL,NULL,NULL,1,'2024-07-25 18:53:58','2024-12-03 17:33:44','29e81ea5-5e0a-4020-8346-903c98f5aee4'),(44541,44260,2,'Norovirus 2',NULL,NULL,NULL,1,'2024-07-25 18:54:10','2024-07-25 18:54:10','a649b77c-0e4c-41e0-a28f-83214a6fd193'),(44542,44261,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:54:33','2024-07-25 18:54:33','146199ce-8080-415b-b002-ae51e5644d47'),(44543,44262,1,NULL,'__temp_uyqfbwinjmatlruonsfqobnthqvmsvorhmir',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Guideline for the Prevention and Control of Norovirus Gastroenteritis Outbreaks in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [44263], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/infection-control/hcp/norovirus-guidelines/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Comprehensive guidance for Norovirus surveillance, prevention and control in healthcare settings.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:54:36','2024-08-07 15:16:58','3ddd406b-6c5b-40c5-aa4d-1d7efee3e57d'),(44544,44263,1,'Healthcare Infection Control Practices Advisory Committee (HICPAC)','healthcare-infection-control-practices-advisory-committee-hicpac','resource-sources/healthcare-infection-control-practices-advisory-committee-hicpac',NULL,1,'2024-07-25 18:55:25','2024-07-25 19:03:34','6529f3d4-7e78-4d87-be5b-d0a07fd15cfb'),(44545,44263,2,'Healthcare Infection Control Practices Advisory Committee (HICPAC)','__temp_lggwkfxozktlxrujophjngphyfioaxoguovn','resource-sources/__temp_lggwkfxozktlxrujophjngphyfioaxoguovn',NULL,1,'2024-07-25 18:55:25','2024-07-25 19:03:34','d2805d7f-92c4-45f5-b6ff-a910b1a3a9d9'),(44546,44264,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:56:21','2024-07-25 18:56:21','21e3110c-4e1a-49f4-9194-6dfdbeacc185'),(44547,44265,1,NULL,'__temp_mwmmabanlwdhcauakvaypeojrzahmlzeaqsl',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Toolkit for Control of Norovirus Outbreaks in Long-Term Care Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [44266], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.health.pa.gov/topics/Documents/Programs/HAIP-AS/Norovirus%20Toolkit.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This toolkit was adapted from the CDC/HICPAC Guideline and may serve as a model for other states; it contains an outbreak response checklist, sample line lists, and outbreak report forms.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:56:26','2024-08-07 15:16:58','3ed91866-7995-4b16-88c3-04b879f683a2'),(44548,44266,1,'Pennsylvania Department of Health','pennsylvania-department-of-health','resource-sources/pennsylvania-department-of-health',NULL,1,'2024-07-25 18:56:45','2024-07-25 19:03:34','73873066-f9ec-4ac0-85f7-955d06cf18ce'),(44549,44266,2,'Pennsylvania Department of Health','__temp_dkurpbwcnnbkwosiunhlsvdyntpedrdychjr','resource-sources/__temp_dkurpbwcnnbkwosiunhlsvdyntpedrdychjr',NULL,1,'2024-07-25 18:56:45','2024-07-25 19:03:34','41f916b1-fd9e-446e-ace4-e7db663fb472'),(44550,44267,1,NULL,NULL,NULL,NULL,1,'2024-07-25 18:59:35','2024-07-25 18:59:35','dcc8ac11-47aa-40c2-a488-3ba31d29bc40'),(44551,44268,1,NULL,'__temp_zgzwyvvkeovmgmxjpcejcymbtnvmbccxdeto',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"EPA\'s Registered Antimicrobial Products Effective Against Norovirus [List G]\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [44093], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.epa.gov/pesticide-registration/epas-registered-antimicrobial-products-effective-against-norovirus-feline\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Environmental cleaning is a key component of norovirus outbreak reponse; this resource includes an interactive table that details antimicrobial products listed as effective against norovirus.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 18:59:41','2024-08-07 15:16:58','6a0a0c7f-ebd7-4090-846a-5ff91170151d'),(44552,44269,1,NULL,NULL,NULL,NULL,1,'2024-07-25 19:00:35','2024-07-25 19:00:35','20c8147e-2483-4bb3-bc72-32d4d8c860a4'),(44553,44270,1,NULL,'__temp_zycsmstxvavfjzspgtjcikqxfnxpbdnjkrha',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Communication Framework: Suspected or Confirmed Norovirus Outbreaks\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [2808], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://snapshot2024.cdc.gov/hai/pdfs/norovirus/216887-A-GICommFramewk508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource offers a template for timely internal communications when a norovirus outbreak is suspected in a healthcare facility.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 19:00:39','2024-08-07 15:16:58','9b2857a8-cda7-4559-a658-d1b510d96820'),(44554,44271,1,NULL,NULL,NULL,NULL,1,'2024-07-25 19:01:17','2024-07-25 19:01:17','dbc0a006-9e5f-4113-bf69-ea98594c56a5'),(44555,44272,1,NULL,'__temp_pglklfhbipbriccyvwwjoqyfsxnjcivwtxxr',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Norovirus in Healthcare Facilities Fact Sheet\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [2808], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://stacks.cdc.gov/view/cdc/26151\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This two page fact sheet can be used to educate healthcare partners about norovirus transmission, diagnosis, and control measures.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 19:01:20','2024-08-07 15:16:58','c96fbc1e-6c2d-456d-873f-efd9738a7f26'),(44556,44273,1,NULL,NULL,NULL,NULL,1,'2024-07-25 19:02:23','2024-07-25 19:02:23','81451d79-c194-45c9-b297-83396a531e82'),(44557,44274,1,NULL,'__temp_erajesfncfiyvehjmsufdonofdoykxmehpth',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Burden of norovirus in healthcare facilities and strategies for outbreak control\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [14914], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668703/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"The authors summarize the challenges and economic burden posed by healthcare associated norovirus outbreaks and offer a tabular summary of CDC/HICPAC control recommendations.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 19:02:26','2024-08-07 15:16:58','cbaff852-1747-4c85-b167-cda43c30a2e6'),(44558,44275,1,'Norovirus','norovirus','diseases-pathogens/norovirus',NULL,1,'2024-07-25 19:03:31','2024-07-25 19:03:31','e2e3faa7-c79c-493c-b524-1f62f5238b10'),(44559,44276,1,NULL,'__temp_bzmoxhjbkupkqxfothbbvstgurpzujnbfqkh',NULL,NULL,1,'2024-07-25 19:03:31','2024-07-25 19:03:31','27a6ef02-0ab3-4552-844f-60e08aff057b'),(44560,44277,1,NULL,'__temp_oemcttyigjpunxlhhjidhajbmvcukdyjlcig',NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Virus\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-07-25 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-07-25 07:00:00\"}}',1,'2024-07-25 19:03:31','2024-07-25 19:03:31','c10be04b-7e29-4536-92da-a9f1953b9e43'),(44561,44278,1,NULL,NULL,NULL,NULL,1,'2024-07-25 19:03:31','2024-07-25 19:03:31','bac8fb46-1320-4ad0-9056-50b11dd6a329'),(44562,44279,1,NULL,'__temp_cmoscdjckdcgdwbjkydycyxnqoelscnjmblu',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Norovirus is a highly contagious virus that causes acute gastroenteritis, marked by vomiting and diarrhea. The virus spreads easily and quickly, both from infected people to others and through contaminated foods and surfaces. An outbreak of is defined as the occurrence of two or more norovirus illnesses resulting from a common exposure. Healthcare, including long-term care facilities and hospitals, represents a common setting for norovirus outbreaks. </p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Norovirus\"}',1,'2024-07-25 19:03:31','2024-07-25 19:03:31','5e119bd3-29c6-4aaf-8cc5-af282bbeb2c9'),(44563,44280,1,NULL,NULL,NULL,NULL,1,'2024-07-25 19:03:32','2024-07-25 19:03:32','b56751f1-47fa-4740-a102-c7d936a70f67'),(44564,44281,1,NULL,'__temp_uyqfbwinjmatlruonsfqobnthqvmsvorhmir',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Guideline for the Prevention and Control of Norovirus Gastroenteritis Outbreaks in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"8d07cb41-da70-4198-9c8d-e5de926d4a0d\": {\"date\": \"2017-02-02 08:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/infection-control/hcp/norovirus-guidelines/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Comprehensive guidance for Norovirus surveillance, prevention and control in healthcare settings.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 19:03:32','2024-07-25 19:03:32','a705d361-282a-46a3-8d52-43e59b14068e'),(44565,44282,1,NULL,NULL,NULL,NULL,1,'2024-07-25 19:03:32','2024-07-25 19:03:32','98f2af79-fd62-4b04-9a65-f9ac330b5213'),(44566,44283,1,NULL,'__temp_mwmmabanlwdhcauakvaypeojrzahmlzeaqsl',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Toolkit for Control of Norovirus Outbreaks in Long-Term Care Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"8d07cb41-da70-4198-9c8d-e5de926d4a0d\": {\"date\": \"2019-08-01 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.health.pa.gov/topics/Documents/Programs/HAIP-AS/Norovirus%20Toolkit.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This toolkit was adapted from the CDC/HICPAC Guideline and may serve as a model for other states; it contains an outbreak response checklist, sample line lists, and outbreak report forms.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 19:03:32','2024-07-25 19:03:32','88a21330-5b0b-4e60-beb2-a8846d83a4f3'),(44567,44284,1,NULL,NULL,NULL,NULL,1,'2024-07-25 19:03:32','2024-07-25 19:03:32','98a17a43-7375-46e2-ac39-bc445e461ee4'),(44568,44285,1,NULL,'__temp_zgzwyvvkeovmgmxjpcejcymbtnvmbccxdeto',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"EPA\'s Registered Antimicrobial Products Effective Against Norovirus [List G]\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.epa.gov/pesticide-registration/epas-registered-antimicrobial-products-effective-against-norovirus-feline\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Environmental cleaning is a key component of norovirus outbreak reponse; this resource includes an interactive table that details antimicrobial products listed as effective against norovirus.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 19:03:32','2024-07-25 19:03:32','87892b16-73ac-4c1d-a84b-a2eca7b2e5ac'),(44569,44286,1,NULL,NULL,NULL,NULL,1,'2024-07-25 19:03:32','2024-07-25 19:03:32','2e1f51e3-85ce-4e7d-8ec7-af40ea069dc3'),(44570,44287,1,NULL,'__temp_zycsmstxvavfjzspgtjcikqxfnxpbdnjkrha',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Communication Framework: Suspected or Confirmed Norovirus Outbreaks\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://snapshot2024.cdc.gov/hai/pdfs/norovirus/216887-A-GICommFramewk508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource offers a template for timely internal communications when a norovirus outbreak is suspected in a healthcare facility.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 19:03:32','2024-07-25 19:03:32','77155c8e-1f93-4dee-81a3-5adcbdd77a71'),(44571,44288,1,NULL,NULL,NULL,NULL,1,'2024-07-25 19:03:32','2024-07-25 19:03:32','9a7f0849-fbe2-417d-83c7-a74488df46aa'),(44572,44289,1,NULL,'__temp_pglklfhbipbriccyvwwjoqyfsxnjcivwtxxr',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Norovirus in Healthcare Facilities Fact Sheet\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"8d07cb41-da70-4198-9c8d-e5de926d4a0d\": {\"date\": \"2012-02-15 08:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://stacks.cdc.gov/view/cdc/26151\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This two page fact sheet can be used to educate healthcare partners about norovirus transmission, diagnosis, and control measures.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 19:03:32','2024-07-25 19:03:32','6e176b34-65d8-4bc4-8ca4-2d84da63e636'),(44573,44290,1,NULL,NULL,NULL,NULL,1,'2024-07-25 19:03:32','2024-07-25 19:03:32','17bc47a5-ca5e-4a6a-bcae-54c8817413fe'),(44574,44291,1,NULL,'__temp_erajesfncfiyvehjmsufdonofdoykxmehpth',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Burden of norovirus in healthcare facilities and strategies for outbreak control\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"8d07cb41-da70-4198-9c8d-e5de926d4a0d\": {\"date\": \"2015-02-04 08:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668703/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"The authors summarize the challenges and economic burden posed by healthcare associated norovirus outbreaks and offer a tabular summary of CDC/HICPAC control recommendations.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 19:03:32','2024-07-25 19:03:32','4f072e86-e47c-4c5b-883d-9e9932367116'),(44581,44298,1,'Norovirus','norovirus','diseases-pathogens/norovirus',NULL,1,'2024-07-25 19:04:27','2024-07-25 19:04:27','91334423-955e-426d-9862-bc1079107b27'),(44582,44299,1,NULL,'__temp_bzmoxhjbkupkqxfothbbvstgurpzujnbfqkh',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Norovirus\"}',1,'2024-07-25 19:04:27','2024-07-25 19:04:27','8dad20b0-7a01-41bd-9fa8-f2322e9a6afa'),(44583,44300,1,NULL,NULL,NULL,NULL,1,'2024-07-25 19:04:27','2024-07-25 19:04:27','05eaa846-38fe-48ab-a780-c2c554d98839'),(44584,44301,1,NULL,'__temp_zgzwyvvkeovmgmxjpcejcymbtnvmbccxdeto',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"EPA\'s Registered Antimicrobial Products Effective Against Norovirus [List G]\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.epa.gov/pesticide-registration/epas-registered-antimicrobial-products-effective-against-norovirus-feline\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Environmental cleaning is a key component of norovirus outbreak reponse; this resource includes an interactive table that details antimicrobial products listed as effective against norovirus.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 19:04:27','2024-07-25 19:04:27','fde68bf4-dd89-4c9e-9fb0-4d096e56a609'),(44585,44302,1,NULL,NULL,NULL,NULL,1,'2024-07-25 19:04:27','2024-07-25 19:04:27','6b5ccc97-8bd8-4ec4-aa39-5abafc457c95'),(44586,44303,1,NULL,'__temp_zycsmstxvavfjzspgtjcikqxfnxpbdnjkrha',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Communication Framework: Suspected or Confirmed Norovirus Outbreaks\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://snapshot2024.cdc.gov/hai/pdfs/norovirus/216887-A-GICommFramewk508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource offers a template for timely internal communications when a norovirus outbreak is suspected in a healthcare facility.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 19:04:27','2024-07-25 19:04:27','50e2e41f-e306-47be-a981-f3e2c4e32c74'),(44587,44304,1,'Water-Associated Organisms','water-associated-organisms','diseases-pathogens/water-associated-organisms','{\"8a0179a9-5d67-4563-85ee-348d0dc6b55d\": false, \"b0e373e6-78db-4059-8c91-7bf51b328e7b\": true, \"f9bb51ff-9dbb-464f-9bc4-ed50685e6e0b\": {\"score\": \"poor\", \"social\": {\"twitter\": {\"title\": \"Water-Associated Organisms - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"Explore water-associated organisms and their role in waterborne diseases, including transmission methods and prevention strategies in healthcare. Download resources.\"}, \"facebook\": {\"title\": \"Water-Associated Organisms - CORHA\", \"handle\": \"\", \"imageId\": \"\", \"description\": \"Explore water-associated organisms and their role in waterborne diseases, including transmission methods and prevention strategies in healthcare. Download resources.\"}}, \"advanced\": {\"robots\": [], \"canonical\": \"\"}, \"keywords\": [{\"rating\": \"poor\", \"keyword\": \"waterborne pathogens\"}, {\"rating\": \"poor\", \"keyword\": \"water-associated diseases\"}, {\"rating\": \"poor\", \"keyword\": \"aquatic organisms\"}, {\"rating\": \"poor\", \"keyword\": \"infectious disease\"}, {\"rating\": \"poor\", \"keyword\": \"disease outbreak\"}], \"titleRaw\": {\"1\": \"Water-Associated Organisms\"}, \"descriptionRaw\": \"Explore water-associated organisms and their role in waterborne diseases, including transmission methods and prevention strategies in healthcare. Download resources.\"}}',1,'2024-07-25 19:05:33','2024-12-03 17:33:12','42ccab95-ea2f-499e-bef1-995d839e7459'),(44589,44306,1,NULL,'__temp_qudbwuzoyjhuptakklfluaacpptnfuvrksqp',NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Various Pathogens\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-07-25 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-07-25 07:00:00\"}}',1,'2024-07-25 19:05:39','2024-08-01 20:39:49','e96031e2-d070-40b0-9c09-0b726c4e098c'),(44590,44307,1,NULL,'__temp_roqevoidgtkjifqthynxphayebbabjemnesy',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Water-Associated Organisms\"}',1,'2024-07-25 19:05:40','2024-07-29 19:55:05','eb3c9a25-b961-4acd-a5d1-430ba026b0ea'),(44591,44308,1,'Pathogen Thumbnail_Water Associated Organisms',NULL,NULL,NULL,1,'2024-07-25 19:07:24','2024-12-03 17:32:05','371a8761-9664-4863-9cd0-9fa89d399400'),(44592,44308,2,'Water Associated Organisms',NULL,NULL,NULL,1,'2024-07-25 19:07:24','2024-07-25 19:07:24','d289d1fb-59fd-4f90-ae4f-a63dec25028c'),(44593,44309,1,'Water Associated Organisms','water-associated-organisms','diseases-pathogens/water-associated-organisms',NULL,1,'2024-07-25 19:15:11','2024-07-25 19:15:11','c1aaa21d-433b-4c75-a05e-785037c3073b'),(44594,44310,1,NULL,NULL,NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Water Associated Organisms\"}',1,'2024-07-25 19:15:11','2024-07-25 19:15:11','e2a7760b-c665-4f42-a23c-891224736724'),(44595,44311,1,NULL,'__temp_qudbwuzoyjhuptakklfluaacpptnfuvrksqp',NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Various Pathogens\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-07-25 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-07-25 07:00:00\"}}',1,'2024-07-25 19:15:11','2024-07-25 19:15:11','eca6a12e-40c3-4972-b687-19c1e6a77bbb'),(44596,44312,1,'Header Image_Water Associated Organisms',NULL,NULL,NULL,1,'2024-07-25 19:54:30','2024-12-03 17:24:02','028cfcbd-874c-48ce-9135-fbefd7b31481'),(44597,44312,2,'Water Associated Organisms 2',NULL,NULL,NULL,1,'2024-07-25 19:55:10','2024-07-25 19:55:10','7e0dc5b2-aab7-44db-9c93-89ca400eb37a'),(44619,44334,1,'Centers for Medicare & Medicaid Services (CMS)','centers-for-medicare-medicaid-services-cms','resource-sources/centers-for-medicare-medicaid-services-cms',NULL,1,'2024-07-25 20:07:48','2024-07-25 20:09:16','08472881-c545-449d-8fba-d9a0c541cb49'),(44620,44334,2,'Centers for Medicare & Medicaid Services (CMS)','__temp_frxkpjtvdrblnrbvgobhrdwnchvxeczdvggn','resource-sources/__temp_frxkpjtvdrblnrbvgobhrdwnchvxeczdvggn',NULL,1,'2024-07-25 20:07:48','2024-07-25 20:09:16','6a8f1713-8146-44e5-9512-5f6198f9d5d5'),(44621,44335,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:09:13','2024-07-25 20:09:13','ccc458eb-faa3-47e5-8c8e-d05c0fa50ff1'),(44622,44336,1,NULL,'__temp_rwlpacukoilaobdjruttbkelpdngvkaclcfo',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Healthcare facilities often have complex distribution pathways and other features which serve as a favorable environment for the proliferation of opportunistic pathogens such as nontuberculous mycobacteria and <i>Legionella</i>, among many others. Water-associated organisms have caused many outbreaks in healthcare settings and these outbreaks can be challenging to detect and control. This page offers a collection of resources to assist with water-related outbreak detection and response. CORHA\'s <a href=\\\"{entry:17663@1:url||https://corha.org/diseases-pathogens/nontuberculous-mycobacteria-ntm}\\\">Nontuberculous mycobacteria</a>, <a href=\\\"{entry:2851@1:url||https://corha.org/diseases-pathogens/b-cepacia}\\\"><i>Burkholderia cepacia</i></a>, and <a href=\\\"{entry:15944@1:url||https://corha.org/diseases-pathogens/legionella}\\\">Legionella</a> resource pages offer additional detailed information.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Water-Associated Organisms\"}',1,'2024-07-25 20:09:13','2024-07-29 19:55:05','fe7ff397-673e-4225-94f9-1e0d4fe7fa56'),(44623,44337,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:09:13','2024-07-25 20:09:13','32b13a92-72f2-40ad-8d58-9a74c01cae99'),(44624,44338,1,NULL,'__temp_yufidpfxmtetnedwvuusixjcjohyfvapttdk',NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Routine clinical care can result in exposure and transmission, either directly or indirectly, from sinks, showers, toilets, and ice machines. Patients also may be exposed to these organisms through medical products (i.e., medications and medical devices), which can become contaminated at the point of manufacture or at the healthcare facility through improper handling (e.g., storage, preparation, or administration of the products near water sources).</p>\"}',1,'2024-07-25 20:09:13','2024-07-25 20:09:13','1cb18cb7-06b1-4b8b-8e8f-7286efe365fb'),(44625,44339,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:09:13','2024-07-25 20:09:13','2f90dd27-8aef-4b9f-b4d2-7b7e0fe8befd'),(44626,44340,1,NULL,'__temp_emfqqzsiyecrzhfzdvgbcyxarwhgyoqugmze',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Reducing Risk from Water, from Plumbing to Patients\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [2808], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/php/toolkit/water-management.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Helpful information, resources, and tools for understanding and reducing infectious risks due to water-associated organisms.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:09:13','2024-08-10 20:50:28','b3a91fc8-05f8-4a71-92e7-4d2750e0725d'),(44627,44341,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:09:13','2024-07-25 20:09:13','4081dd03-f3e7-40c5-b6cb-5ee43eff6168'),(44628,44342,1,NULL,'__temp_zhvnoxdlgcqpalvuishokqfcfntlvoiaajyp',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Tap Water Quality and Infrastructure Discussion Guide for Investigation of Potential Water-Associated Infections in Healthcare Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [2808], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/water-quality-discussion-guide-p.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This guide provides an organized approach to identifying the potential sources of exposure.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:09:13','2024-08-10 20:50:28','a9f7e23c-8614-4084-bf16-2f756c3c0cf7'),(44629,44343,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:09:13','2024-07-25 20:09:13','8a6967a0-9efd-47f2-963b-447826c4ce5f'),(44630,44344,1,NULL,'__temp_lieyoafjcnckwlspkwjdscuwqdnjmvvgzwqn',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare Outbreaks Associated with a Water Reservoir and Infection Prevention Strategies\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [14914], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://academic.oup.com/cid/article/62/11/1423/1745014\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Literature review describing healthcare outbreaks associated with water, common transmission routes, and infection prevention strategies.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:09:13','2024-08-10 20:50:28','c65b7799-0962-468c-ba54-40c15136e45f'),(44631,44345,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:09:13','2024-07-25 20:09:13','de3e8c9c-db0c-4d24-a2d3-f9c8d060aae2'),(44632,44346,1,NULL,'__temp_djkscwdlhxnkuoptzewcmfvlhguiognhoaoo',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Tap Water Avoidance Decreases Rates of Hospital-onset Pulmonary Nontuberculous Mycobacteria\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [14914], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326555/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This outbreak response involved avoiding the use of nonsterile water and offers considerations for expanded use of this strategy.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:09:13','2024-08-10 20:50:28','dd435bab-ba7a-4b6f-b91c-0861ed9aae50'),(44633,44347,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:09:13','2024-07-25 20:09:13','b71464ef-7390-4410-82cf-b8e512881956'),(44634,44348,1,NULL,'__temp_qcogcnxwsqwechfabesvjowdsmnjcgeddymw',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation of healthcare infection risks from water-related organisms: Summary of CDC consultations, 2014-2017\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [14914], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/abs/investigation-of-healthcare-infection-risks-from-waterrelated-organisms-summary-of-cdc-consultations-20142017/0771439B1D60E697C52B37FC24944CC0\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Summary of water-associated organism outbreak consultations that details commonly encountered transmission routes associated with clinical care.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:09:13','2024-08-10 20:50:28','b34f22de-9710-485f-ad4a-1a9af433387b'),(44635,44349,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:09:13','2024-07-25 20:09:13','357daaa1-735e-4333-b10c-f8f19f678fbb'),(44636,44350,1,NULL,'__temp_pyqldwfwpqoqyliwjcqlfeuyyttezmnsqlbc',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Outbreaks of healthcare-associated infections linked to water-containing hospital equipment: a literature review\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [14914], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://aricjournal.biomedcentral.com/articles/10.1186/s13756-021-00935-6\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This paper summarizes common hospital medical devices that use water and have led to outbreaks; the authors propose measures to help mitigate these risks.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:09:13','2024-08-10 20:50:28','05c8a0a9-38bb-46d0-a870-f48ce4374eff'),(44637,44351,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:09:13','2024-07-25 20:09:13','68b731d9-0af9-4775-ae21-6884219b9fb5'),(44638,44352,1,NULL,'__temp_dxkllpryxvqfasjbweozfaxkhviwfnpkshze',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Requirement to Reduce Legionella Risk in Healthcare Facility Water Systems to Prevent Cases and Outbreaks of Legionnaires’ Disease (LD)\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [44334], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Downloads/QSO17-30-HospitalCAH-NH-REVISED-.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Outline of requirements for acute care hospitals and long-term care facilities regarding water management policies and procedures to reduce the risk of growth and spread of Legionella and other opportunistic pathogens.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:09:13','2024-08-10 20:50:28','9d74f5aa-bc4d-42ab-b750-0a3f5964ca00'),(44639,44353,1,'Water Associated Organisms','water-associated-organisms','diseases-pathogens/water-associated-organisms',NULL,1,'2024-07-25 20:09:13','2024-07-25 20:09:13','0e7002c8-cba5-40d9-8fef-775c854de29c'),(44640,44354,1,NULL,'__temp_roqevoidgtkjifqthynxphayebbabjemnesy',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Water Associated Organisms\"}',1,'2024-07-25 20:09:13','2024-07-25 20:09:13','32099448-6489-44ab-a35d-894eb913cadd'),(44641,44355,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:09:13','2024-07-25 20:09:13','365999aa-8a32-454a-b81c-c4dbccf0c261'),(44642,44356,1,NULL,'__temp_rwlpacukoilaobdjruttbkelpdngvkaclcfo',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Healthcare facilities often have complex distribution pathways and other features which serve as a favorable environment for the proliferation of opportunistic pathogens such as nontuberculous mycobacteria and <i>Legionella</i>, among many others. Water-associated organisms have caused many outbreaks in healthcare settings and these outbreaks can be challenging to detect and control. This page offers a collection of resources to assist with water-related outbreak detection and response. CORHA\'s <a href=\\\"{entry:17663@1:url||https://corha.org/diseases-pathogens/nontuberculous-mycobacteria-ntm}\\\">Nontuberculous mycobacteria</a>, <a href=\\\"{entry:2851@1:url||https://corha.org/diseases-pathogens/b-cepacia}\\\"><i>Burkholderia cepacia</i></a>, and <a href=\\\"{entry:15944@1:url||https://corha.org/diseases-pathogens/legionella}\\\">Legionella</a> resource pages offer additional detailed information.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Water Associated Organisms\"}',1,'2024-07-25 20:09:14','2024-07-25 20:09:14','b8f7edbc-dbb0-432a-acfc-5c2bc0b746c3'),(44643,44357,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:09:14','2024-07-25 20:09:14','e0b47980-dbd9-4f7a-93ea-1b1c9ce5023b'),(44644,44358,1,NULL,'__temp_yufidpfxmtetnedwvuusixjcjohyfvapttdk',NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Routine clinical care can result in exposure and transmission, either directly or indirectly, from sinks, showers, toilets, and ice machines. Patients also may be exposed to these organisms through medical products (i.e., medications and medical devices), which can become contaminated at the point of manufacture or at the healthcare facility through improper handling (e.g., storage, preparation, or administration of the products near water sources).</p>\"}',1,'2024-07-25 20:09:14','2024-07-25 20:09:14','81095580-9a83-410e-9a53-fc0885651726'),(44645,44359,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:09:14','2024-07-25 20:09:14','a7abd5f3-a164-409a-9e77-b6e1f53c1339'),(44646,44360,1,NULL,'__temp_emfqqzsiyecrzhfzdvgbcyxarwhgyoqugmze',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Reducing Risk from Water, from Plumbing to Patients\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/php/toolkit/water-management.html?CDC_AAref_Val=https://www.cdc.gov/hai/prevent/environment/water.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Helpful information, resources, and tools for understanding and reducing infectious risks due to water-associated organisms.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:09:14','2024-07-25 20:09:14','2b9be715-d447-47b9-8092-cdee5622eb6c'),(44647,44361,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:09:14','2024-07-25 20:09:14','9942ba02-03eb-4ad8-b870-991bc65f141f'),(44648,44362,1,NULL,'__temp_zhvnoxdlgcqpalvuishokqfcfntlvoiaajyp',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Tap Water Quality and Infrastructure Discussion Guide for Investigation of Potential Water-Associated Infections in Healthcare Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"8d07cb41-da70-4198-9c8d-e5de926d4a0d\": {\"date\": \"2018-12-18 08:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/water-quality-discussion-guide-p.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This guide provides an organized approach to identifying the potential sources of exposure.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:09:14','2024-07-25 20:09:14','ca675810-bdb9-47d3-8a2f-88dc4d5b59ad'),(44649,44363,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:09:14','2024-07-25 20:09:14','d27671b5-c496-4532-b52b-c8243bc2d6b2'),(44650,44364,1,NULL,'__temp_lieyoafjcnckwlspkwjdscuwqdnjmvvgzwqn',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare Outbreaks Associated with a Water Reservoir and Infection Prevention Strategies\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"8d07cb41-da70-4198-9c8d-e5de926d4a0d\": {\"date\": \"2016-06-01 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://academic.oup.com/cid/article/62/11/1423/1745014\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Literature review describing healthcare outbreaks associated with water, common transmission routes, and infection prevention strategies.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:09:14','2024-07-25 20:09:14','c4d0ab07-0a0e-4a2e-9782-1e32a7eb20e0'),(44651,44365,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:09:14','2024-07-25 20:09:14','b38203eb-6820-4575-8eb9-66aba15e3af4'),(44652,44366,1,NULL,'__temp_djkscwdlhxnkuoptzewcmfvlhguiognhoaoo',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Tap Water Avoidance Decreases Rates of Hospital-onset Pulmonary Nontuberculous Mycobacteria\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"8d07cb41-da70-4198-9c8d-e5de926d4a0d\": {\"date\": \"2023-08-01 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326555/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This outbreak response involved avoiding the use of nonsterile water and offers considerations for expanded use of this strategy.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:09:14','2024-07-25 20:09:14','e5a585f3-148f-4130-8ceb-799691f612d3'),(44653,44367,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:09:14','2024-07-25 20:09:14','83fc3b89-220d-44bd-a349-f932c381a91e'),(44654,44368,1,NULL,'__temp_qcogcnxwsqwechfabesvjowdsmnjcgeddymw',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation of healthcare infection risks from water-related organisms: Summary of CDC consultations, 2014-2017\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"8d07cb41-da70-4198-9c8d-e5de926d4a0d\": {\"date\": \"2019-04-03 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/abs/investigation-of-healthcare-infection-risks-from-waterrelated-organisms-summary-of-cdc-consultations-20142017/0771439B1D60E697C52B37FC24944CC0\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Summary of water-associated organism outbreak consultations that details commonly encountered transmission routes associated with clinical care.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:09:14','2024-07-25 20:09:14','25e8396c-6fef-419f-9c2e-f85989ae9458'),(44655,44369,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:09:14','2024-07-25 20:09:14','177423a6-fe59-4ccd-8ef4-e89704885cb0'),(44656,44370,1,NULL,'__temp_pyqldwfwpqoqyliwjcqlfeuyyttezmnsqlbc',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Outbreaks of healthcare-associated infections linked to water-containing hospital equipment: a literature review\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"8d07cb41-da70-4198-9c8d-e5de926d4a0d\": {\"date\": \"2021-05-10 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://aricjournal.biomedcentral.com/articles/10.1186/s13756-021-00935-6\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This paper summarizes common hospital medical devices that use water and have led to outbreaks; the authors propose measures to help mitigate these risks.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:09:14','2024-07-25 20:09:14','259f9805-e53d-41aa-8518-d839a19e9a3e'),(44657,44371,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:09:14','2024-07-25 20:09:14','2174e261-5a6e-4de2-b72f-bb178f80949a'),(44658,44372,1,NULL,'__temp_dxkllpryxvqfasjbweozfaxkhviwfnpkshze',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Requirement to Reduce Legionella Risk in Healthcare Facility Water Systems to Prevent Cases and Outbreaks of Legionnaires’ Disease (LD)\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"8d07cb41-da70-4198-9c8d-e5de926d4a0d\": {\"date\": \"2018-07-06 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Downloads/QSO17-30-HospitalCAH-NH-REVISED-.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Outline of requirements for acute care hospitals and long-term care facilities regarding water management policies and procedures to reduce the risk of growth and spread of Legionella and other opportunistic pathogens.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:09:14','2024-07-25 20:09:14','87265d76-a3b7-45a2-b392-83c6673c2948'),(44679,44393,1,'Header Image_Burkholderia Cepacia',NULL,NULL,NULL,1,'2024-07-25 20:15:42','2024-12-03 19:39:03','de52b8e2-ef71-4fba-87e9-4faa9ef95cc5'),(44680,44393,2,'Burkholderia Cepacia 1',NULL,NULL,NULL,1,'2024-07-25 20:16:15','2024-07-25 20:16:15','8f6f5548-3c41-4257-ac0c-fdd174fa0fcf'),(44681,44394,1,'Burkholderia Cepacia','b-cepacia','diseases-pathogens/b-cepacia',NULL,1,'2024-07-25 20:17:24','2024-07-25 20:17:24','c4f7b5b3-a22c-487d-bc25-d7ecdf95badd'),(44682,44395,1,NULL,'__temp_zvissoqrohojrdbclszibzmnahrexgjahtuo',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also called B. cepacia, Burkholderia cepacia complex, or Bcc</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Burkholderia Cepacia\"}',1,'2024-07-25 20:17:24','2024-07-25 20:17:24','65a683ec-870b-49ef-a0cc-b65f72d33063'),(44683,44396,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Bacteria\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-01 07:00:00\"}}',1,'2024-07-25 20:17:24','2024-07-25 20:17:24','80261b91-12bb-45c2-b523-93be5399d993'),(44684,44397,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:17:24','2024-07-25 20:17:24','5d22eee0-607f-4ba9-92b6-477eaae21651'),(44685,44398,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:17:24','2024-07-25 20:17:24','23ec47c3-4463-4dfd-9f07-92f2f3e7b219'),(44686,44399,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:17:24','2024-07-25 20:17:24','44c50e02-d5ac-41ce-a1c2-931f36297418'),(44687,44400,1,NULL,'__temp_gyyxyaosndrmyibybwuakabethmotizwvlpd',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MedWatch Online Voluntary Reporting Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.accessdata.fda.gov/scripts/medwatch/index.cfm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Use this form to report a Bcc-related outbreak or product concern.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:17:24','2024-07-25 20:17:24','c57d71f7-0693-40bb-9efb-1a2a0a767d02'),(44688,44401,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:17:24','2024-07-25 20:17:24','a13e1ec3-cd3f-4d09-82ea-ddbf086267a1'),(44689,44402,1,NULL,'__temp_rxlggetlyczgjlckkrxqriwsadxtyzlwbvov',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"About Burkholderia cepacia complex\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/b-cepacia/about/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"CDC website on Bcc\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:17:24','2024-07-25 20:17:24','fe834e05-96e7-4bbc-8cb1-5c89e7340e5e'),(44690,44403,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:17:24','2024-07-25 20:17:24','2eb51eca-9cca-44f5-8ae2-412439b108cb'),(44691,44404,1,NULL,'__temp_hvphjihoioblfcvdupxggfixbdkvackxjaoe',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Best practices for manufacturers of non-sterile, water-based drug products\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-drug-manufacturers-burkholderia-cepacia-complex-poses-contamination-risk-non-sterile\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:17:24','2024-07-25 20:17:24','28a43164-ddb2-40b9-b503-2adc18b9bc1d'),(44692,44405,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:17:24','2024-07-25 20:17:24','2c5ca5d7-cd4c-45b0-acff-2f58fe6cf265'),(44693,44406,1,NULL,'__temp_tztcuixrozpicvthmqzccxsparleuheacjoo',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Burkholderia cepacia: This Decision Is Overdue\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.fda.gov/media/81867/download\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"FDA authors reviewed the regulatory and scientific impact of Bcc, describing FDA guidance, manufacturing control measures, and possible points of origin for microbial contamination.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:17:24','2024-07-25 20:17:24','b4ee6595-d0a6-45a6-b326-2eef433dd8db'),(44694,44407,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:17:24','2024-07-25 20:17:24','f7f0d8fe-5627-40a0-8a4a-b87d3fb4e079'),(44695,44408,1,NULL,'__temp_czknwpimpsntsfjtxvusnbyvhrtutknjjcjb',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Bcc: a Feared Contamination Risk in Water-Based Pharmaceutical Products\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194853/pdf/CMR.00139-19.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article summarizes Bcc outbreaks and describes the mechanisms behind pharmaceutical product contamination.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:17:24','2024-07-25 20:17:24','311d410b-8992-4cd3-bb5c-ac01ac4acec9'),(44696,44409,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:17:24','2024-07-25 20:17:24','615212a7-ea11-4321-8c14-ed8daa4a4a78'),(44697,44410,1,NULL,'__temp_zhtsumbkodbulmcqwfmpqroytrhdpgvyzbbj',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Systematic review of healthcare-associated B. cepacia\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335909/pdf/main.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This systematic review summarizes the investigation and control of 111 Bcc healthcare-associated outbreaks.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:17:24','2024-07-25 20:17:24','958000bb-a241-4866-afad-9a2e318b83ea'),(44698,44411,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:17:24','2024-07-25 20:17:24','4e47ec30-c546-4239-88c7-f5bc2f8f6371'),(44699,44412,1,NULL,'__temp_zaqafmavkfqhzybtepzxtuljmhvagumydjmp',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Bcc outbreak linked to a no-rinse cleansing foam product, United States – 2017–2018\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cambridge.org/core/journals/epidemiology-and-infection/article/burkholderia-cepacia-complex-outbreak-linked-to-a-norinse-cleansing-foam-product-united-states-20172018/8ADC180852BDAB19E3E15512EDC248D5\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to intrinsic contamination of a non-sterile skin cleanser product\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:17:24','2024-07-25 20:17:24','78d4fd8f-6f47-446a-b7d6-0733b6ae6556'),(44700,44413,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:17:24','2024-07-25 20:17:24','24543886-5e29-4c16-ad36-9abe16f1846d'),(44701,44414,1,NULL,'__temp_rlwbfucqweuwvobrtqwvvphirdfnczagasrh',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Multistate Outbreak of Bcc Bloodstream Infections After Exposure to Contaminated Saline Flush Syringes — United States, 2016–2017\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476681/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to intrinsic contamination of injectable (sterile medical product) saline flushes\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:17:24','2024-07-25 20:17:24','4817ba2c-73ee-471d-bef0-4ed00fd7bf91'),(44702,44415,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:17:24','2024-07-25 20:17:24','d0abbde8-5ca8-4f79-a2d5-5bbd2bdfdc62'),(44703,44416,1,NULL,'__temp_fdpncqffhvqdwruxcofjowlonaakiubpjkbz',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A multistate investigation of health care–associated Bcc infections related to liquid docusate sodium\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.sciencedirect.com/science/article/abs/pii/S0196655317312877?\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to an intrinsically contaminated non-sterile oral medication\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:17:24','2024-07-25 20:17:24','815dc3ba-a2db-43b5-bd42-1cebb8b312d9'),(44705,44418,1,'JTP 8332 1 1',NULL,NULL,NULL,1,'2024-07-25 20:22:49','2024-07-25 20:22:49','fa022986-7f0a-42b7-acd3-78ff588cdc5e'),(44706,44418,2,'JTP 8332 1 1',NULL,NULL,NULL,1,'2024-07-25 20:22:49','2024-07-25 20:22:49','e8fdb66a-acc8-471e-8c85-92e4a0861cda'),(44707,44419,1,'1 - Overview','overview','chapters/overview','{\"0c9be173-318a-42f5-b27d-86204f3dfa65\": \"Overview\", \"68c04e47-b499-4e50-88f0-a409394e673e\": 1, \"ee09d78e-63c3-4bdf-aaf4-4c05789851fb\": \"Chapter One\"}',1,'2024-07-25 20:22:58','2024-07-25 20:22:58','07fe921a-9013-4703-8d65-be13da94dd26'),(44709,44421,1,'JTP 5941 2 1',NULL,NULL,NULL,1,'2024-07-25 20:23:15','2024-07-25 20:23:15','6192ad9c-8e29-479b-abc5-88da730267d4'),(44710,44421,2,'JTP 5941 2 1',NULL,NULL,NULL,1,'2024-07-25 20:23:16','2024-07-25 20:23:16','48f0ee72-ab5c-4e5d-ae70-006070835e8b'),(44711,44422,1,'2 - Fundamental Concepts','fundamental-concepts','chapters/fundamental-concepts','{\"0c9be173-318a-42f5-b27d-86204f3dfa65\": \"Fundamental Concepts\", \"68c04e47-b499-4e50-88f0-a409394e673e\": 2, \"ee09d78e-63c3-4bdf-aaf4-4c05789851fb\": \"Chapter Two\"}',1,'2024-07-25 20:23:22','2024-07-25 20:23:22','7cd822a2-2567-40da-8e13-1172b3729a7a'),(44732,44443,1,'Burkholderia cepacia','b-cepacia','diseases-pathogens/b-cepacia',NULL,1,'2024-07-25 20:33:44','2024-07-25 20:33:44','a2d7a191-e976-4b6a-8c30-15192e953ee4'),(44733,44444,1,NULL,'__temp_zvissoqrohojrdbclszibzmnahrexgjahtuo',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also called B. cepacia, Burkholderia cepacia complex, or Bcc</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Burkholderia cepacia\"}',1,'2024-07-25 20:33:44','2024-07-25 20:33:44','491a97af-6ca0-468f-8388-fedbbbfa5dbb'),(44734,44445,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:33:44','2024-07-25 20:33:44','7f8c8d4b-df94-4aab-b5b6-cc89fc9667b5'),(44735,44446,1,NULL,'__temp_gyyxyaosndrmyibybwuakabethmotizwvlpd',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MedWatch Online Voluntary Reporting Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.accessdata.fda.gov/scripts/medwatch/index.cfm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Use this form to report a Bcc-related outbreak or product concern.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:33:44','2024-07-25 20:33:44','bc938a2d-1093-40bb-b78c-abbd8951a41d'),(44736,44447,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:33:44','2024-07-25 20:33:44','4dd0ac82-9580-4179-b1fc-7948875fd9d2'),(44737,44448,1,NULL,'__temp_rxlggetlyczgjlckkrxqriwsadxtyzlwbvov',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"About Burkholderia cepacia complex\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/b-cepacia/about/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"CDC website on Bcc\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:33:44','2024-07-25 20:33:44','0ab14bb9-1a29-4481-b9a5-3d78261002e0'),(44738,44449,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:33:44','2024-07-25 20:33:44','0769dde3-2608-4774-ac80-510d0f22057b'),(44739,44450,1,NULL,'__temp_hvphjihoioblfcvdupxggfixbdkvackxjaoe',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Best practices for manufacturers of non-sterile, water-based drug products\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-drug-manufacturers-burkholderia-cepacia-complex-poses-contamination-risk-non-sterile\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:33:44','2024-07-25 20:33:44','fbb60634-d8a2-48ba-8c88-f0ecc0744de8'),(44740,44451,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:33:44','2024-07-25 20:33:44','7a0ef288-3087-43b7-9015-95daf041e683'),(44741,44452,1,NULL,'__temp_tztcuixrozpicvthmqzccxsparleuheacjoo',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Burkholderia cepacia: This Decision Is Overdue\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.fda.gov/media/81867/download\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"FDA authors reviewed the regulatory and scientific impact of Bcc, describing FDA guidance, manufacturing control measures, and possible points of origin for microbial contamination.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:33:44','2024-07-25 20:33:44','b2b4c90b-bf04-482a-b1b2-0b7b6f5690a7'),(44742,44453,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:33:44','2024-07-25 20:33:44','e201c051-d1ef-4151-ba56-2cd29b2f87d6'),(44743,44454,1,NULL,'__temp_czknwpimpsntsfjtxvusnbyvhrtutknjjcjb',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Bcc: a Feared Contamination Risk in Water-Based Pharmaceutical Products\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194853/pdf/CMR.00139-19.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article summarizes Bcc outbreaks and describes the mechanisms behind pharmaceutical product contamination.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:33:45','2024-07-25 20:33:45','6c8e2afe-5d6e-412e-8a2f-255ddf90035c'),(44744,44455,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:33:45','2024-07-25 20:33:45','acbb638b-56e1-44ed-8df4-0a17b9e947c5'),(44745,44456,1,NULL,'__temp_zhtsumbkodbulmcqwfmpqroytrhdpgvyzbbj',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Systematic review of healthcare-associated B. cepacia\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335909/pdf/main.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This systematic review summarizes the investigation and control of 111 Bcc healthcare-associated outbreaks.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:33:45','2024-07-25 20:33:45','805885b4-1061-485e-8b64-96c060c44e10'),(44746,44457,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:33:45','2024-07-25 20:33:45','d3f364ac-88ce-4a3f-a9c4-208e25eb3d47'),(44747,44458,1,NULL,'__temp_zaqafmavkfqhzybtepzxtuljmhvagumydjmp',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Bcc outbreak linked to a no-rinse cleansing foam product, United States – 2017–2018\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cambridge.org/core/journals/epidemiology-and-infection/article/burkholderia-cepacia-complex-outbreak-linked-to-a-norinse-cleansing-foam-product-united-states-20172018/8ADC180852BDAB19E3E15512EDC248D5\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to intrinsic contamination of a non-sterile skin cleanser product\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:33:45','2024-07-25 20:33:45','a9f7e1ab-398e-4c21-8406-c7d22f24a33f'),(44748,44459,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:33:45','2024-07-25 20:33:45','6b7453ba-fd71-44bf-89b0-4f3effd3cf0f'),(44749,44460,1,NULL,'__temp_rlwbfucqweuwvobrtqwvvphirdfnczagasrh',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Multistate Outbreak of Bcc Bloodstream Infections After Exposure to Contaminated Saline Flush Syringes — United States, 2016–2017\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476681/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to intrinsic contamination of injectable (sterile medical product) saline flushes\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:33:45','2024-07-25 20:33:45','6beab2ff-37ea-4d99-ab65-0fe97f0953bb'),(44750,44461,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:33:45','2024-07-25 20:33:45','bee36aa8-8c89-42d4-b38d-4f4bf6b2d5a9'),(44751,44462,1,NULL,'__temp_fdpncqffhvqdwruxcofjowlonaakiubpjkbz',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A multistate investigation of health care–associated Bcc infections related to liquid docusate sodium\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.sciencedirect.com/science/article/abs/pii/S0196655317312877?\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to an intrinsically contaminated non-sterile oral medication\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:33:45','2024-07-25 20:33:45','01bcae61-c379-43f6-9f11-aed220b8bb54'),(44752,44463,1,'Burkholderia cepacia','b-cepacia','diseases-pathogens/b-cepacia',NULL,1,'2024-07-25 20:35:34','2024-07-25 20:35:34','457ef1ad-ca14-49eb-9f44-54af2d55a0ee'),(44753,44464,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:35:34','2024-07-25 20:35:34','8980f053-99de-4ac9-9209-5f3b6a8961cc'),(44754,44465,1,NULL,'__temp_gyyxyaosndrmyibybwuakabethmotizwvlpd',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MedWatch Online Voluntary Reporting Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.accessdata.fda.gov/scripts/medwatch/index.cfm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Use this form to report a Bcc-related outbreak or product concern.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:35:34','2024-07-25 20:35:34','98ee09f2-7aa2-4f27-a1b0-fd58a904b273'),(44755,44466,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:35:34','2024-07-25 20:35:34','1bd1a79b-ebd3-4c03-a00f-ac6530fab2f4'),(44756,44467,1,NULL,'__temp_rxlggetlyczgjlckkrxqriwsadxtyzlwbvov',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"About Burkholderia cepacia complex\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/b-cepacia/about/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"CDC website on Bcc\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:35:34','2024-07-25 20:35:34','e42e4228-b7e3-4f92-a510-f7deb304d9d1'),(44757,44468,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:35:34','2024-07-25 20:35:34','967edcb2-308e-4594-b290-c7861099caa1'),(44758,44469,1,NULL,'__temp_hvphjihoioblfcvdupxggfixbdkvackxjaoe',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Best practices for manufacturers of non-sterile, water-based drug products\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-drug-manufacturers-burkholderia-cepacia-complex-poses-contamination-risk-non-sterile\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:35:34','2024-07-25 20:35:34','5da77269-c59a-4994-9f95-eff0c3c0f54f'),(44759,44470,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:35:34','2024-07-25 20:35:34','e9612093-ebd6-4dee-81a2-7d5107ddc4f5'),(44760,44471,1,NULL,'__temp_tztcuixrozpicvthmqzccxsparleuheacjoo',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Burkholderia cepacia: This Decision Is Overdue\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.fda.gov/media/81867/download\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"FDA authors reviewed the regulatory and scientific impact of Bcc, describing FDA guidance, manufacturing control measures, and possible points of origin for microbial contamination.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:35:34','2024-07-25 20:35:34','9b6d808d-59d8-427c-94e2-a1cac7bcf6dd'),(44761,44472,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:35:34','2024-07-25 20:35:34','f6a9bf9f-4677-4168-913c-c1b6bf7c5f0b'),(44762,44473,1,NULL,'__temp_czknwpimpsntsfjtxvusnbyvhrtutknjjcjb',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Bcc: a Feared Contamination Risk in Water-Based Pharmaceutical Products\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194853/pdf/CMR.00139-19.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article summarizes Bcc outbreaks and describes the mechanisms behind pharmaceutical product contamination.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:35:34','2024-07-25 20:35:34','75f3f3fb-7313-46fc-bb5e-1a64ba3737b7'),(44763,44474,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:35:34','2024-07-25 20:35:34','3f1d96c0-1cc8-4a42-a3d3-2e1eaa667a1a'),(44764,44475,1,NULL,'__temp_zhtsumbkodbulmcqwfmpqroytrhdpgvyzbbj',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Systematic review of healthcare-associated B. cepacia\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335909/pdf/main.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This systematic review summarizes the investigation and control of 111 Bcc healthcare-associated outbreaks.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:35:34','2024-07-25 20:35:34','6fcedecd-c1d2-47cd-b3c0-9a1c4be89a8d'),(44765,44476,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:35:34','2024-07-25 20:35:34','ba5bddd9-fa66-4bc8-ab97-925334531fb2'),(44766,44477,1,NULL,'__temp_zaqafmavkfqhzybtepzxtuljmhvagumydjmp',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Bcc outbreak linked to a no-rinse cleansing foam product, United States – 2017–2018\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cambridge.org/core/journals/epidemiology-and-infection/article/burkholderia-cepacia-complex-outbreak-linked-to-a-norinse-cleansing-foam-product-united-states-20172018/8ADC180852BDAB19E3E15512EDC248D5\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to intrinsic contamination of a non-sterile skin cleanser product\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:35:34','2024-07-25 20:35:34','fb86d6e7-6f6e-4202-a332-f50ef182116c'),(44767,44478,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:35:34','2024-07-25 20:35:34','7af8e78a-d6e0-4bd3-8b60-e6d06c288844'),(44768,44479,1,NULL,'__temp_rlwbfucqweuwvobrtqwvvphirdfnczagasrh',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Multistate Outbreak of Bcc Bloodstream Infections After Exposure to Contaminated Saline Flush Syringes — United States, 2016–2017\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476681/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to intrinsic contamination of injectable (sterile medical product) saline flushes\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:35:34','2024-07-25 20:35:34','10494b0a-1cee-4b14-a443-bc3db53d0112'),(44769,44480,1,NULL,NULL,NULL,NULL,1,'2024-07-25 20:35:35','2024-07-25 20:35:35','44406f38-9f9c-41fb-bd4d-98913df83df4'),(44770,44481,1,NULL,'__temp_fdpncqffhvqdwruxcofjowlonaakiubpjkbz',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A multistate investigation of health care–associated Bcc infections related to liquid docusate sodium\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.sciencedirect.com/science/article/abs/pii/S0196655317312877?\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to an intrinsically contaminated non-sterile oral medication\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 20:35:35','2024-07-25 20:35:35','846ee2a6-720a-4d09-9207-d34b84804e49'),(44781,44492,1,'Header Image_Carbapenem-Resistant Enterobacterales',NULL,NULL,NULL,1,'2024-07-25 21:02:52','2024-12-03 17:42:48','a7f9733f-8fe8-4a35-a4d3-f19aa1ccc76d'),(44782,44492,2,'CRE CORHA 1',NULL,NULL,NULL,1,'2024-07-25 21:03:27','2024-07-25 21:03:27','9a1400fc-ba41-4a5e-9619-e9eab13a6128'),(44783,44493,1,'Carbapenem-Resistant Enterobacterales (CRE)','carbapenem-resistant-enterobacterales','diseases-pathogens/carbapenem-resistant-enterobacterales',NULL,1,'2024-07-25 21:03:33','2024-07-25 21:03:33','a225106d-c103-43f6-acb8-f6462fe6fd3a'),(44784,44494,1,NULL,'__temp_pylubquqdbunksggnmkxlmjnphsltkrjzhlz',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also referred to as CRE</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CRE\"}',1,'2024-07-25 21:03:33','2024-07-25 21:03:33','901eeb74-f55a-41fb-83d5-f5584d132436'),(44785,44495,1,NULL,NULL,NULL,NULL,1,'2024-07-25 21:03:33','2024-07-25 21:03:33','b6126ffb-743f-4c3c-b27b-2317179675a1'),(44786,44496,1,NULL,'__temp_iewdglllnctgpubfqoaqlwjfmwbqhxpcdtku',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE Infection Control\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/cre/hcp/infection-control/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Recommendations that healthcare providers and health departments can use to reduce the spread of CRE infections\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 21:03:33','2024-07-25 21:03:33','0cefe8d1-2aef-4c34-a4a9-f58540228284'),(44787,44497,1,NULL,NULL,NULL,NULL,1,'2024-07-25 21:03:33','2024-07-25 21:03:33','6c919200-151b-4e4b-9de9-b72a8315ecc7'),(44788,44498,1,NULL,'__temp_zhhcdigssqnrjxfnuctgqalhtealjvccwrmg',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Preventing MDROs (multidrug-resistant organisms)\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/php/preventing-mdros/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This website introduces valuable concepts and strategies for preventing and containing MDROs including CRE.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 21:03:33','2024-07-25 21:03:33','4f52a760-3508-4bdf-b50d-294502298404'),(44789,44499,1,NULL,NULL,NULL,NULL,1,'2024-07-25 21:03:33','2024-07-25 21:03:33','0f547e3c-5f58-4198-990a-78701051137d'),(44790,44500,1,NULL,'__temp_ajhzqvrzylszpvkccoqrqhcbodohwriuppsv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE Handout: Information for Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/CRE-handout-V7-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Two-page flyer with CRE information covering nomenclature, transmission, colonization, and prevention\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 21:03:33','2024-07-25 21:03:33','37ca0087-b176-4738-b543-557446a5a612'),(44791,44501,1,NULL,NULL,NULL,NULL,1,'2024-07-25 21:03:33','2024-07-25 21:03:33','f932a627-87d9-40f0-a141-a34f5cd58865'),(44792,44502,1,NULL,'__temp_iystdoheimlpsucfsfktiktitmjpiwzmfhfv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Inter-facility Infection Control Transfer Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/CRE-handout-V7-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An essential aide to facilitate communication during patient transfers, to prevent spread of CRE or other MDROs\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 21:03:33','2024-07-25 21:03:33','c4ecb1ae-2e4a-4642-ab74-793de7c7fa76'),(44803,44513,1,'Carbapenem-Resistant Enterobacterales (CRE)','carbapenem-resistant-enterobacterales','diseases-pathogens/carbapenem-resistant-enterobacterales',NULL,1,'2024-07-25 21:04:28','2024-07-25 21:04:28','e6dac2e3-851a-4db4-b014-c767d8a1fe93'),(44804,44514,1,NULL,'__temp_pylubquqdbunksggnmkxlmjnphsltkrjzhlz',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also referred to as CRE</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Carbapenem-Resistant Enterobacterales (CRE)\"}',1,'2024-07-25 21:04:28','2024-07-25 21:04:28','cfb2dfff-deec-498f-966e-0722c383a789'),(44805,44515,1,NULL,NULL,NULL,NULL,1,'2024-07-25 21:04:28','2024-07-25 21:04:28','8c0f555b-7e0c-4cd1-a302-97af33901a1a'),(44806,44516,1,NULL,'__temp_iewdglllnctgpubfqoaqlwjfmwbqhxpcdtku',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE Infection Control\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/cre/hcp/infection-control/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Recommendations that healthcare providers and health departments can use to reduce the spread of CRE infections\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 21:04:28','2024-07-25 21:04:28','010e8fb4-32b0-43db-b1bc-5b3d475eadbf'),(44807,44517,1,NULL,NULL,NULL,NULL,1,'2024-07-25 21:04:28','2024-07-25 21:04:28','93ed1747-d2d2-4dbf-9a40-8ad5b3ccd624'),(44808,44518,1,NULL,'__temp_zhhcdigssqnrjxfnuctgqalhtealjvccwrmg',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Preventing MDROs (multidrug-resistant organisms)\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/php/preventing-mdros/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This website introduces valuable concepts and strategies for preventing and containing MDROs including CRE.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 21:04:28','2024-07-25 21:04:28','f66d9cba-d32b-48bb-8a9c-acdc4ac0a6c1'),(44809,44519,1,NULL,NULL,NULL,NULL,1,'2024-07-25 21:04:28','2024-07-25 21:04:28','f466e8cc-a4ab-4efc-8bf6-360fb5a5c9cc'),(44810,44520,1,NULL,'__temp_ajhzqvrzylszpvkccoqrqhcbodohwriuppsv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE Handout: Information for Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/CRE-handout-V7-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Two-page flyer with CRE information covering nomenclature, transmission, colonization, and prevention\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 21:04:28','2024-07-25 21:04:28','0a70fa7d-0401-415a-9e1c-e23ecfd8319c'),(44811,44521,1,NULL,NULL,NULL,NULL,1,'2024-07-25 21:04:28','2024-07-25 21:04:28','c2f6bd5e-9ada-4672-a561-67767bfb1e6a'),(44812,44522,1,NULL,'__temp_iystdoheimlpsucfsfktiktitmjpiwzmfhfv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Inter-facility Infection Control Transfer Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/CRE-handout-V7-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An essential aide to facilitate communication during patient transfers, to prevent spread of CRE or other MDROs\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 21:04:28','2024-07-25 21:04:28','c4497dc0-4f8f-4fc9-982b-4c5dc32b9772'),(44823,44533,1,'Carbapenem-Resistant Enterobacterales (CRE)','carbapenem-resistant-enterobacterales','diseases-pathogens/carbapenem-resistant-enterobacterales',NULL,1,'2024-07-25 21:08:01','2024-07-25 21:08:01','02af7839-29b4-4ddd-9969-8340cbb0566c'),(44824,44534,1,NULL,'__temp_pylubquqdbunksggnmkxlmjnphsltkrjzhlz',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also referred to as CRE</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Carbapenem-Resistant Enterobacterales\"}',1,'2024-07-25 21:08:02','2024-07-25 21:08:02','73b92194-ee7b-4046-9792-c3395e5889d9'),(44825,44535,1,NULL,NULL,NULL,NULL,1,'2024-07-25 21:08:02','2024-07-25 21:08:02','f92ef0a4-59a7-4410-af69-b344bbe8f910'),(44826,44536,1,NULL,'__temp_iewdglllnctgpubfqoaqlwjfmwbqhxpcdtku',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE Infection Control\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/cre/hcp/infection-control/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Recommendations that healthcare providers and health departments can use to reduce the spread of CRE infections\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 21:08:02','2024-07-25 21:08:02','f1c46bcc-8c33-46f9-a5cd-db675382c455'),(44827,44537,1,NULL,NULL,NULL,NULL,1,'2024-07-25 21:08:02','2024-07-25 21:08:02','5ca2e10b-9044-4273-b861-a76f81ecda9a'),(44828,44538,1,NULL,'__temp_zhhcdigssqnrjxfnuctgqalhtealjvccwrmg',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Preventing MDROs (multidrug-resistant organisms)\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/php/preventing-mdros/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This website introduces valuable concepts and strategies for preventing and containing MDROs including CRE.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 21:08:02','2024-07-25 21:08:02','7987edbc-fabf-4c97-8e04-4df695006253'),(44829,44539,1,NULL,NULL,NULL,NULL,1,'2024-07-25 21:08:02','2024-07-25 21:08:02','c95f8653-283f-49a6-b94d-803261d7e932'),(44830,44540,1,NULL,'__temp_ajhzqvrzylszpvkccoqrqhcbodohwriuppsv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE Handout: Information for Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/CRE-handout-V7-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Two-page flyer with CRE information covering nomenclature, transmission, colonization, and prevention\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 21:08:02','2024-07-25 21:08:02','35f97a66-2e8c-4202-b656-da8ace6e99bb'),(44831,44541,1,NULL,NULL,NULL,NULL,1,'2024-07-25 21:08:02','2024-07-25 21:08:02','624022ce-eee6-453d-a4c3-aa79a1ceadb6'),(44832,44542,1,NULL,'__temp_iystdoheimlpsucfsfktiktitmjpiwzmfhfv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Inter-facility Infection Control Transfer Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/CRE-handout-V7-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An essential aide to facilitate communication during patient transfers, to prevent spread of CRE or other MDROs\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 21:08:02','2024-07-25 21:08:02','aa0514bf-9463-487c-a23a-cbb909625740'),(44833,44543,1,'Carbapenem-Resistant Enterobacterales (CRE)','carbapenem-resistant-enterobacterales','diseases-pathogens/carbapenem-resistant-enterobacterales',NULL,1,'2024-07-25 21:15:55','2024-07-25 21:15:55','7fc06448-7152-4eb9-9778-dae26bb5c46c'),(44834,44544,1,NULL,NULL,NULL,NULL,1,'2024-07-25 21:15:55','2024-07-25 21:15:55','8a49449c-a670-416e-a7c3-ccc830f02ba8'),(44835,44545,1,NULL,'__temp_iewdglllnctgpubfqoaqlwjfmwbqhxpcdtku',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE Infection Control\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/cre/hcp/infection-control/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Recommendations that healthcare providers and health departments can use to reduce the spread of CRE infections\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 21:15:55','2024-07-25 21:15:55','477ebccd-8e9c-487a-85be-0f793c46d2ef'),(44836,44546,1,NULL,NULL,NULL,NULL,1,'2024-07-25 21:15:55','2024-07-25 21:15:55','3a7c3a99-9f8a-4b90-bcdc-5c3a71d33516'),(44837,44547,1,NULL,'__temp_zhhcdigssqnrjxfnuctgqalhtealjvccwrmg',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Preventing MDROs (multidrug-resistant organisms)\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/php/preventing-mdros/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This website introduces valuable concepts and strategies for preventing and containing MDROs including CRE.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 21:15:55','2024-07-25 21:15:55','3a465ee5-0ec6-45c4-a7a6-3ad679639d3a'),(44838,44548,1,NULL,NULL,NULL,NULL,1,'2024-07-25 21:15:55','2024-07-25 21:15:55','4142a414-51a5-4eb8-acb9-6c3c01cedaff'),(44839,44549,1,NULL,'__temp_ajhzqvrzylszpvkccoqrqhcbodohwriuppsv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE Handout: Information for Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/CRE-handout-V7-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Two-page flyer with CRE information covering nomenclature, transmission, colonization, and prevention\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 21:15:56','2024-07-25 21:15:56','b0e57c09-313f-494a-b1b2-99a039bf2367'),(44840,44550,1,NULL,NULL,NULL,NULL,1,'2024-07-25 21:15:56','2024-07-25 21:15:56','6d5c3e66-17c1-4754-8c0f-271959b59b2c'),(44841,44551,1,NULL,'__temp_iystdoheimlpsucfsfktiktitmjpiwzmfhfv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Inter-facility Infection Control Transfer Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/CRE-handout-V7-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An essential aide to facilitate communication during patient transfers, to prevent spread of CRE or other MDROs\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-25 21:15:56','2024-07-25 21:15:56','b571a0bf-ba2e-471b-a212-4e9c8ee9781a'),(44862,44572,1,'Pathogen Thumbnail_Burkholderia Cepacia',NULL,NULL,NULL,1,'2024-07-29 14:26:14','2024-12-03 19:39:31','1583ebf9-2ec4-4db1-b206-ee6aacdcdb21'),(44863,44572,2,'17371 lores',NULL,NULL,NULL,1,'2024-07-29 14:26:15','2024-07-29 14:26:15','65b98a47-5e3d-49d5-b16b-199b3767e409'),(44864,44573,1,'Burkholderia cepacia','b-cepacia','diseases-pathogens/b-cepacia',NULL,1,'2024-07-29 14:26:19','2024-07-29 14:26:19','b85d5405-e551-4222-b476-dfcf44f33be8'),(44865,44574,1,NULL,'__temp_ytdglvwxqofapzqggxjhltizxvrbfugxoegh',NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Bacteria\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-01 07:00:00\"}}',1,'2024-07-29 14:26:19','2024-07-29 14:26:19','d21e7bbb-22d6-4f16-bfd7-6ee98677dcb5'),(44866,44575,1,NULL,NULL,NULL,NULL,1,'2024-07-29 14:26:19','2024-07-29 14:26:19','44d804ba-2076-4469-a70c-87df9e0af965'),(44867,44576,1,NULL,'__temp_gyyxyaosndrmyibybwuakabethmotizwvlpd',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MedWatch Online Voluntary Reporting Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.accessdata.fda.gov/scripts/medwatch/index.cfm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Use this form to report a Bcc-related outbreak or product concern.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 14:26:19','2024-07-29 14:26:19','265ac1aa-e700-411e-9a13-82a65f809db5'),(44868,44577,1,NULL,NULL,NULL,NULL,1,'2024-07-29 14:26:19','2024-07-29 14:26:19','2141cf10-c968-4973-a6d8-33cbfc24dcd0'),(44869,44578,1,NULL,'__temp_rxlggetlyczgjlckkrxqriwsadxtyzlwbvov',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"About Burkholderia cepacia complex\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/b-cepacia/about/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"CDC website on Bcc\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 14:26:19','2024-07-29 14:26:19','ab44a635-5b9a-4153-8bba-3fa03ae1dde2'),(44870,44579,1,NULL,NULL,NULL,NULL,1,'2024-07-29 14:26:19','2024-07-29 14:26:19','0bd14bd8-31c3-4f3f-bff1-9570f50de66d'),(44871,44580,1,NULL,'__temp_hvphjihoioblfcvdupxggfixbdkvackxjaoe',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Best practices for manufacturers of non-sterile, water-based drug products\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-drug-manufacturers-burkholderia-cepacia-complex-poses-contamination-risk-non-sterile\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 14:26:19','2024-07-29 14:26:19','d7b52421-9124-4483-8d05-6cbe7513c311'),(44872,44581,1,NULL,NULL,NULL,NULL,1,'2024-07-29 14:26:19','2024-07-29 14:26:19','41da8cba-7d1e-4fb8-9180-8de7b2f57bed'),(44873,44582,1,NULL,'__temp_tztcuixrozpicvthmqzccxsparleuheacjoo',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Burkholderia cepacia: This Decision Is Overdue\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.fda.gov/media/81867/download\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"FDA authors reviewed the regulatory and scientific impact of Bcc, describing FDA guidance, manufacturing control measures, and possible points of origin for microbial contamination.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 14:26:19','2024-07-29 14:26:19','b74ab465-38af-4aa1-9f74-4094c2062e51'),(44874,44583,1,NULL,NULL,NULL,NULL,1,'2024-07-29 14:26:19','2024-07-29 14:26:19','48782640-bd52-4805-bb7c-7f41a8ae0408'),(44875,44584,1,NULL,'__temp_czknwpimpsntsfjtxvusnbyvhrtutknjjcjb',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Bcc: a Feared Contamination Risk in Water-Based Pharmaceutical Products\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194853/pdf/CMR.00139-19.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article summarizes Bcc outbreaks and describes the mechanisms behind pharmaceutical product contamination.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 14:26:20','2024-07-29 14:26:20','8d557046-fd05-456b-8a4b-7f5704b4283d'),(44876,44585,1,NULL,NULL,NULL,NULL,1,'2024-07-29 14:26:20','2024-07-29 14:26:20','cf4d194e-4868-443a-ac58-c695d7b3a1ad'),(44877,44586,1,NULL,'__temp_zhtsumbkodbulmcqwfmpqroytrhdpgvyzbbj',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Systematic review of healthcare-associated B. cepacia\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335909/pdf/main.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This systematic review summarizes the investigation and control of 111 Bcc healthcare-associated outbreaks.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 14:26:20','2024-07-29 14:26:20','633741c7-d263-4fa5-8c40-35ef17beada6'),(44878,44587,1,NULL,NULL,NULL,NULL,1,'2024-07-29 14:26:20','2024-07-29 14:26:20','e5e3b552-547f-47a2-862b-b862107d2717'),(44879,44588,1,NULL,'__temp_zaqafmavkfqhzybtepzxtuljmhvagumydjmp',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Bcc outbreak linked to a no-rinse cleansing foam product, United States – 2017–2018\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cambridge.org/core/journals/epidemiology-and-infection/article/burkholderia-cepacia-complex-outbreak-linked-to-a-norinse-cleansing-foam-product-united-states-20172018/8ADC180852BDAB19E3E15512EDC248D5\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to intrinsic contamination of a non-sterile skin cleanser product\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 14:26:20','2024-07-29 14:26:20','9eb44558-5c74-4130-a46a-c716d5f41f7a'),(44880,44589,1,NULL,NULL,NULL,NULL,1,'2024-07-29 14:26:20','2024-07-29 14:26:20','e738ae6d-cdb8-43e2-8d90-526707cb17be'),(44881,44590,1,NULL,'__temp_rlwbfucqweuwvobrtqwvvphirdfnczagasrh',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Multistate Outbreak of Bcc Bloodstream Infections After Exposure to Contaminated Saline Flush Syringes — United States, 2016–2017\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476681/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to intrinsic contamination of injectable (sterile medical product) saline flushes\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 14:26:20','2024-07-29 14:26:20','7d73f10b-738f-4061-969e-f603f643b23a'),(44882,44591,1,NULL,NULL,NULL,NULL,1,'2024-07-29 14:26:20','2024-07-29 14:26:20','b412268b-a3de-427d-b52d-2a36147626ff'),(44883,44592,1,NULL,'__temp_fdpncqffhvqdwruxcofjowlonaakiubpjkbz',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A multistate investigation of health care–associated Bcc infections related to liquid docusate sodium\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.sciencedirect.com/science/article/abs/pii/S0196655317312877?\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to an intrinsically contaminated non-sterile oral medication\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 14:26:20','2024-07-29 14:26:20','d9f76928-5362-4e9e-b517-50f92b5f92dd'),(44885,44594,1,'Category A waste processing and disposal is a critical weakness in the United States response plans for outbreaks of high consequence infectious diseases','category-a-waste-processing-and-disposal-is-a-critical-weakness-in-the-united-states-response-plans-for-outbreaks-of-high-consequence-infectious-diseases','outbreak-news/category-a-waste-processing-and-disposal-is-a-critical-weakness-in-the-united-states-response-plans-for-outbreaks-of-high-consequence-infectious-diseases',NULL,1,'2024-07-29 16:47:38','2024-07-29 16:47:38','76bc2c0f-7a0b-4123-95cb-4388367a3ab4'),(44886,44595,1,NULL,NULL,NULL,'{\"46f8fcfe-c756-437a-ab02-62c34cb70433\": \"American Journal of Infection Control\", \"d327c84a-a0ba-403a-932c-9a807624e3ef\": {\"date\": \"2024-07-17 12:00:57\"}, \"f9e1c7bb-0351-432a-beb2-a1562d8f7e7e\": \"https://www.ajicjournal.org/article/S0196-6553(23)00604-1/abstract\"}',1,'2024-07-29 16:47:38','2024-07-29 16:47:38','80c4c737-a1ae-466d-b4e0-be667c873c03'),(44888,44597,1,'Investigation of a pseudo-outbreak of Mycobacterium franklinni','investigation-of-a-pseudo-outbreak-of-mycobacterium-franklinni','outbreak-news/investigation-of-a-pseudo-outbreak-of-mycobacterium-franklinni',NULL,1,'2024-07-29 16:48:27','2024-07-29 16:48:27','f2514d85-cf84-47be-a322-5c890ae4d547'),(44889,44598,1,NULL,NULL,NULL,'{\"46f8fcfe-c756-437a-ab02-62c34cb70433\": \"American Journal of Infection Control\", \"d327c84a-a0ba-403a-932c-9a807624e3ef\": {\"date\": \"2024-07-03 12:00:30\"}, \"f9e1c7bb-0351-432a-beb2-a1562d8f7e7e\": \"https://www.ajicjournal.org/article/S0196-6553(23)00766-6/abstract?dgcid=raven_jbs_etoc_email\"}',1,'2024-07-29 16:48:27','2024-07-29 16:48:27','b9ba43c5-8f23-4e04-8cf3-dca2b934c5ca'),(44891,44600,1,'Notes from the Field: Potential Outbreak of Extrapulmonary Mycobacterium abscessus subspecies massiliense Infections from Stem Cell Treatment Clinics in Mexico — Arizona and Colorado, 2022','notes-from-the-field-potential-outbreak-of-extrapulmonary-mycobacterium-abscessus-subspecies-massiliense-infections-from-stem-cell-treatment-clinics-in-mexico-arizona-and-colorado-2022','outbreak-news/notes-from-the-field-potential-outbreak-of-extrapulmonary-mycobacterium-abscessus-subspecies-massiliense-infections-from-stem-cell-treatment-clinics-in-mexico-arizona-and-colorado-2022',NULL,1,'2024-07-29 16:50:17','2024-07-29 16:50:17','5dd8cccd-5eeb-4a95-b7a7-f812629fc4b8'),(44892,44601,1,NULL,NULL,NULL,'{\"46f8fcfe-c756-437a-ab02-62c34cb70433\": \"Morbidity and Mortality Weekly Report\", \"d327c84a-a0ba-403a-932c-9a807624e3ef\": {\"date\": \"2024-06-19 12:00:02\"}, \"f9e1c7bb-0351-432a-beb2-a1562d8f7e7e\": \"https://www.cdc.gov/mmwr/volumes/73/wr/mm7318a3.htm?s_cid=mm7318a3_e&ACSTrackingID=USCDC_921-DM127971&ACSTrackingLabel=This%20Week%20in%20MMWR%3A%20Vol.%2073%2C%20May%209%2C%202024&deliveryName=USCDC_921-DM127971\"}',1,'2024-07-29 16:50:17','2024-07-29 16:50:17','8eb3ef90-0f63-400f-9269-51bf99a49bac'),(44895,44604,1,'Use of whole genomic sequencing to detect New Delhi metallo-B-lactamase (NDM)-producing Escherichia coli outbreak associated with endoscopic procedures','use-of-whole-genomic-sequencing-to-detect-new-delhi-metallo-b-lactamase-ndm-producing-escherichia-coli-outbreak-associated-with-endoscopic-procedures','outbreak-news/use-of-whole-genomic-sequencing-to-detect-new-delhi-metallo-b-lactamase-ndm-producing-escherichia-coli-outbreak-associated-with-endoscopic-procedures',NULL,1,'2024-07-29 16:54:44','2024-07-29 16:54:44','b4955990-a4c1-4dfd-aa85-76380458f00f'),(44896,44605,1,NULL,'__temp_swhiumwyzoxoyolntxvzwqmwplvretwsejlp',NULL,'{\"46f8fcfe-c756-437a-ab02-62c34cb70433\": \"Infection Control & Hospital Epidemiology\", \"d327c84a-a0ba-403a-932c-9a807624e3ef\": {\"date\": \"2024-05-22 12:00:33\"}, \"f9e1c7bb-0351-432a-beb2-a1562d8f7e7e\": \"https://shorturl.at/bEhiE\"}',1,'2024-07-29 16:54:44','2024-07-29 16:54:44','13566d6e-fb2e-433f-af7f-d8f22fe81197'),(44898,44607,1,'Candida auris outbreak at a tertiary care hospital during the COVID-19 pandemic','candida-auris-outbreak-at-a-tertiary-care-hospital-during-the-covid-19-pandemic','outbreak-news/candida-auris-outbreak-at-a-tertiary-care-hospital-during-the-covid-19-pandemic',NULL,1,'2024-07-29 17:47:53','2024-07-29 17:47:53','158e98d8-893b-4aa4-893a-d76cab3e83e7'),(44899,44608,1,NULL,NULL,NULL,'{\"46f8fcfe-c756-437a-ab02-62c34cb70433\": \"American Journal of Infection Control\", \"d327c84a-a0ba-403a-932c-9a807624e3ef\": {\"date\": \"2024-04-03 12:00:09\"}, \"f9e1c7bb-0351-432a-beb2-a1562d8f7e7e\": \"https://www.ajicjournal.org/article/S0196-6553(24)00136-6/abstract?dgcid=raven_jbs_aip_email\"}',1,'2024-07-29 17:47:53','2024-07-29 17:47:53','5b1070d6-41a1-4479-b0c2-788acfa78777'),(44915,44624,1,'C. auris','c-auris','diseases-pathogens/c-auris',NULL,1,'2024-07-29 19:12:31','2024-07-29 19:12:31','0b6ce7aa-a9e2-4552-a266-f1c0517c5bcd'),(44916,44625,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:12:31','2024-07-29 19:12:31','5b26fe95-4d28-425f-b189-3a46abe8a205'),(44917,44626,1,NULL,'__temp_xnefwmcxgxryloedzmdvdgpzhhjqthftraze',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Candida auris: Recommended Practices for Healthcare Outbreak Response\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://old.corha.org/wp-content/uploads/2021/08/Candida-auris-Recommendations-for-Healthcare-Outbreak-Response.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CORHA developed product includes proposed investigation/reporting thresholds and an outbreak definition for C. auris.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:12:31','2024-07-29 19:12:31','4c8098ca-a74a-4253-aa13-fa8078d06216'),(44918,44627,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:12:31','2024-07-29 19:12:31','bccb77ce-38b4-49f5-b0a9-e4409016ad0e'),(44919,44628,1,NULL,'__temp_qmhcxyvtsbbfepftnwkiivogawelgczjtxsi',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Control Guidance: Candida auris\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/candida-auris/hcp/infection-control/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CDC product outlines measures to control C. auris including setting-specific guidance.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:12:31','2024-07-29 19:12:31','cd507013-ead0-40c6-a62f-9a71cf59ce51'),(44920,44629,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:12:31','2024-07-29 19:12:31','046b1cf5-a39d-4859-b660-9fc4b6408d32'),(44921,44630,1,NULL,'__temp_odwrxknpunbllrstogttzfwrmsxyltsxnctc',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Screening for Candida auris Colonization\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/candida-auris/hcp/screening-hcp/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CDC resource provides detailed recommendations on screening for C. auris colonization.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:12:31','2024-07-29 19:12:31','6561d601-eb33-45f5-8cd5-4064e96d01a6'),(44922,44631,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:12:31','2024-07-29 19:12:31','ff2648bd-524f-4852-b5d3-c91be41b72b4'),(44923,44632,1,NULL,'__temp_zantjlhdqpstwwdfwekawhdwvzqvkrczjlns',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Antimicrobial Products Effective Against Candida auris\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.epa.gov/pesticide-registration/epas-registered-antimicrobial-products-effective-against-candida-auris-list\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"The EPA\'s List P provides information on registered antimicrobial products listed as effective against C. auris.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:12:31','2024-07-29 19:12:31','b64bc1de-084f-42f7-b228-d37633d55033'),(44924,44633,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:12:31','2024-07-29 19:12:31','6088d670-701a-49cf-b849-4c3531e1bbab'),(44925,44634,1,NULL,'__temp_hcunbavkrfugxblnduessxokbsjwzmjodlqc',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Tracking Candida auris\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/candida-auris/tracking-c-auris/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"C. auris cases are nationally notifiable; this page offers reporting information, case counts and maps.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:12:31','2024-07-29 19:12:31','cecf9bb3-5202-483b-87bb-2d1516c27b99'),(44926,44635,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:12:31','2024-07-29 19:12:31','8357500e-5330-440f-8023-582b24bd356f'),(44927,44636,1,NULL,'__temp_kdhsyvlsnpojsuxumulsjhrzhnbtxodswqtt',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Inter-Facility Infection Control Transfer Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/interfacility-ic-transfer-form-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This toolfosters communication about C. auris colonization and infection at transitions of care, essential to preventing further spread.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:12:31','2024-07-29 19:12:31','02262851-fb25-40a1-a176-02620d971c86'),(44928,44637,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:12:31','2024-07-29 19:12:31','2d2302fe-21c0-4366-8f85-1f028364e8fe'),(44929,44638,1,NULL,'__temp_vvlxghjhqexglvavvjczjbeltdcvwppxlwam',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Implementation of Personal Protective Equipment Use in Nursing Homes to Prevent the Spread of Multidrug-Resistant Organisms\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/long-term-care-facilities/hcp/prevent-mdro/ppe.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This long term care facility specific guidance provides an alternative to Contact Precautions. It clarifies the precautions needed based on the population at risk and the regional prevalence of C. auris.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:12:31','2024-07-29 19:12:31','38ae4d04-c389-4002-9bf9-d1ff78e6fe5f'),(44951,44660,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:23:16','2024-07-29 19:23:16','799e2f19-1210-4783-830c-59ce2c93df88'),(44952,44661,1,NULL,'__temp_hsnnhimrxeckfcordisvncnssbxgwaokkxcg',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Example line list and data collection tool for a Bcc outbreak investigation\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-29 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [2716], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://corha.org/assets/documents/Example-Line-List-and-Data-Collection-Tool.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This form can be adapted by adjusting the fields to collect the specific case and exposure information relevant to the investigation.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:23:16','2024-09-23 18:10:42','23f912ff-35a7-4306-b832-7ee6f9fabba2'),(44953,44662,1,'Burkholderia cepacia','b-cepacia','diseases-pathogens/b-cepacia',NULL,1,'2024-07-29 19:23:17','2024-07-29 19:23:17','59483374-0f61-4214-b2b4-b40239759ac9'),(44954,44663,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:23:17','2024-07-29 19:23:17','52c044ad-b661-4f54-a1e7-e78309d468eb'),(44955,44664,1,NULL,'__temp_hsnnhimrxeckfcordisvncnssbxgwaokkxcg',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Example line list and data collection tool for a Bcc outbreak investigation\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-29 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://old.corha.org/wp-content/uploads/2023/06/Example-Line-List-and-Data-Collection-Tool.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This form can be adapted by adjusting the fields to collect the specific case and exposure information relevant to the investigation.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:23:17','2024-07-29 19:23:17','ceadaad1-7e09-487f-8188-54e254820957'),(44956,44665,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:23:17','2024-07-29 19:23:17','d1dc68de-f3be-437f-b9a1-b9e215bc06c3'),(44957,44666,1,NULL,'__temp_gyyxyaosndrmyibybwuakabethmotizwvlpd',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MedWatch Online Voluntary Reporting Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.accessdata.fda.gov/scripts/medwatch/index.cfm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Use this form to report a Bcc-related outbreak or product concern.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:23:17','2024-07-29 19:23:17','23e09308-df08-4517-899c-2f29ec9ad6a2'),(44958,44667,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:23:17','2024-07-29 19:23:17','6feeda69-8926-4c37-b8b7-8260d5284b6a'),(44959,44668,1,NULL,'__temp_rxlggetlyczgjlckkrxqriwsadxtyzlwbvov',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Burkholderia cepacia in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/b-cepacia/about/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"CDC website on Bcc\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:23:17','2024-07-29 19:23:17','656cc4a3-c890-400f-9d1f-660766b1a302'),(44960,44669,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:23:17','2024-07-29 19:23:17','a975e500-db00-477e-9eb0-894852cc4bfb'),(44961,44670,1,NULL,'__temp_hvphjihoioblfcvdupxggfixbdkvackxjaoe',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Best practices for manufacturers of non-sterile, water-based drug products\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-drug-manufacturers-burkholderia-cepacia-complex-poses-contamination-risk-non-sterile\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource could be helpful to investigators when responding to a Bcc outbreak with potential medical product contamination.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:23:17','2024-07-29 19:23:17','e4addf32-7df2-435c-8062-d2b8130518f6'),(44962,44671,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:23:17','2024-07-29 19:23:17','754ae4dd-9acf-421b-b3a2-91c1cc800928'),(44963,44672,1,NULL,'__temp_tztcuixrozpicvthmqzccxsparleuheacjoo',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Burkholderia cepacia: This Decision Is Overdue\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.fda.gov/media/81867/download\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"FDA authors reviewed the regulatory and scientific impact of Bcc, describing FDA guidance, manufacturing control measures, and possible points of origin for microbial contamination.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:23:17','2024-07-29 19:23:17','a8b5ccb5-d96e-4d9a-aba0-62f5537b8ba9'),(44964,44673,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:23:17','2024-07-29 19:23:17','7b2216f0-054d-4bb4-afdd-b614e6392bd6'),(44965,44674,1,NULL,'__temp_czknwpimpsntsfjtxvusnbyvhrtutknjjcjb',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Bcc: a Feared Contamination Risk in Water-Based Pharmaceutical Products\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194853/pdf/CMR.00139-19.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article summarizes Bcc outbreaks and describes the mechanisms behind pharmaceutical product contamination.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:23:17','2024-07-29 19:23:17','58d13de3-7f0a-46d3-9aa6-a9751c585686'),(44966,44675,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:23:17','2024-07-29 19:23:17','71b525bb-7806-4af1-8c6e-33900f4be7f0'),(44967,44676,1,NULL,'__temp_zhtsumbkodbulmcqwfmpqroytrhdpgvyzbbj',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Systematic review of healthcare-associated B. cepacia\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335909/pdf/main.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This systematic review summarizes the investigation and control of 111 Bcc healthcare-associated outbreaks.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:23:17','2024-07-29 19:23:17','0267891a-7d5f-4ed5-9c5d-60651d9bfd94'),(44968,44677,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:23:17','2024-07-29 19:23:17','b041b7a0-19ca-4e7e-9314-aca2c6c6e542'),(44969,44678,1,NULL,'__temp_zaqafmavkfqhzybtepzxtuljmhvagumydjmp',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Bcc outbreak linked to a no-rinse cleansing foam product, United States – 2017–2018\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cambridge.org/core/journals/epidemiology-and-infection/article/burkholderia-cepacia-complex-outbreak-linked-to-a-norinse-cleansing-foam-product-united-states-20172018/8ADC180852BDAB19E3E15512EDC248D5\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to intrinsic contamination of a non-sterile skin cleanser product\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:23:17','2024-07-29 19:23:17','69c9d3d2-4980-46d9-b2f5-76f6fd598207'),(44970,44679,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:23:17','2024-07-29 19:23:17','cc7274b4-e007-41a6-9b82-05207a29501b'),(44971,44680,1,NULL,'__temp_rlwbfucqweuwvobrtqwvvphirdfnczagasrh',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Multistate Outbreak of Bcc Bloodstream Infections After Exposure to Contaminated Saline Flush Syringes — United States, 2016–2017\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476681/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to intrinsic contamination of injectable (sterile medical product) saline flushes\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:23:17','2024-07-29 19:23:17','1996ec22-83a3-429d-913c-a2951cdb6bdb'),(44972,44681,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:23:17','2024-07-29 19:23:17','656d0908-cd7b-4b09-886d-5412b26b2504'),(44973,44682,1,NULL,'__temp_fdpncqffhvqdwruxcofjowlonaakiubpjkbz',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A multistate investigation of health care–associated Bcc infections related to liquid docusate sodium\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.sciencedirect.com/science/article/abs/pii/S0196655317312877?\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to an intrinsically contaminated non-sterile oral medication\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:23:17','2024-07-29 19:23:17','be6de14f-236d-47ca-96cf-659358ffbb29'),(44989,44698,1,'Candida auris','c-auris','diseases-pathogens/c-auris',NULL,1,'2024-07-29 19:26:29','2024-07-29 19:26:29','4acf4b7f-8700-413a-8ae6-35ecd2b12190'),(44990,44699,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:26:29','2024-07-29 19:26:29','338a8962-c63d-493d-bc65-a2aff1d9c75a'),(44991,44700,1,NULL,'__temp_xnefwmcxgxryloedzmdvdgpzhhjqthftraze',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Candida auris: Recommended Practices for Healthcare Outbreak Response\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://old.corha.org/wp-content/uploads/2021/08/Candida-auris-Recommendations-for-Healthcare-Outbreak-Response.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CORHA developed product includes proposed investigation/reporting thresholds and an outbreak definition for C. auris.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:26:29','2024-07-29 19:26:29','a27db817-73ca-4457-90f2-cd1af2861812'),(44992,44701,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:26:29','2024-07-29 19:26:29','1e112daa-bac7-4471-b63f-235bc2cc379f'),(44993,44702,1,NULL,'__temp_qmhcxyvtsbbfepftnwkiivogawelgczjtxsi',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Control Guidance: Candida auris\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/candida-auris/hcp/infection-control/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CDC product outlines measures to control C. auris including setting-specific guidance.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:26:29','2024-07-29 19:26:29','f153f736-0beb-4815-8c96-a235887c2d33'),(44994,44703,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:26:29','2024-07-29 19:26:29','5c72ad60-b931-48d6-984d-93c333524a94'),(44995,44704,1,NULL,'__temp_odwrxknpunbllrstogttzfwrmsxyltsxnctc',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Screening for Candida auris Colonization\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/candida-auris/hcp/screening-hcp/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CDC resource provides detailed recommendations on screening for C. auris colonization.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:26:29','2024-07-29 19:26:29','b78070b5-ffe8-4fa2-a5ac-e5e4c5d18d98'),(44996,44705,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:26:29','2024-07-29 19:26:29','5800c83f-0c07-4420-b21e-5eb18c213a5c'),(44997,44706,1,NULL,'__temp_zantjlhdqpstwwdfwekawhdwvzqvkrczjlns',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Antimicrobial Products Effective Against Candida auris\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.epa.gov/pesticide-registration/epas-registered-antimicrobial-products-effective-against-candida-auris-list\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"The EPA\'s List P provides information on registered antimicrobial products listed as effective against C. auris.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:26:29','2024-07-29 19:26:29','1cbbf703-22e3-4dd9-a4e7-feb60df78177'),(44998,44707,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:26:29','2024-07-29 19:26:29','1c0989ea-8fb7-45a1-99e5-7f61991910cd'),(44999,44708,1,NULL,'__temp_hcunbavkrfugxblnduessxokbsjwzmjodlqc',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Tracking Candida auris\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/candida-auris/tracking-c-auris/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"C. auris cases are nationally notifiable; this page offers reporting information, case counts and maps.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:26:29','2024-07-29 19:26:29','a8e4ee1e-9cb5-41ae-a50d-6266adabc387'),(45000,44709,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:26:29','2024-07-29 19:26:29','1f23d218-99b1-47ff-9651-35cedeb0b5e9'),(45001,44710,1,NULL,'__temp_kdhsyvlsnpojsuxumulsjhrzhnbtxodswqtt',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Inter-Facility Infection Control Transfer Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/interfacility-ic-transfer-form-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This tool fosters communication about C. auris colonization and infection at transitions of care, essential to preventing further spread.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:26:29','2024-07-29 19:26:29','02ea896d-dc05-4ac7-846c-df991de53b7f'),(45002,44711,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:26:29','2024-07-29 19:26:29','7eb251c2-1dd7-4193-856b-31777b6dd799'),(45003,44712,1,NULL,'__temp_vvlxghjhqexglvavvjczjbeltdcvwppxlwam',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Implementation of Personal Protective Equipment Use in Nursing Homes to Prevent the Spread of Multidrug-Resistant Organisms\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/long-term-care-facilities/hcp/prevent-mdro/ppe.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This long term care facility specific guidance provides an alternative to Contact Precautions. It clarifies the precautions needed based on the population at risk and the regional prevalence of C. auris.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:26:29','2024-07-29 19:26:29','4f9f8115-f77a-44f7-8651-7a51d674c635'),(45013,44722,1,'Clostridioides difficile','c-diff','diseases-pathogens/c-diff',NULL,1,'2024-07-29 19:28:02','2024-07-29 19:28:02','18968217-82fa-42db-af27-8941ebe866d9'),(45014,44723,1,NULL,'__temp_mcpayctrkfgazliqngkcnqsnzbsbazjwvpkk',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also referred to as \'C. diff\' or CDI; formerly Clostridium difficile </i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Clostridioides difficile\"}',1,'2024-07-29 19:28:02','2024-07-29 19:28:02','ed730656-43f1-451b-83c1-ec275510656e'),(45015,44724,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Bacteria\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-07-29 19:28:02','2024-07-29 19:28:02','1e378330-be6e-41a9-9373-7325467f3e71'),(45016,44725,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:28:02','2024-07-29 19:28:02','e809dfff-5ec8-493c-8129-05695bb6dff1'),(45017,44726,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:28:02','2024-07-29 19:28:02','61bb64c1-4263-4b12-b673-f9536a2104be'),(45018,44727,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:28:02','2024-07-29 19:28:02','4e25d742-1ee6-4b38-9b04-8d00e2601616'),(45019,44728,1,NULL,'__temp_dwgqrcejrkxdcgpttgcpadyfsckfcycslotc',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Clostridioides difficile Infection (CDI): Recommendations for Healthcare Outbreak Response\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"Health Departments, Healthcare Facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://staging.corha.org/assets/documents/CDI-Recommendations-for-Healthcare-Outbreak-Response.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CORHA-developed product includes thresholds for investigation and reporting of a possible Clostridioides difficile infection (CDI) outbreak. Additional sections outline important actions and considerations for CDI outbreak investigation and control. This document includes listings of key references and supplemental resources.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:28:02','2024-07-29 19:28:02','4ee0ff33-3732-4b67-9a7c-5cd19804b584'),(45020,44729,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:28:02','2024-07-29 19:28:02','4462eaff-49ae-49e9-8058-474814d0b1a5'),(45021,44730,1,NULL,'__temp_shkokwkieoofqqlgxkpwkashkduitueijbuk',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Slide Presentation: Investigating C. difficile Infections\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdph.ca.gov/Programs/CHCQ/HAI/CDPH%20Document%20Library/CDI_LHD_051717ADA.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This educational resource reviews steps for CDI cluster and outbreak response\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:28:02','2024-07-29 19:28:02','2e18089a-145c-4c98-b7af-0213804bf4dc'),(45022,44731,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:28:02','2024-07-29 19:28:02','ff0aeca6-eb28-436e-aeb3-3fbaca24c943'),(45023,44732,1,NULL,'__temp_utrooqtuzbuyefnwscmkzdmuguvigazymsrn',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"C. diff Guidelines and Prevention Resources\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/c-diff/hcp/resources/?CDC_AAref_Val=https://www.cdc.gov/cdiff/clinicians/resources.html\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:28:02','2024-07-29 19:28:02','72c4d985-1dcc-4bd0-8490-f8789680d3ab'),(45024,44733,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:28:02','2024-07-29 19:28:02','a01be9a4-1e0b-46a2-b600-b0c779985862'),(45025,44734,1,NULL,'__temp_uhpdorqbwhkekskycfhecoifvsjobfmrdwkd',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Compendium of Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/strategies-to-prevent-clostridium-difficile-infections-in-acute-care-hospitals-2014-update/D5ADD87BD88203703AF85707CE799F6E\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:28:02','2024-07-29 19:28:02','d0ebe590-7fb1-48dc-a780-4b97c8932de5'),(45037,44746,1,'COVID-19','covid-19','diseases-pathogens/covid-19',NULL,1,'2024-07-29 19:29:53','2024-07-29 19:29:53','a6c63292-edd9-478f-bdc5-6d140c175355'),(45038,44747,1,NULL,'__temp_bcvyioaejkuuyhtahhowpdlzcyemhcukeojp',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also called SARS-CoV-2 infection</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"COVID-19\"}',1,'2024-07-29 19:29:53','2024-07-29 19:29:53','e3a89c6f-c5ca-4bda-8f6e-fbe973dcd8b1'),(45039,44748,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Virus\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-07-29 19:29:53','2024-07-29 19:29:53','6b0f86e1-c32d-4fe5-be45-619539b373c9'),(45040,44749,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:29:53','2024-07-29 19:29:53','b4e24876-3ec4-4014-87d8-0658ed258a41'),(45041,44750,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:29:53','2024-07-29 19:29:53','908b1a89-b08e-439d-97e0-8db4f5b8e865'),(45042,44751,1,NULL,'__temp_qjcqyooemaxqjsihxhgtmayekgbhjefspdea',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation/Reporting Thresholds and Outbreak Definitions for COVID-19 in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://old.corha.org/wp-content/uploads/2024/01/COVID-19-HC-Outbreak-Definition-Guidance_January-2024.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"These proposed investigation/reporting thresholds and outbreak definitions are provided to support the early detection of possible outbreaks and timely intervention to prevent transmission.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:29:53','2024-07-29 19:29:53','59c58465-bdee-4fb5-ad36-883a2b9295d5'),(45043,44752,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:29:53','2024-07-29 19:29:53','bacb0f9e-d94c-40a2-baba-824475679960'),(45044,44753,1,NULL,'__temp_arjjquljsgcwzmvrzpqzbskknongblwhmpwv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Preventing Transmission of Viral Respiratory Pathogens in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/infection-control/hcp/viral-respiratory-prevention/?CDC_AAref_Val=https://www.cdc.gov/infectioncontrol/guidelines/viral/prevent-viral.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource, published at the start of the 2023-2024 respiratory virus season, provides guidance for preventing all viral respiratory pathogens,  including influenza virus and SARS-CoV-2 infection, in healthcare settings.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:29:53','2024-07-29 19:29:53','1b76d577-422f-42a1-9b51-1ed969facbe4'),(45045,44754,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:29:53','2024-07-29 19:29:53','10771924-e88e-40f9-8bfa-014a14efd87e'),(45046,44755,1,NULL,'__temp_kvdsprjundflhtsgcqzqkobdveghrwtaiwci',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Viral Respiratory Pathogens Toolkit\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/long-term-care-facilities/hcp/respiratory-virus-toolkit/?CDC_AAref_Val=https://www.cdc.gov/longtermcare/prevention/viral-respiratory-toolkit.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This toolkit was published at the start of the 2023-2024 respiratory virus season, alongside general healthcare setting guidance, and serves as a setting-specific resource for nursing homes and long-term care facilities.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:29:53','2024-07-29 19:29:53','79910583-7b94-491c-9a90-f831b222984d'),(45047,44756,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:29:53','2024-07-29 19:29:53','bda19a8f-8f53-4292-830d-b6904e0ae261'),(45048,44757,1,NULL,'__temp_lmmacgglecopwpdkamthpsqhkxqyjzzdxvtv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"The recommendations in this guidance continue to apply after the expiration of the federal COVID-19 Public Health Emergency. This guidance provides a framework for facilities to implement select infection prevention and control practices based on their individual circumstances.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:29:54','2024-07-29 19:29:54','ec71cfa1-47c7-46da-aa3d-4ce24c063588'),(45049,44758,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:29:54','2024-07-29 19:29:54','910838b5-fef2-4d87-92f2-bfa7c193a349'),(45050,44759,1,NULL,'__temp_yxfbxmfnhnihvcpznrwastguhswwmwauqvss',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"National Healthcare Safety Network (NHSN): COVID-19 Modules and Dashboards\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/nhsn/covid19/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes NHSN COVID-19 reference materials relevant to hospital, long-term care facility, and dialysis facility personnel.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:29:54','2024-07-29 19:29:54','51f0097d-ef17-4a5f-8c22-3dba8b841534'),(45062,44771,1,'Carbapenem-Resistant Enterobacterales','carbapenem-resistant-enterobacterales','diseases-pathogens/carbapenem-resistant-enterobacterales',NULL,1,'2024-07-29 19:32:10','2024-07-29 19:32:10','ad231c7b-0e94-4041-b53c-f41c66a1df64'),(45063,44772,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:32:11','2024-07-29 19:32:11','86d42f63-aa5f-4442-825f-6fc4730a5471'),(45064,44773,1,NULL,'__temp_mczeqwfhorlakupyjhxpgtcxndsxmsrleyaj',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE: Recommendations for Healthcare Outbreak Response\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"8d07cb41-da70-4198-9c8d-e5de926d4a0d\": {\"date\": \"2023-02-01 08:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://old.corha.org/wp-content/uploads/2019/06/CORHA-CRE_February-2023-1.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CORHA-developed product addresses outbreak detection, reporting, investigation and control.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:32:11','2024-07-29 19:32:11','6c8e75d2-d280-4e52-8df5-acad39f7992c'),(45065,44774,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:32:11','2024-07-29 19:32:11','78a3ee28-895f-4a34-9af8-ce42e0895983'),(45066,44775,1,NULL,'__temp_iewdglllnctgpubfqoaqlwjfmwbqhxpcdtku',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE Infection Control\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/cre/hcp/infection-control/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Recommendations that healthcare providers and health departments can use to reduce the spread of CRE infections\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:32:11','2024-07-29 19:32:11','8cbd96f7-6f71-4df1-8d8f-c9cadf6481b6'),(45067,44776,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:32:11','2024-07-29 19:32:11','4d52cd3f-41d5-4766-9e40-16bed60317ae'),(45068,44777,1,NULL,'__temp_zhhcdigssqnrjxfnuctgqalhtealjvccwrmg',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Preventing MDROs (multidrug-resistant organisms)\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/php/preventing-mdros/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This website introduces valuable concepts and strategies for preventing and containing MDROs including CRE.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:32:11','2024-07-29 19:32:11','9e1c1a9c-da12-496b-ab36-0a0448fb03b3'),(45069,44778,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:32:11','2024-07-29 19:32:11','210d803a-99cd-4025-826c-7c23d9d84d08'),(45070,44779,1,NULL,'__temp_ajhzqvrzylszpvkccoqrqhcbodohwriuppsv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CRE Handout: Information for Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/CRE-handout-V7-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Two-page flyer with CRE information covering nomenclature, transmission, colonization, and prevention\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:32:11','2024-07-29 19:32:11','0cd6cc97-6dd2-406e-b13d-21f4ff46cba0'),(45071,44780,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:32:11','2024-07-29 19:32:11','6f602e44-6117-4855-a479-aee2004f2e95'),(45072,44781,1,NULL,'__temp_iystdoheimlpsucfsfktiktitmjpiwzmfhfv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Inter-facility Infection Control Transfer Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/CRE-handout-V7-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An essential aide to facilitate communication during patient transfers, to prevent spread of CRE or other MDROs\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:32:11','2024-07-29 19:32:11','cc0b7419-1b0b-4259-9e32-0a0bde7fdb1b'),(45085,44794,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:38:15','2024-07-29 19:38:15','9c0f8fee-53fc-4380-9e45-2691a2afcd0c'),(45086,44795,1,NULL,'__temp_iiatppuxpnrcebggmemkjtqyqygqkkselbfg',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Clinical Overview of NTM\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-29 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [2808], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/nontuberculous-mycobacteria/hcp/clinical-overview/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Information on clinical aspects and epidemiology of NTM including healthcare risks and outbreaks.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:38:16','2024-08-07 18:46:32','a247771c-2513-4ebd-9501-a7753d31cc2c'),(45087,44796,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:38:16','2024-07-29 19:38:16','3b5ebf97-adbb-4018-a036-16c0115808c1'),(45088,44797,1,NULL,'__temp_yonrrzotrvyeiqvaeogprustswjqlfeybrfb',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Water-Associated Organisms\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-29 07:00:00\"}, \"7fc2ffb2-8dd8-458f-aa77-106ca3b15811\": [], \"953e7d07-c006-4b4a-bff3-cec2630ed233\": [2716], \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://corha.org/diseases-pathogens/water-associated-organisms\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Collection of resources to aid in investigating potential outbreaks involving water-associated organisms, including NTM.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:38:16','2024-08-07 18:46:32','62d04b76-8250-463c-892d-43d0235bbff5'),(45089,44798,1,'Nontuberculous Mycobacteria','nontuberculous-mycobacteria-ntm','diseases-pathogens/nontuberculous-mycobacteria-ntm',NULL,1,'2024-07-29 19:38:16','2024-07-29 19:38:16','4fc95e07-d211-4309-9b62-afe00ab655ad'),(45090,44799,1,NULL,'__temp_dzaiifweqpesaqgqizaaazbmzfxhisbgxuce',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also referred to as NTM, atypical mycobacteria, or environmental mycobacteria</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Nontuberculous Mycobacteria\"}',1,'2024-07-29 19:38:16','2024-07-29 19:38:16','874382e7-1c32-47eb-b674-622e8721f795'),(45091,44800,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Bacteria\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-28 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-28 07:00:00\"}}',1,'2024-07-29 19:38:16','2024-07-29 19:38:16','a94f08de-dc67-40e3-9b60-f74ef4ba4084'),(45092,44801,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:38:16','2024-07-29 19:38:16','a6a50f2a-f277-458f-92d9-fe3a86b7c6b6'),(45093,44802,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:38:16','2024-07-29 19:38:16','b96d8014-f802-4aef-8d33-209248d2a9a3'),(45094,44803,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:38:16','2024-07-29 19:38:16','acfd7510-e1ae-4c55-ba9e-a29cd1219437'),(45095,44804,1,NULL,'__temp_djnlqonaihrmvhiebabylsazypsfzcgoeump',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Nontuberculous mycobacteria: Recommended Practices for Healthcare Outbreak Response\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.corha.org/resources/corha-proposed-investigation-reporting-thresholds-and-outbreak-definition-for-extrapulmonary-nontuberculous-mycobacteria-ntm/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource includes recommended practices for NTM outbreak response in healthcare settings, including outbreak detection and reporting, investigation and control measures.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:38:16','2024-07-29 19:38:16','c66282dd-a156-42c5-b80e-9d9bf97f5668'),(45096,44805,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:38:16','2024-07-29 19:38:16','49ae42ce-6c9b-403a-af83-1c1d1434176c'),(45097,44806,1,NULL,'__temp_chphuzaxcpozbfsdfdcxzuwfrraobwdpjkbf',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Extrapulmonary Nontuberculous Mycobacterium (NTM) Investigative Guidelines\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.oregon.gov/oha/PH/DISEASESCONDITIONS/COMMUNICABLEDISEASE/REPORTINGCOMMUNICABLEDISEASE/REPORTINGGUIDELINES/Documents/ntm.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource provides sample investigative guidelines for extrapulmonary NTM in Oregon, where extrapulmonary NTM became a reportable disease in 2014.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:38:16','2024-07-29 19:38:16','296865b4-8903-4854-a20b-dac4ddb81c38'),(45098,44807,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:38:16','2024-07-29 19:38:16','8a1aa8c2-5347-4d28-975b-2e30a82bb1a6'),(45099,44808,1,NULL,'__temp_bvtapsbyeuptftrdkgqulypqtxhrkogiysay',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Public Health Strategies\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/hai/organisms/nontuberculous-mycobacteria.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Recommendations and resources for enhancing outbreak recognition, response, and prevention.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:38:16','2024-07-29 19:38:16','aca07276-c39f-4a37-9a72-b52d506847ba'),(45100,44809,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:38:17','2024-07-29 19:38:17','3bafa3cf-be43-4cbe-ad5b-78419d33347d'),(45101,44810,1,NULL,'__temp_iiatppuxpnrcebggmemkjtqyqygqkkselbfg',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Clinical Overview of NTM\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-29 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/nontuberculous-mycobacteria/hcp/clinical-overview/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Information on clinical aspects and epidemiology of NTM including healthcare risks and outbreaks.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:38:17','2024-07-29 19:38:17','8f5242fd-7c16-4506-93b2-53c297ab8255'),(45102,44811,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:38:17','2024-07-29 19:38:17','5b3caf99-064e-4ac5-bf00-6bec91845419'),(45103,44812,1,NULL,'__temp_yonrrzotrvyeiqvaeogprustswjqlfeybrfb',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Water-Associated Organisms\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-29 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://corha.org/diseases-pathogens/water-associated-organisms\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Collection of resources to aid in investigating potential outbreaks involving water-associated organisms, including NTM.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:38:17','2024-07-29 19:38:17','653dcaa7-0cc1-41eb-b6d5-68f0a8998fee'),(45109,44818,1,'Group A Streptococcus','group-a-streptococcus','diseases-pathogens/group-a-streptococcus',NULL,1,'2024-07-29 19:41:17','2024-07-29 19:41:17','3153319a-e2d1-48ce-a589-e8e6d288ad84'),(45110,44819,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:41:17','2024-07-29 19:41:17','42c02319-008e-4726-b978-d8b758f549c2'),(45111,44820,1,NULL,'__temp_rvkopaqsbubmmvejrxhiekmarmexwnzdniwm',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Decision Tool for Investigating GAS Infections in Long-Term Care Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/group-a-strep/php/ltcf-toolkit/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This toolkit outlines detailed actions that investigators should consider, depending on the number of cases of GAS identified.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:41:17','2024-07-29 19:41:17','5451d514-540e-4bbb-bff2-a822d976e4f5'),(45112,44821,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:41:18','2024-07-29 19:41:18','24e7606f-38e7-47a6-8684-d64608a6606a'),(45113,44822,1,NULL,'__temp_tguaffzxjjypaculktbdqpkfvaohqtbghjqh',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Additional GAS Investigation Resources\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/group-a-strep/php/ltcf-toolkit/resources.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Compilation of links to helpful resources from state health departments including sample line lists and facility letters; CDC\'s interfacility infection control transfer form is also included.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:41:18','2024-07-29 19:41:18','026e27e9-b50b-4ece-b070-0b94c812f7c0'),(45125,44834,1,'Group A Streptococcus','group-a-streptococcus','diseases-pathogens/group-a-streptococcus',NULL,1,'2024-07-29 19:42:15','2024-07-29 19:42:15','9ab4ca66-e6a4-4745-9bf5-7bb0e2bca92a'),(45126,44835,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:42:15','2024-07-29 19:42:15','d792e3b2-f726-46aa-a5b2-70be75e8a47e'),(45127,44836,1,NULL,'__temp_rvkopaqsbubmmvejrxhiekmarmexwnzdniwm',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Decision Tool for Investigating GAS Infections in Long-Term Care Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/group-a-strep/php/ltcf-toolkit/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This toolkit outlines detailed actions that investigators should consider, depending on the number of cases of GAS identified.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:42:15','2024-07-29 19:42:15','d5979c67-7a7f-45b8-b3eb-7934cb921d72'),(45128,44837,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:42:15','2024-07-29 19:42:15','ecb02099-18a8-4b15-aa48-6a22e65b1143'),(45129,44838,1,NULL,'__temp_tguaffzxjjypaculktbdqpkfvaohqtbghjqh',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Additional GAS Investigation Resources\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/group-a-strep/php/ltcf-toolkit/resources.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Compilation of links to helpful resources from state health departments including sample line lists and facility letters; CDC\'s interfacility infection control transfer form is also included.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:42:15','2024-07-29 19:42:15','9c103ea5-5751-4923-91b5-a94e6db21e37'),(45130,44839,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:42:15','2024-07-29 19:42:15','4751d613-5533-4340-b245-aa6493d1bc17'),(45131,44840,1,NULL,'__temp_vuzqxxcouacsacxfjiewyuxxkmpoeqywvlhc',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevention of iGAS among household contacts of case patients and among postpartum and postsurgical patients; recommendations from the Centers for Disease Control and Prevention\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/12355382/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Recommendations for controlling iGAS among exposed household contacts and for responding to postpartum and postsurgical iGAS.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:42:15','2024-07-29 19:42:15','cf7b48d1-8b6a-4b79-b2a6-291a71963e6c'),(45132,44841,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:42:15','2024-07-29 19:42:15','e6b48959-353a-4fc3-b5fb-b623cb5ea1b8'),(45133,44842,1,NULL,'__temp_dwsoomkpzmmvotnvjgklzuaiiajdnypxnxnp',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Cluster of Group A Streptococcal Infections in a Skilled Nursing Facility—the Potential Role of Healthcare Worker Presenteeism\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742861/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Outbreak report that examined the role of working while ill, or “presenteeism,” in the introduction and transmission of GAS within a skilled nursing facility.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:42:15','2024-07-29 19:42:15','8050657a-f61e-481d-b9d1-17a114daabe0'),(45134,44843,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:42:15','2024-07-29 19:42:15','0bd41487-ec5e-4333-a3be-3c1381ebddfc'),(45135,44844,1,NULL,'__temp_otftwxpcqnfrnoryhdbkusswaalvrjzxtjjh',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"ICAR Observation Form - Wound Care\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/infection-control/media/pdfs/icar-ipc-obs-form-wound-care-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Audit tool to help identify infection control issues during wound care, a common source of GAS transmission in LTC outbreaks.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:42:15','2024-07-29 19:42:15','263aa660-5eec-434b-99d7-14a6e1a410a7'),(45150,44859,1,'Epidemic Keratoconjunctivitis','ekc','diseases-pathogens/ekc',NULL,1,'2024-07-29 19:47:06','2024-07-29 19:47:06','375f85d1-b0f1-4f2f-ab5a-bbc154d9f2e5'),(45151,44860,1,NULL,'__temp_syqlioqvmfwwkdyozssjibxyoksivaimtuxn',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also referred to as EKC, severe viral conjunctivitis, or pink eye</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Epidemic Keratoconjunctivitis\"}',1,'2024-07-29 19:47:06','2024-07-29 19:47:06','cce4a467-f490-4774-98f5-ee068ffd12cb'),(45152,44861,1,NULL,'__temp_gnqxifcfdtguttuniqunqojmswdaihfavyed',NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Virus\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2022-10-01 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2021-02-01 08:00:00\"}}',1,'2024-07-29 19:47:06','2024-07-29 19:47:06','64b96460-bc42-4871-8244-99a65903d418'),(45153,44862,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:47:06','2024-07-29 19:47:06','83926786-d956-4618-bf54-c1a2762bcb83'),(45154,44863,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:47:06','2024-07-29 19:47:06','0b01bb81-5aa6-461f-9813-d40dab46a1b8'),(45155,44864,1,NULL,'__temp_sseqicjaqacbrgitdiqarfslhndqaftaxqcp',NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key measures to prevent and control EKC transmission in healthcare settings include: </p><ul><li>Strict adherence to hand hygiene,</li><li>Use of disposable gloves for contact with eye secretions,</li><li>Effective environmental cleaning and disinfection of surfaces and equipment,</li><li>Using single use equipment and eye drops,</li><li>Cohorting of suspected conjunctivitis patients, and </li><li>Work restrictions for symptomatic healthcare personnel.</li></ul>\"}',1,'2024-07-29 19:47:06','2024-07-29 19:47:06','1e0b4f5f-e1d1-4e2e-acce-a17846f0c48f'),(45156,44865,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:47:06','2024-07-29 19:47:06','f0ea5af2-3a12-4281-b3ab-441941d3d900'),(45157,44866,1,NULL,'__temp_axxbiufulhlhgjcxhxdyksgsnxreewobaywa',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent Epidemic Keratoconjunctivitis\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/conjunctivitis/hcp/infection-control-ekc/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource provides cleaning and disinfection guidance for opthalmologic healthcare settings.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:47:06','2024-07-29 19:47:06','d23a457c-e29b-4774-8a5e-e3c5251a1669'),(45158,44867,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:47:06','2024-07-29 19:47:06','88d6179d-130f-43b5-aec5-0b6d85becc8c'),(45159,44868,1,NULL,'__temp_exgohiqdmyewgvuucwzrodipwluabuazjezf',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-09-02 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://old.corha.org/wp-content/uploads/2019/03/Sample-EKC-Line-List.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This is a ready-to-use template to document epidemic keratoconjunctivitis (EKC) outbreak information.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:47:06','2024-07-29 19:47:06','db9c1c9e-3738-4edf-828b-6de74dd160c3'),(45160,44869,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:47:06','2024-07-29 19:47:06','5ef53c41-6273-48f9-93b6-662f69a569b4'),(45161,44870,1,NULL,'__temp_lvdujnegnjelanflaysjgkhpwxiovnjyhyvb',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Epidemic Keratoconjunctivitis (EKC) Outbreak Patient Letter\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://old.corha.org/wp-content/uploads/2019/03/Sample-EKC-Patient-Letter.doc\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource provides sample language for healthcare facilities communicating with patients on epidemic keratoconjunctivitis (EKC) outbreaks.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:47:06','2024-07-29 19:47:06','1d101ec7-9d4e-434f-bb2d-05652f634a76'),(45162,44871,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:47:06','2024-07-29 19:47:06','6856c723-9832-4f70-b93b-ed1bcb31d7c5'),(45163,44872,1,NULL,'__temp_wmsbktpozkcuekkhojrqiawwygtxtejasytv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Adenovirus-Associated Epidemic Keratoconjunctivitis Outbreaks — Four States, 2008–2010\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2013-08-16 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6232a1.htm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CDC MMWR summarizes EKC investigations across four states and recommends outbreak control measures.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:47:06','2024-07-29 19:47:06','d9ff3c79-bc41-4435-b799-f49607751028'),(45174,44883,1,'Epidemic Keratoconjunctivitis','ekc','diseases-pathogens/ekc',NULL,1,'2024-07-29 19:48:12','2024-07-29 19:48:12','fb184890-d8d0-475f-8d7b-d62c5b3dd397'),(45175,44884,1,NULL,'__temp_gnqxifcfdtguttuniqunqojmswdaihfavyed',NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Virus\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-07-29 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2021-02-01 08:00:00\"}}',1,'2024-07-29 19:48:12','2024-07-29 19:48:12','77cf4b13-b419-40df-ae5f-a542e49b906d'),(45176,44885,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:48:12','2024-07-29 19:48:12','a6f0d815-0e83-4081-b627-23a3a35344bb'),(45177,44886,1,NULL,'__temp_axxbiufulhlhgjcxhxdyksgsnxreewobaywa',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent Epidemic Keratoconjunctivitis\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/conjunctivitis/hcp/infection-control-ekc/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource provides cleaning and disinfection guidance for opthalmologic healthcare settings.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:48:12','2024-07-29 19:48:12','908bd660-22eb-454d-b219-800e60bfcd55'),(45178,44887,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:48:12','2024-07-29 19:48:12','725e4b2f-a904-434a-ab7a-d41e2427a093'),(45179,44888,1,NULL,'__temp_exgohiqdmyewgvuucwzrodipwluabuazjezf',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-09-02 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://old.corha.org/wp-content/uploads/2019/03/Sample-EKC-Line-List.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This is a ready-to-use template to document epidemic keratoconjunctivitis (EKC) outbreak information.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:48:12','2024-07-29 19:48:12','5c01ca23-61df-4f80-8b41-61c32ed484b5'),(45180,44889,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:48:12','2024-07-29 19:48:12','a56b65e2-b1ab-402c-a282-b4f10681f08a'),(45181,44890,1,NULL,'__temp_lvdujnegnjelanflaysjgkhpwxiovnjyhyvb',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Epidemic Keratoconjunctivitis (EKC) Outbreak Patient Letter\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://old.corha.org/wp-content/uploads/2019/03/Sample-EKC-Patient-Letter.doc\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource provides sample language for healthcare facilities communicating with patients on epidemic keratoconjunctivitis (EKC) outbreaks.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:48:12','2024-07-29 19:48:12','7a322036-db42-4a4f-926d-a981a876e876'),(45182,44891,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:48:12','2024-07-29 19:48:12','51594144-d30c-4d94-9f06-a9657beee0e6'),(45183,44892,1,NULL,'__temp_wmsbktpozkcuekkhojrqiawwygtxtejasytv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Adenovirus-Associated Epidemic Keratoconjunctivitis Outbreaks — Four States, 2008–2010\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2013-08-16 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6232a1.htm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CDC MMWR summarizes EKC investigations across four states and recommends outbreak control measures.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:48:13','2024-07-29 19:48:13','3df86e74-f5b6-425a-9727-4980f15dc5b2'),(45195,44904,1,'Influenza','influenza','diseases-pathogens/influenza',NULL,1,'2024-07-29 19:52:18','2024-07-29 19:52:18','4fe0f090-d90d-4938-a88b-40187f77de4e'),(45196,44905,1,NULL,'__temp_lazwnamwkwfbioglswfgcirioyrqgzvpurkz',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also called influenza virus or flu</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Influenza\"}',1,'2024-07-29 19:52:18','2024-07-29 19:52:18','bcd49f85-0b4d-4056-9c44-60b5b70b65a2'),(45197,44906,1,NULL,'__temp_zhqxxlshkypwlrwnwxvafddxtlwyxlgwmyzt',NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Virus\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-07-29 19:52:18','2024-07-29 19:52:18','7ec18549-cbb4-46d4-83eb-70ae979e2c5e'),(45198,44907,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:52:18','2024-07-29 19:52:18','847b4129-cc49-440a-9480-c2cec5e15d2f'),(45199,44908,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:52:18','2024-07-29 19:52:18','a398c7ef-394b-4951-9be2-9c546971e6a9'),(45200,44909,1,NULL,'__temp_noxjsfsmguajuhzzkvzwuseloaysvjxbyqza',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CORHA Thresholds for Reporting and Investigating Cases of Influenza\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.corha.org/resources/corha-thresholds-for-reporting-and-investigating-cases-of-influenza/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Suggested thresholds to expedite facilities’ investigation of cases and reporting to public health.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:52:18','2024-07-29 19:52:18','e3d9b361-48ae-4678-a88d-e67feca70289'),(45201,44910,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:52:18','2024-07-29 19:52:18','348ee26a-0c31-4289-92ed-67ae2eda14cb'),(45202,44911,1,NULL,'__temp_ghlgdysibyyfhhemxjocrfigxnqpjpejhgpl',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Interim Guidance for Influenza Outbreak Management in Long-Term Care and Post-Acute Care Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/flu/professionals/infectioncontrol/ltc-facility-guidance.htm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Recommended measures for nursing homes and skilled nursing facilities for suspected or confirmed influenza outbreaks.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:52:18','2024-07-29 19:52:18','e2869034-baa8-4a7e-b594-84c7c410e8d9'),(45203,44912,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:52:18','2024-07-29 19:52:18','6cfb0fb4-5eff-4248-8be5-a9b0f3fdda9d'),(45204,44913,1,NULL,'__temp_etkayuqygpefzuphglzcdhyujvjkbimqtzsb',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Preventing Transmission of Viral Respiratory Pathogens in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-10 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/infectioncontrol/guidelines/viral/prevent-viral.html#:~:text=Preventing%20Transmission%20of%20Viral%20Respiratory%20Pathogens%20in%20Healthcare,6.%20Monitor%20and%20Manage%20Ill%20Healthcare%20Personnel%20\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Guidance for preventing all types of viral respiratory pathogens, including influenza virus and SARS-CoV-2 infection, in healthcare settings.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:52:18','2024-07-29 19:52:18','48973afe-6848-4af8-be1e-3def155bc550'),(45205,44914,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:52:18','2024-07-29 19:52:18','6b46f777-2fd4-4eb2-b38d-bd620c1b871c'),(45206,44915,1,NULL,'__temp_hgkkvtvsjwqftfilechyyxvbclvhcmsdgrjh',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Viral Respiratory Pathogens Toolkit for Nursing Homes\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-10 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/longtermcare/prevention/viral-respiratory-toolkit.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"A setting-specific resource that includes advice on outbreak control measures spanning infuenza, RSV, SARS-CoV-2, and more.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:52:18','2024-07-29 19:52:18','a438057d-8dff-4b1f-9cbe-2b0111807bad'),(45207,44916,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:52:18','2024-07-29 19:52:18','23588356-0cfd-47d1-9b55-a93c43cc95b8'),(45208,44917,1,NULL,'__temp_tddoaxzxqjbgyhcepltnzzxeygclrtcrrmpp',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Example of Annual Long Term Care Facility Infuenza Letter\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-10 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://dph.illinois.gov/content/dam/soi/en/web/idph/publications/idph/topics-and-services/diseases-and-conditions/influenza/influenza-ltcf-outbreak-guidance_202324.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Preventing and control guidance with reporting requirements for a suspected or confirmed outbreak influenza outbreak\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:52:18','2024-07-29 19:52:18','858c82cd-9b2e-4034-9f9b-7a08481ae95c'),(45227,44936,1,'Water-Associated Organisms','water-associated-organisms','diseases-pathogens/water-associated-organisms',NULL,1,'2024-07-29 19:55:06','2024-07-29 19:55:06','f711e80f-a7ac-4697-89b7-11f77441c146'),(45228,44937,1,NULL,'__temp_roqevoidgtkjifqthynxphayebbabjemnesy',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Water-Associated Organisms\"}',1,'2024-07-29 19:55:06','2024-07-29 19:55:06','dafc8986-88f0-4f65-921b-e4f67eb1ac54'),(45229,44938,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:55:06','2024-07-29 19:55:06','7682b8b9-7a5d-47ce-b009-e609fe0ff908'),(45230,44939,1,NULL,'__temp_rwlpacukoilaobdjruttbkelpdngvkaclcfo',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Healthcare facilities often have complex distribution pathways and other features which serve as a favorable environment for the proliferation of opportunistic pathogens such as nontuberculous mycobacteria and <i>Legionella</i>, among many others. Water-associated organisms have caused many outbreaks in healthcare settings and these outbreaks can be challenging to detect and control. This page offers a collection of resources to assist with water-related outbreak detection and response. CORHA\'s <a href=\\\"{entry:17663@1:url||https://corha.org/diseases-pathogens/nontuberculous-mycobacteria-ntm}\\\">Nontuberculous mycobacteria</a>, <a href=\\\"{entry:2851@1:url||https://corha.org/diseases-pathogens/b-cepacia}\\\"><i>Burkholderia cepacia</i></a>, and <a href=\\\"{entry:15944@1:url||https://corha.org/diseases-pathogens/legionella}\\\">Legionella</a> resource pages offer additional detailed information.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Water-Associated Organisms\"}',1,'2024-07-29 19:55:06','2024-07-29 19:55:06','065b00df-9d60-4e1e-b14f-5187ba08660e'),(45231,44940,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:55:06','2024-07-29 19:55:06','747cfefa-d93e-4327-80e5-9a34ecfef034'),(45232,44941,1,NULL,'__temp_emfqqzsiyecrzhfzdvgbcyxarwhgyoqugmze',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Reducing Risk from Water, from Plumbing to Patients\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/php/toolkit/water-management.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Helpful information, resources, and tools for understanding and reducing infectious risks due to water-associated organisms.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:55:06','2024-07-29 19:55:06','257b5100-fc96-47af-b8cf-a75c085df8ef'),(45233,44942,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:55:06','2024-07-29 19:55:06','bfe10a86-0fed-4bc3-8519-7b2dbbfa6571'),(45234,44943,1,NULL,'__temp_zhvnoxdlgcqpalvuishokqfcfntlvoiaajyp',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Tap Water Quality and Infrastructure Discussion Guide for Investigation of Potential Water-Associated Infections in Healthcare Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/healthcare-associated-infections/media/pdfs/water-quality-discussion-guide-p.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This guide provides an organized approach to identifying the potential sources of exposure.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:55:06','2024-07-29 19:55:06','98619432-2037-4e79-8144-28a56b364f5f'),(45235,44944,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:55:06','2024-07-29 19:55:06','563c06ad-7215-4dd7-9641-5496f9bda716'),(45236,44945,1,NULL,'__temp_lieyoafjcnckwlspkwjdscuwqdnjmvvgzwqn',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare Outbreaks Associated with a Water Reservoir and Infection Prevention Strategies\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://academic.oup.com/cid/article/62/11/1423/1745014\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Literature review describing healthcare outbreaks associated with water, common transmission routes, and infection prevention strategies.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:55:06','2024-07-29 19:55:06','6993e063-f6d1-458b-b89e-8944fca45236'),(45237,44946,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:55:06','2024-07-29 19:55:06','bf095c76-f9c5-4e35-8155-040a22bb61ef'),(45238,44947,1,NULL,'__temp_djkscwdlhxnkuoptzewcmfvlhguiognhoaoo',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Tap Water Avoidance Decreases Rates of Hospital-onset Pulmonary Nontuberculous Mycobacteria\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326555/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This outbreak response involved avoiding the use of nonsterile water and offers considerations for expanded use of this strategy.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:55:06','2024-07-29 19:55:06','477a057d-1ada-4404-85b5-2540e7f9bd8a'),(45239,44948,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:55:06','2024-07-29 19:55:06','ea5aa256-8688-48c9-a7cd-7b3548eef181'),(45240,44949,1,NULL,'__temp_qcogcnxwsqwechfabesvjowdsmnjcgeddymw',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation of healthcare infection risks from water-related organisms: Summary of CDC consultations, 2014-2017\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/abs/investigation-of-healthcare-infection-risks-from-waterrelated-organisms-summary-of-cdc-consultations-20142017/0771439B1D60E697C52B37FC24944CC0\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Summary of water-associated organism outbreak consultations that details commonly encountered transmission routes associated with clinical care.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:55:06','2024-07-29 19:55:06','76cd4616-516d-4918-9e56-c1c8f86c052c'),(45241,44950,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:55:06','2024-07-29 19:55:06','d62a916a-edf3-47ca-bcea-b9a3b20409bb'),(45242,44951,1,NULL,'__temp_pyqldwfwpqoqyliwjcqlfeuyyttezmnsqlbc',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Outbreaks of healthcare-associated infections linked to water-containing hospital equipment: a literature review\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://aricjournal.biomedcentral.com/articles/10.1186/s13756-021-00935-6\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This paper summarizes common hospital medical devices that use water and have led to outbreaks; the authors propose measures to help mitigate these risks.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:55:06','2024-07-29 19:55:06','617bf3ab-2d51-471a-b3fa-4e9738c5e7cd'),(45243,44952,1,NULL,NULL,NULL,NULL,1,'2024-07-29 19:55:06','2024-07-29 19:55:06','c0c2ecf1-ad98-449f-8c56-d7612b365c4b'),(45244,44953,1,NULL,'__temp_dxkllpryxvqfasjbweozfaxkhviwfnpkshze',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Requirement to Reduce Legionella Risk in Healthcare Facility Water Systems to Prevent Cases and Outbreaks of Legionnaires’ Disease (LD)\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-25 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Downloads/QSO17-30-HospitalCAH-NH-REVISED-.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Outline of requirements for acute care hospitals and long-term care facilities regarding water management policies and procedures to reduce the risk of growth and spread of Legionella and other opportunistic pathogens.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 19:55:06','2024-07-29 19:55:06','7bc67e81-1e3e-4cc6-a3f8-819c302a4357'),(45256,44965,1,'Ebola','ebola','diseases-pathogens/ebola',NULL,1,'2024-07-29 20:02:46','2024-07-29 20:02:46','39c341e0-3617-48d4-aaa4-73ea6bf69d3d'),(45257,44966,1,NULL,'__temp_cnarfehtmdbgustzqzqmehavxtfthzwzstrv',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Ebola Virus Disease</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Ebola\"}',1,'2024-07-29 20:02:47','2024-07-29 20:02:47','945a3857-60ed-4fe6-a5a9-1ea5227c6a07'),(45258,44967,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Virus\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-07-29 20:02:47','2024-07-29 20:02:47','7d40a3fb-245f-4412-b7a6-d95626e4c3ac'),(45259,44968,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:02:47','2024-07-29 20:02:47','64facdcc-9f77-4ddc-a103-82a382911fdc'),(45260,44969,1,NULL,'__temp_paobkymdvtnqfkostrrfvdsqiaqgxcbtsdbm',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Ebola Virus Disease (EVD) is a rare but severe viral hemorrhagic fever (VHF) caused by the Ebola Virus. Any suspected case(s) of EVD should be promptly reported to public health.  The virus can spread person-to-person through direct contact with blood or bodily fluids of a person who is sick with or has died from EVD. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Preventing transmission of EVD in healthcare settings requires careful application of infection control measures, including but not limited to the effective use of personal protective equipment (PPE).</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Ebola\"}',1,'2024-07-29 20:02:47','2024-07-29 20:02:47','e65b825e-14d0-4d25-9fdd-534f7142bfa8'),(45261,44970,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:02:47','2024-07-29 20:02:47','b4c063d6-e53d-464e-9cb6-1b6df438bd71'),(45262,44971,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:02:47','2024-07-29 20:02:47','f054317a-98a3-4890-b420-1879f36e5584'),(45263,44972,1,NULL,'__temp_agmmcmualdwzdchazbvimtzwwcperxjqcmdf',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Prevention and Control Recommendations for U.S. Hospital Patients with Suspected or Confirmed Viral Hemorrhagic Fevers\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/viral-hemorrhagic-fevers/hcp/infection-control/?CDC_AAref_Val=https://www.cdc.gov/vhf/ebola/clinicians/evd/infection-control.html\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 20:02:47','2024-07-29 20:02:47','ad2c7449-8b77-41af-ac01-a381935f4972'),(45264,44973,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:02:47','2024-07-29 20:02:47','ec587e33-9ae6-4fbe-b07e-8163ebdb8ae1'),(45265,44974,1,NULL,'__temp_hrjaehpqqkzrynczbigvvnzswebaojgpmkvf',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s Health Topics Page on Ebola Virus Disease\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-31 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 20:02:47','2024-07-29 20:02:47','0f83a12e-27df-4604-a6ea-b6f72ce66b3e'),(45266,44975,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:02:47','2024-07-29 20:02:47','81e4055e-7670-44b4-a5ca-61798fb838ed'),(45267,44976,1,NULL,'__temp_xtdhqvklvmmavzhfgvzymdbknssyyynzdcdu',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/viral-hemorrhagic-fevers/php/public-health-strategy/vhf-response-planning.html?CDC_AAref_Val=https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 20:02:47','2024-07-29 20:02:47','4414e103-ed18-466c-8d56-0fc8d0e2d05b'),(45268,44977,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:02:47','2024-07-29 20:02:47','61d502c4-b930-4209-8f8d-749eed6b7bef'),(45269,44978,1,NULL,'__temp_nkrflbxtxcfbmslhlsdrlxukmvxzdljslenw',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s State & Territorial Health Department Directories\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/public-health-gateway/php/communications-resources/health-department-directories.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This website provides links to health department websites in all 50 states and the District of Columbia.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 20:02:47','2024-07-29 20:02:47','1babec19-b985-406b-b389-141bca022f7e'),(45281,44990,1,'Clostridioides difficile','c-diff','diseases-pathogens/c-diff',NULL,1,'2024-07-29 20:04:29','2024-07-29 20:04:29','41289848-06e9-41c9-bb4c-b51d7cb442fe'),(45282,44991,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:04:30','2024-07-29 20:04:30','6a1eb0d5-555f-4b8d-9b98-ebb8ed55e067'),(45283,44992,1,NULL,'__temp_zwfclbyqpicvrtkriozuiqlxfgzloorzqvyx',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p><i>Clostridioides difficile</i> is a type of spore-forming bacteria that can cause life-threatening diarrhea and colitis. C. difficile infection (CDI) is related to antibiotic exposure and is a frequent cause of healthcare-associated infections. CDI can spread from patient to patient and occasionally results in outbreaks among people being cared for in nursing homes and hospitals. </p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About CDI\"}',1,'2024-07-29 20:04:30','2024-07-29 20:04:30','07fc1527-def5-47fd-95ae-d03151529482'),(45284,44993,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:04:30','2024-07-29 20:04:30','efdaf78e-4235-4ee1-8f16-38a986824b74'),(45285,44994,1,NULL,'__temp_dwgqrcejrkxdcgpttgcpadyfsckfcycslotc',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Clostridioides difficile Infection (CDI): Recommendations for Healthcare Outbreak Response\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"Health Departments, Healthcare Facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://staging.corha.org/assets/documents/CDI-Recommendations-for-Healthcare-Outbreak-Response.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CORHA-developed product includes thresholds for investigation and reporting of a possible Clostridioides difficile infection (CDI) outbreak. Additional sections outline important actions and considerations for CDI outbreak investigation and control. This document includes listings of key references and supplemental resources.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 20:04:30','2024-07-29 20:04:30','31da635f-5141-4c4d-b6df-a0ebf966d376'),(45286,44995,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:04:30','2024-07-29 20:04:30','8c9c0844-86f8-42b7-a3c7-120132c345e1'),(45287,44996,1,NULL,'__temp_shkokwkieoofqqlgxkpwkashkduitueijbuk',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Slide Presentation: Investigating C. difficile Infections\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdph.ca.gov/Programs/CHCQ/HAI/CDPH%20Document%20Library/CDI_LHD_051717ADA.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This educational resource reviews steps for CDI cluster and outbreak response\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 20:04:30','2024-07-29 20:04:30','ce977f8a-afcd-494c-87e5-0fd64e5fa4e5'),(45288,44997,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:04:30','2024-07-29 20:04:30','e18c2cd0-7cfd-45f0-a13a-65e15f0597cc'),(45289,44998,1,NULL,'__temp_utrooqtuzbuyefnwscmkzdmuguvigazymsrn',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"C. diff Guidelines and Prevention Resources\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/c-diff/hcp/resources/?CDC_AAref_Val=https://www.cdc.gov/cdiff/clinicians/resources.html\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 20:04:30','2024-07-29 20:04:30','d9ea1d44-d999-44b4-84d1-837ea9d4b44e'),(45290,44999,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:04:30','2024-07-29 20:04:30','a919dff6-e2ee-463e-aa81-1f648128bbf5'),(45291,45000,1,NULL,'__temp_uhpdorqbwhkekskycfhecoifvsjobfmrdwkd',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Compendium of Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/strategies-to-prevent-clostridium-difficile-infections-in-acute-care-hospitals-2014-update/D5ADD87BD88203703AF85707CE799F6E\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 20:04:30','2024-07-29 20:04:30','ef5beb9a-6124-469c-8119-02ffda9228e3'),(45315,45024,1,'Burkholderia cepacia','b-cepacia','diseases-pathogens/b-cepacia',NULL,1,'2024-07-29 20:05:07','2024-07-29 20:05:07','4bf2d30b-1415-448c-bea8-27fab21329d6'),(45316,45025,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:05:07','2024-07-29 20:05:07','61271809-0d49-480d-8b86-2278d5e660f6'),(45317,45026,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>The Burkholderia cepacia complex (Bcc) is a group of closely related Gram negative, rod-shaped bacteria that can be found in soil and water. </p><p>Bcc can be spread by person-to-person contact, contact with contaminated surfaces, and environmental exposure. Outbreaks have been linked to intrinsic and extrinsic contamination of various products used in healthcare settings. These products usually have an aqueous component or are exposed to tap water. Contaminated medical products which have led to outbreaks in healthcare facilities include saline flushes, mouthwash, oral liquid docusate, skin cleanser, ultrasound gel, nasal spray, nebulizers, antiseptics, disinfectant solutions, balloon pumps, and temperature probes. </p><p><strong>Key Point: </strong>Maintain a low threshold (e.g., single case or small cluster) for reporting a Bcc outbreak or product concern.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Bcc\"}',1,'2024-07-29 20:05:07','2024-07-29 20:05:07','cd5bd039-60ab-43a9-84af-74d82052fc9a'),(45318,45027,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:05:07','2024-07-29 20:05:07','37539993-5bd6-4c3d-bd1c-6f7608ffaea3'),(45319,45028,1,NULL,'__temp_hsnnhimrxeckfcordisvncnssbxgwaokkxcg',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Example line list and data collection tool for a Bcc outbreak investigation\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-07-29 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://old.corha.org/wp-content/uploads/2023/06/Example-Line-List-and-Data-Collection-Tool.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This form can be adapted by adjusting the fields to collect the specific case and exposure information relevant to the investigation.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 20:05:07','2024-07-29 20:05:07','a21c2872-d195-4020-9ebe-eeb2e19d55ab'),(45320,45029,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:05:07','2024-07-29 20:05:07','5dffd9f2-9a52-486b-b88f-59dcac541d7c'),(45321,45030,1,NULL,'__temp_gyyxyaosndrmyibybwuakabethmotizwvlpd',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MedWatch Online Voluntary Reporting Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.accessdata.fda.gov/scripts/medwatch/index.cfm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Use this form to report a Bcc-related outbreak or product concern.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 20:05:07','2024-07-29 20:05:07','3296c2bb-dc3d-4315-8e8b-296b3d8d9518'),(45322,45031,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:05:07','2024-07-29 20:05:07','f8f43b88-8a14-4354-a60e-605746ee7632'),(45323,45032,1,NULL,'__temp_rxlggetlyczgjlckkrxqriwsadxtyzlwbvov',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Burkholderia cepacia in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/b-cepacia/about/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"CDC website on Bcc\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 20:05:07','2024-07-29 20:05:07','72dc4d5b-d605-49de-a8ea-53cc993541b7'),(45324,45033,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:05:07','2024-07-29 20:05:07','878a40b7-d598-4101-954c-f265b837e539'),(45325,45034,1,NULL,'__temp_hvphjihoioblfcvdupxggfixbdkvackxjaoe',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Best practices for manufacturers of non-sterile, water-based drug products\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-drug-manufacturers-burkholderia-cepacia-complex-poses-contamination-risk-non-sterile\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource could be helpful to investigators when responding to a Bcc outbreak with potential medical product contamination.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 20:05:07','2024-07-29 20:05:07','e92f384f-341e-4b3f-89d3-c031ea57c7d5'),(45326,45035,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:05:07','2024-07-29 20:05:07','d043acb0-75eb-4d0c-a43a-b21c16b0224c'),(45327,45036,1,NULL,'__temp_tztcuixrozpicvthmqzccxsparleuheacjoo',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Burkholderia cepacia: This Decision Is Overdue\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.fda.gov/media/81867/download\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"FDA authors reviewed the regulatory and scientific impact of Bcc, describing FDA guidance, manufacturing control measures, and possible points of origin for microbial contamination.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 20:05:07','2024-07-29 20:05:07','45312516-8eb9-4692-bc6a-6a6dce11abf1'),(45328,45037,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:05:07','2024-07-29 20:05:07','ca41acdb-557a-49f5-b2d8-13184c66f0d6'),(45329,45038,1,NULL,'__temp_czknwpimpsntsfjtxvusnbyvhrtutknjjcjb',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Bcc: a Feared Contamination Risk in Water-Based Pharmaceutical Products\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194853/pdf/CMR.00139-19.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article summarizes Bcc outbreaks and describes the mechanisms behind pharmaceutical product contamination.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 20:05:07','2024-07-29 20:05:07','e8e86007-c564-4b03-9b6e-208855d18901'),(45330,45039,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:05:07','2024-07-29 20:05:07','bd15e1e2-a3d2-4126-b80a-1dfb026e0c31'),(45331,45040,1,NULL,'__temp_zhtsumbkodbulmcqwfmpqroytrhdpgvyzbbj',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Systematic review of healthcare-associated B. cepacia\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335909/pdf/main.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This systematic review summarizes the investigation and control of 111 Bcc healthcare-associated outbreaks.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 20:05:07','2024-07-29 20:05:07','36e3032c-95a5-4e4d-8468-c50cae4e8be6'),(45332,45041,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:05:07','2024-07-29 20:05:07','e08a330f-fbb6-4683-a58a-21388c9a2014'),(45333,45042,1,NULL,'__temp_zaqafmavkfqhzybtepzxtuljmhvagumydjmp',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Bcc outbreak linked to a no-rinse cleansing foam product, United States – 2017–2018\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cambridge.org/core/journals/epidemiology-and-infection/article/burkholderia-cepacia-complex-outbreak-linked-to-a-norinse-cleansing-foam-product-united-states-20172018/8ADC180852BDAB19E3E15512EDC248D5\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to intrinsic contamination of a non-sterile skin cleanser product\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 20:05:07','2024-07-29 20:05:07','6fd36d27-b59d-4759-90db-54740969b825'),(45334,45043,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:05:07','2024-07-29 20:05:07','75db78f0-df17-4277-aad5-a8819e8135ad'),(45335,45044,1,NULL,'__temp_rlwbfucqweuwvobrtqwvvphirdfnczagasrh',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Multistate Outbreak of Bcc Bloodstream Infections After Exposure to Contaminated Saline Flush Syringes — United States, 2016–2017\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476681/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to intrinsic contamination of injectable (sterile medical product) saline flushes\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 20:05:07','2024-07-29 20:05:07','a04fbc65-cac8-4ab5-9f48-6e1aae3f03bc'),(45336,45045,1,NULL,NULL,NULL,NULL,1,'2024-07-29 20:05:08','2024-07-29 20:05:08','b6533eae-8175-47a0-ad31-a5ea2d01658e'),(45337,45046,1,NULL,'__temp_fdpncqffhvqdwruxcofjowlonaakiubpjkbz',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A multistate investigation of health care–associated Bcc infections related to liquid docusate sodium\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.sciencedirect.com/science/article/abs/pii/S0196655317312877?\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to an intrinsically contaminated non-sterile oral medication\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-29 20:05:08','2024-07-29 20:05:08','9e2bf45f-ff74-4e2f-a717-6ed9ef404b42'),(45357,45066,1,'Environmental Fungi','environmental-fungi','diseases-pathogens/environmental-fungi',NULL,1,'2024-07-30 17:49:18','2024-07-30 17:49:18','18d1718c-517e-4774-8829-254d8cd19a7b'),(45358,45067,1,NULL,'__temp_faiqzxrljuvozxdekdytfkutmgbhkvokbhkk',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>This page addresses pathogenic environmental fungi (including molds) </i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Environmental Fungi\"}',1,'2024-07-30 17:49:18','2024-07-30 17:49:18','53dad870-4f71-4a11-8da9-bc63468054ad'),(45359,45068,1,NULL,'__temp_miklbvlvefjnuudnpgvbyknggyklashgwgrv',NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Fungi\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-07-30 17:49:18','2024-07-30 17:49:18','27f23d56-095a-458a-82c6-96157fac2a70'),(45360,45069,1,NULL,NULL,NULL,NULL,1,'2024-07-30 17:49:18','2024-07-30 17:49:18','88421214-887e-41d7-90fa-be15e216a992'),(45361,45070,1,NULL,NULL,NULL,NULL,1,'2024-07-30 17:49:18','2024-07-30 17:49:18','34377c08-df2d-45bf-8b63-00795a59bd68'),(45362,45071,1,NULL,NULL,NULL,NULL,1,'2024-07-30 17:49:19','2024-07-30 17:49:19','de5d1fdf-7cb2-49cd-a7d3-967173101a7d'),(45363,45072,1,NULL,'__temp_skhlvkcmjvxiqsezdccjtzcfvqxhnswwalhz',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-30 17:49:19','2024-07-30 17:49:19','bfd86674-0399-45ab-9950-8cd5bf2bc5f1'),(45364,45073,1,NULL,NULL,NULL,NULL,1,'2024-07-30 17:49:19','2024-07-30 17:49:19','cce1773a-7215-437b-9b60-aed3d7bbf2cd'),(45365,45074,1,NULL,'__temp_bfvgcsfocondpghwdprtquqthyxnbcajoktr',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/mold-healthcare.html?CDC_AAref_Val=https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-30 17:49:19','2024-07-30 17:49:19','5b61ac84-1d8b-4dbd-8606-cf2093819fcb'),(45366,45075,1,NULL,NULL,NULL,NULL,1,'2024-07-30 17:49:19','2024-07-30 17:49:19','fc683ab6-ed6d-4e79-a3d8-70993caae6c6'),(45367,45076,1,NULL,'__temp_whdpgwlyywqsuixvitiotuuuzikkcbprobfn',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787571/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This publication provides an overview of key challenges and response measures related to investigating Mucormycosis in Healthcare settings. The included information may be applicable to other environmental fungi, such as Aspergillus.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-30 17:49:19','2024-07-30 17:49:19','66dc10b7-d5bd-4ad8-9cb3-a55cd3bd11de'),(45368,45077,1,NULL,NULL,NULL,NULL,1,'2024-07-30 17:49:19','2024-07-30 17:49:19','52c77e13-7d97-4285-a076-bbc5aa61e274'),(45369,45078,1,NULL,'__temp_mqnavntnumgwliikwgkpmttieemiyejdymge',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Targeted Environmental Investigation Checklist for Outbreaks of Invasive Infections Caused by Environmental Fungi\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/pdf/targeted-environmental-investigation-checklist-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This tool is intended to aid in performing an environmental assessment when investigating healthcare-associated disease outbreaks caused by environmental fungi (e.g., Aspergillus spp. and mucormycetes). Not all of sections of this checklist will pertain to every investigation.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-30 17:49:19','2024-07-30 17:49:19','137986ac-4853-403b-852a-9905df5ce2d3'),(45370,45079,1,NULL,NULL,NULL,NULL,1,'2024-07-30 17:49:19','2024-07-30 17:49:19','71de1677-cee0-4004-8f75-08294d8ebe06'),(45371,45080,1,NULL,'__temp_vllypelwfmfaxfldxknoedbtsnnhwfgkqgyb',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-30 17:49:19','2024-07-30 17:49:19','7c38413c-2885-47f4-a450-c140018c7c64'),(45372,45081,1,NULL,NULL,NULL,NULL,1,'2024-07-30 17:49:19','2024-07-30 17:49:19','5d30f3f2-67cc-40e8-8266-03fea43dab44'),(45373,45082,1,NULL,'__temp_jcisbucfobtbrsxklslksuunzubpgusvdqya',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article addresses the intricacies and challenges of making patient notifications in the context of hospital-associated clusters of invasive mold infections, with recommended practices.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-30 17:49:19','2024-07-30 17:49:19','4b3fbe9a-1870-497c-b398-1d365ef42627'),(45374,45083,1,NULL,NULL,NULL,NULL,1,'2024-07-30 17:49:19','2024-07-30 17:49:19','b8699ca4-c6e5-45e1-9f7e-4690eafb8f7a'),(45375,45084,1,NULL,'__temp_krspgaevhxcbtrwskmjnfkiepjjzhbausbzf',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital - Arkansas, June 2019 - May 2021\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://academic.oup.com/ofid/article/9/10/ofac510/6761764\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article describes a large outbreak of healthcare-associated mucormycosis that was potentially linked to linens.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-30 17:49:19','2024-07-30 17:49:19','adf3961a-b607-4f36-9127-e49653f28600'),(45376,45085,1,NULL,NULL,NULL,NULL,1,'2024-07-30 17:49:19','2024-07-30 17:49:19','fc5b25b2-f7cb-4db8-88ce-f842915362d6'),(45377,45086,1,NULL,'__temp_nmrwhqzbygmponhgvsqhirauxxuehqweukil',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Keeping Health Care Linens Clean: Underrecognized Hazards and Critical Control Points to Avoid Contamination of Laundered Health Care Textiles\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ajicjournal.org/article/S0196-6553(22)00544-2/abstract\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article includes checklists for assessing facility linen management practices.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-30 17:49:19','2024-07-30 17:49:19','98dc1e55-c6f4-4984-87a9-6624cd6eeac2'),(45378,45087,1,NULL,NULL,NULL,NULL,1,'2024-07-30 17:49:19','2024-07-30 17:49:19','146f142f-2620-4f2d-8ee8-1ced9c35e54a'),(45379,45088,1,NULL,'__temp_dkgppqqxuzgnomvsrkycdgzctcnofsncxcgx',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Candida auris Resources\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.corha.org/resources-and-products/?filter_cat=c-auris\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Visit this CORHA resource page if you are looking for resources related to Candida auris.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-30 17:49:19','2024-07-30 17:49:19','11294200-a751-442c-8d49-b7fdf281bb17'),(45391,45100,1,'Legionella','legionella','diseases-pathogens/legionella',NULL,1,'2024-07-30 17:53:54','2024-07-30 17:53:54','e30aa39c-05c2-4c42-9919-61061f5764e1'),(45392,45101,1,NULL,'__temp_auhjvbwtkmvcoxtjmqpqjnvsbomymirchbir',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Legionnaires’ disease</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Legionella\"}',1,'2024-07-30 17:53:54','2024-07-30 17:53:54','975bc544-8baa-4b41-97c8-ec4ac66ce9a3'),(45393,45102,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Bacteria\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-07-30 17:53:54','2024-07-30 17:53:54','08acff95-11a4-4f9c-a631-eb62abe56c43'),(45394,45103,1,NULL,NULL,NULL,NULL,1,'2024-07-30 17:53:54','2024-07-30 17:53:54','360b19f7-660f-44a7-bb63-a69722f9db19'),(45395,45104,1,NULL,NULL,NULL,NULL,1,'2024-07-30 17:53:54','2024-07-30 17:53:54','6dff9347-ed73-4a74-9ac0-1ec90603dea7'),(45396,45105,1,NULL,'__temp_eghzzegqoautvdvwieuyxwvhckymfohexgkz',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Public Health Considerations for Healthcare-associated Cases and Outbreaks of Legionnaires’ disease\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/investigate-legionella/php/healthcare-resources/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This website provides guidance for responding to healthcare-associated cases and outbreaks of Legionnaires’ disease, including: an outline of investigation steps; information on case finding, environmental assessment, and immediate control measures; and communications resources.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-30 17:53:54','2024-07-30 17:53:54','bce2a87f-0be7-45d5-a012-433f9e74513b'),(45397,45106,1,NULL,NULL,NULL,NULL,1,'2024-07-30 17:53:55','2024-07-30 17:53:55','6760ee0f-c475-4c31-889c-68a5466b9931'),(45398,45107,1,NULL,'__temp_vyaplsbwlgporyyvxmqihqeuhslddoqtzavw',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC Vital Signs, June 2017: Legionnaires’ Disease, a Problem for Healthcare Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/vitalsigns/pdf/2017-06-vitalsigns.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"CDC Vital Signs June 2017: Legionnaires’ Disease, a Problem for Healthcare Facilities\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-30 17:53:55','2024-07-30 17:53:55','08a851e3-c39a-4216-be41-f70349083816'),(45399,45108,1,NULL,NULL,NULL,NULL,1,'2024-07-30 17:53:55','2024-07-30 17:53:55','a6ed1709-c18b-45df-b6c7-623d71c86a82'),(45400,45109,1,NULL,'__temp_gcrdubuivrcfqjcisusppxgajbboqgnszlfb',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CSTE Legionnaires’ Disease Resources\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cste.org/page/Legionnaires\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This website provides links to a risk communication toolkit and water management program (WMP) evaluation tool that can be used when responding to healthcare-associated Legionnaire\'s disease\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-30 17:53:55','2024-07-30 17:53:55','ee6c5d8b-692f-468a-8327-39152249e2a1'),(45401,45110,1,NULL,NULL,NULL,NULL,1,'2024-07-30 17:53:55','2024-07-30 17:53:55','4219ed6d-713d-4299-af97-242f8c0c01dc'),(45402,45111,1,NULL,'__temp_zfrirbwzvzjbooewrasjyqdteqgsbwmpstwv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Example of patient notification: Legionella outbreak in a general medicine ward\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://old.corha.org/wp-content/uploads/2022/10/CORHA-PP-Chapter-8-1.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"See page 32, Box 8.3 for this example\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-30 17:53:55','2024-07-30 17:53:55','75a057fe-bf2d-4cb6-87b4-48a1f1cd9622'),(45403,45112,1,NULL,NULL,NULL,NULL,1,'2024-07-30 17:53:55','2024-07-30 17:53:55','deff3011-8ad0-407d-b440-f01d1b3dca99'),(45404,45113,1,NULL,'__temp_wclzvwjxhojnljwppzjxpnvvqcejqmyjkmon',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Water-Associated Organisms\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.corha.org/resources-and-products/?filter_cat=water-associated-organisms\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page offers a collection of resources to assist with water-related outbreak detection and response, including items relevant to Legionnaire\'s Disease (e.g., CMS WMP Memo)\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-07-30 17:53:55','2024-07-30 17:53:55','5b8b0865-a597-4b77-9bc4-62addae5b1a0'),(45416,45125,1,'Measles','measles','diseases-pathogens/measles',NULL,1,'2024-07-30 17:59:04','2024-07-30 17:59:04','1bdbb4e1-3dc0-4279-ad49-e8f97c2ef761'),(45417,45126,1,NULL,'__temp_iefgdqbwctupubknmqaoodwvxdahumdkvpwq',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also called rubeola or measles virus</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Measles\"}',1,'2024-07-30 17:59:04','2024-07-30 17:59:04','d871a047-2f7c-46c2-9528-e5bf05b08363'),(45418,45127,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Virus\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-28 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-28 07:00:00\"}}',1,'2024-07-30 17:59:04','2024-07-30 17:59:04','c8aae787-507a-4e4d-8ba7-b1b7853a683d');
